UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

(Amendment No. 1)

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): January 29, 2021

  

ALUSSA ENERGY ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

  

Cayman Islands   001-39145   N/A
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

PO Box 500, 71 Fort Street

Grand Cayman KY1-1106

Cayman Islands

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: +1 345 949 4900

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on
which registered
         
Units, each consisting of one Class A Ordinary Share and one-half of one Redeemable Warrant   ALUS.U   The New York Stock Exchange
         
Class A Ordinary Shares, par value $0.0001 per share   ALUS   The New York Stock Exchange
         
Warrants, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share   ALUS.WS   The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  þ

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Explanatory Note

 

This Amendment No. 1 to the Current Report on Form 8-K amends and restates in its entirety the Current Report on Form 8-K filed with the Securities and Exchange Commission on January 29, 2021 (the “Prior 8-K”) to (a) correct certain typographical errors contained in Item 1.01 of the Prior 8-K, and (b) include certain exhibits that were omitted from the Prior 8-K. 

 

 

 

 

ADDITIONAL INFORMATION

 

FREYR Battery, a company organized under the laws of Luxembourg (“Pubco”), intends to file with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 (as amended, the “Registration Statement”), which will include a preliminary proxy statement of Alussa Energy Acquisition Corp., a Cayman Island exempted company (“Alussa”), and a prospectus in connection with the proposed business combination transaction (the “Business Combination”) involving Alussa, Pubco and FREYR A/S, a company organized under the laws of Norway (“FREYR”). After the Registration Statement is filed and declared effective, the definitive proxy statement and other relevant documents will be mailed to shareholders of Alussa as of a record date to be established for voting on the Business Combination. Shareholders of Alussa and other interested persons are advised to read, when available, the preliminary proxy statement, and amendments thereto, and the definitive proxy statement in connection with Alussa’s solicitation of proxies for the special meetings to be held to approve the Business Combination because these documents will contain important information about Alussa, FREYR, Pubco and the Business Combination. Alussa shareholders and other interested persons will also be able to obtain copies of the Registration Statement and the proxy statement/prospectus, without charge, once available, on the SEC’s website at www.sec.gov or by directing a request to Alussa by contacting its Chief Executive Officer, Daniel Barcelo, c/o Alussa Energy Acquisition Corp. PO Box 500, 71 Fort Street, Grand Cayman KY1-1106, Cayman Islands, at +1(345) 949 4900.

 

Participants in the Solicitation

 

Alussa, Pubco and FREYR and certain of their respective directors, executive officers, other members of management and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies from the shareholders of Alussa in favor of the approval of the Business Combination. Shareholders of Alussa and other interested persons may obtain more information regarding the names and interests in the proposed transaction of Alussa’s directors and officers in Alussa’s filings with the SEC, including Alussa’s annual report on form 10-K for the year-ended December 31, 2019, which was filed with the SEC on March 26, 2020, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing. Additional information regarding the interests of such potential participants will also be included in the Registration Statement and other relevant documents when they are filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

 

Forward-Looking Statements

 

Certain statements made herein or incorporated by reference contain, and certain oral statements made by representatives of Alussa, Pubco and FREYR and their respective affiliates, from time to time may contain, “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Alussa’s, Pubco’s and FREYR’s actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “would,” “believe,” “predict,” “potential,” “might” and “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, Alussa’s, Pubco’s and FREYR’s expectations with respect to future performance and anticipated financial impacts of the Business Combination, the satisfaction of the closing conditions to the Business Combination and the timing of the completion of the Business Combination. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expected results. Most of these factors are outside of the control of Alussa, Pubco or FREYR and are difficult to predict.

 

1

 

 

Factors that may cause such differences include but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement (as defined below); (2) the inability to complete the Business Combination, including due to the failure to obtain approval of the shareholders of Alussa or the shareholders of FREYR or other conditions to closing in the Business Combination Agreement; (3) the inability to obtain or maintain (as applicable) the listing of Pubco’s or Alussa’s common stock on Nasdaq following the Business Combination, (4) the failure to meet the minimum cash requirements of the Business Combination Agreement due to Alussa shareholder redemptions and the failure to obtain replacement financing; (5) the risk that the Business Combination disrupts current plans and operations of FREYR as a result of the announcement and consummation of the Business Combination; (6) the failure to meet projected development and production targets; (7) costs related to the proposed Business Combination; (8) changes in applicable laws or regulations; (9) the ability of the combined company to meet its financial and strategic goals, due to, among other things, competition, the ability of the combined company to pursue a growth strategy and manage growth profitability and hire and retain key employees; (10) the possibility that the combined company may be adversely affected by other economic, business, and/or competitive factors; (11) the effect of the global COVID-19 pandemic on Alussa, Pubco and FREYR and their ability to consummate the Business Combination or any of the foregoing risks; and (12) other risks and uncertainties described herein, as well as those risks and uncertainties to be identified in the Registration Statement and proxy statement/prospectus (when available) relating to the Business Combination, including those under “Risk Factors” therein, and in other filings with the SEC made by Alussa or Pubco. The foregoing list of factors is not exclusive. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Neither Alussa, Pubco nor FREYR undertakes or accepts any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, subject to applicable law.

 

No Offer or Solicitation

 

This Current Report on Form 8-K and the exhibits hereto do not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Business Combination. This Current Report on Form 8-K shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

 

Item 1.01

Entry into a Material Definitive Agreement.

 

Business Combination Agreement

 

This section describes the material provisions of the Business Combination Agreement (as defined below) but does not purport to describe all of the terms and conditions thereof. The following summary is qualified in its entirety by reference to the complete text of the Business Combination Agreement, a copy of which is attached hereto as Exhibit 2.1. Alussa’s shareholders, warrant holders and other interested parties are urged to read such agreement in its entirety. Unless otherwise defined herein, the capitalized terms used below are defined in the Business Combination Agreement.

 

General Terms and Effects

 

On January 29, 2021, Alussa entered into a Business Combination Agreement (the “Business Combination Agreement”) with FREYR A/S, a company organized under the laws of Norway (“FREYR”), Alussa Energy Sponsor LLC, a limited liability company formed under the laws of Delaware, in the capacity as the representative for the Alussa shareholders in accordance with the terms and conditions of the Business Combination Agreement (“Sponsor” or “Purchaser Representative”), FREYR Battery, a corporation in the form of a public limited liability company organized under the laws of Luxembourg (“Pubco”), Norway Sub 1 AS, a private limited liability company under the laws of Norway (“Norway Merger Sub 1”), Norway Sub 2 AS, a private limited liability company under the laws of Norway (“Norway Merger Sub 2” and together with Norway Merger Sub 1, the “Norway Merger Subs”), Adama Charlie Sub, a Cayman Islands exempted company (“Cayman Merger Sub”), certain shareholders of FREYR named in the Business Combination Agreement (the “Major Shareholders”), and ATS NEXT AS, in the capacity as the representative for the Major Shareholders in accordance with the terms and conditions of the Business Combination Agreement (the “Shareholder Representative”).

 

Prior to the completion of the transactions contemplated by the Business Combination Agreement, (i) the Norway Merger Subs shall be wholly-owned subsidiaries of Alussa, (ii) Pubco shall be a wholly-owned subsidiary of Purchaser Representative and (iii) Cayman Merger Sub shall be a wholly-owned subsidiary of Pubco.

 

2

 

 

Pursuant to the terms of the Business Combination Agreement, (a) Alussa will merge with and into Cayman Merger Sub, with Alussa continuing as the surviving entity (the “Cayman Merger”), (b) Alussa will distribute all of its interests in Norway Merger Sub 1 to Pubco, (c) FREYR will merge with and into Norway Merger Sub 2, with Norway Merger Sub 2 continuing as the surviving entity (the “Norway Merger”), (d) Norway Merger Sub 1 will merge with and into Pubco, with Pubco continuing as the surviving entity (the “Cross-Border Merger”), as a result of which, (i) each issued and outstanding security of Alussa immediately prior to the effective time of the Cayman Merger shall be exchanged for the right of the holder thereof to receive securities of Pubco in accordance with the Business Combination Agreement (or, in the case of Dissenting Purchaser Shareholders, if any, the right to receive the fair value of such holder’s Dissenting Purchaser Ordinary Shares and such other rights as are granted by the Cayman Companies Law), (ii) each issued and outstanding security of FREYR immediately prior to the effective time of the Norway Merger shall be exchanged for the right of the holder thereof to receive securities of Norway Merger Sub 1 in accordance with the Business Combination Agreement and (iii) each issued and outstanding security of Norway Merger Sub 1 immediately prior to the Cross-Border Effective Time shall be exchanged for the right of the holder to receive securities of Pubco, all upon the terms and subject to the conditions set forth in the Business Combination Agreement and in accordance with the provisions of applicable law.

 

Prior to the First Closing (as defined below), FREYR will transfer its wind farm business to Sjonfjellet Vindpark Holding AS (“SVPH”), a private limited liability company to be incorporated by way of demerger resulting in such business becoming held by the FREYR shareholders through such company (the “Norway Demerger”) in accordance with the Norway Plan of Demerger.

 

Consideration

 

After the implementation of the Norway Merger and prior to the implementation of the Cross-Border Merger, Pubco shall acquire all preferred shares of Norway Merger Sub 1 (which will be issued in exchange for the preferred shares in FREYR as a part of the Norway Merger) from the Company Preferred Share Transferors (as defined below) in exchange for a number of newly issued shares of Pubco equal to (A) (i) $7,447,500 or, (ii) to the extent the Company Preferred Share Transferors fund a second tranche of investment in preferred shares, $14,895,000, divided by (B) $10.00 per ordinary share (the “PIPE Price”). As part of such transaction, 92,500,000 warrants held by the Company Preferred Share Transferors to subscribe for common shares of Norway Merger Sub 1 (which will be issued in exchange for the warrants in FREYR as a part of the Norway Merger) shall be cancelled. Certain of the Company Preferred Share Transferors and FREYR entered into a Funding Commitment Letter in respect of the preferred share investment on October 23, 2020, as amended or restated, setting forth an agreement to invest either $7,500,000 or up to $15,000,000 into preferred shares and warrants of FREYR. Following the Norway Demerger, the Company Preferred Share Transferors will also receive shares in SVPH. The Company Preferred Share Transferors informed us that they have entered into an agreement with another FREYR shareholders whereby the Company Preferred Share Transferors will exchange their shares in SVPH for shares in Norway Merger Sub 1, to be completed prior to Norway Merger Sub 1’s acquisition by Pubco.

 

As a result of and upon the Second Closing (as defined below), among other things, all outstanding FREYR Shares (other than those held by Pubco), will be exchanged for the right to receive shares in Pubco, which in the aggregate will be a number of Pubco ordinary shares equal to (A) $410,550,000 (the “Base Consideration”), plus or minus (B) any Legal Cost Adjustment (as described below), as applicable, and dividing such number by the lower of (i) the Redemption Price and (ii) the PIPE Price (as defined in the Commitment Agreements), which number shall then be multiplied by (C) the Exchange Ratio. The Legal Cost Adjustment shall be (x) to the extent the legal costs incurred in connection with the Transactions by FREYR up to the Second Closing Date (“FREYR Legal Costs”) exceed $4,500,000, an amount equal to the FREYR Legal Costs minus $4,500,000 (which amount shall be deducted from the consideration above), (y) to the extent the FREYR Legal Costs are less than $2,500,000, an amount equal to $2,500,000 minus the FREYR Legal Costs (which amount shall be added to the consideration above) and (z) to the extent the FREYR Legal Costs are between $2,500,000 and $4,500,000, the Legal Cost Adjustment shall equal $0. The Exchange Ratio is a number equal to the quotient obtained by dividing (a) the Equity Consideration divided by the lower of (i) the Redemption Price and (ii) the PIPE Price, divided by (b) the number of Aggregate Fully Diluted Company Shares. Based on the currently available information with respect to the variables included in the Exchange Ratio calculation, the Exchange Ratio is expected to be 0.179031.

 

An additional 60,000,000 Pubco Ordinary Shares will be purchased at the PIPE Price on or prior to the Second Closing by certain third-party investors (the “PIPE Investment”) pursuant to the Subscription Agreement (as defined below). The proceeds of the PIPE Investment, together with the amounts remaining in Alussa’s Trust Account as of immediately following completion of the Cross-Border Merger, will be retained by Pubco following the Second Closing.

 

3

 

 

Treatment of FREYR Options, FREYR EDGE Warrants and FREYR Warrants

 

As a result of and upon the Second Closing, among other things, all (i) options to purchase FREYR Ordinary Shares, (ii) FREYR warrants issued to EDGE Global LLC and (iii) all other warrants, in each case outstanding as of immediately prior to the effective time of the Norway Merger will be converted into (a) options to purchase Pubco Ordinary Shares (“Pubco Options”), (b) warrants issued to EDGE Global to purchase Pubco Ordinary Shares (“Pubco EDGE Warrants”) and (c) other warrants to purchase Pubco Ordinary Shares (“Pubco Warrants”), respectively.

 

Subject to the terms of the Business Combination Agreement, each Pubco Option, Pubco EDGE Warrant and Pubco Warrant will relate to the number of whole shares of Pubco Ordinary Shares (rounded down to the nearest whole share) equal to (i) the number of Pubco Ordinary Shares subject to the applicable Pubco Option, Pubco EDGE Warrant and Pubco Warrant multiplied by (ii) the Exchange Ratio. The exercise price for each Pubco Option, Pubco EDGE Warrant and Pubco Warrant will equal (i) the exercise price of the applicable Pubco Option, Pubco EDGE Warrant and Pubco Warrant divided by (ii) the Exchange Ratio. Each Pubco Option, Pubco EDGE Warrant and Pubco Warrant will remain subject to the same terms and conditions that were in effect with respect to the related FREYR Option, FREYR EDGE Warrant or FREYR Option, as applicable, prior to the effective time of the Norway Merger.

 

Escrow Shares

 

At or prior to the First Closing Date, Pubco, the Purchaser Representative, the Shareholder Representative and the Escrow Agent shall enter into an Escrow Agreement, effective as of the Second Closing Date (the “Escrow Agreement”), pursuant to which Pubco shall cause to be delivered to the Escrow Agent at the Second Closing a number of Pubco Ordinary Shares (valued at the lower of (i) the Redemption Price and the (ii) PIPE Price) equal to 5% of the amount of Base Consideration (the “Escrow Shares”). Such Escrow Shares shall serve as the Major Shareholders’ obligations after the Closings in respect of indemnification and leakage. Payments in respect of the Major Shareholders’ obligations in respect of indemnification and leakage shall be first settled against the Escrow Shares.

 

The portion of Pubco Ordinary Shares that shall be withheld at the Second Closing for deposit in the Escrow Account shall be allocated among the Major Shareholders based on their respective pro rata equity interests in FREYR (as between the Major Shareholders) immediately prior to the Second Closing. The Escrow Shares shall be released from the Escrow Account 12 months after the Second Closing.

 

Closings

 

The transactions contemplated by the Business Combination Agreement shall be consummated on the First Closing Date and the Second Closing Date. In accordance with the terms and subject to the conditions of the Business Combination Agreement, the First Closing shall take place on the fifth business day after the satisfaction or waiver of the closing conditions set forth in the Business Combination Agreement (other than the closing conditions that by their nature are to be satisfied at the First Closing, but subject to the satisfaction or waiver of those conditions) unless another time or date is mutually agreed to in writing by the parties. In accordance with the terms and subject to the conditions of the Business Combination Agreement, the Second Closing shall take place on the second business day after the First Closing unless another time or date is mutually agreed to in writing by the parties.

 

Representations and Warranties

 

The Business Combination Agreement contains representations and warranties of Alussa, Pubco, FREYR and the Major Shareholders, certain of which are qualified by materiality and Material Adverse Effect (as defined below) and may be further modified and limited by the disclosure schedules. The representations and warranties of Alussa are also qualified by information included in Alussa’s public filings, filed or submitted to the SEC on or prior to the date of the Business Combination Agreement (subject to certain exceptions contemplated by the Business Combination Agreement). The representations and warranties made by Alussa, Pubco, FREYR and the Major Shareholders are customary for similar transactions

 

4

 

 

Representations and Warranties of FREYR

 

FREYR has made representations and warranties relating to, among other things, company organization, subsidiaries, due authorization, no conflict, governmental authorities and consents, capitalization of FREYR and its subsidiaries, financial statements, litigation and proceedings, legal compliance, contracts and no defaults, benefit plans, employment and labor relations, taxes, brokers’ fees, insurance, licenses, tangible personal property, real property, intellectual property, privacy, cybersecurity, information technology, environmental matters, absence of changes, anti-corruption compliance, sanctions and international trade compliance, information supplied, vendors and customers, including memoranda of understanding with potential vendors and customers, related party transactions and sufficiency of assets. The representations and warranties of FREYR identified as fundamental under the terms of the Business Combination Agreement are those made pursuant to: (i) Section 7.1 of the Business Combination Agreement (Organization and Standing), (ii) Section 7.2 of the Business Combination Agreement (Authorization; Binding Agreement), (iii) 7.3(a) of the Business Combination Agreement (Capitalization) and (iv) Section 7.4 of the Business Combination Agreement (Subsidiaries) (collectively, the “FREYR Fundamental Warranties”).

 

Representations and Warranties of Alussa

 

Alussa has made representations and warranties (on behalf of itself and the Norway Merger Subs) relating to, among other things, company organization, due authorization, no conflict, SEC filings, internal controls, listing, financial statements, governmental authorities and consents, legal compliance, trust account, Investment Company Act, absence of changes, capitalization, brokers’ fees, indebtedness, taxes, business activities and no outside reliance.

 

Representations and Warranties of Pubco

 

Pubco has made representations and warranties (on behalf of itself and the Cayman Merger Sub) relating to, among other things, company organization, due authorization, no conflict, governmental authorities and consents, legal compliance, Investment Company Act, absence of changes, capitalization, brokers’ fees, indebtedness, business activities and no outside reliance.

 

Representations and Warranties of the Major Shareholders

 

Each Major Shareholder has made representations and warranties (with respect to itself only) relating to, among other things, company organization, due authorization, no conflict, governmental authorities and consents, title to shares, litigation and proceedings and brokers’ fees. The representations and warranties of the Major Shareholders identified as fundamental under the terms of the Business Combination Agreement are those made pursuant to: (i) Section 8.1 of the Business Combination Agreement (Organization and Standing), (ii) Section 8.2 of the Business Combination Agreement (Authorization; Binding Agreement) and (iii) Section 8.3 of the Business Combination Agreement (Ownership) (collectively, the “Major Shareholder Fundamental Warranties”).

 

Survival of Representations and Warranties

 

The FREYR Fundamental Warranties and the Major Shareholder Fundamental Warranties survive the Second Closing for a period of six years. The representations and warranties of FREYR made in Sections 7.13(a)-(d) (Intellectual Property) and 7.14 (Taxes and Returns) survive the Second Closing for a period equal to the applicable statute of limitations plus 30 days (together with the FREYR Fundamental Warranties and the Major Shareholder Fundamental Warranties, the “Special Reps and Warranties”). All other representations and warranties of FREYR and the Major Shareholders shall survive the Second Closing for a period of 12 months.

 

No claim for indemnification may be made after the applicable expiration date, with the exception of any claims of fraud made in accordance with the terms of the Business Combination Agreement.

 

The representations and warranties of Alussa and Pubco contained in the Business Combination Agreement or in any certificate or instrument delivered by or on behalf of Alussa, Pubco and the Merger Subs pursuant to the Business Combination Agreement do not survive the First Closing and Second Closing. No claims or actions may be asserted against the Purchaser, the Purchaser Representative or their respective Representatives with respect thereto.

 

5

 

 

Indemnification

 

The Major Shareholders have agreed to indemnify Pubco for losses that Pubco may sustain as a result of (i) the breach of any representation or warranty made by FREYR in the Business Combination Agreement or in any certificate executed and delivered by FREYR thereto, (ii) the breach of any covenant, obligation or agreement on the part of FREYR in the Business Combination Agreement or in any certificate delivered by FREYR pursuant thereto, (iii) the breach of any representation or warranty made by the Major Shareholders in the Business Combination Agreement or in any certificate executed and delivered by the Major Shareholders thereto and (iv) the breach of any covenant, obligation or agreement on the part of the Major Shareholders in the Business Combination Agreement or in any certificate delivered by the Major Shareholders pursuant thereto (provided that in the case of (iii) and (iv), the Major Shareholders are not liable in respect of breaches by another Major Shareholder).

 

Pubco is not entitled to receive any indemnification payments unless and until the aggregate amount of losses incurred by Pubco exceeds $2,000,000, in which case the Major Shareholders are obligated to Pubco for the amount of all losses from the first dollar of losses, provided that the basket shall not apply for breaches of any Special Reps and Warranties or in respect of fraud claims. The maximum aggregate amount of payments which each Major Shareholder is obligated to pay (other than with respect to (i) fraud claims and (ii) claims for breaches of Special Reps and Warranties) does not exceed an amount equal to 10% of the sum of (x) the Exchange Shares received by such Major Shareholder at the Second Closing, plus (y) any Escrow Shares withheld from such Major Shareholder at the Second Closing (each such Escrow Share valued at the lower of the Redemption Price and the PIPE Price). The maximum aggregate amount of payments which each Major Shareholder is obligated to pay (other than with respect to (i) fraud claims and (ii) claims for breaches of FREYR Fundamental Warranties and Major Shareholder Fundamental Warranties) does not exceed an amount equal to 25% of the sum of (x) the Exchange Shares received by such Major Shareholder at the Second Closing, plus (y) any Escrow Shares withheld from such Major Shareholder at the Second Closing (each such Escrow Share valued at the lower of the Redemption Price and the PIPE Price). The maximum aggregate amount of payments which each Major Shareholder is obligated to pay (other than with respect to fraud claims), does not exceed an amount equal to 100% of the sum of (x) Exchange Shares received by such Major Shareholder at the Second Closing, plus (y) any Escrow Shares withheld from such Major Shareholder at the Second Closing) (each such Escrow Share valued at the lower of the Redemption Price and the PIPE Price).

 

Indemnification claims against the Major Shareholders shall first be applied against Escrow Shares (based on the relevant Major Shareholder Pro Rata Percentage). After the Escrow Shares are exhausted, each Major Shareholder’s indemnification obligation will be determined by reference to the Shareholder Pro Rata Percentage. After all Escrow Shares are applied with respect to any indemnification obligations, each Major Shareholder shall be entitled to satisfy its indemnification obligations with cash or ordinary shares in Pubco. For purposes of determining the indemnification payment, the value of each Escrow Share or other ordinary share of Pubco used to satisfy indemnification obligations shall be the value-weighted average trading price of ordinary shares in Pubco in the 10 trading days up to the date on which the indemnification claim is finally determined.

 

Leakage

 

Under the Business Combination Agreement, the transaction consideration shall be adjusted on a dollar-for-dollar basis with respect to Leakages between September 30, 2020 and the Second Closing Date (the “Locked Box Period”). “Leakage” shall include, among others, dividends declared to any FREYR shareholder or their affiliates, any transaction bonuses (in excess of $5 million), consultant, advisory or other fees outside of the course and the other Leakages set forth in the Business Combination Agreement, other than Permitted Leakages.

 

If at any time prior to the Second Closing, FREYR becomes aware of the occurrence of any Leakage during the Locked Box Period, FREYR shall notify Alussa of such Leakage and the FREYR shareholder(s) to whom such Leakage is attributable. The consideration attributable to such shareholder(s) on the Second Closing shall be reduced by the amount of such Leakage.

 

Material Adverse Effect

 

Under the Business Combination Agreement, certain representations and warranties of FREYR are qualified in whole or in part by a material adverse effect standard for purposes of determining whether a breach of such representations and warranties has occurred. Pursuant to the Business Combination Agreement, a material adverse effect (“Material Adverse Effect”) means any event, state of facts, development, circumstance, occurrence or effect that has had, or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on (i) the business, assets, liabilities, results of operations or financial condition of FREYR and its subsidiaries, taken as a whole or (ii) the ability of FREYR or its subsidiaries to consummate the transactions contemplated by the Business Combination Agreement or the Ancillary Documents to which they are parties or bound or to perform their obligations thereunder, in each case subject to certain customary exceptions.

 

6

 

 

Covenants and Agreements

 

FREYR has provided covenants relating to, among other things, conduct of business, inspection, preparation and delivery of certain audited and unaudited financial statements and acquisition proposals.

 

Alussa and Pubco have provided covenants relating to, among other things, preparation of the registration statement, employee matters, trust account proceeds, listing, no solicitation by Alussa, Alussa’s conduct of business, post-closing directors and officers, indemnification and insurance, Alussa public filings and PIPE Investment subscriptions.

 

Conduct of Business

 

FREYR has agreed that from the date of the Business Combination Agreement through the earlier of the termination of the Business Combination Agreement and the Second Closing Date (the “Interim Period”), except as otherwise explicitly contemplated by the Business Combination Agreement and the Ancillary Agreements, FREYR shall (and shall cause its subsidiaries to) (i) conduct their respective businesses, in all material respects, in the ordinary course of business consistent with past practice and/or FREYR’s business plan and (ii) comply in all material respects with all laws applicable to FREYR’s direct and indirect subsidiaries and their respective businesses, assets and employees. During the Interim Period, FREYR has also agreed not to, and to cause its subsidiaries not to, take certain specified customary actions except as otherwise contemplated by the Business Combination Agreement, the Ancillary Agreements or FREYR’s business plan, as consented to by Alussa in writing (which consent will not be unreasonably conditioned, withheld, delayed or denied) or as required by applicable law.

 

During the Interim Period and except as otherwise explicitly contemplated by the Business Combination Agreement and the Ancillary Agreements, Alussa, Pubco and the Merger Subs have each agreed to (i) conduct their respective businesses, in all material respects, in the ordinary course of business consistent with past practice and (ii) comply in all material respects with all laws applicable to such person and its businesses, assets and employees. During the Interim Period, except as otherwise contemplated by the Business Combination Agreement or the Ancillary Agreements, Alussa, Pubco and the Merger Subs agreed not to take certain specified customary actions.

 

Covenants of Alussa and Pubco

 

Pursuant to the Business Combination Agreement, Alussa and/or Pubco has agreed (as applicable), among other things, to:

 

adopt, prior to the Second Closing Date, the new equity incentive plan in the form agreed in connection with the Business Combination Agreement;

 

take certain actions so that the Trust Amount will released from the trust account and so that the trust account will terminate thereafter, in each case, pursuant to the terms and subject to the terms and conditions of the Trust Agreement;

 

during the Interim Period, not instruct its representatives not to, initiate any negotiations or enter into any agreements for certain alternative transactions;

 

delist and deregister Alussa units, Class A ordinary shares and Alussa Warrants from the NYSE and to terminate its registration with the SEC as of the First Closing Date;

 

use commercially reasonable efforts to cause Pubco’s ordinary shares to be approved for listing on the NYSE by no later than the First Closing Date, and to remain listed as a public company on the NYSE through the Second Closing Date;

 

7

 

 

take all necessary action so that, effective as of the Second Closing, Pubco’s board of directors will consist of eight natural persons, of whom (i) three shall be appointed by Alussa, of whom at least two shall qualify as independent directors under NYSE rules, (ii) three shall be appointed by FREYR, of whom at least two shall qualify as independent directors under NYSE rules and (iii) two persons shall be mutually agreed between Alussa and FREYR prior to the First Closing Date, who shall qualify as independent under NYSE rules, provided that the parties will ensure that the composition of Pubco’s board of directors satisfies the applicable requirement for Pubco to qualify as a "foreign private issuer" (as defined in the Securities Exchange Act of 1933);

 

take all actions to terminate the existing registration rights agreement, dated November 25, 2019, between Alussa and Alussa Energy Sponsor LLC, effective as of the First Closing;

 

maintain for a period of not less than six years from the Second Closing Date (i) provisions in Pubco’s governing documents and those of its subsidiaries concerning the indemnification and exoneration of Alussa’s and FREYR’s former and current officers, directors and employees and agents, on terms no less favorable than as contemplated by the applicable governing documents of Alussa or FREYR (as applicable), in each case as of the date of the Business Combination Agreement and (ii) a directors’ and officers’ liability insurance policy covering those persons who are currently covered by Alussa and FREYR’s directors’ and officers’ liability insurance policies on terms not less favorable than the terms of such insurance coverage as of the date of the Business Combination Agreement;

 

from the date of the Business Combination Agreement through the effective time of the Merger, keep current and timely file all reports required to be filed or furnished with the SEC and otherwise comply in all material respects with its reporting obligations under applicable law;

 

promptly as practicable after the registration statement is declared effective under the Securities Act, (i) disseminate proxy statement to shareholders of Alussa, (ii) give notice, convene and hold a meeting of the shareholders to vote on the Purchaser Shareholder Approval Matters (as defined in the Business Combination Agreement) in each case in accordance with its governing documents then in effect and Section 312.03 of the NYSE Listing Rules, as soon as practicable following the date the registration statement is declared effective, (iii) solicit proxies from the holders of Public Shares to vote in favor of each of the Purchaser Shareholder Approval Matters, and (iv) provide its shareholders with the opportunity to elect to effect a Redemption; and

 

use its reasonable best efforts to take, or to cause to be taken, all actions required, necessary or that it deems to be proper or advisable to consummate the transaction contemplated by the PIPE Subscription Agreements on the terms described therein, including using its reasonable best efforts to enforce its rights under the PIPE Subscription Agreements to cause the PIPE Investors to pay to (or as directed by) Pubco the applicable purchase price under each PIPE Investor’s applicable Subscription Agreement in accordance with its terms.

 

Covenants of FREYR

 

Pursuant to the Business Combination Agreement, FREYR has agreed, among other things, to:

 

provide Alussa and its accountants, counsel and other representatives reasonable access during the Interim Period such materials and information about FREYR, and specified members of management of FREYR, in each case as Alussa may reasonably request;

 

provide to Pubco and Alussa, as soon as practicable after entry into the Business Combination Agreement, (i) audited financial statements (together with the auditor’s reports thereon) of FREYR and its subsidiaries as of and for (x) the years ended December 31, 2020, 2019 and 2018, audited in accordance with PCAOB auditing standard by a PCAOB qualified auditor and (ii) if required to be provided by law or SEC rule or practice as of the date of the initial filing of the registration statement with the SEC, financial statements as of and for the period ending for as of the latest available calendar quarter end date;

 

at or prior to the Second Closing Date, terminate and settle all shareholders’, voting rights or other similar agreement between the Company and its shareholders without further liability to Alussa, FREYR, Pubco or any of their subsidiaries;

 

at or prior to the Second Closing Date, take all other actions to cancel the remaining unallocated share reserve under the FREYR equity plan and provide that no new FREYR options will be granted under such plan, provided that FREYR may, prior to the Second Closing Date, conditionally grant options under the Pubco equity incentive plan to be effective after Closing;

 

take all actions necessary under applicable law and its governing documents to convene a special meeting of shareholders to approve and adopt the transactions contemplated by the Business Combination Agreement; and

 

8

 

 

during the Interim Period, not, and to use reasonable best efforts to cause its representatives to not, among others, (i) solicit or facilitate the making, submission or announcement of any alternate transaction, (ii) furnish any non-public information regarding itself to any party in connection with or in response to an alternate transaction, or (iii) engage or participate in discussions with any person or group with respect to, or that would reasonably be expected to give rise to, an alternate transaction.

 

Joint Covenants of Alussa and FREYR

 

In addition, each of Alussa, FREYR and Pubco has agreed, among other things, to take certain actions as set forth below:

 

give notice to the other parties as promptly as practicable to such party of facts, circumstances and conditions which would, or would reasonably be expected to cause any closing conditions to not be satisfied, or the satisfaction of certain conditions to be delayed;

 

use commercially reasonable efforts to take, or cause to be taken, all actions necessary, proper or advisable under applicable law and regulations to consummate the transactions contemplated by the Business Combination Agreement;

 

to cause the proxy statement/prospectus, and the Registration Statement, to comply with the rules and regulations promulgated by the SEC, to have the Registration Statement declared effective under the Securities Act as promptly as practicable after such filing and to keep the Registration Statement effective as long as is necessary to consummate the transactions contemplated by the Business Combination Agreement and otherwise ensure that the information contained therein contains no untrue statement of material fact or material omission; and

 

take all actions necessary in respect of the Merger Subs under applicable law and their respective organizational documents to hold shareholders’ meetings and pass resolutions approving and adopting the Business Combination Agreement and the applicable Mergers and other transactions contemplated thereby.

 

Closing Conditions

 

The consummation of the Transactions is conditioned upon the satisfaction or waiver by the applicable parties to the Business Combination Agreement of the conditions summarized below. Therefore, unless these conditions are waived by the applicable parties to the Business Combination Agreement, the Transactions may not be consummated. There can be no assurance that the parties to the Business Combination Agreement would waive any such provisions therein.

 

Conditions to the Obligations of Each Party

 

The obligations of each party to consummate the Transactions are subject to the satisfaction or written waiver (where permissible) by FREYR, Alussa and Purchaser Representative of the following conditions as of the First Closing Date:

 

the relevant shareholder approval matters shall have been approved by the requisite vote of Alussa’s shareholders entitled to vote thereon;

 

the relevant shareholder approval matters shall have been approved by the requisite vote of FREYR’s shareholders entitled to vote thereon;

 

no governmental authority shall have enacted, issued, promulgated, enforced or entered any law (whether temporary, preliminary or permanent) or order that is then in effect and which has the effect of making the transactions or agreements contemplated by the Business Combination Agreement illegal or which otherwise prevents or prohibits consummation of the transactions contemplated by the Business Combination Agreement;

 

9

 

 

there shall not be any pending action brought by a governmental authority seeking to enjoin the consummation of the Transactions;

 

upon the First Closing, after giving effect to the Redemption, Alussa shall have net tangible assets of at least $5,000,001;

 

the members of the Post-Closing Pubco Board shall have been elected or appointed to take effect as of the Second Closing consistent with the requirements stipulated under the Business Combination Agreement;

 

the Registration Statement shall have been declared effective by the SEC and shall remain effective as of the First Closing;

 

the Pubco Ordinary Shares and Pubco Public Warrants shall be approved for listing on the NYSE, subject only to notice of issuance;

 

the Norway Demerger shall have been effected in accordance with the Norway Demerger Plan; and

 

the issuance of Pubco securities to the holders of FREYR securities shall be either exempt from registration, or registered in compliance with applicable securities laws of any state of the United States or the securities laws of any governmental authority.

 

Conditions to the Obligations of FREYR and the Major Shareholders

 

The obligations of FREYR and the Major Shareholders to consummate the Transactions are subject to the satisfaction or written waiver (where permissible) by FREYR and Pubco of the following conditions as of the First Closing Date:

 

all of the representations and warranties of Alussa and Pubco set forth in the Business Combination Agreement and in any certificate delivered by or on behalf of Alussa, Pubco and the Merger Subs pursuant thereto shall be true and correct in all material respects on and as of the date of the Business Combination Agreement and on and as of the First Closing Date as if made on the First Closing Date, except for (i) those that address matters only as of a particular date (which shall have been true and correct in all material respects as of such particular date) and (ii) any failures to be true and correct that (without giving effect to any qualifications or limitations as to materiality), individually or in the aggregate, would not have a material adverse effect on Purchaser, Pubco or the Merger Subs;

 

Alussa, Pubco and the Merger Subs shall have performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under the Business Combination Agreement to be performed or complied with by it on or prior to the First Closing Date;

 

as of the First Closing Date, after giving effect to the completion of the Redemption, commitments in respect of the PIPE Investment and the Funding Commitment Letter, but without giving effect to Alussa’s transaction expenses and the repayment of certain deferred liabilities of Alussa assuming that (A) all funds are drawn under the Funding Commitment Letter, (B) the funds drawn under the Funding Commitment letter are held by Alussa and (C) none of the funds drawn under the Funding Commitment Letter have been used as of the First Closing, Alussa and Pubco shall collectively have at least $400 million in the aggregate in cash and cash equivalents, including funds in the Trust Account and any proceeds from any of the Commitment Agreements, the Funding Commitment Letter or other PIPE Investment (including any funds in respect of the PIPE Investment which are deposited into an escrow account on or prior to First Closing which are to be released to Pubco on the Second Closing in accordance with the applicable Commitment Agreement);

 

the execution and delivery of certain closing deliverables, including (i) officers’ certificates and (ii) copies of (a) the executed Registration Rights Agreement (signed by the Purchaser Representative); (y) the executed Escrow Agreement (signed by the Purchaser Representative); and (z) the amended and restated articles of association of Pubco (the “First Amended Pubco Articles”); and

 

10

 

 

Alussa shall have made appropriate arrangements to have the funds in the Trust Account paid in accordance with the terms of the Business Combination Agreement.

 

Conditions to the Obligations of Alussa

 

The obligations of Alussa to consummate the Transactions are subject to the satisfaction or written waiver (where permissible) by Alussa and Purchaser Representative of the following conditions as of the First Closing:

 

all of the representations and warranties of FREYR and the Major Shareholders set forth in the Business Combination Agreement and in any certificate delivered by or on behalf of FREYR and the Major Shareholders pursuant thereto shall be true and correct in all material respects on and as of the date of the Business Combination Agreement and on and as of the First Closing Date as if made on the First Closing Date, except for (i) those that address matters only as of a particular date (which shall have been true and correct in all material respects as of such particular date) and (ii) any failures to be true and correct that (without giving effect to any qualifications or limitations as to materiality), individually or in the aggregate, would not have a Material Adverse Effect on FREYR (provided that such limitation shall not apply with respect to representations and warranties provided by FREYR regarding its capitalization and subsidiaries);

 

FREYR and the Major Shareholders shall have performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under the Business Combination Agreement to be performed or complied with by it on or prior to the First Closing Date;

 

since the date of the Business Combination Agreement, no Material Adverse Effect shall have occurred with respect to FREYR and its subsidiaries, taken as a whole, and be continuing; and

 

the delivery or receipt of certain closing deliverables to Alussa (including (i) an officer’s certificate from FREYR, (ii) a certificate from the Shareholder Representative, and (iii) copies of (A) the executed Registration Rights Agreement; (B) the executed Escrow Agreement; (C) the conversion of certain convertible loans of FREYR into shares; and (D) at or prior to the First Closing, the termination of the shareholders’ agreement between certain Major Shareholders and the Company).

 

Termination; Effectiveness

 

The Business Combination Agreement may be terminated and the transactions contemplated therein may be abandoned at any time prior to the First Closing:

 

by mutual written consent of Alussa and FREYR;

 

by written notice by Alussa or FREYR if the First Closing shall not have occurred by July 31, 2021 (the “Outside Date”); provided, however, that such right to terminate is not available to a party if the breach or violation of such party or its affiliates of any representation, warranty, covenant or obligation under the Business Combination Agreement was the primary cause of the failure of the First Closing to occur on or before the Outside Date;

 

by written notice by Alussa or FREYR if a governmental authority of competent jurisdiction shall have issued an order or taken any other action permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by the Business Combination Agreement, and such order or other action has become final and non-appealable; provided, however, that such right to terminate is not available to a party if the breach or violation of such party or its affiliates to comply with any provision of the Business Combination Agreement has been the primary cause of such action by such governmental authority;

 

by written notice by FREYR to Alussa, if (i) there has been a breach by Alussa, Pubco or the Merger Subs of any of its representations, warranties, covenants or agreements contained in the Business Combination Agreement, or if any representation or warranty of Alussa, Pubco or the Merger Subs shall have become untrue or inaccurate, in any case, which would result in a failure of certain Closing conditions to be satisfied (treating the First Closing Date for such purposes as the date of the Business Combination Agreement or, if later, the date of such breach), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) twenty (20) days after written notice of such breach or inaccuracy is provided to Alussa by FREYR or (B) the Outside Date; provided, that FREYR shall not have the right to terminate the Business Combination Agreement if at such time FREYR or the Major Shareholders is in material uncured breach of the Business Combination Agreement;

 

11

 

 

by written notice by FREYR to Alussa, if (i) there has been a breach by FREYR or the Major Shareholders of any of their respective representations, warranties, covenants or agreements contained in the Business Combination Agreement, or if any representation or warranty of such parties shall have become untrue or inaccurate, in any case, which would result in a failure of certain Closing conditions to be satisfied (treating the First Closing Date for such purposes as the date of the Business Combination Agreement or, if later, the date of such breach), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) twenty (20) days after written notice of such breach or inaccuracy is provided to FREYR by Alussa or (B) the Outside Date; provided, that Alussa shall not have the right to terminate the Business Combination Agreement if at such time Alussa, Pubco or any of the Merger Subs is in material uncured breach of the Business Combination Agreement;

 

by written notice by either FREYR or Alussa if the special meeting of Alussa shareholders is held and has concluded, Alussa shareholders have duly voted, and the Required Purchaser Shareholder Approval was not obtained;

 

by written notice by Alussa to FREYR if the special meeting of FREYR is held, has concluded, FREYR Shareholders have duly voted, and the Required Company Shareholder Approval was not obtained;

 

by FREYR if Alussa makes any Purchaser Change of Recommendation (as defined in the Business Combination Agreement); provided that with respect to any particular Purchaser Change of Recommendation, the right to terminate under this provision shall expire on the 10th day following the occurrence of such Purchaser Change of Recommendation; or

 

by Alussa if FREYR makes any Company Change of Recommendation (as defined in the Business Combination Agreement); provided that with respect to any particular Company Change of Recommendation, the right to terminate under this provision shall expire on the 10th day following the occurrence of such Company Change of Recommendation.

 

In the event of the termination of the Business Combination Agreement, the Business Combination Agreement will become void and have no effect, without any liability on the part of any party thereto or its respective representative, as the case may be, for any willful breach of the Business Combination Agreement occurring prior to such termination, other than with respect to certain exceptions contemplated by the Business Combination Agreement that will survive any termination of the Business Combination Agreement.

 

Fees and Expenses

 

All Expenses incurred in connection with the Business Combination Agreement and the transactions contemplated therein shall be paid by the party incurring such expenses. As used in the Business Combination Agreement, “Expenses” shall mean all out-of-pocket expenses (including all fees and expenses of counsel, accountants, investment bankers, financial advisors, financing sources, experts and consultants to a party thereto or any of its affiliates) incurred by a party or on its behalf in connection with or related to the authorization, preparation, negotiation, execution or performance of the Business Combination Agreement or any Ancillary Agreement related hereto and all other matters related to the consummation of the Business Combination Agreement. With respect to Alussa, Expenses shall include any and all deferred expenses (including fees or commissions payable to the underwriters and any legal fees) of the IPO upon consummation of a business combination and any ordinary course administrative costs and expenses and Expenses incurred in connection with the consummation of the Transactions incurred by Alussa, including any PIPE Investment.

 

Ancillary Agreements

 

This section describes the material provisions of certain additional agreements entered into or to be entered into pursuant to the Business Combination Agreement (the “Ancillary Agreements”) but does not purport to describe all of the terms thereof. The following summary is qualified in its entirety by reference to the complete text of each of the Ancillary Agreements, copies of each of which are attached hereto as exhibits. Shareholders and other interested parties are urged to read such Ancillary Agreements in their entirety.

 

12

 

 

Lock-Up Agreements

 

As of the date of the Business Combination Agreement, certain FREYR shareholders, Pubco and Purchaser Representative entered into Lock-Up Agreements. Pursuant to the Lock-Up Agreement, effective as of the Second Closing Date, and subject to certain limited exceptions, the applicable FREYR shareholders and the Sponsor agree not to transfer any Pubco Ordinary Shares (including Pubco Ordinary Shares issued or issuable upon the exercise of FREYR options exchanged into options of Pubco), during the period commencing from the Second Closing and ending on the earlier of (a) one (1) year after the Second Closing Date, (b) a date subsequent to the Second Closing Date, if the last sale price of the Pubco Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Second Closing Date and (c) the date on which Pubco completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of Pubco’s shareholders having the right to exchange their Pubco Ordinary Shares for cash, securities or other property. The FREYR shareholders who are party to a Lock-Up Agreement shall be permitted to sell a certain number of Pubco Ordinary Shares to settle their tax liabilities.

 

The Sponsor also agrees not to transfer any Pubco Warrants (or Pubco Ordinary Shares issued or issuable upon the conversion of the Pubco Warrants), until 30 days after the Second Closing.

 

The form of Lock-Up Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K, and the foregoing description thereof is qualified in its entirety by reference to the full text of the Lock-Up Agreement.

 

Registration Rights Agreement

 

Prior to the First Closing Date, Pubco, FREYR, the Major Shareholders and the Purchaser Representative will use their commercially reasonable efforts to enter into the Registration Rights Agreement in the agreed form, pursuant to which Pubco will agree to register for resale, pursuant to Rule 415 under the Securities Act, certain Pubco Ordinary Shares and other equity securities of Pubco that are held by the parties thereto from time to time. Under the terms of the Registration Rights Agreement, the Purchaser Representative and the Major Shareholders, can demand that Pubco register their registrable securities under certain circumstances and will also have piggyback registration rights for these securities in connection with certain registrations of securities that Pubco undertakes. Following the consummation of the Business Combination, Pubco intends to file and maintain an effective registration statement under the Securities Act covering such securities. A form of the Registration Rights Agreement is filed as Exhibit 10.2 to this Current Report on Form 8-K, and the foregoing description thereof is qualified in its entirety by reference to the full text of the Registration Rights Agreement.

 

Purchaser Shareholder Irrevocable Undertakings

 

In connection with the execution of the Business Combination Agreement, Alussa has entered into irrevocable undertakings with FREYR and certain Alussa shareholders holding at least 25% of the Purchaser ordinary shares as of the date of the Business Combination Agreement (the “Purchaser Shareholder Irrevocable Undertakings”), pursuant to which those Alussa shareholders committed to, among other things, vote in favor of the Purchaser Shareholder Approval Matters at any meeting of Alussa shareholders and take other actions in furtherance of the Purchaser Shareholder Approval Matters until the earlier of (i) the Cayman Effective Time and (ii) the termination of the Business Combination Agreement. A form of the Purchaser Shareholder Irrevocable Undertakings is filed as Exhibit 10.3 to this Current Report on Form 8-K, and the foregoing description thereof is qualified in its entirety by reference to the full text of the Purchaser Shareholder Irrevocable Undertakings.

 

FREYR Shareholder Irrevocable Undertakings

 

In connection with the execution of the Business Combination Agreement, certain FREYR shareholders holding at least 55.76% of FREYR ordinary shares as of the date of the Business Combination Agreement have entered into irrevocable undertakings with FREYR and Alussa on January 29, 2021, pursuant to which such shareholders committed to, among other things, vote in favor of the Company Shareholder Approval Matters and take other actions in furtherance of the Purchaser Shareholder Approval Matters until the earlier at any meeting or written resolutions of the shareholders held prior to or on the earlier of (i) the Second Closing and (ii) the termination of the Business Combination Agreement. A form of the FREYR Shareholder Irrevocable Undertakings is filed as Exhibit 10.4 to this Current Report on Form 8-K, and the foregoing description thereof is qualified in its entirety by reference to the full text of the FREYR Shareholder Irrevocable Undertakings.

 

13

 

 

Preferred Share Acquisition Agreement

 

Simultaneously with the execution of the Business Combination Agreement, Encompass Capital Master Fund LP, BEMAP Master Fund LP Ltd. and Encompass Capital E L Master Fund L.P. (the “Company Preferred Share Transferors”) have entered into the preferred share acquisition agreement (the “Company Preferred Share Acquisition Agreement”) with Pubco, pursuant to which the Company Preferred Share Transferors have agreed to transfer, and Pubco has agreed to acquire for shares of Pubco, all of the preferred shares in Norway Merger Sub 1 held by the Company Preferred Share Transferors at the Second Closing. A form of the Company Preferred Share Acquisition Agreement is filed as Exhibit 10.5 to this Current Report on Form 8-K, and the foregoing description thereof is qualified in its entirety by reference to the full text of the Company Preferred Share Acquisition Agreement.

 

Subscription Agreements

 

In connection with the execution of the Business Combination Agreement, Alussa entered into subscription agreements (each, a “Subscription Agreement”) with Pubco and various investors, pursuant to which such investors will collectively have committed to purchase 60,000,000 Pubco Ordinary Shares at the Second Closing for a purchase price of $10 per share, representing aggregate gross proceeds of $600 million. The obligation of the parties to consummate the purchase and sale of the shares covered by the Subscription Agreements is conditioned upon (i) there not being in force any injunction or order enjoining or prohibiting the issuance and sale of the shares covered by the Subscription Agreements and (ii) all conditions precedent to the consummation of the Transactions set forth in the Business Combination Agreement having been satisfied or waived (other than those conditions which, by their nature, are to be satisfied at the applicable Closing Date under the Business Combination Agreement).

 

The Subscription Agreements provide that, solely with respect to subscriptions by third-party investors, Pubco is required to file with the SEC, within 30 days after the consummation of the transactions contemplated by the Business Combination Agreement, a shelf registration statement covering the resale of the Pubco Ordinary Shares to be issued to any such third-party investor and to use its commercially reasonable efforts to have such registration statement declared effective as soon as practicable after the filing thereof but no later than the earlier of (i) the 90th day following the filing date thereof if the SEC notifies Pubco that it will “review” such registration statement and (ii) the 10th business day after the date Pubco is notified (orally or in writing, whichever is earlier) by the SEC that such registration statement will not be “reviewed” or will not be subject to further review.

 

A form of the Subscription Agreement is filed as Exhibit 10.6 to this Current Report on Form 8-K, and the foregoing description thereof is qualified in its entirety by reference to the full text of the Subscription Agreement

 

Item 3.02. Unregistered Sales of Equity Securities

 

The disclosure set forth above under the heading “Subscription Agreements” in Item 1.01 of this Current Report on Form 8-K are incorporated by reference into this Item 3.02. The Pubco Ordinary Shares to be issued in connection with the Subscription Agreements and Pubco securities to be issued to the holders of FREYR securities are not to be registered under the Securities Act in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act, Regulation S and/or Regulation D promulgated thereunder.

 

Item 7.01 Regulation FD Disclosure.

 

On January 29, 2021, Alussa and FREYR issued a joint press release announcing the execution of the Business Combination Agreement described in Item 1.01 above. The press release is attached hereto as Exhibit 99.1.

 

Attached as Exhibit 99.2 is the investor presentation that will be used by Alussa, Pubco and FREYR with respect to the transactions contemplated by the Business Combination Agreement.

 

14

 

 

On January 29, 2021, Alussa and FREYR held an investor conference call regarding the proposed Business Combination. A copy of the prepared remarks for the call is attached hereto as Exhibit 99.3.

 

The foregoing items are being furnished pursuant to Item 7.01 and will not be deemed to be filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that section, nor will they be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

 

 

Exhibit No.

  Description
2.1*   Business Combination Agreement, dated as of January 29, 2021, by and among Alussa, FREYR, Sponsor, Pubco, Norway Merger Sub 1, Norway Merger Sub 2, Cayman Merger Sub, the Shareholder Representative and the Major Shareholders.
     
10.1   Form of Lock-up Agreement
     
10.2   Form of Registration Rights Agreement
     
10.3   Form of Purchaser Shareholder Irrevocable Undertakings
     
10.4   Form of FREYR Shareholder Irrevocable Undertakings
     
10.5   Form of Preferred Share Acquisition Agreement
     
10.6   Form of Subscription Agreement
     
99.1   Press Release, dated January 29, 2021
     
99.2   Investor Presentation, dated January 2021
     
99.3   Script of Prepare Remarks for Investor Call, dated January 29, 2021

 

* Certain exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). Alussa agrees to furnish supplementally a copy of any omitted exhibit or schedule to the SEC upon its request.

 

15

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ALUSSA ENERGY ACQUISITION CORP.
     
  By: /s/ Daniel Barcelo
    Name: Daniel Barcelo
    Title: Chief Executive Officer and President
     
Dated: January 29, 2021    

 

 

16

 

 

Exhibit 2.1

 

EXECUTION VERSION

 

 

 

 

BUSINESS COMBINATION AGREEMENT

 

 

by and among

 

 

ALUSSA ENERGY ACQUISITION CORP.

 

 

as Purchaser,

 

 

ALUSSA ENERGY SPONSOR LLC,

 

 

in the capacity as the Purchaser Representative,

 

 

FREYR AS,

 

 

as the Company,

 

 

ATS AS,

 

 

in the capacity as the Shareholder Representative,

 

NORWAY SUB 1 AS,

 

NORWAY SUB 2 AS,

 

ADAMA CHARLIE SUB,

 

FREYR BATTERY,

 

AND

 

THE MAJOR SHAREHOLDERS

 

Dated as of January 29, 2021

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page
Article I
DISTRIBUTIOn; PREFERRED Share Transfer
 
1.1 Distribution 3
1.2 Preferred Share Transfer 3

 

Article II
MERGERS
 
2.1 Mergers 3
2.2 Effective Times 4
2.3 Effect of the Mergers 4
2.4 Organizational Documents of Surviving Corporations 5
2.5 Directors and Officers of the Surviving Corporations 5
2.6 Effect of Mergers on Issued Securities of Purchaser, Pubco, the Merger Subs and the Company 6
2.7 Exchange Procedures 8
2.8 Treatment of Company Options, Company Warrants and EDGE Warrants. 9
2.9 Fractional Pubco Securities 10
2.10 Tax Consequences 10
2.11 Termination of Certain Agreements 10

 

Article III
ESCROW
 
3.1 Escrow 11

 

Article IV
CLOSINGS
 
4.1 First Closing 11
4.2 Second Closing 11
4.3 Signatures for the Closings 12

 

Article V
REPRESENTATIONS AND WARRANTIES OF PURCHASER
 
5.1 Organization and Standing 12
5.2 Authorization; Binding Agreement 12
5.3 Governmental Approvals 13
5.4 Non-Contravention 13
5.5 Capitalization 13
5.6 SEC Filings and Purchaser Financials 15
5.7 Absence of Certain Changes 16
5.8 Compliance with Laws 16
5.9 Actions; Orders; Permits 16

 

i

 

 

5.10 Taxes and Returns 17
5.11 Employees 17
5.12 Investment Company Act 17
5.13 Finders and Brokers 17
5.14 Certain Business Practices 17
5.15 Independent Investigation 18
5.16 Trust Account 18
5.17 Exclusivity of Representations and Warranties 18

 

Article VI
REPRESENTATIONS AND WARRANTIES OF PUBCO
 
6.1 Organization and Standing 19
6.2 Authorization; Binding Agreement 19
6.3 Governmental Approvals 19
6.4 Non-Contravention 20
6.5 Capitalization 20
6.6 Ownership of Exchange Shares 21
6.7 Compliance with Laws 21
6.8 Pubco and Cayman Merger Sub Activities 21
6.9 Finders and Brokers 21
6.10 Investment Company Act 21
6.11 Information Supplied 22
6.12 Independent Investigation 22
6.13 Exclusivity of Representations and Warranties 22

 

Article VII
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
 
7.1 Organization and Standing 23
7.2 Authorization; Binding Agreement 23
7.3 Capitalization 23
7.4 Subsidiaries 24
7.5 Governmental Approvals 25
7.6 Non-Contravention 25
7.7 Financial Statements 26
7.8 Absence of Certain Changes 27
7.9 Compliance with Laws 27
7.10 Company Permits 27
7.11 Litigation 27
7.12 Material Contracts 27
7.13 Intellectual Property 30
7.14 Taxes and Returns 31
7.15 Real Property 32
7.16 Title to and Sufficiency of Assets 33
7.17 Employee Matters 33
7.18 Benefit Plans 35
7.19 Environmental Matters 36
7.20 Transactions with Related Persons 37
7.21 Business Insurance 37

 

ii

 

 

7.22 Customers and Vendors 38
7.23 Certain Business Practices 38
7.24 Data Protection and Cybersecurity 38
7.25 Information Technology 39
7.26 Investment Company Act 39
7.27 Finders and Brokers 40
7.28 Information Supplied 40
7.29 Solvency 40
7.30 Disclosed MOUs 40
7.31 Exclusivity of Representations and Warranties 41
7.32 Independent Investigation 41

 

Article VIII
Representations and warranties of the major shareholders
 
8.1 Organization and Standing 41
8.2 Authorization; Binding Agreement 41
8.3 Ownership 42
8.4 Governmental Approvals 42
8.5 Non-Contravention 42
8.6 No Litigation 42
8.7 Finders and Brokers 42
8.8 Independent Investigation 42

 

Article IX
COVENANTS
 
9.1 Access and Information 43
9.2 Conduct of Business of the Company 43
9.3 Conduct of Business of Purchaser, Pubco and Merger Subs 46
9.4 Purchaser Public Filings 47
9.5 No Solicitation 48
9.6 No Trading 49
9.7 Notification of Certain Matters 49
9.8 Efforts 49
9.9 Further Assurances 50
9.10 The Registration Statement 50
9.11 Public Announcements 53
9.12 Post-Closing Board of Directors 53
9.13 Indemnification of Directors and Officers; Tail Insurance 54
9.14 Trust Account Proceeds 55
9.15 Commitment Agreements 55
9.16 Registration of the Exchange Shares 56
9.17 Delisting and Deregistration 57
9.18 Pubco NYSE Listing 57
9.19 Equity Plans 57
9.20 Company Shareholder Approval 57
9.21 Merger Subs’ and Pubco Shareholder Approvals 58
9.22 Section 16 of the Exchange Act 58
9.23 Transfer Taxes 58
9.24 Registration Rights Agreement 59
9.25 Resignations 59
9.26 Termination of Existing Registration Rights Agreement 59
9.27 First Amended Pubco Articles 59

 

iii

 

 

9.28 Net Tangible Assets 59
9.29 Company Disclosure Schedules 59
9.30 Norway Demerger 59
9.31 No Leakage 59
9.32 Employment Agreements 60

 

Article X
SURVIVAL
 
10.1 Survival 60
10.2 Indemnification 61
10.3 Limitations and General Indemnification Provisions 61
10.4 Indemnification Procedures 62
10.5 Indemnification Payments 63
10.6 Exclusive Remedy 63

 

Article XI
LEAKAGE; legal costS adjustments
 
11.1 Leakage 64
11.2 Legal Cost Adjustment 65

 

Article XII
CLOSINGs CONDITIONS
 
12.1 Conditions to Each Party’s Obligations 65
12.2 Conditions to Obligations of the Company and the Major Shareholders 66
12.3 Conditions to Obligations of Purchaser 67
12.4 Second Closing 68
12.5 Frustration of Conditions 68

 

Article XIII
TERMINATION AND EXPENSES
 
13.1 Termination 68
13.2 Effect of Termination 70
13.3 Fees and Expenses 70

 

Article XIV
WAIVERS AND RELEASES
 
14.1 Waiver of Claims Against Trust 71
14.2 No Recourse 72

 

iv

 

 

Article XV
MISCELLANEOUS
 
15.1 Notices 72
15.2 Binding Effect; Assignment 74
15.3 Third Parties 74
15.4 Arbitration 74
15.5 Governing Law; Jurisdiction 74
15.6 Specific Performance 75
15.7 Severability 75
15.8 Amendment 75
15.9 Waiver 75
15.10 Entire Agreement 75
15.11 Interpretation 76
15.12 Counterparts 76
15.13 Purchaser Representative 77
15.14 Shareholder Representative 78
15.15 Legal Representation 79
15.16 No Liability 80

 

Article XVI
DEFINITIONS
 
16.1 Certain Definitions 81

 

 

INDEX OF EXHIBITS

 

Exhibit Description
   
Exhibit A Form of Norway Demerger Plan
Exhibit B Form of Cayman Merger Plan
Exhibit C Form of Norway Merger Plan
Exhibit D Form of Cross-Border Merger Plan
Exhibit E Form of Escrow Agreement
Exhibit F Form of Pubco Equity Plan
Exhibit G Form of Registration Rights Agreement
Exhibit H Form of First Amended Pubco Articles
Exhibit I Form of Final Amended Pubco Articles
Exhibit J Employment Term Sheets

 

v

 

 

BUSINESS COMBINATION AGREEMENT

 

This Business Combination Agreement (this “Agreement) is made and entered into as of January 29, 2021 by and among (i) Alussa Energy Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with its successors, “Purchaser), (ii) Alussa Energy Sponsor LLC, a limited liability company formed under the laws of Delaware, in the capacity as the representative from and after the First Closing (as defined below) for the shareholders of Purchaser, as well as Pubco, in accordance with the terms and conditions of this Agreement (the “Purchaser Representative), (iii) FREYR Battery, a corporation in the form of a public limited liability company (société anonyme) incorporated under the laws of Luxembourg, with registered office at 412F, route d’Esch, L-2086 Luxembourg, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés) (“Pubco), (iv) Norway Sub 1 AS, a private limited liability company under the laws of Norway (“Norway Merger Sub 1”), (v) Norway Sub 2 AS, a private limited liability company under the laws of Norway (“Norway Merger Sub 2” and, together with Norway Merger Sub 1, the “Norway Merger Subs”), (vi) Adama Charlie Sub, an exempted company incorporated under the laws of the Cayman Islands (“Cayman Merger Sub” and, together with the Norway Merger Subs, the “Merger Subs”), (vii) FREYR AS, a company organized under the laws of Norway (the “Company), (viii) certain shareholders of the Company as set forth in Schedule 8.3 (the “Major Shareholders”) and (ix) ATS AS, in the capacity as the representative for the Major Shareholders in accordance with the terms and conditions of this Agreement (the “Shareholder Representative). Purchaser, the Purchaser Representative, Pubco, the Merger Subs, the Company, the Major Shareholders and the Shareholder Representative are sometimes referred to herein individually as a “Party and, collectively, as the “Parties.

 

RECITALS:

 

WHEREAS, the Company, directly and indirectly through its subsidiaries, engages in the business of energy storage;

 

WHEREAS, Pubco is a wholly-owned subsidiary of the Purchaser Representative;

 

WHEREAS, Cayman Merger Sub is a wholly-owned subsidiary of Pubco;

 

WHEREAS, Norway Merger Sub 1 is a wholly-owned subsidiary of the Purchaser;

 

WHEREAS, Norway Merger Sub 2 is a wholly-owned subsidiary of Norway Merger Sub 1;

 

WHEREAS, prior to the First Closing, the Company intends to transfer its wind farm business to Sjonfjellet Vindpark Holding AS (“SVPH”), a private limited liability company to be incorporated by way of demerger resulting in such business becoming held by the Company’s shareholders through such company (the “Norway Demerger”) in accordance with the plan of demerger substantially in the form set forth in Exhibit A (the “Norway Plan of Demerger”);

 

WHEREAS, simultaneously with the execution of this Agreement, Encompass Capital Master Fund LP, BEMAP Master Fund Ltd. and Encompass Capital E L Master Fund L.P. (the “Encompass Holders” or the “Transferors”) have entered into a share acquisition agreement (the “Preferred Share Acquisition Agreement”) with Pubco and the Company, pursuant to which the Transferors have agreed to contribute in kind all of the Company Preferred Shares and the Company Preferred Shares Linked Warrants (the “Preferred Share Transfer”);

 

1

 

 

WHEREAS, the Parties desire and intend to effect a business combination transaction whereby (a) the Purchaser will merge with and into Cayman Merger Sub, with the Purchaser continuing as the surviving entity and Pubco issuing the consideration contemplated thereby (the “Cayman Merger”), (b) the Purchaser will distribute all of its interests in Norway Merger Sub 1 to Pubco, (c) the Company will merge with and into Norway Merger Sub 2, with Norway Merger Sub 2 continuing as the surviving entity and Norway Merger Sub 1 issuing the consideration contemplated thereby (the “Norway Merger), (d) Norway Merger Sub 1 will merge with and into Pubco, with Pubco continuing as the surviving entity and Pubco issuing the consideration contemplated thereby (the “Cross-Border Merger” and, together with the Cayman Merger and the Norway Merger, the “Mergers”, and the Mergers, together with the Preferred Share Transfer and the other transactions contemplated by this Agreement and the Ancillary Documents (as defined below), the “Transactions), as a result of which, (i) each issued and outstanding security of the Purchaser immediately prior to the Cayman Effective Time (as defined below) shall be exchanged for the right of the holder thereof to receive securities of Pubco in accordance with this Agreement (or, in the case of Dissenting Purchaser Shareholders, if any, the right to receive the fair value of such holder’s Dissenting Purchaser Ordinary Shares and such other rights as are granted by the Cayman Companies Act), (ii) each issued and outstanding security of the Company immediately prior to the Norway Effective Time (as defined below) shall be exchanged for the right of the holder thereof to receive securities of Norway Merger Sub 1 in accordance with this Agreement and (iii) each issued and outstanding security of Norway Merger Sub 1 (other than those held by Pubco) immediately prior to the Cross-Border Effective Time (as defined below) shall be exchanged for the right of the holder to receive securities of Pubco, all upon the terms and subject to the conditions set forth in this Agreement and in accordance with the provisions of applicable law;

 

WHEREAS, on or prior to the date hereof, certain Purchaser Shareholders holding at least 25% of the Purchaser Ordinary Shares as of the date this Agreement have entered into irrevocable undertakings with the Purchaser and Company (the “Purchaser Shareholder Irrevocable Undertakings”), pursuant to which those Purchaser Shareholders committed to vote in favor of the Purchaser Shareholder Approval Matters;

 

WHEREAS, on or prior to the date hereof, the Major Shareholders, who in aggregate hold 55.76% of the Company Shares as of the date of this Agreement, have entered into irrevocable undertakings with the Company and Purchaser (the “Major Shareholder Irrevocable Undertakings”), pursuant to which the Major Shareholders committed to vote in favor of the Company Shareholder Approval Matters;

 

WHEREAS, on or prior to the date hereof, (i) Pubco, on the one hand, and (ii) Purchaser or certain of the other Major Shareholders, on the other hand, have entered into lock-up agreements (each, a “Lock-Up Agreement” and collectively the “Lock-Up Agreements”);

 

WHEREAS, the sole director, boards of directors or members (as applicable) of Purchaser, the Purchaser Representative, the Company, Pubco, the Merger Subs and the Major Shareholders (which are not natural Persons) have each (a) determined that the Transactions (to the extent such Transactions are applicable to such Person) are fair, advisable and in the best interests of their respective companies and security holders, and (b) approved this Agreement and the Transactions (to the extent such Transactions are applicable to such Person), upon the terms and subject to the conditions set forth herein;

 

WHEREAS, based on the capitalization of the Company as of the date hereof, and assuming (i) none of the Purchaser Shareholders have exercised a Redemption or dissent rights in accordance with Section 238 of the Cayman Companies Act, (ii) that each of the PIPE Investments contemplated under the Commitment Agreements are consummated, (iii) that there are no adjustments to the Equity Consideration and (iv) the additional 7,500,000 Company Preferred Shares pursuant to the Funding Commitment Letter are issued prior to the First Closing, the Transactions would result in Pubco being owned 30% by the Company Shareholders (on a fully-diluted basis) and the Transferors pursuant to the Preferred Share Acquisition Agreement, 26% by the shareholders of Purchaser and 44% by the investors under the Commitment Agreements;

 

2

 

 

WHEREAS, it is the intention of the Parties that Pubco will have its securities listed on the NYSE; and

 

WHEREAS, certain capitalized terms used herein are defined in Article XVI hereof.

 

NOW, THEREFORE, in consideration of the premises set forth above, and the representations, warranties, covenants and agreements contained in this Agreement, and intending to be legally bound hereby, the Parties hereto agree as follows:

 

Article I
DISTRIBUTIOn; PREFERRED Share Transfer

 

1.1 Distribution. On the Second Closing, and prior to the consummation of the transactions contemplated by Section 1.2, the Purchaser shall pay a dividend in favor of Pubco which shall be satisfied in-kind by the distribution of all of its interests in Norway Merger Sub 1 to Pubco.

 

1.2 Preferred Share Transfer. On the Second Closing, immediately following the Norway Effective Time and immediately prior to the Cross-Border Effective Time, Pubco shall cause the consummation of the transactions contemplated by the Preferred Share Acquisition Agreement.

 

Article II
MERGERS

 

2.1 Mergers.

 

(a) On the First Closing, in accordance with the applicable provisions of the Cayman Companies Act, Pubco, the Purchaser and Cayman Merger Sub shall consummate the Cayman Merger by taking those steps in accordance with Section 2.2(i), pursuant to which Cayman Merger Sub shall be merged with and into the Purchaser with Purchaser being the surviving entity, following which the separate corporate existence of the Cayman Merger Sub shall cease and the Purchaser shall continue as the surviving company (the “Cayman Surviving Corporation”) (provided that references in this Agreement to the Cayman Merger Sub for periods after the Cayman Effective Time shall include the Cayman Surviving Corporation) in accordance with a plan of merger for the Cayman Merger (the “Cayman Plan of Merger”) substantially in the form set forth in Exhibit B.

 

(b) On the Second Closing, in accordance with the applicable provisions of the Norwegian Companies Act, the Company, Norway Merger Sub 2 and Norway Merger Sub 1 shall consummate the Norway Merger by taking those steps in accordance with Section 2.2(ii), pursuant to which the Company shall be merged with and into Norway Merger Sub 2 with Norway Merger Sub 2 being the surviving entity, following which the separate corporate existence of the Company shall cease and Norway Merger Sub 2 shall continue as the surviving corporation (the “Norway Surviving Corporation”) (provided that references in this Agreement to the Company for periods after the Norway Effective Time shall include the Norway Surviving Corporation) in accordance with the plan of merger (the “Norway Plan of Merger”) substantially in the form set forth in Exhibit C.

 

3

 

 

(c) Immediately following the completion of the Preferred Share Transfer, in accordance with the applicable provisions of the Luxembourg Companies Act and the Norwegian Companies Act, Pubco and Norway Merger Sub 1 shall consummate the Cross-Border Merger by taking those steps in accordance with Section 2.2(iii), pursuant to which Norway Merger Sub 1 shall be merged with and into Pubco with Pubco being the surviving entity, following which the separate corporate existence of Norway Merger Sub 1 shall cease and Pubco shall continue as the surviving corporation (the “Lux Surviving Corporation” and, together with the Cayman Surviving Corporation and the Norway Surviving Corporation, the “Surviving Corporations”) (provided that references in this Agreement to Norway Merger Sub 1 for periods after the Cross-Border Effective Time shall include the Lux Surviving Corporation) in accordance with the plan of merger (the “Cross-Border Plan of Merger”) substantially in the form set forth in Exhibit D.

 

2.2 Effective Times. (i) On the First Closing, the Purchaser and Cayman Merger Sub shall cause the executed Cayman Plan of Merger and other required Cayman Merger Filing Documents to be filed with the Cayman Registrar (the time the Cayman Plan of Merger is registered by the Cayman Registrar, or such later time as may be specified in the Cayman Plan of Merger, being the “Cayman Effective Time), (ii) on the Second Closing, the Company, Norway Merger Sub 2 and Norway Merger Sub 1 shall cause the Norway Merger to be consummated in accordance with the Norway Plan of Merger and with the relevant provisions of the Norwegian Companies Act, and by making the required filings, and after the end of the creditor period, register the completion of Norway Merger in the Norwegian Business Register (the time when such registration of completion is completed, being the “Norway Effective Time”) and (iii) immediately following, and for the avoidance of doubt, subject to and conditional upon the, completion of the Preferred Share Transfer, Pubco and Norway Merger Sub 1 shall cause the Cross-Border Merger to be consummated in accordance with the Cross-Border Plan of Merger, by (a) making the required filings and obtaining a certificate of merger for Norway Merger Sub 2, in form and substance reasonably acceptable to Purchaser and the Company (the “Norwegian Certificate of Merger”) from the Norwegian Business Registry, (b) causing the Cross-Border Merger Resolutions to be published in the RESA, in form and substance reasonably acceptable to Purchaser and the Company (the “Cross-Border Merger Publication”) and (c) causing a representative of Pubco to appear before a Luxembourg notary to record that all conditions precedent to the Cross-Border Merger set out in the Cross-Border Merger Resolutions have been satisfied (the “Cross-Border Merger Deed of Record” and, together with the Cross-Border Merger Publication, the Cayman Certificate of Merger and the Norway Certificate of Merger, the “Certificates of Merger”), all in accordance with the relevant provisions of the Norwegian Companies Act and the Luxembourg Companies Act, or such later time as may be specified in the Cross-Border Merger Resolutions, being the “Cross-Border Effective Time, and, together with the Cayman Effective Time and the Norway Effective Time, the “Effective Times”, and each an “Effective Time”).

 

2.3 Effect of the Mergers. At the relevant Effective Time, the effect of the Mergers shall be as provided in this Agreement, the Certificates of Merger, the Cross-Border Plan of Merger, the Norway Plan of Merger, the Cayman Plan of Merger and the applicable provisions of the Cayman Companies Act, the Luxembourg Companies Act and the Norwegian Companies Act, as applicable. Without limiting the generality of the foregoing, and subject thereto, at each applicable Effective Time, all the property, rights, privileges, agreements, powers and franchises, debts, Liabilities, duties and obligations of:

 

(a) the Purchaser and the Cayman Merger Sub shall become the property, rights, privileges, agreements, powers and franchises, debts, Liabilities, duties and obligations of the Purchaser as the surviving company (including all rights and obligations with respect to the Trust Account), which shall include the assumption by the Cayman Surviving Corporation of any and all agreements, covenants, duties and obligations of the Purchaser and the Cayman Merger Sub set forth in this Agreement to be performed after the Cayman Effective Time, and the Cayman Surviving Corporation shall continue its existence as a wholly-owned Subsidiary of Pubco;

 

4

 

 

(b) the Company and Norway Merger Sub 2 shall become the property, rights, privileges, agreements, powers and franchises, debts, Liabilities, duties and obligations of Norway Merger Sub 2 as the surviving corporation, which shall include the assumption by the Norway Surviving Corporation of any and all agreements, covenants, duties and obligations of the Company and Norway Merger Sub 2 set forth in this Agreement to be performed after the Norway Effective Time, and the Norway Surviving Corporation shall continue its existence as, following completion of the Cross-Border Merger, a wholly-owned Subsidiary of Pubco; and

 

(c) Pubco and Norway Merger Sub 1 shall become the property, rights, privileges, agreements, powers and franchises, debts, Liabilities, duties and obligations of Pubco as the surviving corporation, which shall include the assumption by Pubco of any and all agreements, covenants, duties and obligations of Pubco and Norway Merger Sub 1 set forth in this Agreement to be performed after the Cross-Border Effective Time.

 

2.4 Organizational Documents of Surviving Corporations.

 

(a) At the Cayman Effective Time, the Purchaser Articles, as in effect immediately prior to the Cayman Effective Time, shall remain the memorandum and articles of association of the Cayman Surviving Corporation. Immediately following the Second Closing, Pubco shall amend and restate the memorandum and articles of association of the Cayman Surviving Corporation to read in their entirety in the form of the articles of association of the Cayman Merger Sub immediately prior to the Cayman Effective Time.

 

(b) At the Norway Effective Time, the Articles of Association of Norway Merger Sub 2, as in effect immediately prior to the Norway Effective Time, shall remain the Articles of Association of Norway Merger Sub 2 (except that the name of the corporation shall be updated therein) and, as so amended, shall be the Articles of Association of the Norway Surviving Corporation, until thereafter amended in accordance with the terms thereof and the Norwegian Companies Act.

 

(c) At the Cross-Border Effective Time, the applicable Pubco Articles, as in effect immediately prior to the Cross-Border Effective Time, shall be amended to read in their entirety in the form of the Final Amended Pubco Articles and, as so amended, shall be the articles of association of the Lux Surviving Corporation, until thereafter amended in accordance with the terms thereof and the Luxembourg Companies Act.

 

2.5 Directors and Officers of the Surviving Corporations.

 

(a) At the relevant Effective Time, the board of directors and executive officers of the Company, Purchaser, Cayman Merger Sub and the Norway Merger Subs shall resign and the boards of directors and executive officers of the Cayman Surviving Corporation and Norway Surviving Corporation shall be as determined by Pubco, each to hold office in accordance with the Organizational Documents of the Cayman Surviving Corporation and the Norway Surviving Corporation until their respective successors are duly elected or appointed and qualified.

 

(b) At the Cayman Effective Time, the board of directors of Pubco shall resign and the board of directors of Pubco shall be appointed in accordance with Section 9.12 and, at the Cross-Border Effective Time, the board of directors of Pubco (as the Lux Surviving Corporation) shall be appointed in accordance with Section 9.12.

 

5

 

 

2.6 Effect of Mergers on Issued Securities of Purchaser, Pubco, the Merger Subs and the Company. At the relevant Effective Time, by virtue of the Mergers and without any action on the part of any Party or the holders of securities of Purchaser, the Company, Pubco or the Merger Subs:

 

(a) Purchaser Units. Each Purchaser Unit outstanding immediately prior to the Cayman Effective Time shall be automatically detached and the holder thereof shall be deemed to hold one Purchaser Ordinary Share and one-half of a Purchaser Warrant in accordance with the terms of the applicable Purchaser Unit, which underlying Purchaser Securities shall be converted in accordance with the applicable terms of this Section 2.6 below.

 

(b) Purchaser Ordinary Shares.

 

(i) Each Purchaser Ordinary Share issued and outstanding immediately prior to the Cayman Effective Time (other than those described in Section 2.6(b)(ii) and 2.6(c) below) shall be converted into the right to receive one Pubco Ordinary Share, following which all issued and outstanding Purchaser Ordinary Shares shall be held by Pubco.

 

(ii) Dissenting Purchaser Ordinary Shares. Each Dissenting Purchaser Ordinary Share issued and outstanding immediately prior to the Cayman Effective Time held by a Dissenting Purchaser Shareholder, if any, shall be cancelled and extinguished and each Dissenting Purchaser Shareholder shall be entitled to be paid the fair value of such Dissenting Purchaser Ordinary Share and such other rights as are granted by the Cayman Companies Act.

 

(c) Cancellation of Capital Stock Owned by Purchaser. Each share of Purchaser owned by Purchaser as treasury shares immediately prior to the Cayman Effective Time, if any, shall be cancelled and extinguished without any conversion thereof or payment therefor.

 

(d) Cancellation of Shares of Cayman Merger Sub. Each Cayman Merger Sub Share issued and outstanding immediately prior to the Cayman Effective Time shall automatically be cancelled and shall cease to exist.

 

(e) Purchaser Warrants. Pursuant to the terms of the Purchaser Public Warrants and Purchaser Private Warrants, each (i) Purchaser Public Warrant outstanding immediately prior to the Cayman Effective Time shall be exchanged for the right to receive one Pubco Public Warrant and (ii) each Purchaser Private Warrant outstanding immediately prior to the Cayman Effective Time shall be exchanged for the right to receive one Pubco Private Warrant, and all Purchaser Warrants shall thereupon be deemed terminated and no longer outstanding. Pursuant to the terms of the Purchaser Public Warrants and Purchaser Private Warrants, each of the Pubco Public Warrants shall have, and be subject to, substantially the same terms and conditions set forth in the Purchaser Public Warrants, and each of the Pubco Private Warrants shall have, and be subject to, substantially the same terms and conditions set forth in the Purchaser Private Warrants, except that in each case they shall represent the right to acquire Pubco Ordinary Shares in lieu of Purchaser Ordinary Shares (subject to any amendment required by the Luxembourg Companies Act). At or prior to the Cayman Effective Time, Pubco shall take all corporate action necessary to reserve for future issuance, and shall maintain such reservation for so long as any of the Pubco Warrants remain outstanding, a sufficient number of Pubco Ordinary Shares for delivery or issuance upon the exercise of such Pubco Warrants.

 

6

 

 

(f) Company Shares, Company Preferred Shares and Company Preferred Share Linked Warrants. Each Company Share (other than those described in Section 2.6(j) below), each Company Preferred Share and each Company Preferred Share Linked Warrant issued and outstanding immediately prior to the Norway Effective Time shall automatically be converted into one Norway Merger Sub 1 Share, Norway Merger Sub 1 Preferred Share and Norway Merger Sub 1 Preferred Share Linked Warrant, respectively, following which all such Company Shares, Company Preferred Shares and Company Preferred Share Linked Warrants shall cease to be outstanding and shall automatically be cancelled and cease to exist, and each Norway Merger Sub 1 Share, Norway Merger Sub 1 Preferred Share and Norway Merger Sub 1 Preferred Linked Warrant held by Pubco at the Norway Effective Time shall be cancelled (or redeemed).

 

(g) Norway Merger Sub 1 Shares, Norway Merger Sub 1 Preferred Shares and Norway Merger Sub 1 Preferred Share Linked Warrants. Each Norway Merger Sub 1 Share issued and outstanding immediately prior to the Cross-Border Effective Time (other than those held by Pubco) shall automatically be converted into the right to receive the number of Pubco Ordinary Shares equal to the Exchange Ratio (subject to the withholding of the Escrow Shares in accordance with Section 3.1) (such aggregate number of Pubco Ordinary Shares, the “Exchange Shares”), following which all such Norway Merger Sub 1 Shares shall cease to be outstanding and shall automatically be cancelled and shall cease to exist. Any Norway Merger Sub 1 Shares, Norway Merger Sub 1 Preferred Shares and Norway Merger Sub 1 Preferred Share Linked Warrants held by Pubco shall be cancelled and shall cease to exist.

 

(h) Restricted Securities. The Exchange Shares issued by Pubco to the Norway Merger Sub 1 Shareholders pursuant to the terms and conditions set forth in this Agreement will have such hold periods as are required under applicable securities laws and as a result may not be sold, transferred or otherwise disposed of, except pursuant to an effective registration statement under the Securities Act, or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in each case only in accordance with all applicable securities laws. The book entry evidencing the Exchange Shares will include appropriate restrictions in order to reflect the fact that the Exchange Shares will be issued by Pubco to the Norway Merger Sub 1 Shareholders pursuant to an exemption from the registration requirements of the Securities Act and may not be offered or sold, directly or indirectly, in the United States (as defined in the Securities Act) or to U.S. persons (as defined in the Securities Act) except in accordance with an effective registration statement under the Securities Act, or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in each case only in accordance with applicable state securities laws. In addition, hedging transactions involving the Exchange Shares may not be conducted unless in compliance with the Securities Act.

 

(i) Redemption of Pubco Shares held by Purchaser Representative. All Pubco Shares held by Purchaser Representative prior to the First Closing shall be redeemed by Pubco for a cash payment equal to the issuance price of such shares. For the avoidance of doubt, this Section 2.6(i) shall not apply to any Pubco Securities acquired by the Purchaser Representative in connection with the Mergers.

 

(j) Cancellation of Capital Stock Owned by the Company. Each share of capital stock of the Company owned by the Company as treasury shares shall be cancelled and extinguished without any conversion thereof or payment therefor.

 

7

 

 

2.7 Exchange Procedures.

 

(a) Appointment of Transfer Agent. Prior to the First Closing, Pubco shall appoint the Norwegian electronic securities register, Verdipapirsentralen ASA (“Euronext VPS”) as registrar and appoint a transfer agent reasonably acceptable to the Company (the “Transfer Agent”), as its agent, for the purpose of exchanging (i) Norway Merger Sub 1 Shares for Company Shares and (ii) Pubco Securities for Purchaser Securities and Norway Merger Sub 1 Shares, as applicable. Norway Merger Sub 1 agrees to issue Norway Merger Sub 1 Shares as and to the extent required by this Agreement and the Norway Plan of Merger to the holders of Company Shares (other than Pubco). Pubco agrees to issue Pubco Securities as and to the extent required by this Agreement and the Cayman Plan of Merger to the holders of Purchaser Ordinary Shares, Purchaser Warrants and Norway Merger Sub 1 Shares. The Transfer Agent shall effect the exchange of Company Shares for a number of Norway Merger Sub 1 Shares, and Purchaser Securities and Norway Merger Sub 1 Shares for a number of Pubco Securities, each in accordance with the terms of this Agreement, the Norway Plan of Merger, the Cayman Plan of Merger or the Cross-Border Plan of Merger, and, to the extent applicable, customary transfer agent procedures and the rules and regulations of the Depository Trust Company.

 

(b) Transfers of Ownership. Outstanding Purchaser Securities, Company Shares and Norway Merger Sub 1 Shares converted into the right to receive the consideration provided in Section 2.6 will be deemed, from and after the applicable Effective Time, to evidence only the right to secure the consideration to which the holder thereof is entitled hereunder. In the case of (i) certificated shares, each certificate previously evidencing shares, or (ii) non-certificated shares represented by book entry, each document as may be required to be provided to the Transfer Agent pursuant to the applicable letter of transmittal as evidence, of (A) Purchaser Ordinary Shares (other than those described in Section 2.6(b)(ii) and Section 2.6(c)) shall be exchanged for a book entry representing a number of Pubco Ordinary Shares determined in accordance with Section 2.6, (B) Company Shares shall be exchanged for a book entry representing a number of Norway Merger Sub 1 Shares determined in accordance with Section 2.6(f) and (C) Norway Merger Sub 1 Shares (other than those held by Pubco) shall be exchanged for a book entry representing a number of Pubco Ordinary Shares determined in accordance with Section 2.6(g) to the extent applicable, upon the surrender of such certificate (in the case of certificated shares) or applicable document (in the case of non-certificated shares) in accordance with this Section 2.7(b). Until surrendered in accordance with this Section 2.7(b), each Purchaser Ordinary Share, Company Share and Norway Merger Sub 1 Share (other than those described in Section 2.6(b)(ii), Section 2.6(c) and Section 2.6(j) and the Norway Merger Sub 1 Shares held by Pubco) shall thereafter represent only the right to receive a number of Norway Merger Sub 1 Shares or Pubco Ordinary Shares, as applicable, determined in accordance with this Agreement and, in the case of the Company Shares, the Norway Plan of Merger, and in the case of the Purchaser Ordinary Shares, the Cayman Plan of Merger.

 

(c) No Liability. Notwithstanding anything to the contrary in this Section 2.7, none of the Surviving Corporations, including Pubco, or any other Party hereto shall be liable to any Person for any amount properly paid to a public official pursuant to any applicable abandoned property, escheat or similar law.

 

(d) Surrender of Purchaser Securities, Company Shares and Norway Merger Sub 1 Shares. All securities issued upon the surrender (to the extent applicable) of Purchaser Securities, Company Shares and Norway Merger Sub 1 Shares in accordance with the terms hereof shall be deemed to have been issued in full satisfaction of all rights pertaining to such securities, provided that any restrictions on the sale and transfer of Purchaser Securities, Norway Merger Sub 1 Shares or Company Shares shall also apply to the Norway Merger Sub 1 Shares or Pubco Securities, as applicable, so issued in exchange.

 

(e) Lost, Stolen or Destroyed Certificates. In the event any certificates shall have been lost, stolen or destroyed, Norway Merger Sub 1 shall issue in exchange for such lost, stolen or destroyed certificates, as the case may be, upon the making of an affidavit of that fact by the holder thereof, such securities, as may be required pursuant to Section 2.6; provided, however, that Norway Merger Sub 1 may, in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen or destroyed certificates to agree to indemnify the Surviving Corporations, or deliver a bond in such sum as it may reasonably direct as indemnity against any claim that may be made against the Surviving Corporations with respect to the certificates alleged to have been lost, stolen or destroyed.

 

8

 

 

2.8 Treatment of Company Options, Company Warrants and EDGE Warrants.

 

(a) Immediately prior to the Norway Effective Time, each Company Option set forth on Schedule 2.8(a) and that is outstanding as of such time shall be converted into the right to receive an option relating to Pubco Ordinary Shares upon substantially the same terms and conditions as are in effect with respect to such Company Options immediately prior to the Norway Effective Time (subject to any amendments required by the Luxembourg Companies Act), including with respect to vesting and termination-related provisions (each, a “Pubco Option”) except that (i) such Pubco Options shall relate to that whole number of Pubco Ordinary Shares (rounded down to the nearest whole share) equal to the number of shares of Company Shares subject to such Company Option, multiplied by the Exchange Ratio, and (ii) the exercise price per share for each such Pubco Option shall be equal to the exercise price per share of such Company Option in effect immediately prior to the Norway Effective Time as set forth in Section 7.3(a) of the Company Disclosure Schedules, divided by the Exchange Ratio and, to the fullest extent permitted by the terms of such Company Option or by consent from the holder of such Company Option, translated into US dollars based on the Relevant NOK/USD Exchange Rate (the exercise price per share, as so determined, being rounded up to the nearest full øre (1/100 of one NOK) or cent, as the case may be); provided, however, that the conversion of the Company Options will be made in a manner consistent with Treasury Regulation Section 1.424-1, such that such conversion will not constitute a “modification” of such Company Options for purposes of Section 409A or Section 424 of the Code.

 

(b) Immediately prior to the Norway Effective Time, each Company Warrant that is then outstanding shall be converted into the right to receive a warrant relating to Pubco Ordinary Shares upon substantially the same terms and conditions as are in effect with respect to such warrant immediately prior to the Norway Effective Time (subject to any amendments required by the Luxembourg Companies Act), including with respect to vesting and termination-related provisions (each, a “Pubco Warrant”) except that (a) such Pubco Warrant shall relate to that whole number of Pubco Ordinary Shares (rounded down to the nearest whole share) equal to the number of shares of Company Shares subject to such Company Warrant, multiplied by the Exchange Ratio, and (b) the exercise price per share for each such Pubco Warrant shall be equal to the exercise price per share of such Company Warrant in effect immediately prior to the Norway Effective Time as set forth in Section 7.3(a) of the Company Disclosure Schedules, divided by the Exchange Ratio and, to the fullest extent permitted by the terms of such Company Warrant or by consent from the holder of such Company Warrant, translated into US dollars based on the Relevant NOK/USD Exchange Rate (the exercise price per share, as so determined, being rounded up to the nearest full øre (1/100 of one NOK) or cent, as the case may be); provided, however, that the conversion of the Company Warrants will be made in a manner consistent with Treasury Regulation Section 1.424-1, such that such conversion will not constitute a “modification” of such Company Warrants for purposes of Section 409A or Section 424 of the Code.

 

(c) Immediately prior to the Norway Effective Time, each Company EDGE Warrant that is then outstanding shall be converted into the right to receive a warrant relating to Pubco Ordinary Shares upon substantially the same terms and conditions as are in effect with respect to such warrant immediately prior to the Norway Effective Time (subject to any amendments required by the Luxembourg Companies Act), including with respect to vesting and termination-related provisions (each, a “Pubco EDGE Warrant”) except that (a) such Pubco EDGE Warrant shall relate to that whole number of Pubco Ordinary Shares (rounded down to the nearest whole share) equal to the number of shares of Company Shares subject to such Company EDGE Warrant, multiplied by the Exchange Ratio, and (b) the exercise price per share for each such Pubco EDGE Warrant shall be equal to the exercise price per share of such Company EDGE Warrant in effect immediately prior to the Norway Effective Time as set forth in Section 7.3(a) of the Company Disclosure Schedules, divided by the Exchange Ratio and, to the fullest extent permitted by the terms of such Company EDGE Warrant or by consent from the holder of such Company EDGE Warrant, translated into US dollars based on the Relevant NOK/USD Exchange Rate (the exercise price per share, as so determined, being rounded up to the nearest full øre (1/100 of one NOK) or cent, as the case may be); provided, however, that the conversion of the Company EDGE Warrants will be made in a manner consistent with Treasury Regulation Section 1.424-1, such that such conversion will not constitute a “modification” of such Company EDGE Warrants for purposes of Section 409A or Section 424 of the Code.

 

9

 

 

(d) Pubco and Company shall take all necessary actions to effect the treatment of Company Options, Company Warrants and EDGE Warrants pursuant to Section 2.8 in accordance with, as applicable, the Company Benefit Plan, the applicable award agreements, the terms of the EDGE Warrants set forth in the Company’s shareholders’ resolutions passed July 8, 2020 and October 6, 2020, respectively and the applicable agreement set forth in Schedule 2.8(d).

 

(e) Pubco shall take all necessary action to ensure that no Pubco Option, Pubco Warrant or Pubco EDGE Warrant may be exercised prior to the effective date of an applicable Form S-8 (or other applicable registration form or exemption therefrom) of Pubco.

 

(f) Pubco shall take all necessary actions to ensure that each Pubco Ordinary Share underlying each Pubco Option, Pubco Warrant and Pubco EDGE Warrant issued pursuant to this Section 2.8 shall promptly, and in any event within sixty (60) calendar days from the date on which Pubco files the Form 8-K relating to the Second Closing, be registered on an applicable Form S-8 (or other applicable form) of Pubco.

 

2.9 Fractional Pubco Securities. Notwithstanding anything to the contrary contained herein, no fraction of a Pubco Security will be issued by Pubco by virtue of this Agreement or the transactions contemplated hereby, and each Person who would otherwise be entitled to a fraction of a Pubco Security (after aggregating all fractional Pubco Securities that would otherwise be received by such Person) shall instead have the number of Pubco Securities issued to such Person rounded down in the aggregate to the nearest whole Pubco Security.

 

2.10 Tax Consequences. The Parties hereby agree and acknowledge that, for U.S. federal income tax purposes, (i) the Cayman Merger is intended to qualify as a reorganization within the meaning of Section 368(a)(1)(F) of the Code, (ii) Preferred Share Transfer, the Norway Merger and the Cross-Border Merger are intended to be treated as a single integrated transaction that qualifies as a reorganization within the meaning of Section 368(a) of the Code, and (iii) this Agreement is intended to constitute and the Parties hereby adopt this Agreement as a “plan of reorganization” within the meaning of Treasury Regulation sections 1.368-2(g) and 1.368-3(a). The Parties hereby agree to file all Tax and other returns on a basis consistent with such characterization. Each of the Parties acknowledges and agrees that each (i) has had the opportunity to obtain independent legal and tax advice with respect to the transactions contemplated by this Agreement, and (ii) is responsible for paying its own Taxes, including any Taxes that may arise if the Cayman Merger does not qualify as a reorganization within the meaning of Section 368(a)(1)(F) of the Code or the Norway Merger does not qualify as a reorganization within the meaning of Section 368(a) of the Code.

 

2.11 Termination of Certain Agreements. The Company and the Major Shareholders shall, effective as of the Second Closing, cause any shareholders, voting or similar agreement among the Company and any of the Shareholders with respect to the Company Securities, and each Major Shareholder shall cause such agreements to terminate in full without any loss or liability to the Company whatsoever. Further, the Company and each Major Shareholder hereby waives any obligations of the Parties under the Company’s Organizational Documents or any agreement described in the sentence above with respect to the transactions contemplated by this Agreement and the Ancillary Documents, and any failure of the Parties to comply with the terms thereof in connection with the Transactions.

 

10

 

 

Article III
ESCROW

 

3.1 Escrow. At or prior to the First Closing, Pubco, the Purchaser Representative, the Shareholder Representative and the Escrow Agent shall enter into an Escrow Agreement, effective as of the Second Closing, in substantially the form attached hereto as Exhibit E (the “Escrow Agreement), pursuant to which Pubco shall cause to be delivered to the Escrow Agent at the Second Closing a number of Exchange Shares (each valued at the lower of (i) the Redemption Price and the (ii) PIPE Price) equal to five percent (5%) of the Base Consideration (including any equity securities paid as dividends or distributions with respect to such shares or into which such shares are exchanged or converted, the “Escrow Shares”) (which Escrow Shares would have otherwise been deliverable to the Major Shareholders at the Second Closing), with the Escrow Shares, along with any dividends, distributions and other earnings thereon and other Escrow Property, to be held by the Escrow Agent in a segregated escrow account (“Escrow Account) and disbursed therefrom in accordance with the terms and conditions of this Agreement and the Escrow Agreement. The Escrow Shares and other Escrow Property shall serve as partial security for the Major Shareholders’ obligations after the Second Closing under Article X and Article XI. The portion of the Exchange Shares that shall be withheld at the Second Closing for deposit in the Escrow Account shall be allocated among the Major Shareholders based on their respective Major Shareholder Pro Rata Percentage (such percentage being each such Major Shareholder’s “Escrow Allocation). For the avoidance of doubt, no Exchange Shares to be received by Shareholders other than the Major Shareholders shall be withheld at the Second Closing and deposited into the Escrow Account. Each Major Shareholder shall be deemed to be the owner of its Escrow Allocation of the Escrow Shares and to be entitled to the related dividends, distributions and other earnings thereon in respect of its Escrow Allocation of such Escrow Shares upon release from escrow to the Major Shareholders, subject to the retention of any dividends, distributions and other earnings thereon in the Escrow Account until disbursed therefrom in accordance with the terms and conditions of this Agreement and the Escrow Agreement. Each Major Shareholder shall have the right to vote its Escrow Allocation of such Escrow Shares during the time held in the Escrow Account as Escrow Shares.

 

Article IV
CLOSINGS

 

4.1 First Closing. Subject to the satisfaction or waiver of the conditions set forth in Article XII, the consummation of the transactions contemplated by Section 2.1(a) (the “First Closing) shall take place by means of telecommunication on the fifth (5th) Business Day after all the Closings conditions to this Agreement set forth in Article XII have been satisfied or waived at 5:00 p.m. Central European Time (other than the Closings conditions that by their terms are to be satisfied at the First Closing, but subject to the satisfaction or waiver of such conditions), or at such other date, time or place as Purchaser and the Company may agree in writing (the date and time at which the First Closing is actually held being the “First Closing Date). Notwithstanding Sections 4.1 or 4.2, the Parties may, by mutual agreement in writing, postpone the Closing Dates as necessary to disapply the dissenters’ rights available to Purchaser Shareholders under the Cayman Companies Act with respect to the Transactions.

 

4.2 Second Closing. The consummation the transactions contemplated by this Agreement (other than those which occur on the First Closing) (the “Second Closing” and together with the First Closing, the “Closings” and each, a “Closing”) shall take place by means of telecommunication on the second (2nd) Business Day after the First Closing at 5:00 p.m. Central European Time, or at such other date, time or place as Purchaser and the Company may agree in writing (the date and time at which the Second Closing is actually held being the “Second Closing Date, and together with the First Closing Date, the “Closing Dates” and each, a “Closing Date”).

  

4.3 Signatures for the Closings. Signatures for the Closings may be transmitted by emailed PDF files or by facsimile.

 

11

 

 

Article V
REPRESENTATIONS AND WARRANTIES OF PURCHASER

 

Except as set forth in (i) the disclosure schedules delivered by Purchaser to the Company on the date hereof (the “Purchaser Disclosure Schedules), the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to which they refer, or (ii) the SEC Reports that are available on the SEC’s website through EDGAR (other than disclosures in the “Risk Factors” or “Special Notes Regarding Forward-Looking Statements” sections of such reports and other disclosures that are similarly predictive or forward-looking in nature), Purchaser represents and warrants to the Company, as of the date hereof and as of the First Closing, as follows:

 

5.1 Organization and Standing. Purchaser is an exempted company duly incorporated, validly existing and in good standing under the Laws of the Cayman Islands. Each Norway Merger Sub is a corporation duly incorporated and validly existing under the Laws of Norway. Each of Purchaser and the Norway Merger Subs has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Purchaser and each of the Norway Merger Subs is duly qualified or licensed and in good standing to do business in each jurisdiction in which the character of the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except where the failure to be so qualified or licensed or in good standing can be cured without material cost or expense. Purchaser has heretofore made available to the Company accurate and complete copies of the Organizational Documents of Purchaser and the Norway Merger Subs, each as currently in effect. Neither Purchaser nor the Norway Merger Subs are in violation of any provision of its Organizational Documents in any material respect.

 

5.2 Authorization; Binding Agreement. Each of Purchaser and the Norway Merger Subs has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is a party, to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby, subject to obtaining the Required Purchaser Shareholder Approval, Norway Merger Sub 1 Shareholder Approval and Norway Merger Sub 2 Shareholder Approval. The execution and delivery of this Agreement and each Ancillary Document to which it is a party and the consummation of the transactions contemplated hereby and thereby (a) have been duly and validly authorized by the board of directors of Purchaser and the Norway Merger Subs and (b) other than the Required Purchaser Shareholder Approval, Norway Merger Sub 1 Shareholder Approval and Norway Merger Sub 2 Shareholder Approval, no other corporate proceedings on the part of Purchaser or the Norway Merger Subs are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary Document to which Purchaser or the Norway Merger Subs is a party shall be when delivered, duly and validly executed and delivered by Purchaser and, assuming the due authorization, execution and delivery of this Agreement and such Ancillary Documents by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of such Party, enforceable against such Party in accordance with its terms, except to the extent that enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization and moratorium laws and other laws of general application affecting the enforcement of creditors’ rights generally or by any applicable statute of limitation or by any valid defense of set-off or counterclaim, and the fact that equitable remedies or relief (including the remedy of specific performance) are subject to the discretion of the court from which such relief may be sought (collectively, the “Enforceability Exceptions).

 

12

 

 

5.3 Governmental Approvals. Except as otherwise described in Schedule 5.3, no Consent of or with any Governmental Authority, on the part of Purchaser or the Norway Merger Subs is required to be obtained or made in connection with the execution, delivery or performance by such Party of this Agreement and each Ancillary Document to which it is a party or the consummation by Purchaser or the Norway Merger Subs of the transactions contemplated hereby and thereby, other than (a) pursuant to Antitrust Laws, (b) such filings and Consents as are contemplated by this Agreement, (c) any filings required with NYSE or the SEC with respect to the Transactions, (d) applicable requirements, if any, of the Securities Act, the Exchange Act, and/or any state “blue sky” securities Laws, and the rules and regulations thereunder, and (e) where the failure to obtain or make such Consents or to make such filings or notifications, would not, individually or in the aggregate, reasonably be expected to have a material impact on the ability of Purchaser or the Norway Merger Subs on a timely basis to consummate the Transactions.

 

5.4 Non-Contravention. Except as otherwise described in Schedule 5.4, the execution and delivery by Purchaser and the Norway Merger Subs of this Agreement and each Ancillary Document to which it is a party, the consummation by such Party of the transactions contemplated hereby and thereby, and compliance by such Party with any of the provisions hereof and thereof, will not (a) subject to receiving the Required Purchaser Shareholder Approval, the Norway Merger Sub 1 Shareholder Approval and the Norway Merger Sub 2 Shareholder Approval, conflict with or violate any provision of such Party’s Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in Section 5.3 hereof, and the waiting periods referred to therein having expired, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent applicable to such Party or any of its properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by such Party under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien (other than a Permitted Lien) upon any of the properties or assets of such Party under, (viii) give rise to any obligation to obtain any Consent from or provide any notice to any Person who is not a Party or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of, any material Contract to which such Party is a party, except for any deviations from any of the foregoing clauses (a), (b) or (c) that would not reasonably be expected to adversely affect the Purchaser in any material respect or have a material impact on the ability of Purchaser or the Norway Merger Subs on a timely basis to consummate the Transactions.

 

5.5 Capitalization.

 

(a) Purchaser is authorized to issue 200,000,000 Class A ordinary shares of par value $0.0001 each, 20,000,000 Class B ordinary shares of par value $0.0001 each and 2,000,000 preference shares of par value $0.0001 each. As of the date of this Agreement, there are no issued or outstanding Purchaser Preferred Shares. As of the date of this Agreement, Norway Merger Sub 1 has issued 3,000 shares of par value of NOK 10.00 and Norway Merger Sub 2 has issued 3,000 shares of par value of NOK 10.00. All outstanding Purchaser Ordinary Shares, Norway Merger Sub 1 Shares and Norway Merger Sub 2 Shares are duly authorized, validly issued, fully paid and non-assessable and are not subject to or issued in violation of any purchase option, right of first refusal, preemptive right, subscription right or any similar right under any provision of the Cayman Companies Act, the Norway Companies Act or the respective Party’s Organizational Documents. None of the outstanding Purchaser Securities, Norway Merger Sub 1 Shares or the Norway Merger Sub 2 Shares has been issued in violation of any applicable securities Laws. Prior to giving effect to the transactions contemplated by this Agreement, Purchaser and the Norway Merger Subs do not have any Subsidiaries (other than the Norway Merger Subs in the case of Purchaser, and Norway Merger Sub 2 in the case of Norway Merger Sub 1), or own any equity, profits or voting interests in any other Person (other than Purchaser’s 100% ownership of the Norway Merger Subs, and Norway Merger Sub 1’s 100% ownership of Norway Merger Sub 2), or have any agreement or commitment to purchase any such interest, and each of Purchaser and the Norway Merger Subs has not agreed, is not obligated to make, and is not bound by any written, oral or other agreement, contract, binding understanding, instrument, note, option, warrant, purchase order, license, commitment or undertaking of any nature (other than this Agreement and the Ancillary Documents) under which it is or may upon the occurrence of certain events specified therein become obligated to make, any investment in or capital contribution to any other entity.

 

13

 

 

(b) Except as set forth in Schedule 5.5(b) there are no (i) outstanding options, warrants, puts, calls, convertible securities, preemptive or similar rights, (ii) bonds, debentures, notes or other Indebtedness having general voting rights or that are convertible or exchangeable into securities having such rights or (iii) subscriptions or other rights, agreements, arrangements, Contracts or commitments of any character (other than this Agreement and the Ancillary Documents), (A) relating to the issued or unissued shares of Purchaser or the Norway Merger Subs or (B) obligating Purchaser or the Norway Merger Subs to issue, transfer, deliver or sell or cause to be issued, transferred, delivered or sold any options or shares or securities convertible into or exchangeable for such shares, or (C) obligating Purchaser or the Norway Merger Subs to grant, extend or enter into any such option, warrant, call, subscription or other right, agreement, arrangement or commitment for such capital shares. Other than the Redemption or as expressly set forth in this Agreement, the Purchaser’s Organizational Documents, there are no outstanding obligations of Purchaser or the Norway Merger Subs to repurchase, redeem or otherwise acquire any shares or other securities of Purchaser or the Norway Merger Subs (as applicable) or to provide funds to make any investment (in the form of a loan, capital contribution or otherwise) in any Person. Except as set forth in Schedule 5.5(b), and other than the Purchaser Shareholder Irrevocable Undertakings and the Insider Letter, Purchaser and Norway Merger Subs are not party to any agreement which contains registration rights other than the Existing Registration Rights Agreement, there are no shareholders agreements, voting trusts or other agreements or understandings to which Purchaser or the Norway Merger Subs is a party with respect to the voting of any shares of Purchaser or the Norway Merger Subs. As a result of the consummation of the transactions contemplated hereby, except as set forth on Schedule 5.5(b), no warrants, options or other securities of Purchaser or Norway Merger Subs are issuable and no rights in connection with any shares, warrants, options or other securities of Purchaser or the Norway Merger Subs accelerate or otherwise become triggered (whether as to voting, exercisability, convertibility or otherwise).

 

(c) All Indebtedness of Purchaser as of the date of this Agreement is disclosed on Schedule 5.5(c). No Indebtedness of Purchaser contains any restriction upon (i) the prepayment of any of such Indebtedness, (ii) the incurrence of Indebtedness by Purchaser or (iii) the ability of Purchaser to grant any Lien on its properties or assets. None of the Norway Merger Subs has any Indebtedness.

 

(d) As of the date hereof, Purchaser has Purchaser Warrants comprised of 8,750,000 Purchaser Private Warrants and 14,375,000 Purchaser Public Warrants. The Purchaser Public Warrants are exercisable for one (1) Purchaser Class A Ordinary Share per warrant at a purchase price of $11.50 per share. The Purchaser Private Warrants are exercisable for one (1) Purchaser Class A Ordinary Share per warrant at a purchase price of $11.50 per share. No Purchaser Warrants are exercisable until the Closings. All outstanding Purchaser Warrants (i) have been duly authorized and validly issued and are fully paid and non-assessable; (ii) have been offered, sold and issued in compliance with applicable Law, and all requirements set forth in (1) the Purchaser Organizational Documents and (2) any other applicable contracts governing the issuance of such securities; and (iii) are not subject to, nor have they been issued in violation of, any purchase option, call option, right of first refusal, preemptive right, subscription right or any similar right under any provision of any applicable Law, Purchaser’s Organizational Documents or any Contract to which Purchaser is a party or otherwise bound.

 

14

 

 

(e) Purchaser is not entering into this Agreement or the transactions contemplated hereby with the actual intent to hinder, delay or defraud either present or future creditors of Purchaser or any of its Affiliates. At the Second Closing and, after giving effect to the release of the funds held in the Trust Account, Purchaser and its Subsidiaries (i) will be solvent (in that both the fair value of its assets will not be less than the sum of its debts and that the present fair saleable value of its assets will not be less than the amount required to pay its probable liability on its recourse debts as they mature or become due); (ii) will have adequate capital and liquidity with which to engage in its business and all businesses in which it is about to engage; and (iii) will not have incurred and does not plan to incur debts beyond its ability to pay as they mature or become due.

 

(f) Except as set forth in Schedule 5.5(f), since the date of formation of Purchaser and the Norway Merger Subs, and except as contemplated by this Agreement, Purchaser and the Norway Merger Subs have not declared or paid any distribution or dividend in respect of its shares and has not repurchased, redeemed or otherwise acquired any of its shares, and Purchaser’s and the Norway Merger Subs’ boards of directors have not authorized any of the foregoing.

 

5.6 SEC Filings and Purchaser Financials.

 

(a) Purchaser, since the IPO, has filed all forms, reports, schedules, statements, registration statements, prospectuses and other documents required to be filed or furnished by Purchaser with the SEC under the Securities Act and/or the Exchange Act, together with any amendments, restatements or supplements thereto, and will file all such forms, reports, schedules, statements and other documents required to be filed subsequent to the date of this Agreement. Except to the extent available on the SEC’s web site through EDGAR, Purchaser has delivered to the Company copies in the form filed with the SEC of all of the following: (i) Purchaser’s annual reports on Form 10-K for each fiscal year of Purchaser beginning with the first year Purchaser was required to file such a form, (ii) Purchaser’s quarterly reports on Form 10-Q for each fiscal quarter that Purchaser filed such reports to disclose its quarterly financial results since the beginning of the first fiscal year of Purchaser referred to in clause (i) above, (iii) all other forms, reports, registration statements, prospectuses and other documents (other than preliminary materials) filed by Purchaser with the SEC since the beginning of the first fiscal year referred to in clause (i) above (the forms, reports, registration statements, prospectuses and other documents referred to in clauses (i), (ii) and (iii) above, whether or not available through EDGAR are, collectively, the “SEC Reports) and (iv) all certifications and statements required by (A) Rules 13a-14 or 15d-14 under the Exchange Act, and (B) 18 U.S.C. §1350 (Section 906 of SOX) with respect to any report referred to in clause (i) or (ii) above (collectively, the “Public Certifications). The SEC Reports (x) were prepared in all material respects in accordance with the requirements of the Securities Act and the Exchange Act, as the case may be, and the rules and regulations thereunder and (y) did not, as of their respective effective dates (in the case of SEC Reports that are registration statements filed pursuant to the requirements of the Securities Act) and at the time they were filed with the SEC (in the case of all other SEC Reports) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The Public Certifications are each true as of their respective dates of filing. As used in this Section 5.6, the term “file” shall be broadly construed to include any manner permitted by SEC rules and regulations in which a document or information is filed, furnished, supplied or otherwise made available to the SEC. As of the date of this Agreement, to the Knowledge of the Purchaser, the SEC Reports are not currently subject to any SEC review and there are no open SEC comments to any SEC Reports which have not been responded to. As of the date of this Agreement, (A) the Purchaser Units, the Purchaser Class A Ordinary Shares and the Purchaser Public Warrants are listed on the NYSE, (B) Purchaser has not received any written deficiency notice from the NYSE relating to the continued listing requirements of such Purchaser Securities, (C) there are no Actions pending or, to the Knowledge of Purchaser, threatened against Purchaser by the NYSE or the Financial Industry Regulatory Authority with respect to any intention by such entity to suspend, prohibit or terminate the quoting of such Purchaser Securities on the NYSE and (D) Purchaser is in compliance with all of the applicable corporate governance rules of the NYSE.

 

15

 

 

(b) The financial statements and notes of Purchaser contained or incorporated by reference in the SEC Reports (the “Purchaser Financials), complied as to form with the published rules and regulations of the SEC with respect thereto, were prepared in accordance with GAAP applied on a consistent basis throughout the periods involved and fairly present in all material respects the financial position and the results of operations, changes in shareholders’ equity, and cash flows of Purchaser at the respective dates of and for the periods referred to in such financial statements (except as may be indicated in the notes thereto and for the omission of notes and audit adjustments in the case of unaudited quarterly financial statements to the extent permitted by Regulation S-X or Regulation S-K, as applicable).

 

(c) Purchaser maintains disclosure controls and procedures that satisfy the requirements of Rule 13a-15 under the Exchange Act, and such disclosure controls and procedures are designed to ensure that all material information concerning Purchaser is made known on a timely basis to the individuals responsible for the preparation of Purchaser’s filings with the SEC and other public disclosure documents.

 

(d) Except as and to the extent reflected or reserved against in the Purchaser Financials, Purchaser has not incurred any Liabilities or obligations of the type required to be reflected on a balance sheet in accordance with GAAP that are not adequately reflected or reserved on or provided for in the Purchaser Financials, other than Liabilities that have been incurred in the ordinary course of business consistent with past practice since the date of the last balance sheet.

 

5.7 Absence of Certain Changes. As of the date of this Agreement, except as set forth in Schedule 5.7, Purchaser has, (a) since its formation, conducted no business other than its formation, the public offering of its securities (and the related private offerings), public reporting and its search for an initial Business Combination as described in the IPO Prospectus (including the investigation of the Target Companies and the negotiation and execution of this Agreement) and related activities and (b) since December 31, 2019, there has not been any event or occurrence that has had, or would reasonably be expected to have, individually or in the aggregate, an adverse effect on the Purchaser, in any material respect.

 

5.8 Compliance with Laws. Each of Purchaser and the Norway Merger Subs is, and has since its formation been, in compliance with all Laws applicable to it and the conduct of its business except for such noncompliance which would not reasonably be expected to have an adverse effect on the Purchaser and the Norway Merger Subs, in any material respect, and neither Purchaser nor the Norway Merger Subs has received written notice alleging any violation of applicable Law in any material respect by Purchaser or the Norway Merger Subs.

 

5.9 Actions; Orders; Permits. There is no pending or, to the Knowledge of Purchaser, threatened Action to which Purchaser is subject which would reasonably be expected to have an adverse effect on Purchaser, in any material respect. There is no material Action that Purchaser has pending against any other Person. Neither Purchaser, nor, to the Knowledge of Purchaser, any of its directors or officers are subject to any material Orders of any Governmental Authority, nor are any such Orders pending. None of Purchaser’s directors or officers have in the past five (5) years been charged with, indicted for, arrested for, or convicted of any felony or any crime involving fraud. Purchaser holds all material Permits necessary to lawfully conduct its business as presently conducted, and to own, lease and operate its assets and properties, all of which are in full force and effect, except where the failure to hold such Permit or for such Permit to be in full force and effect would not reasonably be expected to have an adverse effect on Purchaser, in any material respect.

 

16

 

 

5.10 Taxes and Returns.

 

(a) Purchaser has timely filed, or caused to be timely filed, all material Tax Returns required to be filed by it, and all such Tax Returns are true, accurate, correct and complete in all material respects, and has paid, collected or withheld, or caused to be paid, collected or withheld, all material Taxes required to be paid, collected or withheld, other than such Taxes for which adequate reserves in the Purchaser Financials have been established in accordance with GAAP. There are no material audits, examinations, investigations or other proceedings pending against Purchaser in respect of any material Tax, and Purchaser has not been notified in writing of any material proposed Tax claims or assessments against Purchaser (other than, in each case, claims or assessments for which adequate reserves in the Purchaser Financials have been established in accordance with GAAP or are immaterial in amount). There are no material Liens with respect to Taxes upon any of Purchaser’s assets, other than Permitted Liens. Purchaser has no outstanding waivers or extensions of any applicable statute of limitations to assess any material amount of Taxes. There are no outstanding requests by Purchaser for any extension of time within which to file any Tax Return or within which to pay any Taxes shown to be due on any Tax Return.

 

(b) Purchaser is not aware of the existence of any fact, or any action it has taken (or failed to take) or agreed to take, that would reasonably be expected to prevent or impede the Norway Merger from qualifying as reorganizations within the meaning of Section 368(a) of the Code.

 

5.11 Employees. Other than reimbursement of any out-of-pocket expenses incurred by the Purchaser’s officers and directors in connection with activities on the Purchaser’s behalf in an aggregate amount not in excess of the amount of cash held by the Purchaser outside of the Trust Account, the Purchaser has no unsatisfied material liability with respect to any employee, officer or director. The Purchaser has never, and does not currently maintain, sponsor, contribute to or have any direct liability under any employee benefit plan nonqualified deferred compensation plan, bonus, stock option, stock purchase, restricted stock, incentive, deferred compensation, retiree medical or life insurance, supplemental retirement, severance, change in control, fringe benefit, sick pay and vacation plans or arrangements or other employee benefit plans, programs or arrangements.

 

5.12 Investment Company Act. Purchaser is not an “investment company” or a Person directly or indirectly “controlled” by or acting on behalf of an “investment company”, or required to register as an “investment company”, in each case within the meaning of the Investment Company Act.

 

5.13 Finders and Brokers. Except as set forth on Schedule 5.13, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from Purchaser or any of its Affiliates in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of Purchaser.

 

5.14 Certain Business Practices.

 

(a) Since the formation of Purchaser, neither Purchaser, nor any of its Representatives acting on its behalf, has in material violation of applicable Law (i) used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees, to foreign or domestic political parties or campaigns or violated any provision of Anti-Bribery Laws or (iii) directly or indirectly, given or agreed to give any unlawful gift or similar benefit in any material amount to any customer, supplier, governmental employee or other Person who is or may be in a position to help or hinder Purchaser or assist it in connection with any actual or proposed transaction.

 

(b) The operations of Purchaser are and have been conducted at all times in material compliance with money laundering statutes in all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority, and no Action involving Purchaser with respect to any of the foregoing is pending or, to the Knowledge of Purchaser, threatened.

 

17

 

 

(c) None of Purchaser or any of its directors or officers, or, to the Knowledge of Purchaser, any other Representative acting on behalf of Purchaser is currently identified on the specially designated nationals or other blocked person list or otherwise currently the subject of any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC), and Purchaser has not directly or indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary, joint venture partner or other Person, in connection with any sales or operations in any other country targeted under comprehensive sanctions by OFAC (such countries, as of the date hereof, being the Crimea region of Ukraine, Cuba, Iran, North Korea, and Syria) or for the purpose of financing the activities of any Person the subject of, or otherwise in violation of, any U.S. sanctions administered by OFAC, in each case in violation of applicable sanctions.

 

5.15 Independent Investigation. Each of Purchaser and the Norway Merger Subs has conducted its own independent investigation, review and analysis of the business, results of operations, condition (financial or otherwise) or assets of the Target Companies and acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents and data of the Target Companies for such purpose. Each of Purchaser and the Norway Merger Subs acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties of the Company and the Major Shareholders set forth in this Agreement (including the related portions of the Company Disclosure Schedules) and in any certificate delivered to Purchaser or the Norway Merger Subs pursuant hereto; and (b) none of the Company, the Major Shareholders or their respective Representatives have made any representation or warranty as to the Target Companies, the Major Shareholders or this Agreement, except as expressly set forth in this Agreement (including the related portions of the Company Disclosure Schedules) or in any certificate delivered to Purchaser or the Norway Merger Subs pursuant hereto and each of Purchaser and the Norway Merger Subs is expressly disclaiming any reliance on any representations or warranties other than those set forth in Articles VII and VIII of this Agreement.

 

5.16 Trust Account. As of the date hereof, there is at least $279 million invested in the Trust Account, maintained by the Trustee pursuant to the Trust Agreement. Prior to the Second Closing, none of the funds held in the Trust Account may be released except in accordance with the Trust Agreement. Amounts in the Trust Account are invested in United States government securities or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act. Purchaser has performed all material obligations required to be performed by it to date under, and is not in material default, breach or delinquent in performance or any other respect (claimed or actual) in connection with, the Trust Agreement, and no event has occurred which, with due notice in lapse of time or both, would constitute a material breach thereunder. As of the date hereof, there are no claims or proceedings pending with respect to the Trust Account. As of the date hereof, assuming the accuracy of the representations and warranties of the Company contained herein and the compliance by the Company with its obligations hereunder and the satisfaction of the other conditions to the Closings set forth in Article XII, Purchaser has no reason to believe that any of the conditions to the use of the funds in the Trust Account on the Second Closing Date (net of obligations with respect to redemptions and the payment of Taxes and other permitted payments or distributions) will not be satisfied as of the First Closing Date.

 

5.17 Exclusivity of Representations and Warranties. Except as otherwise expressly provided in this Article V (as modified by the Purchaser Disclosure Schedules), the Ancillary Documents and any certificates delivered pursuant to this Agreement, the Purchaser hereby expressly disclaims and negates, any other express or implied representation or warranty whatsoever (whether at Law or in equity) with respect to the Purchaser, its Affiliates, and any matter relating to any of them, including their affairs, the condition, value or quality of the assets, liabilities, financial condition or results of operations, or with respect to the accuracy or completeness of any other information made available to the Company, its affiliates or any of their respective Representatives by, or on behalf of, the Purchaser, and any such representations or warranties are expressly disclaimed.

 

18

 

 

Article VI
REPRESENTATIONS AND WARRANTIES OF PUBCO

 

Pubco represents and warrants to the Company, as of the date hereof and as of the First Closing and Second Closing (provided that the representations and warranties of Pubco as of the Second Closing shall be deemed qualified to give effect to any transactions contemplated to occur on the First Closing), as follows:

 

6.1 Organization and Standing. Pubco is a corporation in the form of a public limited liability company (société anonyme) duly incorporated and validly existing under the laws of Luxembourg. Cayman Merger Sub is an exempted company, duly incorporated, validly existing and in good standing under the Laws of the Cayman Islands. Each of Pubco and the Cayman Merger Sub has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Each of Pubco and the Cayman Merger Sub is duly qualified or licensed and, in the case of Cayman Merger Sub is in good standing, to do business in each jurisdiction in which the character of the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary. Pubco has heretofore made available to Purchaser accurate and complete copies of the Organizational Documents of Pubco and the Cayman Merger Sub each as currently in effect. Neither Pubco nor the Cayman Merger Sub is in violation of any provision of its Organizational Documents in any material respect.

 

6.2 Authorization; Binding Agreement. Subject to obtaining the Required Pubco Shareholder Approval and the Required Cayman Merger Sub Shareholder Approval, each of Pubco and the Cayman Merger Sub has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is a party, to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and each Ancillary Document to which it is a party and the consummation of the transactions contemplated hereby and thereby have been duly and validly authorized by the board of directors and shareholders of Pubco and the Cayman Merger Sub and no other corporate proceedings, other than as expressly set forth elsewhere in this Agreement, on the part of Pubco or the Cayman Merger Sub is necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary Document to which Pubco or the Cayman Merger Sub is a party has been or shall be when delivered, duly and validly executed and delivered by such Party and, assuming the due authorization, execution and delivery of this Agreement and such Ancillary Documents by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of such Party, enforceable against such Party in accordance with its terms, subject to the Enforceability Exceptions.

 

6.3 Governmental Approvals. Except as otherwise described on Schedule 6.3, no Consent of or with any Governmental Authority, on the part of Pubco or the Cayman Merger Sub is required to be obtained or made in connection with the execution, delivery or performance by such Party of this Agreement and each Ancillary Document to which it is a party or the consummation by such Party of the transactions contemplated hereby and thereby, other than (a) pursuant to Antitrust Laws, (b) such filings or Consents as contemplated by this Agreement, (c) any filings required with the NYSE or the SEC with respect to the transactions contemplated by this Agreement, (d) applicable requirements, if any, of the Securities Act, the Exchange Act, and/or any state “blue sky” securities Laws, and the rules and regulations thereunder, and (e) where the failure to obtain or make such Consents or to make such filings or notifications, would not, individually or in the aggregate, reasonably be expected to have a material impact on the ability of Pubco or the Cayman Merger Sub on a timely basis to consummate the Transactions.

 

19

 

 

6.4 Non-Contravention. The execution and delivery by Pubco and the Cayman Merger Sub of this Agreement and each Ancillary Document to which it is a party, the consummation by such Party of the transactions contemplated hereby and thereby, and compliance by such Party with any of the provisions hereof and thereof, will not (a) conflict with or violate any provision of such Party’s Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in Section 6.3 hereof, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent applicable to such Party or any of its properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by such Party under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of such Party under, (viii) give rise to any obligation to obtain any Consent from or provide any notice to any Person who is not a Party or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of, any material Contract of such Party, except for any deviations from any of the foregoing clauses (a), (b) or (c) that would not, individually or in the aggregate, reasonably be expected to have a material impact on the ability of Pubco or Cayman Merger Sub on a timely basis to consummate the Transactions.

 

6.5 Capitalization.

 

(a) As of the date hereof, Pubco’s outstanding share capital consists of 40,000 fully paid redeemable shares with no nominal value. As of the date hereof, Cayman Merger Sub is authorized to issue 50,000 ordinary shares, of par value $1.00 each. The issued and outstanding Cayman Merger Sub Shares consist of one ordinary share, of par value $1.00. Prior to giving effect to the transactions contemplated by this Agreement, other than the Cayman Merger Sub, Pubco does not have any Subsidiaries or own any equity interests in any other Person.

 

(b) Except with respect to the Commitment Agreements and the Preferred Share Purchase Agreement, there are no (i) outstanding options, warrants, puts, calls, convertible securities, preemptive or similar rights, (ii) bonds, debentures, notes or other Indebtedness having general voting rights or that are convertible or exchangeable into securities having such rights or (iii) subscriptions or other rights, agreements, arrangements, Contracts or commitments of any character (other than this Agreement and the Ancillary Documents), (A) relating to the issued or unissued shares of Pubco or the Cayman Merger Sub or (B) obligating Pubco and the Cayman Merger Sub to issue, transfer, deliver or sell or cause to be issued, transferred, delivered, sold or repurchased any options or shares or securities convertible into or exchangeable for such shares, or (C) obligating Pubco or the Cayman Merger Sub to grant, extend or enter into any such option, warrant, call, subscription or other right, agreement, arrangement or commitment for such capital shares. Each of Pubco and the Cayman Merger Sub is not a party to any agreement which contains registration rights, there are no shareholders agreements, voting trusts or other agreements or understandings to which each of Pubco or the Cayman Merger Sub is a party with respect to the voting of any shares of Pubco or the Cayman Merger Sub (other than this Agreement and the Ancillary Documents). As a result of the consummation of the transactions contemplated hereby, no warrants, options or other securities of Pubco or the Cayman Merger Sub are issuable and no rights in connection with any shares, warrants, options or other securities of Pubco or the Cayman Merger Sub accelerate or otherwise become triggered (whether as to voting, exercisability, convertibility or otherwise).

 

20

 

 

(c) Neither Pubco nor the Cayman Merger Sub has any Indebtedness.

 

(d) Since the date of formation of Pubco and the Cayman Merger Sub, and except as contemplated by this Agreement, each of Pubco and the Cayman Merger Sub has not declared or paid any distribution or dividend in respect of its shares and has not repurchased, redeemed or otherwise acquired any of its shares, and each of Pubco’s and the Cayman Merger Sub’s board of directors has not authorized any of the foregoing.

 

6.6 Ownership of Exchange Shares. (i) All Exchange Shares to be issued and delivered in accordance with Article II shall be, upon issuance and delivery of such Exchange Shares, duly authorized, validly issued, fully paid, non-assessable and free and clear of all Liens, and (ii) upon issuance and delivery of such Exchange Shares, each holder of such Exchange Shares shall have good and valid title to its portion of such Exchange Shares, in each case of clauses (i) and (ii), other than restrictions arising from applicable securities Laws, the Lock-Up Agreements, the Registration Rights Agreement, the Pubco Articles, the provisions of this Agreement and any Liens incurred by such holder and (iii) the issuance of such Exchange Shares pursuant hereto will not be subject to or give rise to any preemptive rights or rights of first refusal.

 

6.7 Compliance with Laws. Each of Pubco and the Cayman Merger Sub is, and has since its formation been, in compliance with all Laws applicable to it and the conduct of its business except for such noncompliance which would not reasonably be expected to have an adverse effect on any of the Pubco or the Cayman Merger Sub, in any material respect, and each of Pubco and the Cayman Merger Sub has not received written notice alleging any violation of applicable Law in any material respect by the Pubco or the Cayman Merger Sub.

 

6.8 Pubco and Cayman Merger Sub Activities. Since their formation, Pubco and the Cayman Merger Sub have not engaged in any business activities other than as contemplated by this Agreement, do not own directly or indirectly any ownership, equity, profits or voting interest in any Person (other than Pubco’s 100% ownership of the Cayman Merger Sub) and have no assets or Liabilities except those incurred in connection with this Agreement and the Ancillary Documents to which they are a party and the Transactions, and, other than this Agreement and the Ancillary Documents to which they are a party, Pubco and the Cayman Merger Sub are not party to or bound by any Contract.

 

6.9 Finders and Brokers. No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from Purchaser, Pubco, the Target Companies or any of their respective Affiliates in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of Pubco or the Cayman Merger Sub.

 

6.10 Investment Company Act. Pubco is not an “investment company”, a Person directly or indirectly controlled by or acting on behalf of an “investment company”, or required to register as an “investment company”, in each case within the meanings of the Investment Company Act.

 

21

 

 

6.11 Information Supplied. None of the information supplied or to be supplied by Pubco or the Cayman Merger Sub expressly for inclusion or incorporation by reference: (a) in any Current Report on Form 8-K, and any exhibits thereto or any other report, form, registration or other filing made with any Governmental Authority (including the SEC) or stock exchange (including the NYSE) with respect to the transactions contemplated by this Agreement or any Ancillary Documents; (b) in the Registration Statement; or (c) in the mailings or other distributions to the holders of Purchaser Securities or Pubco’s stockholders and/or prospective investors with respect to the consummation of the transactions contemplated by this Agreement or in any amendment to any of documents identified in (a) through (c), will, when filed, made available, mailed or distributed, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. None of the information supplied or to be supplied by Pubco or the Cayman Merger Sub expressly for inclusion or incorporation by reference in any of the Signing Press Release, the Signing Filing, the Closing Filing and the Closing Press Release will, when filed or distributed, as applicable, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, neither Pubco nor the Cayman Merger Sub makes any representation, warranty or covenant with respect to any information supplied by or on behalf of Purchaser, the Target Companies, the Shareholders or any of their respective Affiliates.

 

6.12 Independent Investigation. Each of Pubco and the Cayman Merger Sub has conducted its own independent investigation, review and analysis of the business, results of operations, condition (financial or otherwise) or assets of the Target Companies and Purchaser and acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents and data of the Target Companies and Purchaser for such purpose. Each of Pubco and the Cayman Merger Sub acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties of the Company and Purchaser set forth in this Agreement (including the related portions of the Company Disclosure Schedules and the Purchaser Disclosure Schedules) and in any certificate delivered to Pubco or the Cayman Merger Sub pursuant hereto; and (b) none of the Company, the Major Shareholders or their respective Representatives have made any representation or warranty as to the Target Companies, the Major Shareholders or this Agreement, except as expressly set forth in this Agreement (including the related portions of the Company Disclosure Schedules), in any Ancillary Document or in any certificate delivered to Pubco or the Cayman Merger Sub pursuant hereto and Pubco is expressly disclaiming any reliance on any representations or warranties other than those set forth in Articles VII and VIII of this Agreement.

 

6.13 Exclusivity of Representations and Warranties Except as otherwise expressly provided in this Article VI (as modified by the Pubco Disclosure Schedules), the Ancillary Documents and any certificates delivered pursuant to this Agreement, Pubco expressly disclaims and negates, any other express or implied representation or warranty whatsoever (whether at Law or in equity) with respect to Pubco, its Affiliates, and any matter relating to any of them, including their affairs, the condition, value or quality of the assets, liabilities, financial condition or results of operations, or with respect to the accuracy or completeness of any other information made available to the Company, its affiliates or any of their respective Representatives by, or on behalf of, the Pubco, and any such representations or warranties are expressly disclaimed.

 

Article VII
REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

Except as set forth in the disclosure schedules delivered by the Company to Purchaser no later than the time immediately preceding the entering into of this Agreement (the “Company Disclosure Schedules), the Company hereby represents and warrants to Purchaser and Pubco, as of the time of entering into of this Agreement and, subject to any updates delivered by the Company to Purchaser pursuant to Section 9.29, as of the time immediately preceding the First Closing and as of the time immediately preceding the Second Closing, that the statements contained in this Article VII are true and correct (provided that such disclosure shall be deemed to qualify or provide disclosure in response to (x) the section or subsection of this Article VII under which such disclosure is made in the Company Disclosure Schedules, and (y) any other section or subsection of this Article VII to the extent it is reasonably apparent on its face), as follows:

 

22

 

 

7.1 Organization and Standing. The Company is a company duly organized and validly existing under the Laws of Norway and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Each other Target Company is a corporation or other entity duly formed, validly existing and in good standing under the Laws of its jurisdiction of organization and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted. Each Target Company is duly qualified or licensed and in good standing in the jurisdiction in which it is incorporated or registered and in each other jurisdiction where it does business or operates to the extent that the character of the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or licensing necessary, except where the failure to be so qualified or licensed or in good standing would not be material to the Target Companies, taken as a whole. Schedule 7.1 lists the jurisdiction of organization of each Target Company and all names other than its legal name under which any Target Company does business as of the date hereof. The Company has provided to Purchaser or Purchaser’s counsel accurate and complete copies of the Organizational Documents of each Target Company, each as amended to date and as currently in effect. No Target Company is in violation of any provision of its Organizational Documents in any material respect.

 

7.2 Authorization; Binding Agreement. Other than with respect to the Required Company Shareholder Approval, the Company has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which it is or is required to be a party, to perform the Company’s obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and each Ancillary Document to which the Company is or is required to be a party and the consummation of the transactions contemplated hereby and thereby, (a) have been, subject to receipt of the Required Company Shareholder Approval, duly and validly authorized by the board of directors and shareholders of the Company in accordance with the Company’s Organizational Documents and the Norwegian Companies Act any other applicable Law and any Contract to which the Company or any of its shareholders are party or bound and (b) no other corporate proceedings on the part of the Company are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated hereby and thereby (other than the approval by the Company’s board of directors of the Norway Demerger Plan and the Norway Merger Plan, the Required Company Shareholder Approval and the filing and recordation of appropriate documents, in connection with the Agreement and each Ancillary Document to which the Company is or is required to be a party, as required by applicable Law). This Agreement has been, and each Ancillary Document to which the Company is or is required to be a party at the applicable Closing shall be when delivered, duly and validly executed and delivered by the Company and assuming the due authorization, execution and delivery of this Agreement and any such Ancillary Document by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions.

 

7.3 Capitalization.

 

(a) The Company is authorized to issue an additional 108,112,829 Company Shares, of which 15,612,829 are authorized to be issued by way of the Company Warrants and EDGE Warrants and 92,500,000 Company Shares are authorized to be issued by way of the Company Preferred Share Linked Warrants. As of the date hereof, the outstanding capital shares of the Company consists of 209,196,827 Company Shares and 7,500,000 Company Preferred Shares, which are owned legally (registered) and beneficially by the Persons set forth on Schedule 7.3(a), and there are no other outstanding equity interests of the Company other than the Company Options referred to in Section 2.8(a) and 7.3(b). After giving effect to the transactions contemplated by this Agreement and the Preferred Share Acquisition Agreement, Pubco shall own all of the issued and outstanding equity interests of the Company free and clear of any Liens. Except as set forth on Schedule 7.3(a), all of the outstanding shares and other equity interests of the Company have been duly authorized, are fully paid and non-assessable and were not issued in violation of any purchase option, right of first refusal, preemptive right, subscription right or any similar right under any provision of the Norwegian Companies Act, any other applicable Law, the Company’s Organizational Documents or any Contract to which the Company is a party or by which the Company or its securities are bound. As of the date hereof, the Company holds 0 shares in treasury.

 

23

 

 

(b) Schedule 7.3(b) sets forth a true and complete list, as of the date hereof of each Company Equity Plan. The board of directors of the Company shall amend the Company Equity Plan and take all other necessary actions, effective as of immediately prior to the First Closing, in order to (i) cancel the remaining unallocated share reserve under the Company Equity Plan and provide that shares in respect of Company Options that for any reason become re-eligible for future issuance, shall be cancelled, and (ii) provide that no new Company Options will be granted under the Company Equity Plan. Schedule 2.8(a) sets forth the beneficial and record owners of all outstanding Company Options as of the date hereof (including the number of Company Options held), all of which Company Options will be fully satisfied by the Company at or promptly following the Second Closing (except for such Company Options that will be rolled over into options relating to equity of Pubco pursuant to the provisions of Section 2.8(a)). Except as set forth on Schedule 7.3(b), there are no Company Convertible Securities or preemptive rights or rights of first refusal or first offer, nor are there any Contracts, commitments, arrangements or restrictions to which the Company or, to the Knowledge of the Company, any of its shareholders are a party or bound relating to any equity securities of the Company, whether or not outstanding. Other than the Company Equity Plan, there are no outstanding or authorized equity appreciation, phantom equity or similar rights with respect to the Company. Other than the Major Shareholder Irrevocable Undertakings, there are no voting trusts, proxies, shareholder agreements or any other agreements or understandings with respect to the voting of the Company’s equity interests. Except as set forth in the Company’s Organizational Documents, there are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise acquire any of its equity interests or securities, nor has the Company granted any registration rights to any Person with respect to its equity securities. All of the issued and outstanding securities of the Company have been granted, offered, sold and issued in compliance with all applicable securities Laws. As a result of the consummation of the transactions contemplated by this Agreement, no equity interests of the Company are issuable and, other than in connection with the Company Equity Plan, Company Warrants and EDGE Warrants), in each case consistent with Section 2.8(a), Section 2.8(b) and Section 2.8(c), no rights in connection with any interests, warrants, rights, options or other securities of the Company accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or otherwise).

 

(c) Since the Locked Box Date, the Company has not declared or paid any distribution or dividend in respect of its equity interests and has not repurchased, redeemed or otherwise acquired any equity interests of the Company, and the board of directors of the Company has not authorized any of the foregoing.

 

7.4 Subsidiaries. Schedule 7.4 sets forth the name of each Subsidiary of the Company as of the date hereof, and with respect to each Subsidiary (a) its jurisdiction of organization, (b) its authorized shares or other equity interests (if applicable), and (c) the number of issued and outstanding shares or other equity interests and the record holders and beneficial owners thereof. All of the outstanding equity securities of each Subsidiary of the Company are duly authorized and validly issued, fully paid and non-assessable (if applicable), and were offered, sold and delivered in compliance with all applicable securities Laws, and owned by one or more of the Target Companies free and clear of all Liens. There are no Contracts to which the Company or any of its Affiliates is a party or bound with respect to the voting (including voting trusts or proxies) of the equity interests of any Subsidiary of the Company other than the Organizational Documents of any such Subsidiary. Except as set forth on Schedule 7.4, there are no outstanding or authorized options, warrants, rights, agreements, subscriptions, convertible securities or commitments to which any Subsidiary of the Company is a party or which are binding upon any Subsidiary of the Company providing for the issuance or redemption of any equity interests of any Subsidiary of the Company. Except for the equity interests of the Subsidiaries listed on Schedule 7.4, there are no outstanding equity appreciation, phantom equity, profit participation or similar rights granted by any Subsidiary of the Company. The Company does not own or have any rights to acquire, directly or indirectly, any equity interests of, or otherwise Control, any Person. No Target Company is a participant in any joint venture, partnership or similar arrangement. There are no outstanding contractual obligations of a Target Company to provide funds to, or make any investment (in the form of a loan, capital contribution or otherwise) in, any other Person (other than another Target Company).

 

24

 

 

7.5 Governmental Approvals. Except as otherwise described in Schedule 7.5, no Consent of or with any Governmental Authority on the part of any Target Company is required to be obtained or made in connection with the execution, delivery or performance by the Company of this Agreement or any Ancillary Documents or the consummation by the Company of the transactions contemplated hereby or thereby other than (a) such Consents as are expressly contemplated by this Agreement or any Ancillary Document, (b) pursuant to Antitrust Laws, (c) any filings required with the NYSE or the SEC with respect to the Transactions, (d) applicable requirements, if any, of the Securities Act, the Exchange Act, and/or any state “blue sky” securities Laws, and the rules and regulations thereunder, and (e) those Consents, the failure of which to obtain prior to the respective Closing, would not individually or in the aggregate reasonably be expected to be material to the Target Companies, taken as a whole, or the ability of the Company to perform its obligations under this Agreement or the Ancillary Documents to which it is or required to be a party or otherwise bound.

 

7.6 Non-Contravention. Except as otherwise described in Schedule 7.6, the execution and delivery by the Company (or any other Target Company, as applicable) of this Agreement and each Ancillary Document to which any Target Company is or is required to be a party or otherwise bound, and the consummation by any Target Company of the transactions contemplated hereby and thereby and compliance by any Target Company with any of the provisions hereof and thereof, will not (a) conflict with or violate any provision of any Target Company’s Organizational Documents, (b) subject to obtaining the Consents from Governmental Authorities referred to in Section 7.5 hereof, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent applicable to any Target Company or any of its properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by any Target Company under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments (including a Change of Control Payment) or provide compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of any Target Company under, (viii) give rise to any obligation to obtain any Consent from or provide any notice to any Person who is not a Party or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of any Company Material Contract, except in the case of clauses (b) and (c) as would not individually or in the aggregate reasonably be expected to be material to the Target Companies taken as a whole, or materially affect the ability of the Company to perform its obligations under this Agreement or the Ancillary Documents to which it is or required to be a party or otherwise bound.

 

25

 

 

7.7 Financial Statements.

 

(a) As used herein, the term “Company Financials means (i) the Company prepared unaudited consolidated financial statements of the Target Companies (including, in each case, any related notes thereto), consisting of the unaudited consolidated balance sheets of the Target Companies as of December 31, 2019 and December 31, 2018, and the related consolidated unaudited income statements, changes in shareholder equity and statements of cash flows for the years then ended, (ii) the Company prepared unaudited financial statements, consisting of the unaudited consolidated balance sheets of the Target Companies as of September 30, 2020 (the “Interim Balance Sheet Date”) and the related unaudited consolidated income statement, changes in shareholder equity and statement of cash flows for the nine (9) months then ended, and (iii) when delivered in accordance with Section 9.10(g), the Required Registration Statement Company Financials. True and correct copies of the Company Financials have been or, in the case of the Required Registration Statement Company Financials, will be, provided to Purchaser. The Company Financials (i) were prepared in accordance with GAAP, consistently applied throughout and among the periods involved and (ii) were prepared from, and in accordance in all material respects, with the books and records of the Target Companies. The Company Financials fairly present in all material respects the consolidated financial position of the Company as of the respective dates thereof. No Target Company has ever been subject to the reporting requirements of Section 13(g) and 15(d) of the Exchange Act.

 

(b) All of the financial books and records of the Target Companies are complete and accurate in all material respects and have been maintained in the ordinary course consistent with past practice and in accordance with applicable Laws in all material respects. All of the financial books and records of the Target Companies are complete and accurate in all material respects and have been maintained in the ordinary course consistent with past practice and in accordance with applicable Laws in all material respects. The Company has not been subject to or involved in any fraud that involves management or other employees who have a significant role in the internal controls over financial reporting of any Target Company. No Target Company, nor, any of its officers, directors or employees has received any written complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies or methods of such Target Company or its internal accounting controls, including any material written complaint, allegation, assertion or claim that such Target Company has engaged in questionable accounting or auditing practices.

 

(c) As of the date hereof, the Target Companies do not have any Indebtedness other than the Indebtedness set forth on Schedule 7.7(c) and in such amounts (including principal and any accrued but unpaid interest or other obligations with respect to such Indebtedness), as set forth on Schedule 7.7(b). Except as disclosed on Schedule 7.7(b), no Indebtedness of any Target Company contains any restriction upon (i) the prepayment of any of such Indebtedness, (ii) the incurrence of Indebtedness by any Target Company, (iii) the ability of the Target Companies to grant any Lien on their respective properties or assets or (iv) the consummation of the transactions contemplated by this Agreement or by the Ancillary Documents. Except as disclosed on Schedule 7.7(c), no Indebtedness requires the Company or any Target Company to make any payment to another Person related to, in connection with, or as a result of the transactions contemplated by this Agreement (a “Change of Control Payment”) and the Ancillary Documents or that gives a third party a right to receive or elect to receive a Change of Control Payment.

 

(d) All financial projections with respect to the Target Companies that were made available by or on behalf of the Company to the Purchaser or its Representatives were prepared in good faith using assumptions that the Company believes to be reasonable.

 

26

 

 

7.8 Absence of Certain Changes. Except for actions expressly contemplated by this Agreement, since September 30, 2020, each Target Company (a) has conducted its business only in the ordinary course of business consistent with past practice, (b) has not been subject to a Material Adverse Effect and (c) has not taken any action or committed or agreed to take any action, other than the issuance of any equity or equity-linked instruments between the Locked Box Date and the date of this Agreement and reflected in Schedule 7.3(a), that would be prohibited by Section 9.2 (without giving effect to Schedule 9.2) if such action were taken on or after the date hereof without the consent of Purchaser.

 

7.9 Compliance with Laws.

 

(a) In the past five (5) years, except as set forth on Schedule 7.9(a), no Target Company is or has been, in any material respects, in non-compliance with, or in violation of, nor has any Target Company received any written or, to the Knowledge of the Company, oral notice of any non-compliance with, or violation of, any applicable Laws by which it or any of its properties, assets, employees, business or operations are or were bound or affected.

 

(b) The Company and the Target Companies maintain a program of policies, procedures, and internal controls reasonably designed and implemented to (i) prevent the use of the products and services of the Company and the Target Companies in a manner that violates applicable Law (including money laundering or fraud), and (ii) otherwise provide reasonable assurance that violations of applicable Law by any of the Company’s or the Target Companies’ directors, officers, employees or its or their respective agents, representatives or other Persons, acting on behalf of the Company or any of the Company’s Subsidiaries, will be prevented, detected and deterred.

 

7.10 Company Permits. The Company has made available to Purchaser true, correct and complete copies of all material Company Permits, all of which material Company Permits are listed on Schedule 7.10. All of the material Company Permits are in full force and effect, and no suspension or cancellation of any of the material Company Permits is pending or, to the Company’s Knowledge, threatened. No Target Company is in violation in any material respect of the terms of any material Company Permit, and no Target Company has received any written or, to the Knowledge of the Company, oral notice of any Actions relating to the revocation, suspension or modification of any material Company Permit, and no Target Company has received any notice that any Governmental Authority that has issued any material Permit intends to cancel, suspend, terminate or not renew any such material Permit.

 

7.11 Litigation. As of the date hereof, there is no (a) Action of any nature currently pending or, to the Knowledge of the Company, threatened; or (b) Order now pending or outstanding or that was rendered by a Governmental Authority, in either case of (a) or (b) by or against any Target Company, its current or former directors or officers (provided, that any litigation involving the directors or officers of a Target Company must be related to the Target Company’s business), its business, equity securities or assets. In the past five (5) years, none of the current or former officers, senior management or directors of any Target Company have been charged with, indicted for, arrested for, or convicted of any felony or any crime involving fraud.

 

7.12 Material Contracts.

 

(a) Schedule 7.12(a) sets forth, as of the date of this Agreement, a true, correct and complete list of, and the Company has made available to Purchaser, true, correct and complete copies of, each Contract to which any Target Company is a party or bound (each Contract required to be set forth on Schedule 7.12(a), a “Company Material Contract) that:

 

27

 

 

(i) contains covenants that limit the ability of any Target Company (A) to compete in any line of business or with any Person or in any geographic area or to sell, or provide any service or product or solicit any Person, including any non-competition covenants, employee and customer non-solicit covenants, exclusivity restrictions, rights of first refusal or most-favored pricing clauses or (B) to purchase or acquire an interest in any other Person;

 

(ii) involves any joint venture, profit-sharing, partnership, limited liability company or other similar agreement or arrangement relating to the formation, creation, operation, management or control of any partnership or joint venture;

 

(iii) involves any exchange traded, over the counter or other swap, cap, floor, collar, futures contract, forward contract, option or other derivative financial instrument or Contract, based on any commodity, security, instrument, asset, rate or index of any kind or nature whatsoever, whether tangible or intangible, including currencies, interest rates, foreign currency and indices;

 

(iv) evidences Indebtedness (whether incurred, assumed, guaranteed or secured by any asset) of any Target Company that is greater than $100,000 (other than obligations of, or payments to, the Target Companies, arising from purchase or sale agreements entered into in the ordinary course of business);

 

(v) involves the acquisition or disposition, directly or indirectly (by merger or otherwise), of assets with an aggregate value in excess of $250,000 or shares or other equity interests of the Target Companies or another Person;

 

(vi) relates to any merger, amalgamation, consolidation or other business combination with any other Person or the acquisition or disposition of any other entity or its business or material assets or the sale of any Target Company, its business or material assets;

 

(vii) by its terms, individually or with all related Contracts, calls for aggregate payments or receipts by the Target Companies under such Contract or Contracts of at least $100,000 per year or $250,000 in the aggregate;

 

(viii) is with any Company Customer in excess of $1,000,000, or with the top 10 Company Vendors by amounts paid for each of (a) the twelve months ended on December 31, 2019 and (b) the period from January 1, 2020 through the Interim Balance Sheet Date;

 

(ix) obligates the Target Companies to provide continuing indemnification or a guarantee of obligations of a Person who is not a Party after the date hereof in excess of $250,000;

 

(x) is between any Target Company, on the one hand, and any directors, officers or employees of a Target Company or Related Person, on the other hand (other than at-will employment arrangements with employees entered into in the ordinary course of business consistent with past practice), including all non-competition, severance and indemnification agreements;

 

(xi) obligates the Target Companies to make any capital commitment or expenditure in excess of $250,000 (including pursuant to any joint venture) in any calendar year;

 

28

 

 

(xii) grants to any Person (other than the Companies or the Target Companies) a right of first refusal, first offer or similar preferential right to purchase or acquire equity interests in any Company or any of the Target Companies;

 

(xiii) (A) relates to a material settlement entered into within three (3) years prior to the date of this Agreement, or (B) under which any Target Company or counterparty thereto has outstanding material obligations (other than customary confidentiality obligations);

 

(xiv) evidencing a Company Real Property Lease involving aggregate payments in excess of $100,000 in any calendar year;

 

(xv) provides for the ownership of, leasing of, title to, use of, or any leasehold or other interest in any personal property that involves aggregate payments in excess of $100,000 in any calendar year;

 

(xvi) is with a current officer, manager, director, employee or worker of, or consultant to, the Company or any of the Target Companies that provide annual base compensation (excluding bonus and other benefits) in excess of $100,000, or that provides for change in control, retention or similar payments or benefits contingent upon, accelerated by or triggered by the consummation of the transactions contemplated hereby;

 

(xvii) requires the Company or any Target Company to assign to any Person any of its rights in any Intellectual Property developed by the Company or any Target Company under such Contract;

 

(xviii) requires any current or former officer, manager, director, employee or worker of, or consultant to, the Company or any of the Target Companies, who is or was substantially involved in or had substantially contributed to the invention, creation or development of any Intellectual Property used in connection with the conduct of the respective businesses of the Target Companies to assign to the Company or any of the Target Companies any Intellectual Property arising from the services performed for the Company or Target Company by such Persons;

 

(xix) is a collective bargaining (or similar) agreement or Contract between any Company or any of the Target Companies, on one hand, and any labor union, works council or other body representing employees of any Company or any of the Target Companies, on the other hand;

 

(xx) grants to any Person (other than the Companies or the Target Companies) a right of first refusal, first offer or similar preferential right to purchase or acquire equity interests in any Company or any of the Target Companies;

 

(xxi) (A) grants to a third Person the right to use or register any Intellectual Property owned by the Company or (B) grants the right to use or register any Intellectual Property owned by a third Person that is material to the business of the Company other than (i) Contracts granting nonexclusive rights to use commercially available off-the-shelf software, (ii) Contracts granted to customers in the ordinary course of business that are substantially in the same form as the Company’s standard form customer agreements as have been provided to Purchaser on or prior to the date of this Agreement, (iii) licenses granted to service providers who access Intellectual Property owned by the Company on behalf of the Company as part of their provision of services to the Company; or (iv) nondisclosure agreements entered into in the ordinary course of business;

 

29

 

 

(xxii) provides another Person (other than another Target Company or any manager, director or officer of any Target Company) with a power of attorney that relate to the Company or its business;

 

(xxiii) will be required to be filed as an exhibit to the Registration Statement under applicable SEC requirements;

 

(xxiv) grants to any third Person (A) any “most favored nation rights” or (B) price guarantees for a period greater than one year from the date of this Agreement and requires aggregate future payments to the Companies and their Target Companies in excess of $250,000 in any calendar year;

 

(xxv) is with a Governmental Authority other than any Company Permits;

 

(xxvi) any outstanding written commitment to enter into any Contract described in subsections (i) to (xxv) of this Section 7.12(a).

 

(b) Except as disclosed in Schedule 7.12(b), with respect to each Company Material Contract: (i) such Company Material Contract is valid and binding and enforceable in all respects against the Target Company party thereto and; (ii) to the Knowledge of the Company, each other party thereto, and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions); (iii) no Target Company is in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice or both would constitute a material breach or default by any Target Company, or permit termination or acceleration by the other party thereto, under such Company Material Contract; (iv) to the Knowledge of the Company, no other party to such Company Material Contract is in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice or both would constitute such a material breach or default by such other party, or permit termination or acceleration by any Target Company, under such Company Material Contract; (v) no Target Company has received written or, to the Knowledge of the Company, oral notice of an intention by any party to any such Company Material Contract to terminate such Company Material Contract or amend the terms thereof, other than modifications in the ordinary course of business that do not adversely affect any Target Company in any material respect, and (vi) no Target Company has waived any material rights under any such Company Material Contract.

 

7.13 Intellectual Property.

 

(a) Schedule 7.13(a) sets forth, as of the date hereof, all Patents and Patent applications, Trademarks and service mark registrations and applications, copyright registrations and applications and registered Internet Assets and applications in which a Target Company is the owner, applicant or assignee, specifying as to each item, if applicable: (A) the nature of the item, including the title, (B) the owner of the item, (C) the jurisdictions in which the item is issued or registered or in which an application for issuance or registration has been filed and (D) the issuance, registration or application numbers and dates; and (the foregoing, “Material Company IP). Each Target Company owns, free and clear of all Liens, all Material Company IP. All Material Company IP is owned exclusively by the applicable Target Company without obligation to pay royalties, licensing fees or other fees, or otherwise account to any Person who is not a Party with respect to such Material Company IP.

 

30

 

 

(b) Except as, individually or in the aggregate, has not and would not reasonably be expected to adversely affect the Target Companies, taken as a whole, in any material respect, each Target Company has a valid and enforceable license to use all Intellectual Property that is used or held for use in the business of such Target Company as currently conducted.

 

(c) All registrations for Copyrights, Patents, Trademarks and Internet Assets that are owned by any Target Company are subsisting and in force, and all applications to register any Copyrights, Patents and Trademarks are pending and in good standing, all without challenge of any kind.

 

(d) Except as, individually or in the aggregate, has not had and would not reasonably be expected to adversely affect the Target Companies, taken as a whole, in any material respect: (i) no Action is pending or threatened against a Target Company that challenges the validity, enforceability, ownership, or right to use, sell, license or sublicense any Intellectual Property currently owned, licensed or used by the Target Companies; (ii) no Target Company has received any written notice, or to the Knowledge of the Company, oral notice or claim asserting or suggesting that any infringement, misappropriation, violation, dilution or unauthorized use of the Intellectual Property of any other Person is or may be occurring or has or may have occurred, as a consequence of the business activities of any Target Company, nor to the Knowledge of the Company is there a reasonable basis therefor; (iii) there are no Orders to which any Target Company is a party (or is bound and of which the Target Company has actual written notice) that (A) restrict the rights of a Target Company to use, transfer, license or enforce any Intellectual Property owned by a Target Company, (B) restrict the conduct of the business of a Target Company in order to accommodate a third Person’s Intellectual Property, or (C) grant any third Person any right with respect to any Intellectual Property owned by a Target Company; (iv) no Target Company is, or is expected to be, infringing, misappropriating or otherwise violating or has, in the past, infringed, misappropriated or violated any Intellectual Property of any other Person in connection with the conduct of the respective businesses of the Target Companies as currently or previously conducted, or as currently contemplated to be conducted; and (v) to the Company’s Knowledge, no Person is infringing upon, has misappropriated or is otherwise violating any Intellectual Property owned, or exclusively licensed to any Target Company (“Company IP).

 

(e) All current and former officers, employees and independent contractors of a Target Company who are or were materially involved in or have materially contributed to the invention, creation or development of any Intellectual Property used in connection with the conduct of the respective businesses of the Target Companies have assigned to the Target Companies all Intellectual Property arising from the services performed for a Target Company by such Persons. To the Knowledge of the Company, no current or former officers, employees or independent contractors of a Target Company have claimed in writing any ownership interest in any Intellectual Property owned by a Target Company. Each Target Company has taken reasonable security measures in order to protect the secrecy, confidentiality and value of the Company IP.

 

7.14 Taxes and Returns.

 

(a) Each Target Company has timely filed, or caused to be timely filed, all material Tax Returns required to be filed by it (taking into account all available extensions), and all such Tax Returns are true, accurate, correct and complete in all material respects, and has paid, collected or withheld, or caused to be paid, collected or withheld, all material Taxes required to be paid, collected or withheld, other than such Taxes for which adequate reserves in the Company Financials have been established.

 

31

 

 

(b) No jurisdiction in which a Target Company does not file Tax Returns or pay Taxes has claimed to such Target Company in writing that such Target Company it is or may be subject to taxation by that jurisdiction.

 

(c) There are no audits, examinations, investigations or other proceedings pending against any Target Company in respect of any Tax, and no Target Company has been notified in writing of any proposed Tax claims or assessments against any Target Company (other than, in each case, claims or assessments for which adequate reserves in the Company Financials have been established).

 

(d) There are no Liens with respect to any Taxes upon any Target Company’s assets, other than Permitted Liens.

 

(e) No Target Company has any outstanding waivers or extensions of any applicable statute of limitations to assess any material amount of Taxes. There are no outstanding requests by a Target Company for any extension of time within which to file any Tax Return or within which to pay any Taxes shown to be due on any Tax Return.

 

(f) No Target Company has made any change in accounting method (except as required by a change in Law) or received a ruling from, or signed an agreement with, any taxing authority that would reasonably be expected to have a material impact on its Taxes following the Closings.

 

(g) No Target Company that is treated as a domestic corporation (as such term is defined in Section 7701 of the Code) has participated in, or sold, distributed or otherwise promoted, any “reportable transaction,” as defined in U.S. Treasury Regulation section 1.6011-4.

 

(h) No Target Company has any Liability for the Taxes of another Person (other than another Target Company) (i) under any applicable Tax Law, (ii) as a transferee or successor, or (iii) by contract, indemnity or otherwise (excluding commercial agreements entered into in the ordinary course of business, the primary purpose of which is not the sharing of Taxes). No Target Company is a party to or bound by any Tax indemnity agreement, Tax sharing agreement or Tax allocation agreement or similar agreement, arrangement or practice (excluding commercial agreements entered into in the ordinary course of business, the primary purpose of which is not the sharing of Taxes) with respect to Taxes (including advance pricing agreement, closing agreement or other agreement relating to Taxes with any Governmental Authority).

 

(i) No Target Company has requested, or is it the subject of or bound by any private letter ruling, technical advice memorandum, closing agreement or similar ruling, memorandum or agreement with any Governmental Authority with respect to any Taxes, nor is any such request outstanding.

 

(j) No Target Company is treated as a domestic corporation (as such term is defined in Section 7701 of the Code) for U.S. federal income tax purposes.

 

7.15 Real Property.

 

(a) Schedule 7.15(a) contains a complete and accurate list as of the date hereof of (i) all material real property and interests in real property owned in fee by a Target Company as of the date hereof (collectively, the “Company Owned Properties). With respect to each parcel of the Company Owned Property: (i) the Target Companies have good and marketable fee title to all Company Owned Properties, free and clear of all Liens (ii) the Target Companies have not leased or otherwise granted to any Person the right to use or occupy such Company Owned Property or any material portion thereof, and (iii) there are no options, rights of first refusal or rights of first offer to purchase such Company Owned Properties or any portion thereof or interest therein.

 

32

 

 

(b) All of the Company Real Properties and buildings, fixtures and improvements thereon, taken as a whole, (i) (A) are in reasonable operating condition without material structural defects, and all material mechanical and other systems located thereon are in reasonable operating condition, and (B) no condition exists requiring material repairs, alterations or corrections and (ii) are suitable, sufficient and appropriate in all material respects for their current and contemplated uses. None of the material improvements located on the Company Real Properties constitute a legal non-conforming use or otherwise require any special dispensation, variance or special permit under any Laws or Contract. With respect to the Company Real Properties: (i) there are no material condemnation or eminent domain Actions pending or threatened in writing relating to any Company Real Property, and the Company has not received any notice of the intention of any Governmental Authority or other Person to take or use all or any material part thereof; (ii) there are no material Actions relating to boundary lines, ingress and egress, adverse possession or similar issues which are pending or threatened in writing; (iii) except as are not and would not reasonably be expect to be, individually or in the aggregate, material to the Target Companies, the existing buildings and improvements located on the Company Real Properties are located entirely within the boundary lines of such Company Real Property or on permanent easements on adjoining land benefiting such Company Real Property and may lawfully be used under applicable zoning and land use laws for the purposes for which they are presently being used; and (iv) the Company Real Properties are in compliance in all material respects with the terms and provisions of any restrictive covenants, easements, or agreements affecting such Company Real Property.

 

(c) Schedule 7.15(c) contains a complete and accurate list as of the date hereof of all premises currently leased or subleased or otherwise used or occupied by a Target Company for the operation of the business of a Target Company (the “Company Leased Propertiesand together with the Company Owned Properties, the “Company Real Properties), and of all current leases, lease guarantees, agreements and documents related thereto, including all amendments, terminations and modifications thereof or waivers thereto (collectively, the “Company Real Property Leases). The Company has provided to Purchaser a true and complete copy of each of the Company Real Property Leases. With respect to each Company Real Property Lease, (i) each Company Real Property Lease is valid, binding and enforceable in accordance with its terms and are in full force and effect and (ii) there is not any existing material default on the part of a Target Company of the Company Real Property Leases, and no Target Company has received notice of any such condition.

 

7.16 Title to and Sufficiency of Assets. Each Target Company has good and marketable title to, or a valid leasehold interest in or right to use, all of its material assets, free and clear of all Liens other than (i) Permitted Liens, and (ii) Liens set forth on Schedule 7.16. The assets (including contractual rights) of the Target Companies constitute all of the material assets, rights and properties that are used in the operation of the businesses of the Target Companies as it is now conducted, and taken together, are adequate and sufficient in all material respects for the operation of the businesses of the Target Companies as currently conducted, provided, that no representations or warranties are made in this Section 7.16 with respect to Intellectual Property rights.

 

7.17 Employee Matters.

 

(a) No Target Company is a party to any collective bargaining agreement or other Contract covering any group of employees, labor organization or other representative of any of the employees of any Target Company nor is there a duty to consult with any such part or body and the Company has no Knowledge of any activities or proceedings of any labor union or other party to organize or represent such employees. There has not occurred or, to the Knowledge of the Company, been threatened any strike, slow-down, picketing, work-stoppage, or other similar labor activity with respect to any such employees. There are no unresolved labor controversies (including unresolved grievances and age, claims regarding any enhanced benefits or other discrimination claims) that are pending or, to the Knowledge of the Company, threatened between any Target Company and Persons employed by or providing services as independent contractors to a Target Company.

 

33

 

 

(b) Each Target Company (i) is and has been in compliance in all material respects with all applicable Laws respecting employment and employment practices, terms and conditions of employment, health and safety and wages and hours, and other Laws relating to discrimination, disability, labor relations, hours of work, payment of wages and overtime wages, pay equity, immigration, workers compensation, working conditions, employee scheduling, occupational safety and health, family and medical leave, and employee terminations, and has not received written or, to the Knowledge of the Company, oral notice that there is any pending Action involving unfair labor practices against a Target Company, (ii) is not liable for any past due arrears of wages or any penalty for failure to comply with any of the foregoing, and (iii) is not liable for any payment to any Governmental Authority with respect to unemployment compensation benefits, social security or other benefits or obligations for employees, independent contractors or consultants (other than routine payments to be made in the ordinary course of business and consistent with past practice). There are no Actions pending or, to the Knowledge of the Company, threatened against a Target Company brought by or on behalf of any applicant for employment, any current or former employee, any Person alleging to be a current or former employee, or any Governmental Authority, relating to any such Law or regulation, or alleging breach of any express or implied contract of employment, wrongful termination of employment, or alleging any other discriminatory, wrongful or tortious conduct in connection with the employment relationship.

 

(c) Schedule 7.17(c) sets forth a complete and accurate information regarding the employees of the Target Companies as of the date hereof, showing for each employee (i) the employee’s job title or description, employer, location, salary level (including any bonus, commission, deferred compensation or other remuneration payable (other than any such arrangements under which payments are at the discretion of the Target Companies)), (ii) any bonus, commission or other remuneration other than salary paid during the calendar year ending December 31, 2019, and (iii) any wages, salary, bonus, commission or other compensation due and owing to each employee during or for the calendar year ending December 31, 2020. Except as set forth on Schedule 7.17(c), the Target Companies have paid in full to all their employees all wages, salaries, commission, bonuses and other compensation due to their employees, including overtime compensation, and no Target Company has any obligation or Liability (whether or not contingent) with respect to severance payments to any such employees under the terms of any written or, to the Company’s Knowledge, oral agreement, or commitment or any applicable Law, custom, trade or practice. Except as set forth in Schedule 7.17(c), each Target Company employee has entered into the Company’s standard form of employee non-disclosure, inventions and restrictive covenants agreement with a Target Company (whether pursuant to a separate agreement or incorporated as part of such employee’s overall employment agreement), a copy of which has been made available to Purchaser by the Company. For the purposes of applicable Law, all independent contractors who are currently, or within the last three (3) years have been, engaged by a Target Company are bona fide independent contractors and not employees of a Target Company and no independent contractor has claimed otherwise.

 

(d) No employee of a Target Company with annual base salary of $100,000 or more or at a senior management or technical level has provided written or, to the Knowledge of the Company, oral notice of his or her plan to terminate his or her employment.

 

(e) To the Knowledge of the Company, no current or former employee, worker or independent contractor of the Company or any Target Company is in violation of (i) any restrictive covenant, nondisclosure obligation or fiduciary duty to the Company or any Target Company or (ii) any restrictive covenant or nondisclosure obligation to a former employee or engager of any such individual relating to (A) the right of any such individual to work for or provide services to the Company or any of the Target Companies or (B) the knowledge or use of any Trade Secrets or proprietary information.

 

34

 

 

7.18 Benefit Plans.

 

(a) Set forth on Schedule 7.18(a) is a true and complete list as of the date hereof of each Foreign Plan of a Target Company (each, a “Company Benefit Plan) and the Company has no liability (whether current, contingent or prospective) in respect of any other employee benefit. Except as set forth on Schedule 7.18(a), no Target Company has ever maintained or contributed to (or had an obligation to contribute to) any Benefit Plan, whether or not subject to ERISA, which is not a Foreign Plan.

 

(b) With respect to each Company Benefit Plan which covers any current or former officer, director, consultant or employee (or beneficiary thereof) of a Target Company, the Company has made available to Purchaser accurate and complete copies, if applicable, of: (i) all plan documents and related trust agreements or annuity Contracts (including any amendments, modifications or supplements thereto), and written descriptions of any Company Benefit Plans which are not in writing; (ii) the most recent annual and periodic accounting of plan assets; (iii) the most recent actuarial valuation; and (iv) all communications with any Governmental Authority concerning any matter that is still pending or for which a Target Company has any outstanding Liability or obligation.

 

(c) Except as, individually or in the aggregate, has not had and would not reasonably be expected to adversely affect the Target Companies, taken as a whole, in any material respect, with respect to each Company Benefit Plan: (i) such Company Benefit Plan has been administered and enforced in accordance with its terms and the requirements of all applicable Laws, and has been maintained, where required, in good standing with applicable regulatory authorities and Governmental Authorities; (ii) no breach of fiduciary duty has occurred; (iii) no Action is pending, or to the Company’s Knowledge, threatened (other than routine claims for benefits arising in the ordinary course of administration); (iv) all contributions, premiums and other payments (including any special contribution, interest or penalty) required to be made with respect to a Company Benefit Plan have been timely made; (v) all benefits accrued under any unfunded Company Benefit Plan have been paid, accrued, or otherwise adequately reserved in accordance with GAAP and are reflected on the Company Financials; (vi) no Company Benefit Plan provides for retroactive increases in contributions, premiums or other payments in relation thereto; and (vii) no Target Company has incurred any obligation in connection with the termination of, or withdrawal from, any Company Benefit Plan.

 

(d) To the extent applicable, the present value of the accrued benefit liabilities (whether or not vested) under each Company Benefit Plan, determined as of the end of the Company’s most recently ended fiscal year on the basis of reasonable actuarial assumptions, each of which is reasonable, did not exceed the current value of the assets of such Company Benefit Plan allocable to such benefit liabilities.

 

(e) Other than pursuant to the Company Equity Plan, the consummation of the transactions contemplated by this Agreement and the Ancillary Documents will not, either alone or in combination with another event: (i) entitle any individual to severance pay, unemployment compensation or other benefits or compensation under any Company Benefit Plan or under any applicable Law; or (ii) accelerate the time of payment or vesting, or increase the amount of any compensation due, or in respect of, any director, employee or independent contractor of a Target Company. The consummation of the transactions contemplated hereby will not, alone or in combination with another event, result in any “excess parachute payment” under Section 280G of the Code to any employee, officer or other individual service provider of the Company or of a Subsidiary of the Company. No Company Benefit Plan provides for a Tax gross-up, make whole or similar payment with respect to the Taxes imposed under Sections 409A or 4999 of the Code.

 

35

 

 

(f) All Company Options have been granted in accordance with the terms of the Company Equity Plan. The treatment of Company Options under this Agreement does not violate the terms of the Company Equity Plan or any Contract governing the terms of such awards. Each Company Benefit Plan that constitutes in any part a “nonqualified deferred compensation plan” (as defined under Section 409A(d)(1) of the Code) subject to Section 409A of the Code has been maintained, in form and operation, in all material respects In material compliance with Section 409A of the Code.

 

(g) Except to the extent required by applicable Law, no Target Company provides health or welfare benefits to any former or retired employee or is obligated to provide such benefits to any active employee following such employee’s retirement or other termination of employment or service.

 

(h) All Company Benefit Plans can be terminated at any time as of or prior to the First Closing Date without resulting in any material Liability to any Target Company, Pubco, Purchaser or their respective Affiliates for any additional contributions, penalties, premiums, fees, fines, excise taxes or any other charges or liabilities.

 

7.19 Environmental Matters. Except as, individually or in the aggregate, has not had and would not reasonably be expected to adversely affect the Target Companies, taken as a whole, in any material respect, or as set forth in Schedule 7.19:

 

(a) Each Target Company is and has been in compliance with all applicable Environmental Laws, including obtaining, maintaining in good standing, and complying with all Permits required for its business and operations by Environmental Laws (“Environmental Permits), no Action is pending or, to the Company’s Knowledge, threatened to revoke, modify, or terminate any such Environmental Permit, and, to the Company’s Knowledge, no facts, circumstances, or conditions currently exist that could adversely affect such continued compliance with Environmental Laws and Environmental Permits or require capital expenditures to achieve or maintain such continued compliance with Environmental Laws and Environmental Permits.

 

(b) No Target Company is the subject of any outstanding Order or Contract with any Governmental Authority or other Person in respect of any (i) Environmental Laws, (ii) Remedial Action, or (iii) Release or threatened Release of a Hazardous Material. No Target Company has assumed, contractually or by operation of Law, any Liabilities or obligations under any Environmental Laws.

 

(c) No Action has been made or is pending, or to the Company’s Knowledge, threatened against any Target Company or any assets of a Target Company alleging either or both that a Target Company may be in material violation of any Environmental Law or Environmental Permit or may have any material Liability under any Environmental Law. There is no investigation of the business, operations, or currently owned, operated, or leased property of a Target Company or, to the Company’s Knowledge, previously owned, operated, or leased property of a Target Company pending or, to the Company’s Knowledge, threatened that could lead to the imposition of any Liens under any Environmental Law or Environmental Liabilities.

 

(d) No Target Company has manufactured, treated, stored, disposed of, arranged for or permitted the disposal of, generated, handled or Released any Hazardous Material, or owned or operated any property or facility, in a manner that has given or would reasonably be expected to give rise to any Liability or obligation under applicable Environmental Laws.

 

36

 

 

(e) The Company has provided to Purchaser all environmental site assessments, audits, studies, reports, analysis and results of investigations that have been performed in respect of the currently or previously owned, leased, or operated properties of any Target Company that are in a Target Company’s possession.

 

7.20 Transactions with Related Persons. Except (i) for payment of salary for services rendered in the ordinary course of business consistent with past practice, (ii) for reimbursement for reasonable expenses incurred on behalf of the Company or any of the Target Companies in the ordinary course of business consistent with past practice, (iii) for other employee benefits made in the ordinary course of business consistent with past practice, (iv) as described in the Company Financials delivered on or prior to the date of this Agreement, or (v) as set forth on Schedule 7.20, no Target Company nor any of its Affiliates, nor any officer, director, manager, employee, trustee or beneficiary of a Target Company or any of its Affiliates, nor any immediate family member of any of the foregoing (whether directly or indirectly through an Affiliate of such Person) (each of the foregoing, a “Related Person”) is presently, or in the past three (3) years has been, a party to any transaction with a Target Company, including any Contract (a) providing for the furnishing of services by (other than as officers, directors or employees of the Target Company), (b) providing for the rental of real property or Personal Property from or (c) otherwise requiring payments to (other than for services or expenses as directors, officers or employees of the Target Company in the ordinary course of business consistent with past practice) any Related Person or any Person in which any Related Person has an interest as an owner, officer, manager, director, trustee or partner or in which any Related Person has any direct or indirect interest. Except as set forth on Schedule 7.20, no Related Person owns any real property or Personal Property, or right, tangible or intangible (including Intellectual Property) which is used in the business of any Target Company. The assets of the Target Companies do not include any receivable or other obligation from a Related Person, and the liabilities of the Target Companies do not include any payable or other obligation to any Related Person.

 

7.21 Business Insurance.

 

(a) Schedule 7.21(a) lists all insurance policies (by policy number, insurer, coverage period, coverage amount, annual premium and type of policy) under which the Target Companies are insured, a named insured or otherwise the principal beneficiary of coverage as of the date of this Agreement, copies of which have been provided to the Purchaser. All premiums due and payable under all such insurance policies have been timely paid and the Target Companies are otherwise in material compliance with the terms of such insurance policies. Each such insurance policy (i) is legal, valid, binding, enforceable and in full force and effect and (ii) will continue to be legal, valid, binding, enforceable, and in full force and effect on identical terms following the Closings. To the Knowledge of the Company, there is no threatened termination of, or material premium increase with respect to, any of such insurance policies. No Target Company has received any notice from, or on behalf of, any insurance carrier relating to any refusal to issue an insurance policy or non-renewal of a policy. No Target Company has any self-insurance or other co-insurance program. Except as set forth in Schedule 7.21(a), there are no claims related to the business of the Company pending under any such insurance policies as to which coverage has been questioned, denied or disputed or in respect of which there is an outstanding reservation of rights.

 

37

 

 

7.22 Customers and Vendors. Schedule 7.22 lists, by dollar volume received or paid, as applicable, for each of (a) the twelve (12) months ended on December 31, 2019 and (b) the period from January 1, 2020 through the Interim Balance Sheet Date, all customers of the Target Companies (the “Company Customers”) and all vendors of goods or services to the Target Companies (the “Company Vendors”), along with the amounts of such dollar volumes. The relationships of each Target Company with the Company Customers and Company Vendors are good commercial working relationships, and no Company Vendor or Company Customer within the last twelve (12) months has cancelled or otherwise terminated, or has notified the Company in writing that it intends to cancel or otherwise terminate, any material relationships of such Person with a Target Company, (i) no Company Vendor or Company Customer has during the last twelve (12) months decreased materially or, to the Company’s Knowledge, threatened to stop or materially decrease, limit, or modify its material relationships with a Target Company, and (ii) no Target Company has within the past two (2) years been engaged in any material dispute with any Company Vendor or Company Customer.

 

7.23 Certain Business Practices.

 

(a) Since December 31, 2017, none of the Target Companies, nor, to the Company’s Knowledge, any of the Target Companies’ directors or officers, agents or employees acting on its behalf, has (i) used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees, to foreign or domestic political parties or campaigns or violated any provision of any Anti-Bribery Laws or (iii) directly or indirectly, given or agreed to give any unlawful gift or similar benefit in any material amount to any customer, supplier, governmental employee or other Person who is or may be in a position to help or hinder any Target Company or assist any Target Company in connection with any actual or proposed transaction.

 

(b) The Company and the Target Companies have instituted and maintain policies and procedures reasonably designed to ensure compliance in all material respects with any local or foreign and money laundering statutes and Anti-Bribery Laws.

 

(c) The operations of each Target Company are and have been conducted at all times in compliance with money laundering statutes in all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority, and no Action involving a Target Company with respect to any of the foregoing is pending or, to the Knowledge of the Company, threatened.

 

(d) No Target Company or any of their respective directors or officers, or, to the Knowledge of the Company, any other Representative acting on behalf of a Target Company, is currently identified on the specially designated nationals or other blocked person list or otherwise currently the subject of any U.S. sanctions administered by OFAC, and no Target Company has directly or indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary, joint venture partner or other Person, in connection with any sales or operations in any country targeted under comprehensive sanctions by OFAC (such countries, as of the date hereof, being the Crimea region of Ukraine, Cuba, Iran, North Korea and Syria) or for the purpose of financing the activities of any Person the subject of, or otherwise in violation of, any U.S. sanctions administered by OFAC, in each case in violation of applicable sanctions.

 

7.24 Data Protection and Cybersecurity.

 

(a) For the purposes of this Section 7.24(a), the terms “personal data,” “personal data breach,” “process” (and its cognates) and “supervisory authority” shall have the meaning given to them in applicable Data Protection Laws.

 

38

 

 

(b) Each Target Company complies in all material respects with Data Protection Laws through the implementation and ongoing monitoring of appropriate written policies, notices, logs, and procedures, including by safeguarding all transfers of personal data to and from third parties located outside the European Economic Area by way of a valid data transfer mechanism under Data Protection Laws. Each Target Company maintains accurate and up-to-date records of all their personal data processing activities as required under Data Protection Laws.

 

(c) Each Target Company has, where required by applicable Law, entered into contracts with its material suppliers that meet the requirements of Data Protection Laws in all material respects.

 

(d) Each Target Company has, where required by applicable Law, implemented appropriate technical and organizational measures, to protect against personal data breaches and cybersecurity incidents, as monitored through penetration tests and vulnerability assessments (including by remediating any and all material identified vulnerabilities).

 

(e) Since January 1, 2018, no Target Company has: (i) suffered any material personal data breach or cybersecurity incident; (ii) been subject to investigations, notices or requests from any supervisory authority or other regulatory authority in relation to their data processing activities and compliance with Data Protection Laws; or (iii) received written notice from any individuals or Governmental Authority alleging non-compliance with Data Protection Laws.

 

7.25 Information Technology.

 

(a) The IT Systems are in satisfactory working order in all material respects and have functioned materially in accordance with all applicable specifications and requirements of the business of the Company.

 

(b) The Target Companies have implemented security, maintenance, backup, archiving, and virus and malicious device scanning and protection measures with respect to the IT Systems in accordance with industry best practices.

 

(c) Since January 1, 2019, the IT systems have not (i) experienced a defect, bug or virus that caused a material disruption to the operations of any Target Company; or (ii) suffered any unauthorized access by any Person who is not a Party. Adequate business continuity and disaster recovery procedures for the IT Systems have been implemented in order to prevent the loss of and enable the recovery of data to ensure the continuation of the business of each Target Company without any disruption or loss in the event of any failure of the IT Systems.

 

(d) All use and distribution of software and open source materials by each Target Company is in material compliance with all open source licenses applicable thereto. No Target Company has used any copyleft materials in a manner that requires any software or products, or any portion thereof, to be subject to copyleft licenses or other restrictions or obligations that would have an adverse effect on the Target Companies.

 

7.26 Investment Company Act. No Target Company is an “investment company” or a Person directly or indirectly “controlled” by or acting on behalf of an “investment company”, or required to register as an “investment company”, in each case within the meaning of the Investment Company Act.

 

39

 

 

7.27 Finders and Brokers. Except as set forth in Schedule 7.27, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of any Target Company.

 

7.28 Information Supplied. None of the information supplied or to be supplied by the Company expressly for inclusion or incorporation by reference: (a) in any current report on Form 8-K, and any exhibits thereto or any other report, form, registration or other filing made with any Governmental Authority (including the SEC) or stock exchange (including the NYSE) with respect to the transactions contemplated by this Agreement or any Ancillary Documents; (b) in the Registration Statement; (c) in this Agreement or the Company Disclosure Schedules or (d) in the mailings or other distributions to holders of Purchaser Securities or Company Securities and/or prospective investors with respect to the consummation of the transactions contemplated by this Agreement or in any amendment to any of documents identified in (a) through (d), will, when filed, made available, mailed or distributed, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. None of the information supplied or to be supplied by the Company expressly for inclusion or incorporation by reference in any of the Signing Press Release, the Signing Filing, the Closing Press Release and the Closing Filing will, when filed or distributed, as applicable, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading.

 

7.29 Solvency. The Company is not entering into this Agreement or the transactions contemplated hereby with the actual intent to hinder, delay or defraud either present or future creditors of the Company or any of its Affiliates. After giving effect to the Mergers contemplated hereby, at and immediately after the Cross-Border Effective Time, the Company and its Subsidiaries (i) will be solvent (in that both the fair value of its assets will not be less than the sum of its debts and that the present fair saleable value of its assets will not be less than the amount required to pay its probable liability on its recourse debts as they mature or become due); (ii) will have adequate capital and liquidity with which to engage in its business and all businesses in which it is about to engage; and (iii) will not have incurred and does not plan to incur debts beyond its ability to pay as they mature or become due.

 

7.30 Disclosed MOUs.

 

(a) The Company has set out in folders 3.1.3 and 3.1.6 of the Data Room, true, complete and accurate copies of all non-binding memoranda of understandings, letters of intent and other such agreements with potential customers and suppliers as of the date hereof (the “Disclosed MOUs”) which, if the Company were to enter into definitive documents in accordance with the terms of such agreements on the date hereof, would be reasonably likely to constitute a Top Customer Contract or a Top Vendor Contract.

 

(b) As of the date hereof, the Company is pursuing discussions and taking such action in good faith to enter into definitive agreements with the potential customers and suppliers with whom they have entered into the Disclosed MOUs, except to the extent that entry into such definitive agreements would be or become mutually exclusive of one another.

 

40

 

 

7.31 Exclusivity of Representations and Warranties. Except as otherwise expressly provided in this Article VII (as modified by the Company Disclosure Schedules), the Ancillary Documents and any certificates delivered pursuant to this Agreement, the Company hereby expressly disclaims and negates, any other express or implied representation or warranty whatsoever (whether at Law or in equity) with respect to the Company, its affiliates, and any matter relating to any of them, including their affairs, the condition, value or quality of the assets, liabilities, financial condition or results of operations, or with respect to the accuracy or completeness of any other information made available to Purchaser, its affiliates or any of their respective Representatives by, or on behalf of, Company, and any such representations or warranties are expressly disclaimed. Without limiting the generality of the foregoing, except as expressly set forth in this Agreement, neither Company nor any other Person on behalf of Company has made or makes, any representation or warranty, whether express or implied, with respect to any projections, forecasts, estimates or budgets made available to the Purchaser, its affiliates or any of their respective Representatives of future revenues, future results of operations (or any component thereof), future cash flows or future financial condition (or any component thereof) of the Company (including the reasonableness of the assumptions underlying any of the foregoing), whether or not included in any management presentation or in any other information made available to the Purchaser, its affiliates or any of their respective Representatives or any other Person, and that any such representations or warranties are expressly disclaimed.

 

7.32 Independent Investigation. The Company has conducted its own independent investigation, review and analysis of the business, results of operations, condition (financial or otherwise) or assets of Purchaser and acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents and data of Purchaser for such purpose. The Company acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties of Purchaser set forth in this Agreement (including the related portions of the Purchaser Disclosure Schedules) and in any certificate delivered to the Company pursuant hereto; and (b) none of Purchaser or its respective Representatives have made any representation or warranty as to Purchaser or this Agreement, except as expressly set forth in this Agreement (including the related portions of the Purchaser Disclosure Schedules), in any Ancillary Document or in any certificate delivered to Company pursuant hereto and the Company is expressly disclaiming any reliance on any representations or warranties other than those set forth in Article V of this Agreement.

 

Article VIII
Representations and warranties of the major shareholders

 

Each Major Shareholder represents and warrants to Purchaser (in respect of itself only and not in respect of any other Major Shareholder), as of the date hereof and as of the First Closing and Second Closing, as follows:

 

8.1 Organization and Standing. Such Major Shareholder, if not a natural Person, is an entity duly organized, validly existing and in good standing under the Laws of the jurisdiction of its formation and has all requisite power and authority to own, lease and operate its properties and to carry on its business as now being conducted.

 

8.2 Authorization; Binding Agreement. Such Major Shareholder has all requisite power, authority and legal right and capacity to execute and deliver this Agreement and each Ancillary Document to which it is a party, to perform such Major Shareholder’s obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary Document to which such Major Shareholder is or is required to be a party has been or shall be when delivered, duly and validly executed and delivered by such Major Shareholder and assuming the due authorization, execution and delivery of this Agreement and any such Ancillary Document by the other parties hereto and thereto, constitutes, or when delivered shall constitute, the legal, valid and binding obligation of such Major Shareholder, enforceable against such Major Shareholder in accordance with its terms, subject to the Enforceability Exceptions.

 

41

 

 

8.3 Ownership. Each Major Shareholder owns good and valid title to the Company Shares set opposite such Major Shareholder’s name on Schedule 8.3 (free and clear of any and all Liens). There are no proxies, voting rights, shareholders’ agreements or other agreements to which such Major Shareholder is a party or by which such Major Shareholder is bound, with respect to the voting or transfer of any of such Major Shareholder’s Company Shares (other than this Agreement and any Ancillary Document).

 

8.4 Governmental Approvals. No Consent of or with any Governmental Authority on the part of such Major Shareholder is required to be obtained or made in connection with the execution, delivery or performance by such Major Shareholder of this Agreement or any Ancillary Documents or the consummation by such Major Shareholder of the transactions contemplated hereby or thereby other than (a) such filings as expressly contemplated by this Agreement, (b) pursuant to Antitrust Laws, (c) any filings required with the NYSE or the SEC with respect to the transactions contemplated by this Agreement, (d) applicable requirements, if any, of the Securities Act, the Exchange Act, and/or any state “blue sky” securities Laws, and the rules and regulations thereunder and (e) where the failure to obtain or make such Consents or to make such filings or notifications, would not, individually or in the aggregate, reasonably be expected to have a material impact on the ability of such Major Shareholder on a timely basis to consummate the Transactions.

 

8.5 Non-Contravention. The execution and delivery by such Major Shareholder of this Agreement and each Ancillary Document to which it is a party or otherwise bound and the consummation by such Major Shareholder of the transactions contemplated hereby and thereby, and compliance by such Major Shareholder with any of the provisions hereof and thereof, will not, (a) if such Major Shareholder is an entity, conflict with or violate any provision of such Major Shareholder’s Organizational Documents, (b) conflict with or violate any Law, Order or Consent applicable to such Major Shareholder or any of its properties or assets or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by such Major Shareholder under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of such Major Shareholder under, (viii) give rise to any obligation to obtain any Consent from a Person who is not a Party or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of, any Contract to which such Major Shareholder is a party or such Major Shareholder or its properties or assets are otherwise bound, except for any deviations from any of the foregoing clauses (a), (b) or (c) that has not had and would not reasonably be expected to materially impair or delay the ability of such Major Shareholder to consummate the Transactions.

 

8.6 No Litigation. There is no Action pending or threatened, nor any Order is outstanding, against or involving such Major Shareholder, whether at law or in equity, before or by any Governmental Authority, which would reasonably be expected to materially and adversely affect the ability of such Major Shareholder to consummate the transactions contemplated by, and discharge its obligations under, this Agreement and the Ancillary Documents to which such Major Shareholder is or is required to be a party.

 

8.7 Finders and Brokers. No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from Purchaser, Pubco, the Company or any of their respective Affiliates in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of such Major Shareholder.

 

8.8 Independent Investigation. Such Major Shareholder has conducted its own independent investigation, review and analysis of the business, results of operations, condition (financial or otherwise) or assets of Purchaser. Such Major Shareholder acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, it has relied solely upon its own investigation; and (b) none of Purchaser, or their respective Representatives have made any representation or warranty to such Major Shareholder as to Purchaser.

 

42

 

 

Article IX
COVENANTS

 

9.1 Access and Information.

 

(a) During the period from the date of this Agreement and continuing until the earlier of the termination of this Agreement in accordance with Section 13.1 or the Second Closing (the “Interim Period), upon reasonable advance written notice from Purchaser, the Company will provide, and use its commercially reasonable efforts to cause its Representatives to provide, Purchaser and its Representatives reasonable access, at Purchaser’s expense, during normal business hours, under the supervision of personnel of the Company or its Representatives, and in such a manner as not to unreasonably interfere with the normal operations of the business of the Target Companies, to (a) such materials and information about the Target Companies as Purchaser may reasonably request, and (b) specified members of management of the Target Companies as the Purchaser may reasonably request. Notwithstanding the foregoing, the Company will not be required to disclose any information to Purchaser or its Representatives if such disclosure would be reasonably likely to (i) jeopardize any attorney-client or other legal privilege, or (ii) contravene any applicable Law or Contract.

 

(b) During the Interim Period, upon reasonable advance written notice from the Company, Purchaser, Pubco and the Merger Subs will provide, and use its commercially reasonable efforts to cause its Representatives to provide, the Company and its Representatives reasonable access, at the Company’s expense, during normal business hours, under the supervision of personnel of Purchaser or its Representatives, and in such a manner as not to unreasonably interfere with the normal operations of the business of Purchaser, to (a) such materials and information about Purchaser, Pubco and the Merger Subs as the Company may reasonably request, and (b) specified members of management of Purchaser, Pubco and the Merger Subs as the Company may reasonably request. Notwithstanding the foregoing, Purchaser will not be required to disclose any information to the Company or its Representatives if such disclosure would be reasonably likely to (i) jeopardize any attorney-client or other legal privilege, or (ii) contravene any applicable Law or Contract.

 

9.2 Conduct of Business of the Company.

 

(a) Unless Purchaser shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the Interim Period, except as expressly contemplated by this Agreement or the Ancillary Documents or as set forth on Schedule 9.2, the Company shall, and shall cause its Subsidiaries to, (i) conduct their respective businesses, in all material respects, in the ordinary course of business consistent with past practice and/or the Company Business Plan (as applicable) and (ii) comply in all material respects with all Laws applicable to the Target Companies and their respective businesses, assets and employees.

 

(b) Without limiting the generality of Section 9.2(a) and except as contemplated by the terms of this Agreement, the Ancillary Documents, the Company Business Plan or as set forth on Schedule 9.2, during the Interim Period, without the prior written consent of Purchaser (such consent not to be unreasonably withheld, conditioned or delayed), the Company shall not, and each shall cause its Subsidiaries to not:

 

43

 

 

(i) amend, waive or otherwise change, in any respect, its or any of the Target Companies’ Organizational Documents or form or cause to be formed any new Subsidiary;

 

(ii) authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities, or other securities, including any securities convertible into or exchangeable for any of its shares or other equity securities or securities of any class and any other equity-based awards, or engage in any hedging transaction with a third Person with respect to such securities, or permit the cashless conversion or exercise of any of its securities and any other equity-based awards; provided that the Company shall be permitted to (a) issue equity securities pursuant to the Funding Commitment Letter, (b) commit to grant 2,200,000 Pubco Options in accordance with the contemplated terms of and pursuant to the Pubco Equity Plan and subject to receipt of any approvals required under Applicable Law and (c) commit to grant up to 333,333 Pubco Options in any month in accordance with the contemplated terms of and pursuant to the Pubco Equity Plan and subject to receipt of any approvals required under Applicable Law, which grants shall be made subject to the Second Closing having occurred; provided, that any individual commitment to grant in excess of 50,000 Pubco Options shall be subject to the prior written approval of the Purchaser (such approval not to be unreasonably withheld, conditioned or delayed); and, provided, further, that in respect of any conditional grant in respect of (b) and (c), in the event that the Second Closing does not occur, the Company may grant Company Fallback Options in such numbers and on such terms as it shall determine;

 

(iii) split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities other than pursuant to the terms of the Funding Commitment Letter and to effect the Norway Demerger;

 

(iv) (A) incur, create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $100,000 or $250,000 in the aggregate other than pursuant to the terms of the Funding Commitment Letter, (B) make a loan or advance to or investment in any Person in excess of $100,000 individually or $250,000 in the aggregate (other than advancement of expenses to employees in the ordinary course of business consistent with past practice), or (C) guarantee or endorse any Indebtedness or obligation of any Person, in any such case in excess of $100,000 individually or $250,000 in the aggregate;

 

(v) (A) increase the wages, salaries or compensation of its employees and other service providers other than in the ordinary course of business and consistent with past practice, (B) make or commit to make any bonus payment (whether in cash, property or securities) to any employee or other service provider which exceed $100,000, (C) grant any severance, retention, change in control or termination or similar pay, other than as provided for in any written agreements, in the ordinary course of business, consistent with past practice or as required by applicable Law, (D) establish any trust or take any other action to secure the payment of any compensation payable by the Company, or (E) materially increase other benefits of employees generally, or enter into, establish, amend or terminate any Company Benefit Plan with, for or in respect of any current consultant, officer, manager director or employee, in each case other than as required by applicable Law, or pursuant to the terms of any Company Benefit Plan;

 

44

 

 

(vi) transfer, pledge or exclusively license to any Person or permit to lapse or fail to preserve any Material Company IP;

 

(vii) modify, terminate or waive or assign any material right under, any Company Material Contract, or enter into any Contract that would be a Company Material Contract;

 

(viii) enter into any new line of business;

 

(ix) limit the right of the Company or any of the Target Companies to engage in any line of business or in any geographic area, to develop, market or sell products or services, or to compete with any Person or grant any exclusive or similar rights to any Person;

 

(x) amend in a manner detrimental to the Company or any of the Target Companies, terminate, cancel, surrender, permit to lapse or fail to renew or use reasonable best efforts to maintain any authorization from a Governmental Authority or Permit required for the conduct of the business of the Company or any of the Target Companies or otherwise fail to use reasonable best efforts to maintain and preserve its relationships with any Governmental Authority, customers, suppliers, contractors and other Persons with which it has material business relations;

 

(xi) acquire, including by merger, amalgamation, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets, in each case outside the ordinary course of business consistent with past practice

 

(xii) make capital expenditures in excess of $100,000 (individually for any project (or set of related projects) or $250,000 in the aggregate);

 

(xiii) adopt a plan of complete or partial liquidation, dissolution, merger, amalgamation, consolidation, restructuring, recapitalization or other reorganization (except to the extent permitted by clause (xii) above);

 

(xiv) enter into any agreement, understanding or arrangement with respect to the voting of equity securities of the Company;

 

(xv) take any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental Authority to be obtained in connection with this Agreement;

 

(xvi) acquire any ownership interest in any real property;

 

(xvii) enter into, amend, waive or terminate (other than terminations in accordance with their terms) any transaction with any Related Person (other than compensation and benefits and advancement of expenses, in each case, in the ordinary course of business consistent with past practice, as reasonably necessary to conduct the business and on arms-length terms);

 

45

 

 

(xviii) waive, release, settle, compromise or otherwise resolve any investigation, claim, Action, litigation or other legal proceedings, other than such actions which result in the Company being obligated to pay monetary damages in an amount less than $100,000;

 

(xix) make or rescind any material election relating to Taxes (other than elections made in the ordinary course of business), settle any material claim, action, suit, litigation, proceeding, arbitration, investigation, audit or controversy relating to Taxes, file any material amended Tax Return or claim for refund in a manner inconsistent with past practice (including surrendering any right to a refund), or make any material change in its accounting or Tax policies or procedures; or

 

(xx) authorize or agree to do any of the foregoing actions.

 

(c) Each of Purchaser, Pubco and the Merger Subs acknowledges and agrees that (i) nothing contained in this Agreement shall give any such Person, directly or indirectly, the right to control or direct the Company’s or the Target Companies’ operations during the Interim Period, (ii) during the Interim Period, the Company shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over it and its subsidiaries’ operations; and (iii) the Company Business Plan shall be understood in the context of the Company being in an initial development phase and that the Company Business Plan is meant for high-level guidance only, and the Company shall be deemed to conduct its operations in accordance with the Company Business Plan to the extent that it conducts its business with the good faith aim of increasing the value of its business and in a manner generally consistent with the Company Business Plan.

 

9.3 Conduct of Business of Purchaser, Pubco and Merger Subs.

 

(a) Unless the Company shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed, during the Interim Period), except as expressly contemplated by this Agreement or the Ancillary Documents or as set forth on Schedule 9.3, Purchaser, Pubco and Merger Subs shall each (i) conduct its respective business, in all material respects, in the ordinary course of business consistent with past practice, and (ii) comply in all material respects with all Laws applicable to such Person and its business, assets and employees.

 

(b) Without limiting the generality of Section 9.3(a) and except as contemplated by the terms of this Agreement or the Ancillary Documents or as set forth on Schedule 9.3, during the Interim Period, none of Purchaser, Pubco or the Merger Subs shall:

 

(i) amend, waive or otherwise change, in any respect, its Organizational Documents, except to the extent required by applicable Law;

 

(ii) authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities, or other securities, including any securities convertible into or exchangeable for any of its equity securities or other security interests of any class and any other equity-based awards, or engage in any hedging transaction with a third Person with respect to such securities;

 

(iii) split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its shares or other equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities;

 

46

 

 

(iv) incur, create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $250,000 (individually or in the aggregate), make a loan or advance to or investment in any Person, or guarantee or endorse any Indebtedness, Liability or obligation of any Person (provided, that this Section 9.3(b)(iv) shall not prevent Purchaser from borrowing funds necessary to finance its ordinary course administrative costs and expenses and Expenses incurred in connection with the consummation of the Transactions, including any PIPE Investment (such expenses, “Purchaser Transaction Expenses”));

 

(v) amend, waive, terminate or otherwise change the Trust Agreement in any manner adverse to Purchaser, the Company or Pubco;

 

(vi) adopt a plan of complete or partial liquidation, dissolution, merger, amalgamation, consolidation, restructuring, recapitalization or other reorganization (other than with respect to the Mergers);

 

(vii) acquire, including by merger, amalgamation, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets outside the ordinary course of business;

 

(viii) enter into any new Contracts or commitments other than Contracts providing for payments by Purchaser, Pubco and the Merger Subs, collectively, on an annual basis of less than $250,000 and Contracts entered into in connection with the consummation of the Transactions, including any PIPE Investment;

 

(ix) take any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental Authority to be obtained in connection with this Agreement; or

 

(x) authorize or agree to do any of the foregoing actions.

 

9.4 Purchaser Public Filings. During the Interim Period, Purchaser will keep current and timely file all of the forms, reports, schedules, statements and other documents required to be filed by Purchaser with the SEC, including all necessary amendments and supplements thereto, and otherwise comply in all material respects with applicable securities Laws (the “Additional SEC Reports). All such Additional SEC Reports (including any financial statements or schedules included therein) shall be prepared in accordance and comply in all material respects with the requirements of the Securities Act or the Exchange Act, as the case may be, and the rules and regulations of the SEC thereunder applicable to such Additional SEC Reports. The Additional SEC Reports (including any financial statements or schedules included therein) will not, at the time they are filed or subsequently amended, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. As used in this Section 9.4, the term “file” shall be broadly construed to include any manner in which a document or information is filed, furnished, supplied or otherwise made available to the SEC. During the Interim Period, Purchaser shall use its commercially reasonable efforts prior to the Mergers to maintain the listing of the Purchaser Units, the Purchaser Class A Ordinary Shares and the Purchaser Public Warrants on the NYSE; provided, that the Parties acknowledge and agree that from and after the First Closing, the Parties intend to list on the NYSE only the Pubco Ordinary Shares and the Pubco Public Warrants.

 

47

 

 

9.5 No Solicitation.

 

(a) For purposes of this Agreement, (i) an “Acquisition Proposal means any inquiry, proposal or offer, or any indication of interest in making an offer or proposal, from any Person or group at any time relating to an Alternative Transaction, and (ii) an “Alternative Transactionmeans (A) with respect to the Company and the Target Companies, a transaction (other than the transactions contemplated by this Agreement) concerning the sale or transfer of (x) more than 20% of the business or assets of the Target Companies, taken as a whole (calculated on the basis of the fair market value thereof), or (y) more than 20% of the voting securities of the Company or the Target Companies, in any case, whether such transaction takes the form of a sale of shares or other equity interests, assets, merger, amalgamation, consolidation, joint venture or partnership, or otherwise and (B) with respect to Purchaser, Pubco, Merger Subs or and their Affiliates, a transaction (other than the transactions contemplated by this Agreement) concerning a Business Combination involving Purchaser.

 

(b) During the Interim Period, in order to induce the other Parties to continue to commit to expend management time and financial resources in furtherance of the transactions contemplated hereby, each Party shall not, and shall direct its Representatives to not, without the prior written consent of the Company and Purchaser, directly or indirectly, (i) solicit, assist, initiate or facilitate the making, submission or announcement of, or intentionally encourage, any Acquisition Proposal, (ii) furnish any non-public information regarding such Party or its Affiliates or their respective businesses, operations, assets, Liabilities, financial condition, prospects or employees to any Person or group (other than a Party to this Agreement or their respective Representatives) in connection with or in response to an Acquisition Proposal, (iii) engage or participate in discussions or negotiations with any Person or group with respect to, or that would reasonably be expected to lead to, an Acquisition Proposal, (iv) approve, endorse or recommend, or publicly propose to approve, endorse or recommend, any Acquisition Proposal, (v) negotiate or enter into any letter of intent, agreement in principle, acquisition agreement or other similar agreement related to any Acquisition Proposal, or (vi) release any third Person from, or waive any provision of, any confidentiality agreement to which such Party is a party.

 

(c) The Purchaser and the Company shall notify the other as promptly as practicable (and in any event within 48 hours of becoming aware thereof) in writing of the receipt by such Party or any of Affiliates or its or their Representatives of (i) any bona fide inquiries, proposals or offers, requests for information or requests for discussions or negotiations regarding or constituting any Acquisition Proposal or any bona fide inquiries, proposals or offers, requests for information or requests for discussions or negotiations that could reasonably be expected to result in an Acquisition Proposal, and (ii) any request for non-public information relating to such Party or its Affiliates in connection with an Acquisition Proposal, specifying in each case, (A) the material terms and conditions thereof (including a copy thereof (if in writing) or a written summary thereof (if oral)) and (B) the identity of the party making such inquiry, proposal, offer or request for information. Each Party shall keep the others promptly informed of the status of any such inquiries, proposals, offers or requests for information (provided that the Purchaser shall not be required to keep the Company informed of such status where it does not commence discussions with the potential transaction counterparty or its Representatives regarding such potential Alternative Transaction). During the Interim Period, each Party shall, and shall direct its Representatives to, immediately cease and cause to be terminated any solicitations, discussions or negotiations with any Person with respect to any Acquisition Proposal and shall, and shall direct its Representatives to, cease and terminate any such solicitations, discussions or negotiations.

 

48

 

 

9.6 No Trading. The Company and the Major Shareholders each acknowledge and agree that it is aware, and that their respective Affiliates are aware (and each of their respective Representatives is aware or, upon receipt of any material nonpublic information of Purchaser, will be advised) of the restrictions imposed by U.S. federal securities laws and the rules and regulations of the SEC and the NYSE promulgated thereunder or otherwise (the “Federal Securities Laws) and other applicable foreign and domestic Laws on a Person possessing material nonpublic information about a publicly traded company. The Company, and the Major Shareholders each hereby agree that it shall not purchase or sell any securities of Purchaser, communicate such information to any Person who is not a Party, take any other action with respect to Purchaser in violation of such Laws, or cause or encourage any Person to do any of the foregoing. The Purchaser agrees that it shall not purchase or sell any Company Securities in violation of Law or cause or encourage any Person to do any of the foregoing.

 

9.7 Notification of Certain Matters. During the Interim Period, each Party shall give notice to the other Parties as promptly as practicable if such Party or its Affiliates: (a) fails to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it or its Affiliates hereunder in a manner as would reasonably be expected to cause or result in any of the conditions set forth in Article XII not being satisfied or the satisfaction of those conditions being materially delayed; (b) receives any notice or other communication in writing from any Person who is not a Party (including any Governmental Authority) alleging (i) that the Consent of such Person is or may be required in connection with the transactions contemplated by this Agreement or (ii) that the consummation of the Transactions by such Party or its Affiliates would violate applicable Law; (c) receives any notice or other communication from any Governmental Authority in connection with the transactions contemplated by this Agreement; (d) discovers any fact or circumstance that, or becomes aware of the occurrence or non-occurrence of any event the occurrence or non-occurrence of which, would reasonably be expected to cause or result in any of the conditions set forth in Article XII not being satisfied or the satisfaction of those conditions being materially delayed, or (e) becomes aware of the commencement or threat, in writing, of any Action against such Party or any of its Affiliates, or any of their respective properties or assets, or, to the Knowledge of such Party, any officer, director, partner, member or manager, in his, her or its capacity as such, of such Party or of its Affiliates with respect to the consummation of the transactions contemplated by this Agreement. No such notice shall constitute an acknowledgement or admission by the Party providing the notice regarding whether or not any of the conditions to the First Closing have been satisfied or in determining whether or not any of the representations, warranties or covenants contained in this Agreement have been breached.

 

9.8 Efforts.

 

(a) Subject to the terms and conditions of this Agreement, each Party shall use its commercially reasonable efforts, and shall cooperate fully with the other Parties, to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper or advisable under applicable Laws and regulations to consummate the transactions contemplated by this Agreement (including the receipt of all applicable Consents of Governmental Authorities) and to comply as promptly as practicable with all requirements of Governmental Authorities applicable to the transactions contemplated by this Agreement.

 

49

 

 

(b) As soon as reasonably practicable following the date of this Agreement, and in any event within ten (10) Business Days thereafter, the Parties shall reasonably cooperate with each other and use (and shall cause their respective Affiliates to use) their respective commercially reasonable efforts to prepare and file with Governmental Authorities requests for approval of the transactions contemplated by this Agreement and shall use all commercially reasonable efforts to have such Governmental Authorities approve the transactions contemplated by this Agreement. Each Party shall give prompt written notice to the other Parties if such Party or any of its Representatives receives any notice from such Governmental Authorities in connection with the transactions contemplated by this Agreement, and shall promptly furnish to the other Parties with a copy of such Governmental Authority notice. If any Governmental Authority requires that a hearing or meeting be held in connection with its approval of the transactions contemplated hereby prior to the respective Closing, each Party shall, if requested by such Governmental Authority or by the other Party, arrange for its Representatives to be present for such hearing or meeting. If any objections are asserted with respect to the transactions contemplated by this Agreement under any applicable Law or if any Action is instituted (or threatened to be instituted) by any applicable Governmental Authority or any private Person challenging any of the transactions contemplated by this Agreement or any Ancillary Document as violative of any applicable Law or which would otherwise prevent, materially impede or materially delay the consummation of the transactions contemplated hereby or thereby, the Parties shall use their commercially reasonable efforts to resolve any such objections or Actions so as to timely permit consummation of the transactions contemplated by this Agreement and the Ancillary Documents, including in order to resolve such objections or Actions which, in any case if not resolved, could reasonably be expected to prevent, materially impede or materially delay the consummation of the transactions contemplated hereby or thereby. In the event any Action is instituted (or threatened to be instituted) by a Governmental Authority or private Person challenging the transactions contemplated by this Agreement, or any Ancillary Document, the Parties shall, and shall cause their respective Representatives to, reasonably cooperate with each other and use their respective commercially reasonable efforts to contest and resist any such Action and to have vacated, lifted, reversed or overturned any Order, whether temporary, preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation of the transactions contemplated by this Agreement or the Ancillary Documents.

 

(c) Prior to the respective Closing, each Party shall use its commercially reasonable efforts to obtain any Consents of Governmental Authorities or other third Persons as may be necessary for the consummation by such Party or its Affiliates of the transactions contemplated by this Agreement or required as a result of the execution or performance of, or consummation of the transactions contemplated by, this Agreement by such Party or its Affiliates, and the other Parties shall provide reasonable cooperation in connection with such efforts. Notwithstanding the foregoing, other than as explicitly set forth in this Agreement no Party shall be required to pay any fees, rents or make similar payments to any third Persons in order to comply with the terms of this Section 9.8.

 

9.9 Further Assurances. The Parties hereto shall further cooperate with each other and use their respective commercially reasonable efforts to take or cause to be taken all actions, and do or cause to be done all things, necessary, proper or advisable on their part under this Agreement and applicable Laws to consummate the transactions contemplated by this Agreement as soon as reasonably practicable, including preparing and filing as soon as practicable all documentation to effect all necessary notices, reports and other filings.

 

9.10 The Registration Statement.

 

(a) As promptly as practicable after the date hereof, Purchaser and Pubco shall prepare with the reasonable assistance of the Company, and file with the SEC, a registration statement on Form S-4 (as amended or supplemented from time to time, and including the Proxy Statement contained therein, the “Registration Statement) in connection with the registration under the Securities Act of the Pubco Securities to be issued under this Agreement to the holders of Purchaser Securities prior to the Cayman Effective Time, which Registration Statement will also contain a proxy statement of Purchaser (as amended, the “Proxy Statement) for the purpose of soliciting proxies from Purchaser Shareholders for the matters to be acted upon at the Purchaser Special Meeting and providing the Purchaser Shareholders an opportunity in accordance with Purchaser’s Organizational Documents and the IPO Prospectus to have their Purchaser Class A Ordinary Shares redeemed (the “Redemption) in conjunction with the Purchaser Shareholder vote on the Purchaser Shareholder Approval Matters. The Proxy Statement shall include proxy materials for the purpose of soliciting proxies from Purchaser Shareholders to vote, at an extraordinary general meeting of the Purchaser Shareholders to be called and held for such purpose (such meeting, together with an adjourned meeting, the “Purchaser Special Meeting), in favor of resolutions approving the Purchaser Shareholder Approval Matters, and the adjournment of the Purchaser Special Meeting, if necessary or desirable in the reasonable determination of Purchaser.

 

50

 

 

(b) In connection with the Registration Statement, Purchaser and Pubco will file with the SEC financial and other information about the transactions contemplated by this Agreement in accordance with applicable Law and applicable proxy solicitation and registration statement rules set forth in Purchaser’s Organizational Documents and the rules and regulations of the SEC and the NYSE. The Company shall provide Purchaser and Pubco with such information concerning the Target Companies and their equity holders, officers, directors, employees, assets, Liabilities, condition (financial or otherwise), business and operations that may be required or appropriate for inclusion in the Registration Statement, or in any amendments or supplements thereto, which information provided by the Company shall be true and correct and not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not materially misleading.

 

(c) Purchaser and Pubco shall take any and all reasonable and necessary actions required to satisfy the requirements of the Securities Act, the Exchange Act and other applicable Laws in connection with the Registration Statement, the Purchaser Special Meeting and the Redemption. Each of Purchaser, Pubco and the Company shall, and shall cause each of its Subsidiaries to, make their respective officers and employees, upon reasonable advance notice, available to the Company, Pubco, Purchaser and their respective Representatives in connection with the drafting of the public filings with respect to the transactions contemplated by this Agreement, including the Registration Statement, and responding in a timely manner to comments from the SEC. Each Party shall promptly correct any information provided by it for use in the Registration Statement (and other related materials) if and to the extent that such information is determined to have become false or misleading in any material respect or as otherwise required by applicable Laws. Purchaser and Pubco shall amend or supplement the Registration Statement and cause the Registration Statement, as so amended or supplemented, to be filed with the SEC and to be disseminated to the Purchaser Shareholders, in each case as and to the extent required by applicable Laws and subject to the terms and conditions of this Agreement and Purchaser’s Organizational Documents.

 

(d) Purchaser and Pubco, with the assistance of the other Parties, shall promptly respond to any SEC comments on the Registration Statement and shall otherwise use their commercially reasonable efforts to (i) “clear” comments from the SEC, (ii) cause the Registration Statement to become effective and (iii) keep the Registration Statement effective for as long as necessary to consummate the transactions contemplated hereby.

 

51

 

 

(e) As soon as practicable after the SEC declares the Registration Statement effective, Purchaser shall distribute the Proxy Statement contained in the Registration Statement to the Purchaser Shareholders and, pursuant thereto, shall duly call, give notice of, convene and hold (subject to the last sentence of this Section 9.10(e)) the Purchaser Special Meeting in accordance with the Cayman Companies Act, Purchaser’s Organizational Documents and the rules and regulations applicable to the SEC and NYSE for a date as soon as practicable following the date on which the SEC declared the Registration Statement effective and shall solicit proxies from the holders of Purchaser Ordinary Shares to vote in favor of the Purchaser Shareholder Approval Matters. Purchaser, acting through its board of directors, shall include in the Proxy Statement the recommendation of its board of directors that the holders of Purchaser Ordinary Shares vote in favor of the Purchaser Shareholder Approval Matters, and shall otherwise use its best efforts to obtain the Required Purchaser Shareholder Approval. Purchaser shall provide the Company with (a) updates with respect to the tabulated vote counts received by Purchaser, and (b) the right to review and comment on all communication sent to Purchaser Shareholders, holders of Purchaser Warrants and/or proxy solicitation firms. Subject to applicable Law, neither Purchaser’s board of directors nor any committee or agent or representative thereof shall (i) withdraw (or modify in any manner adverse to the Company), or propose publicly to withdraw (or modify in any manner adverse to the Company), Purchaser board’s recommendation that Purchaser Shareholders vote in favor of the Purchaser Shareholder Approval Matters, (ii) approve, recommend or declare advisable, or propose publicly to approve, recommend or declare advisable, any Alternative Transaction, (iii) approve, recommend or declare advisable, or propose publicly to approve, recommend or declare advisable, or allow Purchaser to execute or enter into, any agreement related to an Alternative Transaction, (iv) enter into any agreement, letter of intent, or agreement in principle requiring Purchaser to abandon, terminate or fail to consummate the transactions contemplated hereby or breach its obligations hereunder, (v) fail to recommend against any Alternative Transaction, (vi) fail to re-affirm the aforementioned Purchaser board recommendation at the written request of the Company within five (5) Business Days of such request or (vii) resolve or agree in writing to do any of the foregoing (any of the actions listed in sub-clauses (i) through (vii) of this sentence, a “Purchaser Change of Recommendation). If on the date for which the Purchaser Special Meeting is scheduled, Purchaser has not received proxies representing a sufficient number of shares to obtain the Required Purchaser Shareholder Approval, whether or not a quorum is present, Purchaser may make one or more successive postponements or adjournments of the Purchaser Special Meeting, and shall hold the Purchaser Special Meeting as soon as reasonably practicable upon Purchaser’s determination that it has received proxies representing a sufficient number of shares to obtain the Required Purchaser Shareholder Approval.

 

(f) Purchaser and Pubco shall comply with all applicable Laws, any applicable rules and regulations of the SEC, the NYSE, Purchaser’s and Pubco’s Organizational Documents, respectively, the Cayman Companies Act and this Agreement in the preparation, filing and distribution of the Registration Statement, any solicitation of proxies thereunder, the calling and holding of the Purchaser Special Meeting and the Redemption.

 

(g) As promptly as practicable after the date hereof and to the extent required by applicable law, rules or practices of the SEC or the requirements of any applicable securities exchange, the Company shall provide to Purchaser and Pubco (collectively, the “Required Registration Statement Company Financials): (i) consolidated financial statements of the Target Companies (including, in each case, any related notes thereto), consisting of the consolidated balance sheets of the Target Companies as of December 31, 2020, December 31, 2019 and December 31, 2018, and the related consolidated audited income statements, changes in shareholder equity and statements of cash flows for the years then ended, and (to the extent required by applicable Law or rules or practices of the SEC with respect to the Registration Statement ) audited in accordance with PCAOB auditing standards by a PCAOB qualified auditor, and (ii) if required to be provided by applicable Law or rules or practices of the SEC as of the date of the initial filing of the Registration Statement with the SEC in order for the SEC to accept and review such filing the Company prepared and auditor reviewed financial statements, consisting of the consolidated balance sheets of the Target Companies as of the latest available calendar quarter end date and the related consolidated income statement, changes in shareholder equity and statement of cash flows for the period then ended.

 

52

 

 

9.11 Public Announcements.

 

(a) The Parties agree that, during the Interim Period, no public release, filing or announcement concerning this Agreement or the Ancillary Documents or the transactions contemplated hereby or thereby shall be issued by any Party or any of their Affiliates without the prior written consent (not be unreasonably withheld, conditioned or delayed) of Purchaser, Pubco and the Company, except as such release or announcement may be required by applicable Law or the rules or regulations of any securities exchange, in which case the applicable Party shall use commercially reasonable efforts to allow the other Parties reasonable time to comment on, and arrange for any required filing with respect to, such release or announcement in advance of such issuance.

 

(b) The Purchaser and Company shall issue a press release announcing the execution of this Agreement (the “Signing Press Release) in the form agreed by the Purchaser and the Company as promptly as practicable after the execution of this Agreement. Promptly after the issuance of the Signing Press Release, Purchaser shall file a current report on Form 8-K (the “Signing Filing) with the Signing Press Release and a description of this Agreement as required by Federal Securities Laws, which the Company shall review and comment upon prior to filing (with the Company reviewing and commenting upon such Signing Filing in any event no later than the third (3rd) Business Day after the execution of this Agreement). The Purchaser, Pubco and Company shall mutually agree upon and, on the date of the Second Closing issue a press release announcing the consummation of the transactions contemplated by this Agreement (the “Closing Press Release). Promptly after the issuance of the Closing Press Release, Pubco shall file a current report on Form 8-K (the “Closing Filing) with the Closing Press Release and a description of the Closings as required by Federal Securities Laws which each of Shareholder Representative and Purchaser Representative shall review and comment upon prior to filing, and Pubco shall use reasonable efforts to incorporate such comments. In connection with the preparation of the Signing Press Release, the Signing Filing, the Closing Filing, the Closing Press Release, or any other report, statement, filing notice or application made by or on behalf of a Party to any Governmental Authority or other Person in connection with the transactions contemplated hereby, each Party shall, upon request by any other Party, furnish the Parties with all information concerning themselves, their respective directors, officers and equity holders, and such other matters as may be reasonably necessary or advisable in connection with the transactions contemplated hereby, or any other report, statement, filing, notice or application made by or on behalf of a Party to any Person who is not a Party and/or any Governmental Authority in connection with the transactions contemplated hereby. To the extent that a Party is required to furnish information concerning themselves in accordance with the foregoing sentence, such Party shall be provided a reasonable opportunity to review and comment on the disclosure containing such information regarding such Party, and the Purchaser and Company shall use reasonable efforts to incorporate any such comments from such Party.

 

(c) During the Interim Period, each of the Company and the Purchaser shall provide the other Party with a draft of any press release or other public announcement it intends to make about the Company at least one Business Day prior to publishing such press release or other public announcement.

 

9.12 Post-Closing Board of Directors. The Parties shall take all necessary action, including causing the directors of Pubco to resign, so that, effective as of the First Closing, Pubco’s board of directors will consist of three (3) directors identified by the Purchaser Representative. The Parties shall take all necessary action, including causing the directors of Pubco to resign, so that effective as of the Second Closing, Pubco’s board of directors (the “Post-Closing Pubco Board) will consist of eight (8) natural Persons. The Parties shall take all necessary action to designate and appoint to the Post-Closing Pubco Board (a) the three (3) Persons that are designated in writing by Purchaser prior to the First Closing (the “Purchaser Directors”), at least two (2) of whom shall qualify as independent directors under NYSE rules, (b) the three (3) Persons that are designated in writing by the Company prior to the First Closing, at least one (1) of whom shall be required to qualify as an independent director under NYSE rules and (c) the two (2) Persons that shall be mutually agreed in writing between the Purchaser and the Company prior to the First Closing whom shall qualify as an independent director under NYSE rules, provided that the Parties shall ensure that the composition of the Post-Closing Board satisfies the applicable requirement for Pubco to qualify as a “foreign private issuer” (as defined in the Securities Act). Purchaser Representative shall be entitled to remove any Purchaser Director prior to the lock-up period applicable to Purchaser Representative under the Lock-Up Agreement. In the event that any of the Purchaser Directors is removed, resigns, retires or otherwise ceases to be a director prior to the later of (x) the expiration of the lock-up period applicable to the Purchaser Representative pursuant to the Lock-Up Agreement or (y) the date that the Pubco shares are permitted to be resold as a result of the effectiveness of a registration statement (or statements), sufficient to permit the resale of the Pubco shares issued to Purchaser Representative in connection with the Transactions, the Purchaser Representative shall have the right to nominate and appoint a replacement Purchaser Director.

 

53

 

 

9.13 Indemnification of Directors and Officers; Tail Insurance.

 

(a) The Parties agree that all rights to exculpation, indemnification and advancement of expenses existing in favor of the current or former directors and officers of Purchaser and each Person who served as a director, officer, member, trustee or fiduciary of another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise at the request of Purchaser (the “Purchaser D&O Indemnified Persons) as provided in Purchaser’s Organizational Documents or under any indemnification, employment or other similar agreements between any Purchaser D&O Indemnified Person and Purchaser, in each case as in effect on the date of this Agreement, shall survive the Closings and continue in full force and effect in accordance with their respective terms to the extent permitted by applicable Law. For a period of six (6) years after the Second Closing, Pubco shall cause the Organizational Documents of Pubco to contain provisions no less favorable with respect to exculpation and indemnification of and advancement of expenses to Purchaser D&O Indemnified Persons than are set forth as of the date of this Agreement in the Organizational Documents of Purchaser to the extent permitted by applicable Law. The provisions of this Section 9.13 shall survive the Closings and are intended to be for the benefit of, and shall be enforceable by, each of the Purchaser D&O Indemnified Persons and their respective heirs and representatives.

 

(b) For the benefit of Purchaser’s directors and officers, Purchaser, in coordination with Pubco and the Company, shall be permitted prior to the Second Closing Date to obtain and fully pay the premium for a “tail” insurance policy that provides coverage for up to a six-year period from and after the Second Closing Date for events occurring prior to the Second Closing Date (the “D&O Tail Insurance) that is substantially equivalent to and in any event not less favorable in the aggregate than the Purchaser’s existing policy or, if substantially equivalent insurance coverage is unavailable, the best available coverage. If obtained, Pubco and Purchaser shall maintain the D&O Tail Insurance in full force and effect, and continue to honor the obligations thereunder, and Pubco and Purchaser shall timely pay or cause to be paid all premiums with respect to the D&O Tail Insurance.

 

(c) The Parties agree that all rights to exculpation, indemnification and advancement of expenses existing in favor of the current or former directors and officers of the Company and each Person who served as a director, officer, member, trustee or fiduciary of another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise at the request of the Company (the “Company D&O Indemnified Persons) as provided in the Company’s Organizational Documents or under any indemnification, employment or other similar agreements between any Company D&O Indemnified Person and the Company, in each case as in effect on the date of this Agreement, shall survive the Closings and continue in full force and effect in accordance with their respective terms to the extent permitted by applicable Law. For a period of six (6) years after the Second Closing, Pubco shall cause the Organizational Documents of Pubco to contain provisions no less favorable with respect to exculpation and indemnification of and advancement of expenses to Company D&O Indemnified Persons than are set forth as of the date of this Agreement in the Organizational Documents of the Company to the extent permitted by applicable Law. The provisions of this Section 9.13 shall survive the Closings and are intended to be for the benefit of, and shall be enforceable by, each of the Company D&O Indemnified Persons and their respective heirs and representatives.

 

54

 

 

(d) For the benefit of the Company’s directors and officers, the Company, in coordination with Pubco and Purchaser, shall be permitted prior to the Second Closing Date to obtain and fully pay the premium for a “tail” insurance policy that provides coverage for up to a six-year period from and after the Second Closing Date for events occurring prior to the Second Closing Date (the “Company D&O Tail Insurance) that is substantially equivalent to and in any event not less favorable in the aggregate than the Company’s existing policy or, if substantially equivalent insurance coverage is unavailable, the best available coverage. If obtained, Pubco and the Company shall maintain the Company D&O Tail Insurance in full force and effect, and continue to honor the obligations thereunder, and Pubco and the Company shall timely pay or cause to be paid all premiums with respect to the Company D&O Tail Insurance.

 

9.14 Trust Account Proceeds. The Parties agree that after the Second Closing, the funds in the Trust Account, after taking into account payments for the Redemption and any proceeds received by Pubco or Purchaser from any PIPE Investment shall first be used to pay (i) Purchaser’s accrued Expenses, including Purchaser Transaction Expenses and deferred Expenses of the IPO and (ii) any loans owed by Purchaser to the Purchaser Representative for Expenses (including deferred Expenses), other administrative costs and expenses incurred by or on behalf of Purchaser. Such amounts, as well as any Expenses that are required or permitted to be paid by delivery of Pubco Securities, will be paid at the Second Closing. Any remaining cash will be used for Pubco’s working capital and general corporate purposes. Prior to the Second Closing, none of the funds held in the Trust Account may be released except as explicitly permitted by the Trust Agreement.

 

9.15 Commitment Agreements. Purchaser and Pubco shall each use its reasonable best efforts to satisfy the conditions of the investors’ closing obligations contained in the Commitment Agreements, and consummate the transactions contemplated thereby. Purchaser and Pubco shall not terminate, amend or waive in any manner adverse to the Company, Purchaser or Pubco, the Commitment Agreements without the Company’s and Purchaser’s prior written consent (as applicable) (not to be unreasonably withheld, delayed or conditioned) and Purchaser and Pubco shall, except with the Company’s or Purchaser’s prior written consent (as applicable) (not to be unreasonably withheld, delayed or conditioned with respect to any Commitment Agreement if the condition set forth in Section 12.2(c) will otherwise be satisfied without the closing under such Commitment Agreement), use its best efforts to enforce each of the Commitment Agreements in accordance with its terms. In the event that there is an actual or threatened material breach or default by an investor under a Commitment Agreement, or Purchaser reasonably believes in good faith that such investor otherwise is not willing or able to consummate the transactions contemplated thereby upon the satisfaction of the conditions of such investor’s closing obligations thereunder, then notwithstanding anything to the contrary herein, except with the Company’s prior written consent, or if Purchaser has evidence reasonably satisfactory to the Company that the condition set forth in Section 12.2(c) will otherwise be satisfied based on the deadline for the Redemption having passed, Purchaser and Pubco shall be required to use their respective reasonable best efforts to enter into and consummate replacement agreements for the PIPE Investment, which agreements shall become Commitment Agreements for purposes of this Agreement and included as part of the PIPE Investment, and Purchaser, Pubco and the Company shall, and shall cause their respective Representatives to, reasonably cooperate with Purchaser, Pubco and their respective Representatives in connection with such replacement PIPE Investment and use their respective commercially reasonable efforts to cause such replacement PIPE Investment to occur (including having the Company’s senior management participate in any investor meetings and roadshows as reasonably requested by Purchaser).

 

55

 

 

9.16 Registration of the Exchange Shares.

 

(a) Pubco agrees that, within thirty (30) calendar days following the Second Closing Date (such deadline, the “Filing Deadline”), Pubco will submit to or file with the SEC a registration statement for a shelf registration on Form S-1 or Form S-3 (if Pubco is then eligible to use a Form S-3 shelf registration) (the “Resale Shelf Registration Statement”), in each case, covering the resale of the Exchange Shares held by the Norway Merger Sub 1 Shareholders (determined as of two (2) Business Days prior to such submission or filing) (the “Registrable Shares”) and Pubco shall use its commercially reasonable efforts to have the Resale Shelf Registration Statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) the 90th calendar day following the filing date thereof if the SEC notifies Pubco that it will “review” the Resale Shelf Registration Statement and (ii) the 10th Business Day after the date Pubco is notified (orally or in writing, whichever is earlier) by the SEC that the Resale Shelf Registration Statement will not be “reviewed” or will not be subject to further review (such earlier date, the “Effectiveness Deadline”); provided, however, that Pubco’s obligations to include the Registrable Shares in the Resale Shelf Registration Statement are contingent upon the applicable Norway Merger Sub 1 Shareholder (which, for the avoidance of doubt for this Section 9.16, shall exclude Pubco) furnishing in writing to Pubco such information regarding the shareholder, Exchange Shares held by such shareholder and the intended method of disposition of the Registrable Shares (which shall be limited to non-underwritten public offerings) as shall be required under applicable securities laws to effect the registration of the Registrable Shares, and such shareholder shall execute such documents as are required under applicable securities laws in connection with such registration, including providing that Pubco shall be entitled to postpone and suspend the effectiveness or use of the Resale Shelf Registration Statement, if applicable, as permitted hereunder; provided that such shareholder shall not in connection with the foregoing be required to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer the Registrable Shares (other than the Lock-Up Agreements). Pubco shall provide Shareholder Representative reasonable access to all relevant Pubco documents, records, and other information requested by Shareholder Representative in connection with the transactions contemplated under this Section 9.16, and shall provide Shareholder Representative adequate opportunity to ask questions of, and receive answers from, Pubco’s officers, employees, agents, accountants, and representatives concerning Pubco’s business, operations, financial condition, assets, liabilities, and all other matters relevant to its holding of the Exchange Shares. For as long as the applicable Norway Merger Sub 1 Shareholder holds Exchange Shares, Pubco will use commercially reasonable efforts to file all reports for so long as the condition in Rule 144(c)(1) (or Rule 144(i)(2), if applicable) is required to be satisfied, and provide all customary and reasonable cooperation, necessary to enable the undersigned to resell such shares pursuant to Rule 144 of the Securities Act (in each case, when Rule 144 of the Securities Act becomes available to the shareholders). Each of the Parties further acknowledges and agrees that the Shareholder Representative shall have the authority, on behalf of such Shareholders, to enforce the terms of the foregoing provision, without any further actions being taken by any such shareholders. Pubco shall take any and all reasonable actions necessary to ensure that the issuance of the Exchange Shares pursuant to this Section 9.16(a) complies with the requirements of Regulation S, including, without limitation, to the extent reasonable and necessary or required by applicable Governmental Authorities, amending its organizational documents to comply with the terms of 17 CFR § 230.903(b)(3)(iii)(B)(3)-(4), and if after taking such actions, such compliance is not possible, the Parties shall mutually agree an alternative method for the issuance of the Exchange Shares in compliance with the Securities Act.

 

(b) Pubco agrees to indemnify, to the extent permitted by law, the Norway Merger Sub 1 Shareholders (to the extent a seller under the Resale Shelf Registration Statement), its directors and officers and each person who controls such shareholder (within the meaning of the Securities Act), to the extent permitted by law, against all losses, claims, damages, liabilities and reasonable and documented out of pocket expenses (including reasonable and documented attorneys’ fees of one law firm) caused by any untrue or alleged untrue statement of material fact contained in any Resale Shelf Registration Statement, prospectus included in any Resale Shelf Registration Statement (“Prospectus”) or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, in the light of the circumstances under which they were made) not misleading, except insofar as the same are caused by or contained in any information or affidavit so furnished in writing to Pubco by or on behalf of any such Norway Merger Sub 1 Shareholder expressly for use therein.

 

56

 

 

9.17 Delisting and Deregistration. The Parties shall take all actions necessary or reasonably requested by another Party to cause the Purchaser Units, Purchaser Class A Ordinary Shares and Purchaser Warrants to be delisted from the NYSE (or be succeeded by the Pubco Securities) and to terminate its registration with the SEC pursuant to Sections 12(b), 12(g) and 15(d) of the Exchange Act (or be succeeded by Pubco) as of the First Closing Date.

 

9.18 Pubco NYSE Listing. The Purchaser and Pubco shall use commercially reasonable efforts to cause the Pubco Ordinary Shares to be approved for listing on the NYSE by no later than the First Closing Date, and to remain listed as a public company on the NYSE through the Second Closing Date.

 

9.19 Equity Plans.

 

(a) The Company shall amend the Company Equity Plan and take all other necessary actions, effective as of immediately prior to the Second Closing, in order to (i) cancel the remaining unallocated share reserve under the Company Equity Plan and provide that shares in respect of Company Options that for any reason become re-eligible for future issuance, shall be cancelled, and (ii) provide that no new Company Options will be granted under the Company Equity Plan.

 

(b) In connection with the Transactions, Pubco shall adopt, prior to or effective upon the Second Closing, a new Equity Incentive Plan in the form attached as Exhibit F hereto (the “Pubco Equity Plan), which will provide that the total awards under such Pubco Equity Plan will be a number of Pubco Ordinary Shares equal to ten percent (10%) of the aggregate number of Pubco Ordinary Shares issued and outstanding immediately after the Second Closing.

 

9.20 Company Shareholder Approval.

 

(a) The Company shall take all action necessary under applicable Law and its Organizational Documents to, as soon as possible after the date hereof, call, give notice of, convene and hold a special meeting of the Shareholders to pass resolutions (the “Company Special Meeting”) approving (A) the adoption and approval of the Norway Plan of Demerger and the Norway Plan of Merger in accordance with the Company’s Organizational Documents and the Norwegian Companies Act and (B) such other matters as the Company and Purchaser shall hereafter mutually determine to be necessary or appropriate in order to effect the Transactions (the approvals described in foregoing clauses (A) and (B), collectively, the “Company Shareholder Approval Matters”). The Company, acting through its board of directors, shall include in the materials distributed to the Shareholders in connection with the Company Shareholder Approval Matters a recommendation of its board of directors that the Shareholders vote in favor of the adoption of Company Shareholder Approval Matters.

 

(b) Neither the Company’s board of directors nor any committee or agent or representative thereof shall (i) withdraw (or modify in any manner adverse to the Purchaser), or propose publicly to withdraw (or modify in any manner adverse to the Purchaser), the Company board’s recommendation that the Shareholders vote in favor of the adoption of the Norway Plan of Merger (ii) approve, recommend or declare advisable, or propose publicly to approve, recommend or declare advisable, any Alternative Transaction, (iii) approve, recommend or declare advisable, or propose publicly to approve, recommend or declare advisable, or allow the Company to execute or enter into, any agreement related to an Alternative Transaction, (iv) enter into any agreement, letter of intent, or agreement in principle requiring the Company to abandon, terminate or fail to consummate the transactions contemplated hereby or breach its obligations hereunder, (v) fail to recommend against any Alternative Transaction, (vi) fail to re-affirm the aforementioned Company board recommendation at the written request of the Purchaser within five (5) Business Days of such request or (vii) resolve or agree in writing to do any of the foregoing (any of the actions listed in sub-clauses (i) through (vii) of this sentence, a “Company Change of Recommendation).

 

57

 

 

9.21 Merger Subs’ and Pubco Shareholder Approvals.

 

(a) Each Merger Sub and Pubco shall take all action necessary under applicable Law and its Organizational Documents to, as soon as possible after the date hereof, (i) call, give notice of, convene and hold a special meeting of its shareholders to pass resolutions or (ii) request its shareholders to pass written resolutions, in each case approving (A) the adoption and approval of this Agreement and the Mergers and other transactions contemplated hereby (as applicable) by their shareholders in accordance with their respective Organizational Documents and the Norwegian Companies Act, the Luxembourg Companies Act or the Cayman Companies Act (as applicable) and (B) such other matters as the Company and Purchaser shall hereafter mutually determine to be necessary or appropriate in order to effect the Transactions (the approvals described in foregoing clauses (A) and (B), in respect of Norway Merger Sub 1, the “Norway Merger Sub 1 Shareholder Approval Matters”, in respect of Norway Merger Sub 2, the “Norway Merger Sub 2 Shareholder Approval Matters” and in respect of Cayman Merger Sub, the “Cayman Merger Sub Shareholder Approval Matters” and, collectively, the “Merger Subs’ Shareholder Approval Matters”) and, in respect of Pubco (the “Pubco Shareholder Approval Matters”).

 

(b) Purchaser Representative shall vote in favor of the Pubco Shareholder Approval Matters.

 

(c) Pubco shall vote in favor of the Cayman Merger Sub Shareholder Approval Matters.

 

(d) Purchaser shall vote in favor of the Norway Merger Sub 1 Shareholder Approval Matters, provided that Purchaser shall not be required to do so until after the Required Purchaser Shareholder Approval is obtained.

 

(e) Norway Merger Sub 1 shall vote in favor of the Norway Merger Sub 2 Shareholder Approval Matters.

 

9.22 Section 16 of the Exchange Act. Prior to the First Closing, the board of directors of Pubco, or an appropriate committee of nonemployee directors thereof, shall adopt a resolution consistent with the interpretative guidance of the SEC so that the acquisition of Pubco Securities pursuant to this Agreement by any officer or director of the Purchaser or Company who is expected to become a “covered person” of Pubco for purposes of Section 16 of the Exchange Act and the rules and regulations thereunder (“Section 16”) shall be an exempt transaction for purposes of Section 16.

 

9.23 Transfer Taxes. Pubco shall be liable for and agrees to pay any and all transfer, documentary, sales, use, stamp, registration and other similar Taxes and fees (including any associated penalties and interest) (“Transfer Taxes”) incurred in connection with or arising out of the transactions contemplated by this Agreement. The parties shall cooperate in the execution and delivery of any and all instruments and certificates with respect to such Transfer Taxes and the applicable party Surviving Corporation shall file all necessary Tax Returns and other documentation with respect to any such Transfer Taxes.

 

58

 

 

9.24 Registration Rights Agreement. Pubco, the Company, the Major Shareholders and Purchaser Representative will enter into the Registration Rights Agreement substantially in the form attached hereto as Exhibit G.

 

9.25 Resignations. Purchaser shall use its commercially reasonable best efforts to procure that all of the officers and directors of Purchaser shall resign from all of their positions at Purchaser prior to or effective upon the Second Closing.

 

9.26 Termination of Existing Registration Rights Agreement. The Purchaser and the Purchaser Representative shall terminate the Existing Registration Rights Agreement effective as of the Second Closing.

 

9.27 First Amended Pubco Articles. Prior to the First Closing, the Purchaser Representative shall use its reasonable best efforts to adopt the First Amended Pubco Articles as of the First Closing.

 

9.28 Net Tangible Assets. The Purchaser shall use reasonable best efforts to maintain net tangible assets of at least $5,000,001 (including after giving effect to any Redemption).

 

9.29 Company Disclosure Schedules. Up until the third Business Day prior to the First Closing, the Company may supplement or amend the Company Disclosure Schedules and deliver such supplemented or amended Company Disclosure Schedules to Purchaser with respect to any fact, occurrence, event, effect, change, circumstance or development that occurs after the date of this Agreement. If any such supplement or amendment gives Purchaser a right to terminate this Agreement pursuant to Section 13.1(e) (determined solely by reference to the condition precedent set out in Section 12.3(a) as far as it relates to the representations and warranties made as of the First Closing or Second Closing, but specifically excluding the representations and warranties set out in Sections 7.3(a) and Section 7.4). and Purchaser elects to waive or fails to timely exercise its right to terminate this Agreement and consummates the transactions contemplated hereunder, then such supplement or amendment will be deemed to have amended the Company Disclosure Schedules, to have modified the relevant representations and warranties contained in Article VIII (but only as of the First Closing or Second Closing, and not as of the date hereof) and to have cured any misrepresentation or any inaccuracy or breach of any such representation or warranty that otherwise might have existed hereunder by reason of such fact, occurrence, event, effect, change, circumstance or development (and the Company will have no liability to Indemnitees with respect to such fact, occurrence, event, effect, change, circumstance or development), as it relates to the representations and warranties made as of the First Closing or Second Closing. If any such supplement or amendment does not give Purchaser a right to terminate this Agreement pursuant to Article XIII, then Indemnitees will still be entitled to seek indemnification for any Losses related to such supplement or amendment in accordance with the terms and provisions of this Agreement. For the avoidance of doubt, nothing in this Section 9.30 (or in any such supplemented, updated or amended Company Disclosure Schedule) affects representations and warranties made as of the date of this Agreement.

 

9.30 Norway Demerger. Prior to the First Closing, the Company shall do everything within its control to effect the Norway Demerger in accordance with the Norway Demerger Plan.

 

9.31 No Leakage. From the date hereof to the Second Closing Date, the Company and the Major Shareholders shall not permit the occurrence of any Leakage (other than Permitted Leakage).

 

59

 

 

9.32 Employment Agreements. As soon as reasonably practicable following the date hereof, the Company and Pubco (as applicable) shall enter into employment agreements with the applicable directors and officers of the Company or Pubco (as applicable) in accordance with the term sheets attached hereto as Exhibit J.

 

Article X
SURVIVAL

 

10.1 Survival.

 

(a) All representations and warranties of the Company and the Major Shareholders contained in this Agreement (including all schedules and exhibits hereto and all certificates, documents and instruments furnished pursuant to this Agreement on or after the date hereof) shall survive the Closings through and until the applicable Expiration Date (other than the Fundamental Representations which shall survive the Second Closing for six (6) years after the Second Closing). No claim for indemnification hereunder may be made after the Expiration Date; provided, that there shall be no time limitation with respect to any Fraud Claims, and provided further, that if an Indemnitee delivers to the Indemnitor a Claim Notice in accordance with Section 10.4(b), with respect to a claim for any Loss incurred as a result of a breach of any representation, warranty or covenant before the Expiration Date in accordance with this Section 10.1(a), then the relevant representations, warranties or covenant shall survive solely as to such claim, until the claim has been finally resolved. All covenants, obligations and agreements (in each case, including any indemnification obligations with respect thereto) of the Company, any Major Shareholder or the Shareholder Representative contained in this Agreement (including all schedules and exhibits hereto and all certificates, documents and instruments furnished by the Company and the Major Shareholders pursuant to this Agreement on or after the date hereof) (x) that are required to be performed prior to or at the applicable Closing, shall survive until the first anniversary of the applicable Closing Date, and (y) that are required to the performed after the applicable Closing, shall survive the applicable Closing and continue until fully performed in accordance with their terms; provided that the covenants, obligations and agreements contained in Section 9.7 (Notification of Certain Matters) shall not survive the Closings and no claim for indemnification hereunder may be made with respect to Section 9.7 (Notification of Certain Matters).

 

(b) The representations and warranties of the Purchaser and Pubco contained in this Agreement or in any certificate or instrument delivered by or on behalf of the Purchaser, Pubco and the Merger Subs pursuant to this Agreement shall not survive the Closings, and from and after the Second Closing, the Purchaser, the Purchaser Representative, and their respective Representatives shall not have any further obligations, nor shall any claim be asserted or Action be brought against the Purchaser, the Purchaser Representative or their respective Representatives with respect thereto. The covenants and agreements made by the Purchaser, Pubco and the Merger Subs and/or the Purchaser Representative in this Agreement or in any certificate or instrument delivered pursuant to this Agreement, including any rights arising out of any breach of such covenants or agreements, shall not survive the Closings, except for those covenants and agreements contained herein and therein that by their terms apply or are contemplated to be performed in whole or in part after the Closings (which such covenants shall survive the Closings and continue until fully performed in accordance with their terms). Purchaser Representative shall not have any liability whatsoever and all Parties waive any and all claims against Purchaser Representative, and Pubco shall indemnify and hold harmless Purchaser Representative for any actions, responsibilities, obligations or statements of Pubco pursuant to, with respect to or in connection with this Agreement or the transactions contemplated hereby.

 

60

 

 

10.2 Indemnification. Subject to the terms and conditions of this Article X, from and after the Second Closing, the Major Shareholders and their respective successors and assigns (each, with respect to any claim made pursuant to this Agreement, an “Indemnitor”) will severally, based on their Major Shareholder Pro Rata Percentage (with respect to the Escrow Shares) and their Shareholder Pro Rata Percentage otherwise, and, in each case, not jointly, indemnify, defend and hold harmless Pubco and its officers, directors, managers, employees, successors and permitted assigns (only in their capacities as such), but, for clarity, excluding any shareholders of Pubco (each, with respect to any claim made pursuant to this Agreement, an “Indemnitee”), from and against any and all losses, liabilities, damages (including consequential damages to the extent awarded by an applicable court), diminution in value (to the extent awarded by the applicable court), Taxes, interest, penalties, Liens, amounts paid in settlement (subject to compliance with Section 10.4), costs and expenses (including reasonable court costs and reasonable attorneys’ fees and expenses but excluding any exemplary, punitive or special damages unless actually paid to a Person that is not an Indemnitee) (any of the foregoing, including those resulting from Actions or Orders, a “Loss”) paid, suffered or incurred by, or imposed upon, any Indemnitee to the extent arising in whole or in part out of or resulting directly or indirectly from (whether or not involving a Third Party Claim): (A) the breach of any representation or warranty made by the Company set forth in this Agreement or in any certificate executed and delivered by the Company pursuant to this Agreement; (B) the breach of any covenant, obligation or agreement on the part of the Company set forth in this Agreement, or in any certificate delivered by the Company pursuant to this Agreement on or after the date hereof, in each case to the extent obligated to be performed prior to Closing, or (C) (i) the breach of any representation or warranty made by a Major Shareholder in this Agreement or in any certificate executed and delivered by a Major Shareholder pursuant to this Agreement or (ii) the breach of any covenant, obligation or agreement on the part of a Major Shareholder set forth in this Agreement or in any certificate delivered by a Major Shareholder pursuant to this Agreement on or after the date hereof (provided that no Major Shareholder shall be liable under this Section 10.2(C) for a breach by another Major Shareholder).

 

10.3 Limitations and General Indemnification Provisions.

 

(a) Except as otherwise expressly provided in this Article X, the Indemnitees will not be entitled to receive any indemnification payments under Section 10.2 unless and until the aggregate amount of Losses incurred by the Indemnitees for which they are otherwise entitled to indemnification under this Article X exceeds the value of $2,000,000 (the “Basket”), in which case the Indemnitors shall be obligated to the Indemnitees for the amount of all Losses of the Indemnitees from the first dollar of Losses of the Indemnitees, subject to the other limitations herein; provided, however, that the Basket shall not apply to (i) indemnification claims for breaches of any Special Representations or (ii) Fraud Claims.

 

(b) The maximum aggregate amount of indemnification payments which each Indemnitor shall be obligated to pay under Section 10.2 (other than in respect of (i) Fraud Claims or (ii) any indemnification claims for breaches of any Special Representations) shall not exceed an amount equal to the number of Pubco Ordinary Shares constituting ten percent (10%) of the sum of (x) Exchange Shares received by such Indemnitor at Second Closing, plus (y) any Escrow Shares withheld from such Indemnitor at Second Closing in accordance with Section 3.1.

 

(c) The maximum aggregate amount of indemnification payments which each Indemnitor shall be obligated to pay under Section 10.2 (other than in respect of (i) Fraud Claims or (ii) any indemnification claims for breaches of any Fundamental Representations) shall not exceed an amount equal to the number of Pubco Ordinary Shares constituting twenty-five percent (25%) of the sum of (x) Exchange Shares received by such Indemnitor at Second Closing, plus (y) any Escrow Shares withheld from such Indemnitor at Second Closing in accordance with Section 3.1.

 

61

 

 

(d) The maximum aggregate amount of indemnification payments which each Indemnitor shall be obligated to pay under Section 10.2 (other than in respect of Fraud Claims) shall not exceed an amount equal to the number of Pubco Ordinary Shares constituting one hundred percent (100%) of the sum of (x) Exchange Shares received by such Indemnitor at Second Closing, plus (y) any Escrow Shares withheld from such Indemnitor at Second Closing in accordance with Section 3.1.

 

(e) For the avoidance of doubt, to the extent recovery is sought in respect of any indemnifiable Losses in excess of the Escrow Shares, each Major Shareholder shall only be liable for its Shareholder Pro Rata Percentage of any such Loss.

 

(f) In no event will any Indemnitee be entitled to any recovery for any Loss more than once.

 

(g) Solely for purposes of determining the amount of Losses under this Article X (and, for the avoidance of doubt, not for purposes of determining whether there has been a breach giving rise to the indemnification claim), all of the representations, warranties and covenants set forth in this Agreement (including the disclosure schedules hereto) or any Ancillary Document that are qualified by materiality, Material Adverse Effect or words of similar import or effect will be deemed to have been made without any such qualification.

 

(h) After becoming aware of any event or occurrence that would reasonably be expected to give rise to an indemnification right under this Article X, each Indemnitee shall use their reasonable best efforts, to the extent required by applicable Law, to mitigate all Losses arising therefrom; provided, however, that in no event shall any Indemnitee be required to mitigate any Losses directly or indirectly resulting from (i) any actions taken at the written direction of the Purchaser, (ii) any change in applicable Laws (including for the avoidance of doubt, any change in the applicable Tax rate applicable to the Company), or (iii) any Losses as having been reflected or accrued in the Company Financials.

 

(i) In no event shall any Indemnitee be obligated to provide indemnification under Section 10.2 to the extent any such Losses are related to, attributable to or arise from any facts, circumstances, events or matters of which Purchaser or its Representatives had knowledge prior to the execution of this Agreement

 

10.4 Indemnification Procedures.

 

(a) The Purchaser Representative shall have the sole right and sole ability to act on behalf of the Indemnitees with respect to any indemnification claims made pursuant to this Article X, including bringing and settling any indemnification claims hereunder and receiving any notices on behalf of the Indemnitees. The Shareholder Representative shall have the sole right and ability to act on behalf of the Indemnitors with respect to any indemnification claims made pursuant to this Article X, including defending and settling any indemnification claims hereunder and receiving any notices on behalf of the Indemnitors.

 

(b) In order to make a claim for indemnification hereunder, the Purchaser Representative must, on behalf of an Indemnitee provide written notice (a “Claim Notice”) of such claim to the Shareholder Representative on behalf of the Indemnitors, which Claim Notice shall include (i) a reasonable description of the facts and circumstances which relate to the subject matter of such indemnification claim to the extent then known and (ii) the amount of Losses suffered by the Indemnitee in connection with the claim to the extent known or reasonably estimable (provided, that the Purchaser Representative may thereafter adjust the amount of Losses with respect to the claim by providing a revised Claim Notice to the Shareholder Representative and the Escrow Agent); provided, that the copy of any Claim Notice provided to the Escrow Agent shall be redacted for any confidential or proprietary information of the Indemnitor or the Indemnitee described in clause (i).

 

62

 

 

(c) In the case of any claim for indemnification under this Article X arising from a claim of any Person who is not a Party (including any Governmental Authority) (a “Third Party Claim”), the Shareholder Representative will have the right, but not the obligation, to assume the defense, at its own expense and by counsel of its own choosing, of such Third Party Claim and any Third Party Claims related to the same or a substantially similar set of facts. If the Shareholder Representative so undertakes to defend any such Third Party Claim, it shall notify the Purchaser Representative of its intention to do so, and the Indemnitees shall reasonably cooperate with the Shareholder Representative and its counsel in the defense against, and settlement of, any such Third Party Claim; provided, however, that the Shareholder Representative shall be expressly authorized to settle any such Third Party Claim in its sole discretion unless such settlement involves (i) any injunctive relief against or any finding or admission of any violation of Law or wrongdoing by the Indemnitee, (ii) any money damages which will be borne by the Indemnitees or (iii) a claim of a criminal nature that could reasonably be expected to lead to criminal proceedings against the Indemnitee. Subject to the foregoing, the Indemnitees shall have the right to employ separate legal counsel and to participate in but not control the defense of such Third Party Claim at its own cost and expense. In any event, the Indemnitees shall cause its legal counsel to cooperate with the Shareholder Representative and its legal counsel. No Indemnitee may settle any Third Party Claim without the written consent of the Shareholder Representative (not to be unreasonably withheld, conditioned or delayed). If the Shareholder Representative does not assume the defense of a Third Party Claim, it shall nevertheless be entitled to participate in the defense of such proceeding at its own cost and expense, and the Indemnitees shall reasonably cooperate with the Shareholder Representative and its counsel in the defense against, and settlement of, any such Third Party Claim.

 

(d) The Purchaser Representative on behalf of the Indemnitee may not compromise or settle any Third Party Claim without consulting the Shareholder Representative.

 

10.5 Indemnification Payments. Any indemnification claims against the Indemnitors shall first be applied against the Escrow Shares (based on their relevant Major Shareholder Pro Rata Percentage) before any Indemnitor shall be required to make any out-of-pocket payment for indemnification, and after the Escrow Shares are exhausted, each Indemnitor’s obligation pursuant to Section 10.3 shall be determined by reference to the Shareholder Pro Rata Percentage, provided that the Indemnitors shall be entitled to use Pubco Ordinary Shares to settle some or all of its indemnification obligations. Any indemnification obligation of an Indemnitor under this Article X will be paid within ten (10) Business Days after the final non-appealable determination of such obligation in accordance with this Agreement (and the Purchaser Representative and the Shareholder Representative will provide or cause to be provided to the Escrow Agent any written instructions or other information or documents required by the Escrow Agent to do so). Notwithstanding anything to the contrary contained herein, any indemnification payments will be made to Pubco or its successors. With respect to any indemnification payment, the value of each Escrow Share or any other Pubco Ordinary Shares for purposes of determining the indemnification payment to be made by delivery of Escrow Shares or Pubco Ordinary Shares shall be the Pubco Share Price as of the date that the indemnification claim is finally determined in accordance with this Article X. Any Escrow Shares or any other Pubco Ordinary Shares received by Pubco as an indemnification payment shall be promptly cancelled by Pubco after its receipt thereof.

 

10.6 Exclusive Remedy. From and after the Second Closing, except with respect to (i) claims relating to the Exchange Shares, which shall be exclusively governed by Article II, (ii) claims relating to Leakage, which shall be governed exclusively by Article XI, (iii) claims seeking injunctions, specific performance or other equitable relief, (iv) Fraud Claims or (v) claims under the Ancillary Documents, indemnification pursuant to this Article X shall be the sole and exclusive remedy for the Parties with respect to matters arising under this Agreement of any kind or nature (whether or not arising from a Third Party Claim) with respect to any misrepresentation or breach of any warranty, or breach of any covenant contained in this Agreement or in any certificate or instrument delivered pursuant to this Agreement or otherwise relating to such subject matter of this Agreement, including the negotiation and discussion thereof, and the Indemnitees shall not otherwise be entitled, whether under law or in equity, to seek contribution, cost recovery, Losses or any other recourse or remedy from any Shareholder personally (excluding pursuant to the Escrow Account).

 

63

 

 

Article XI
LEAKAGE; legal costS adjustments

 

11.1 Leakage.

 

(a) As of the date hereof, no Leakage (other than Permitted Leakages) has occurred since the Locked Box Date. If at any time prior to the Second Closing, the Company becomes aware of the occurrence of any Leakage during the Locked Box Period, the Company shall promptly notify the Purchaser of the occurrence of such Leakage, the Major Shareholder to whom such Leakage is attributable, and the amount thereof and other reasonable details of such Leakage (the “Agreed Leakage Amount”). In respect of any Agreed Leakage Amount, the Major Shareholder shall, within two Business Days of the Second Closing, return the applicable number of Exchange Shares to Pubco to settle all of its payment obligations in respect of the Agreed Leakage Amount. The value of each Exchange Share for purposes of determining the payment in accordance with Section 11.1(a) shall be the Redemption Price.

 

(b) In the case of any Leakage or any portion of any Leakage which occurs during the Locked Box Period, but for which the number of Exchange Shares has not been returned to Pubco pursuant to Section 11.1(a), Purchaser Representative may demand on behalf of and for the benefit of Pubco, and the Major Shareholders must pay an amount equal to, on a dollar for dollar basis, the amount of the Leakage from the Major Shareholder(s) to whom such Leakage is attributable.

 

(c) For the avoidance of doubt, the fact that an Agreed Leakage Amount has been determined pursuant to Section 11.1(a) in respect of any Leakage shall not preclude the Purchaser Representative from recovering any further amounts payable under Section 11.1 in respect of such Leakage which was not taken into account in the Agreed Leakage Amount.

 

(d) Any claims in respect of Leakage against a Major Shareholder in accordance with Section 11.1(b) shall first be applied against the Escrow Shares before any Major Shareholder shall be required to make any out-of-pocket payment in respect of such Leakage. The Major Shareholders shall be entitled to use Pubco Ordinary Shares to settle some or all of its out-of-pocket payment obligations in respect of Leakage. With respect to payment in respect of Leakage, the value of each Escrow Share or any other Pubco Ordinary Shares for purposes of determining the payment in accordance with Section 11.1(b) shall be the Redemption Price.

 

(e) Any Exchange Shares, Escrow Shares or any other Pubco Ordinary Shares received by Pubco in respect of Leakage shall be promptly cancelled by Pubco after its receipt thereof.

 

(f) To the extent a Major Shareholder does not make payment in respect of Leakage in accordance with Section 11.1(a) within 2 Business Days, or Section 11.1(b) within 15 days, of being notified by the Purchaser Representative thereof, Pubco shall be entitled to a cancel a number of Pubco Ordinary Shares held by such Major Shareholder equal to the Leakage (based on the Redemption Price).

 

64

 

 

(g) No Major Shareholder shall be liable to make a payment under Section 11.1(b) unless Purchaser Representative has notified the Shareholder Representative in writing of the Leakage, stating in reasonable detail the nature of the breach and, if practicable, the amount claimed, on or before the date falling twelve (12) months after the Second Closing.

 

11.2 Legal Cost Adjustment.

 

(a) Three Business Days prior to the First Closing, the Company shall provide the Purchaser with a schedule, prepared in good faith, setting out the Transaction Legal Costs. The Purchaser shall have an opportunity to review and comment on such schedule, and the Purchaser and Company shall discuss in good faith any changes to such schedule, provided that if the Purchaser and Company are unable to agree to any adjustments two Business Days prior to the First Closing, then the amounts set forth in the schedule as delivered by the Company shall be for purposes of calculating Transaction Legal Costs and any adjustments to the Equity Consideration to be made as of the Second Closing.

 

(b) To the extent that the Transaction Legal Costs are within the Legal Expenses Collar, there shall be no adjustment to the Equity Consideration. To the extent that there is any Legal Cost Adjustment, the Legal Cost Adjustment shall be added to or deducted from the Equity Consideration, as applicable.

 

(c) The Purchaser Representative may pursue claims post-Closings against the Major Shareholders for any Transaction Legal Costs not agreed pre-Second Closing to the extent they are outside of the Legal Expenses Collar, but only to the extent of such Major Shareholder’s Shareholder Pro Rata Percentage thereof.

 

Article XII
CLOSINGs CONDITIONS

 

12.1 Conditions to Each Party’s Obligations. The obligations of each Party to consummate the Transactions shall be subject to the satisfaction or written waiver (where permissible) by the Company, Purchaser and Purchaser Representative of the following conditions as of the First Closing Date.

 

(a) Required Purchaser Shareholder Approval. The Purchaser Shareholder Approval Matters shall have been approved by the requisite vote of the Purchaser Shareholders entitled to vote thereon at the Purchaser Special Meeting in accordance with Purchaser’s Organizational Documents and applicable Law (the “Required Purchaser Shareholder Approval).

 

(b) Required Company Shareholder Approval. The Company Shareholder Approval Matters shall have been approved by the requisite vote of the Shareholders entitled to vote thereon at the Company Special Meeting in accordance with the Company’s Organizational Documents and applicable Law (the “Required Company Shareholder Approval).

 

(c) No Law or Order. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent) or Order that is then in effect and which has the effect of making the transactions or agreements contemplated by this Agreement illegal or which otherwise prevents or prohibits consummation of the transactions contemplated by this Agreement.

 

(d) No Litigation. There shall not be any pending Action brought by a Governmental Authority seeking to enjoin the consummation of the Transactions.

 

65

 

 

(e) Net Tangible Assets Test. Upon the First Closing, after giving effect to the Redemption, the Purchaser shall have net tangible assets of at least $5,000,001.

 

(f) Appointment to the Board. The members of the Post-Closing Pubco Board shall have been elected or appointed to take effect as of the Second Closing consistent with the requirements of Section 9.12.

 

(g) Registration Statement. The Registration Statement shall have been declared effective by the SEC and shall remain effective as of the First Closing.

 

(h) NYSE Listing. The Pubco Ordinary Shares and Pubco Public Warrants shall be approved for listing on the NYSE, subject only to notice of issuance.

 

(i) Demerger Plan. The Norway Demerger shall have been effected in accordance with the Norway Demerger Plan.

 

(j) Valid Issuance. The issuance of each of the Exchange Shares, and Pubco Ordinary Shares underlying the Pubco Options, Pubco Warrants and Pubco EDGE Warrants granted to the Norway Merger Sub 1 Shareholders, and the holders of Company Options, Company Warrants and Company EDGE Warrants, respectively, shall be either exempt from registration, or registered, in each case permitting the issuance of such Exchange Shares in compliance with applicable securities laws of any state of the United States or the securities laws of any Governmental Authority.

 

12.2 Conditions to Obligations of the Company and the Major Shareholders. In addition to the conditions specified in Section 12.1, the obligations of the Company and Major Shareholders to consummate the Transactions are subject to the satisfaction or written waiver (by the Company and Pubco) of the following conditions as of the First Closing Date:

 

(a) Representations and Warranties. All of the representations and warranties of Purchaser and Pubco set forth in this Agreement and in any certificate delivered by or on behalf of Purchaser, Pubco and the Merger Subs pursuant hereto (without giving effect to any qualifications or limitations as to materiality) shall be true and correct in all material respects on and as of the date of this Agreement and on and as of the First Closing Date as if made on the First Closing Date, except for (i) those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been true and correct in all material respects as of such date) and (ii) any failures to be true and correct that (without giving effect to any qualifications or limitations as to materiality), individually or in the aggregate, have not had and would not reasonably be expected to have a materially adverse effect on, or with respect to, each of the Purchaser, Pubco or the Merger Subs provided that this Section 12.2(a)(ii) shall not apply to the representations and warranties of the Purchaser contained in Section 5.5(a) and 6.5(a), which representations and warranties shall have been true and correct in all material respects.

 

(b) Agreements and Covenants. Purchaser, Pubco and the Merger Subs shall have performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under this Agreement to be performed or complied with by it on or prior to the First Closing Date.

 

66

 

 

(c) Minimum Cash Condition. As of the First Closing, after giving effect to the completion of the Redemption, the commitments in respect of the PIPE Investment and the Funding Commitment Letter, but without giving effect to the payment of Purchaser’s Expenses, any liabilities described in clause (ii) of Section 9.14 and assuming that (A) all funds are drawn under the Funding Commitment Letter, (B) the funds drawn under the Funding Commitment letter are held by the Purchaser and (C) none of the funds drawn under the Funding Commitment Letter have been used as of the First Closing, Purchaser and Pubco shall collectively have at least 400 million U.S. Dollars ($400,000,000) in the aggregate in cash and cash equivalents, including funds in the Trust Account and any proceeds from any of the Funding Commitment Letter or other PIPE Investment (including any funds in respect of the PIPE Investment which are deposited into an escrow account on or prior to First Closing which shall be released to Pubco on the Second Closing in accordance with the applicable Commitment Agreement).

 

(d) Closing Deliveries.

 

(i) Officer Certificate. Purchaser shall have delivered to the Company and Pubco a certificate, dated the First Closing Date, signed by a director of Purchaser in such capacity, certifying as to the satisfaction of the conditions specified in Sections 12.2(a), 12.2(b) (in respect of Purchaser and the Norway Merger Subs) and 12.2(c). Pubco shall have delivered to the Company a certificate, dated the First Closing Date, signed by an executive officer or director of Pubco in such capacity, certifying as to the satisfaction of the conditions specified in Sections 12.2(a), 12.2(b) (in respect of Pubco and the Cayman Merger Sub) and 12.2(c).

 

(ii) Registration Rights Agreement. The Company and Pubco shall have received a copy of a Registration Rights Agreement, by and among Pubco, the Purchaser Representative and the Major Shareholders, in substantially the form attached as Exhibit G hereto (the “Registration Rights Agreement), duly executed by the Purchaser Representative.

 

(iii) Escrow Agreement. The Company and Pubco shall have received a copy of the Escrow Agreement, duly executed by the Purchaser Representative.

 

(iv) First Amended Pubco Articles. Prior to the First Closing, the Purchaser Representative shall have adopted the amended and restated articles of association of Pubco in the form attached as Exhibit H hereto (the “First Amended Pubco Articles).

 

(e) Trust Funds. Purchaser shall have made appropriate arrangements to have the funds in the Trust Account paid in accordance with Section 9.14.

 

12.3 Conditions to Obligations of Purchaser. In addition to the conditions specified in Section 12.1, the obligations of Purchaser to consummate the Transactions are subject to the satisfaction or written waiver (by Purchaser and Purchaser Representative) of the following conditions as of the First Closing:

 

(a) Representations and Warranties. All of the representations and warranties of the Company and the Major Shareholders set forth in this Agreement and in any certificate delivered by or on behalf of the Company and the Major Shareholders pursuant hereto shall be true and correct on and as of the date of this Agreement and on and as of the First Closing Date as if made on the First Closing Date, except for (i) those representations and warranties that address matters only as of a particular date (which representations and warranties shall have been accurate as of such date), and (ii) any failures to be true and correct that (without giving effect to any qualifications or limitations as to materiality or Material Adverse Effect), individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect on, or with respect to, the Target Companies, taken as a whole (provided that this Section 12.3(a)(ii) shall not apply to the representations and warranties of the Company contained in Sections 7.3(a) and 7.4, which representations and warranties shall have been true and correct in all material respects).

 

67

 

 

(b) Agreements and Covenants. The Company and the Major Shareholders shall have performed in all material respects all of their respective obligations and complied in all material respects with all of their respective agreements and covenants under this Agreement to be performed or complied with by them on or prior to the First Closing Date.

 

(c) No Material Adverse Effect. Since the date of this Agreement, no Material Adverse Effect shall have occurred with respect to the Target Companies, taken as a whole, and be continuing.

 

(d) Closing Deliveries.

 

(i) Officer Certificate. Purchaser shall have received a certificate from the Company, dated as the First Closing Date, signed by an executive officer or director of the Company in such capacity, certifying as to the satisfaction of the conditions specified in Sections 12.3(a), 12.3(b) and 12.3(c) (in respect of the Company).

 

(ii) Shareholder Representative Certificate. Purchaser shall have received a certificate from the Shareholder Representative, dated as the First Closing Date, certifying as to the satisfaction of the conditions specified in Sections 12.3(a) and 12.3(b) (in respect to the Major Shareholders).

 

(i) Registration Rights Agreement. Purchaser shall have received a copy of the Registration Rights Agreement, duly executed by Pubco, the Purchaser Representative and the Major Shareholders;

 

(ii) Escrow Agreement. Purchaser shall have received a copy of the Escrow Agreement, duly executed by Pubco, the Shareholder Representative and the Escrow Agent.

 

(iii) Termination of Company Shareholders’ Agreement. At or prior to the First Closing, Shareholders’ Agreement shall be terminated with effect from the Second Closing.

 

12.4 Second Closing. Upon completion of the First Closing, the Second Closing shall be unconditional other than the Registration Statement remaining effective.

 

12.5 Frustration of Conditions. Notwithstanding anything contained herein to the contrary, no Party may rely on the failure of any condition set forth in this Article XII to be satisfied if such failure was primarily caused by the failure of such Party or its Affiliates (including, with respect to the Purchaser, Pubco or the Merger Subs, or with respect to the Company, any Target Company or the Major Shareholders) to comply with or perform any of its covenants or obligations set forth in this Agreement.

 

Article XIII
TERMINATION AND EXPENSES

 

13.1 Termination. This Agreement may be terminated and the transactions contemplated hereby may be abandoned at any time prior to the First Closing as follows:

 

(a) by mutual written consent of Purchaser and the Company;

 

68

 

 

(b) by written notice by Purchaser or the Company if the First Closing shall not have occurred by July 31, 2021 (the “Outside Date); provided, however, that the right to terminate this Agreement under this Section 13.1(b) shall not be available to a Party if the breach or violation by such Party or its Affiliates (including, with respect to the Purchaser, Pubco or the Merger Subs, or with respect to the Company, the Major Shareholders) of any representation, warranty, covenant or obligation under this Agreement was the primary cause of the failure of the First Closing to occur on or before the Outside Date;

 

(c) by written notice by either Purchaser or the Company if a Governmental Authority of competent jurisdiction shall have issued an Order or taken any other action permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement, and such Order or other action has become final and non-appealable; provided, however, that the right to terminate this Agreement pursuant to this Section 13.1(c) shall not be available to a Party if the failure by such Party or its Affiliates (including, with respect to the Purchaser, Pubco, or the Merger Subs, or with respect to the Company, the Major Shareholders) to comply with any provision of this Agreement has been the primary cause of such action by such Governmental Authority;

 

(d) by written notice by the Company to Purchaser, if (i) there has been a breach by Purchaser, Pubco or the Merger Subs of any of its representations, warranties, covenants or agreements contained in this Agreement, or if any representation or warranty of Purchaser, Pubco or the Merger Subs shall have become untrue or inaccurate, in any case, which would result in a failure of a condition set forth in Section 12.2(a) or Section 12.2(b) to be satisfied (treating the First Closing Date for such purposes as the date of this Agreement or, if later, the date of such breach), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) twenty (20) days after written notice of such breach or inaccuracy is provided to Purchaser by the Company or (B) the Outside Date; provided, that the Company shall not have the right to terminate this Agreement pursuant to this Section 13.1(d) if at such time the Company or the Major Shareholders is in material uncured breach of this Agreement;

 

(e) by written notice by Purchaser to the Company, if (i) there has been a breach by the Company or the Major Shareholders of any of their respective representations, warranties, covenants or agreements contained in this Agreement, or if any representation or warranty of such Parties shall have become untrue or inaccurate, in any case, which would result in a failure of a condition set forth in Section 12.3(a) or Section 12.3(b) to be satisfied (treating the First Closing Date for such purposes as the date of this Agreement or, if later, the date of such breach), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) twenty (20) days after written notice of such breach or inaccuracy is provided to the Company by Purchaser or (B) the Outside Date; provided, that Purchaser shall not have the right to terminate this Agreement pursuant to this Section 13.1(e) if at such time Purchaser, Pubco or any of the Merger Subs is in material uncured breach of this Agreement;

 

(f) by written notice by either the Company or the Purchaser if the Purchaser Special Meeting is held (including any adjournment or postponement thereof) and has concluded, Purchaser Shareholders have duly voted, and the Required Purchaser Shareholder Approval was not obtained;

 

(g) by written notice by the Purchaser to the Company if the Company Special Meeting is held (including any adjournment or postponement thereof) and has concluded, the Shareholders have duly voted, and the Required Company Shareholder Approval was not obtained;

 

(h) by the Company if Purchaser makes any Purchaser Change of Recommendation; provided that with respect to any particular Purchaser Change of Recommendation, the right to terminate under this Section 13.1(h) shall expire on the 10th day following the occurrence of such Purchaser Change of Recommendation; or

 

69

 

 

(i) by the Purchaser if the Company makes any Company Change of Recommendation; provided that with respect to any particular Company Change of Recommendation, the right to terminate under this Section 13.1(i) shall expire on the 10th day following the occurrence of such Company Change of Recommendation.

 

13.2 Effect of Termination. This Agreement may only be terminated in the circumstances described in Section 13.1 and pursuant to a written notice delivered by the applicable Party to the other applicable Parties, which sets forth the basis for such termination, including the provision of Section 13.1 under which such termination is made. In the event of the valid termination of this Agreement pursuant to Section 13.1, this Agreement shall forthwith become void, and there shall be no Liability on the part of any Party or any of their respective Representatives, and all rights and obligations of each Party shall cease, except: (i) Sections 9.11, 13.3, Article XIV, Article XV and this Section 13.2 shall survive the termination of this Agreement, and (ii) nothing herein shall relieve any Party from Liability for any willful breach of any representation, warranty, covenant or obligation under this Agreement or any Fraud Claim against such Party, in either case, prior to termination of this Agreement (in each case of clauses (i) and (ii) above, subject to Section 14.1). Without limiting the foregoing, and except as provided in Section 13.3 and this Section 13.2 (but subject to Section 14.1, and subject to the right to seek injunctions, specific performance or other equitable relief in accordance with Section 15.6), the Parties’ sole right prior to the First Closing with respect to any breach of any representation, warranty, covenant or other agreement contained in this Agreement by another Party or with respect to the transactions contemplated by this Agreement shall be the right, if applicable, to terminate this Agreement pursuant to Section 13.1.

 

13.3 Fees and Expenses. Subject to Section 14.1, all Expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the Party incurring such expenses. As used in this Agreement, “Expensesshall mean all out-of-pocket expenses (including all fees and expenses of counsel, accountants, investment bankers, financial advisors, financing sources, experts and consultants to a Party hereto or any of its Affiliates) incurred by a Party or on its behalf in connection with or related to the authorization, preparation, negotiation, execution or performance of this Agreement or any Ancillary Document related hereto and all other matters related to the consummation of this Agreement. With respect to Purchaser, Expenses shall include any and all deferred expenses (including fees or commissions payable to the underwriters and any legal fees) of the IPO upon consummation of a Business Combination and any Purchaser Transaction Expenses.

 

70

 

 

Article XIV
WAIVERS AND RELEASES

 

14.1 Waiver of Claims Against Trust.

  

(a) Reference is made to the IPO Prospectus. The Company and the Major Shareholders hereby represent and warrant that they have read the IPO Prospectus and understand that Purchaser has established the Trust Account containing the proceeds of the IPO and the overallotment shares acquired by Purchaser’s underwriters and from certain private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of Purchaser’s public shareholders (including overallotment shares acquired by Purchaser’s underwriters) (the “Public Shareholders) and that, except as otherwise described in the IPO Prospectus, Purchaser may disburse monies from the Trust Account only: (a) to the Public Shareholders in the event they elect to redeem their Purchaser Ordinary Shares in connection with the consummation of its initial business combination (as such term is used in the IPO Prospectus) (“Business Combination) or in connection with an amendment to Purchaser’s Organizational Documents to extend Purchaser’s deadline to consummate a Business Combination, (b) to the Public Shareholders if Purchaser fails to consummate a Business Combination within twenty-four (24) months after the closing of the IPO (or prior to any other deadline to consummate a Business Combination established pursuant to an amendment to Purchaser’s Organizational Documents), subject to an amendment to Purchaser’s Organizational Documents to extend Purchaser’s deadline to consummate a Business Combination, (c) with respect to any interest earned on the amounts held in the Trust Account, amounts necessary to pay for any franchise or income taxes, and (d) to Purchaser after or concurrently with the consummation of a Business Combination. For and in consideration of Purchaser entering into this Agreement and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each of the Company and the Major Shareholders hereby agrees on behalf of itself and its Affiliates that, notwithstanding anything to the contrary in this Agreement, none of the Company and the Major Shareholders nor any of their respective Affiliates do now or shall at any time hereafter have any right, title, interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom, regardless of whether such claim arises as a result of, in connection with or relating in any way to, this Agreement or any proposed or actual business relationship between Purchaser or any of its Representatives, on the one hand, and the Company, the Major Shareholders or any of their respective Representatives, on the other hand, or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (collectively, the “Released Claims). Each of the Company and the Major Shareholders on behalf of itself and its Affiliates hereby irrevocably waives any Released Claims that any such Party or any of its Affiliates may have against the Trust Account (including any distributions therefrom) now or in the future as a result of, or arising out of, any negotiations, contracts or agreements with Purchaser or its Representatives and will not seek recourse against the Trust Account (including any distributions therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with Purchaser or its Affiliates). The Company and the Major Shareholders each agrees and acknowledges that such irrevocable waiver is material to this Agreement and specifically relied upon by Purchaser and its Affiliates to induce Purchaser to enter in this Agreement, and each of the Company and the Major Shareholders further intends and understands such waiver to be valid, binding and enforceable against such Party and each of its Affiliates under applicable Law. To the extent that the Company, the Major Shareholders or any of their respective Affiliates commences any Action based upon, in connection with, relating to or arising out of any matter relating to Purchaser or its Representatives, which proceeding seeks, in whole or in part, monetary relief against Purchaser or its Representatives, each of the Company and the Major Shareholders hereby acknowledges and agrees that its and its Affiliates’ sole remedy shall be against funds held outside of the Trust Account and that such claim shall not permit such Party or any of its Affiliates (or any Person claiming on any of their behalves or in lieu of them) to have any claim against the Trust Account (including any distributions therefrom) or any amounts contained therein. This Section 14.1(a) shall survive termination of this Agreement for any reason and continue indefinitely.

 

(b) Nothing in Section 14.1(a) shall serve to limit or prohibit the Company and the Major Shareholders’ right to pursue a claim against Purchaser for legal relief against monies or other assets held outside the Trust Account, for specific performance or other equitable relief in connection with the consummation of the Transactions (including a claim for Purchaser to specifically perform its obligations under this Agreement) and (y) nothing herein shall serve to limit or prohibit any claims that the Company may have in the future against Purchaser’s assets or funds that are not held in the Trust Account (including any funds that have been released from the Trust Account and any assets that have been purchased or acquired with any such funds).

 

71

 

 

14.2 No Recourse. Except as expressly set forth in this Agreement, notwithstanding any rights of a Party at law or in equity, in the event of any default or breach by another Party under this Agreement, such Party’s remedies shall be restricted to enforcement of its rights against the property and assets of (i) the Company, (ii) Purchaser, (iii) Pubco and (iv) the Major Shareholders (the “Liable Parties”), and no liability whatsoever shall attach to, be imposed on or otherwise be incurred by, any former, current or future director, officer, employee, agent, general or limited partner, manager, member, shareholder, stockholder or Affiliate of a Party (other than the Liable Parties), any stockholder, or any former, current or future director, officer, employee, agent, general or limited partner, manager, member, shareholder, stockholder or Affiliate (other than a Liable Party) of any of the foregoing (the “Non-Liable Parties”), whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable Law, for any obligations or Liabilities of the parties to this Agreement or for any claim based on, in respect of, or by reason of, the transactions contemplated hereby. Without limiting the generality of the foregoing, each Party hereto agrees that it shall, and shall cause its Affiliates to, not file, or threaten to file, any claim, suit, action or proceeding in violation of this Section 14.2. Notwithstanding the foregoing, nothing herein will relinquish the rights of a Party to specifically enforce the terms of this Agreement in accordance with Section 15.6 hereof. Nothing in this Section 14.2 shall limit the liability of a Non-Liable Party in the case of fraud or willful and intentional breach of this Agreement or any Ancillary Document.

 

Article XV
MISCELLANEOUS

 

15.1 Notices. All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered (i) in person, (ii) by e-mail when sent (except where the sender receives a failed delivery message), (iii) by facsimile, with affirmative confirmation of receipt, (iv) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (v) three (3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable Party at the following addresses (or at such other address for a Party as shall be specified by like notice):

 

If to Purchaser, Pubco or the Merger Subs at or prior to the Second Closing, to:

 

Alussa Energy Acquisition Corp.
PO Box 500, 71 Fort Street
Grand Cayman KY1-1106

Attention: Daniel Barcelo
Email: Daniel@alussaenergy.com

 

with a copy (which will not constitute notice) to:

 

Skadden, Arps, Slate, Meagher & Flom (UK) LLP
40 Bank Street
London, United Kingdom E14 5DS

Attention: Danny Tricot
Denis Klimentchenko
Email: danny.tricot@skadden.com
denis.klimentchenko@skadden.com

 

If to the Purchaser Representative, to:

 

Alussa Energy Sponsor LLC
PO Box 500, 71 Fort Street
Grand Cayman KY1-1106

Attention: Daniel Barcelo
Email: Daniel@alussaenergy.com

 

72

 

 

with a copy (which will not constitute notice) to:

 

Skadden, Arps, Slate, Meagher & Flom (UK) LLP
40 Bank Street
London, United Kingdom E14 5DS

Attention: Danny Tricot
Denis Klimentchenko
Email: danny.tricot@skadden.com
denis.klimentchenko@skadden.com

 

If to the Company at or prior to the Second Closing, to:

 

Freyr AS
Nytorget 1
8622 Mo i Rana, Norway

Attention: Chief Legal Officer
Email: contract-notifications@freyrbattery.com

 

with a copy (which will not constitute notice) to:

 

Wilson, Sonsini, Goodrich & Rosati
28 State Street, 37th Floor

Boston, MA 02109-1700, United States

Attention: Mark Solakian and Mark Baudler
Email: msolakian@wsgr.com and MBaudler@wsgr.com

 

and

 

Advokatfirmaet BAHR AS
Tjuvholmen allé 16
0252 Oslo, Norway

Attention: John Christian Thaulow and Svein Gerhard Simonnaes
Email: jct@bahr.no and sgs@bahr.no

 

If to the Shareholder Representative, to:

 

ATS AS
Kleivveien 19B
1356 Bekkestua, Norway

Attention: Torstein Sjøtveit
Email: torstein.sjotveit@freyrbattery.com

 

with a copy (which will not constitute notice) to:

 

Wilson, Sonsini, Goodrich & Rosati
28 State Street, 37th Floor

Boston, MA 02109-1700, United States

Attention: Mark Solakian and Mark Baudler
Email: msolakian@wsgr.com and MBaudler@wsgr.com

 

73

 

 

and

 

Advokatfirmaet BAHR AS
Tjuvholmen allé 16
0252 Oslo, Norway

Attention: John Christian Thaulow and Svein Gerhard Simonnaes
Email: jct@bahr.no and sgs@bahr.no

 

15.2 Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the Parties hereto and their respective successors and permitted assigns. This Agreement shall not be assigned by operation of Law or otherwise without the prior written consent of, prior to the Second Closing, Purchaser, Pubco, the Company and Shareholder Representative, and after the Second Closing, the Purchaser Representative and the Shareholder Representative, and any assignment without such consent shall be null and void; provided that no such assignment shall relieve the assigning Party of its obligations hereunder.

 

15.3 Third Parties. Except for the rights of the D&O Indemnified Persons set forth in Section 9.14, the Persons set forth in Section 9.16 (other than those Persons who are Parties to this Agreement), the Persons set forth in Section 10.2 (other than those Persons who are Parties to this Agreement) and the Persons set forth in Section 14.2 (other than those Persons who are Parties to this Agreement), which the Parties acknowledge and agree are express third party beneficiaries of this Agreement, nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any Person that is not a Party hereto or thereto or a successor or permitted assign of such a Party.

 

15.4 Arbitration. Any and all disputes, controversies or claims arising out of, relating to, or in connection with this Agreement or the breach, termination or validity hereof, or the transactions contemplated hereby (a “Dispute) shall be finally resolved by arbitration under the Rules of Arbitration of the ICC (the “ICC Rules). To the extent that the ICC Rules and this Agreement are in conflict, the terms of this Agreement shall control. The seat of arbitration shall be in New York County, State of New York. The language of the arbitration shall be English. The tribunal shall consist of three arbitrators. The parties to the Dispute shall each be entitled to nominate one arbitrator, provided that where there are multiple claimants or multiple respondents, the multiple claimants jointly and the multiple respondents jointly shall nominate an arbitrator. The third arbitrator, who shall be the presiding arbitrator on the tribunal, shall be nominated by the agreement of the two party-nominated arbitrators or, if they fail to agree on a nomination within fifteen (15) days of the nomination date of the second arbitrator, the third arbitrator shall be promptly selected and appointed by the ICC. The arbitrators shall decide the Dispute in accordance with the substantive law of the state of New York. The proceedings shall be streamlined and efficient. An arbitration award rendered by the tribunal shall be final and binding on the parties to the Dispute. Judgment on the award may be entered in any court having jurisdiction thereof.

 

15.5 Governing Law; Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State of New York (save to the extent necessary to give effect to the Mergers or Demerger, which shall be governed by the laws of the Cayman Islands, Norway or Luxembourg (as applicable)) without regard to the conflict of laws principles thereof.

 

74

 

 

15.6 Specific Performance. Each Party acknowledges that the rights of each Party to consummate the transactions contemplated hereby are unique, recognizes and affirms that in the event of a breach of this Agreement by any Party, money damages may be inadequate and the non-breaching Parties may have no adequate remedy at law, and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed by an applicable Party in accordance with their specific terms or were otherwise breached. Accordingly, each Party shall be entitled to seek an injunction, restraining order or other equitable relief to prevent breaches of this Agreement and to seek to enforce specifically the terms and provisions hereof, including the obligation to effect the Closings, without the requirement to post any bond or other security or to prove that money damages would be inadequate, this being in addition to any other right or remedy to which such Party may be entitled under this Agreement, at law or in equity.

 

15.7 Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

 

15.8 Amendment. This Agreement may be amended, supplemented or modified only by execution of a written instrument signed by (i) prior to the Second Closing Date, the Company, Pubco, the Merger Subs, Purchaser, Purchaser Representative and Shareholder Representative and (ii) after the Second Closing Date, by Pubco, Purchaser Representative and Shareholder Representative.

 

15.9 Waiver. Each of Purchaser, Purchaser Representative, Pubco and the Company on behalf of itself and its Affiliates, and the Shareholder Representative on behalf of itself and, if applicable, the Major Shareholders, may in its sole discretion (i) extend the time for the performance of any obligation or other act of any other non-Affiliate hereto, (ii) waive any inaccuracy in the representations and warranties by such other non-Affiliate contained herein or in any document delivered pursuant hereto and (iii) waive compliance by such other non-Affiliate with any covenant or condition contained herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by the Party or Parties to be bound thereby (including by the Purchaser Representative or the Shareholder Representative in lieu of such Party to the extent provided in this Agreement). Notwithstanding the foregoing, no failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder. Notwithstanding the foregoing, any waiver of any provision of this Agreement by Pubco or Purchaser shall also require the prior written consent of the Purchaser Representative.

 

15.10 Entire Agreement. This Agreement and the documents or instruments referred to herein, including any exhibits, annexes and schedules attached hereto, which exhibits, annexes and schedules are incorporated herein by reference, together with the Ancillary Documents, embody the entire agreement and understanding of the Parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, representations, warranties, covenants or undertakings, other than those expressly set forth or referred to herein or the documents or instruments referred to herein, which collectively supersede all prior agreements and the understandings among the Parties with respect to the subject matter contained herein (it being understood that the Letter of Intent between Purchaser and the Company is hereby terminated in its entirety and shall be of no further force and effect, except with respect to Clause 3 (Waiver against Trust) set forth therein).

 

75

 

 

15.11 Interpretation. The table of contents and the Article and Section headings contained in this Agreement are solely for the purpose of reference, are not part of the agreement of the Parties and shall not in any way affect the meaning or interpretation of this Agreement. In this Agreement, unless the context otherwise requires: (a) any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and words in the singular form, including any defined terms, include the plural and vice versa; (b) reference to any Person includes such Person’s successors and assigns but, if applicable, only if such successors and assigns are permitted by this Agreement, and reference to a Person in a particular capacity excludes such Person in any other capacity; (c) any accounting term used and not otherwise defined in this Agreement or any Ancillary Document has the meaning assigned to such term in accordance with GAAP, based on the accounting principles used by the applicable Person; (d) “including” (and with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (e) the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement; (f) the word “if” and other words of similar import when used herein shall be deemed in each case to be followed by the phrase “and only if”; (g) the term “or” means “and/or”; (h) any agreement, instrument, insurance policy, Law or Order defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument, insurance policy, Law or Order as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes, regulations, rules or orders) by succession of comparable successor statutes, regulations, rules or orders and references to all attachments thereto and instruments incorporated therein; (i) except as otherwise indicated, all references in this Agreement to the words “Section,” “Article”, “Schedule”, “Annex” and “Exhibit” are intended to refer to Sections, Articles, Schedules, Annexes and Exhibits to this Agreement; and (j) the term “Dollars” or “$” means United States dollars. Any reference in this Agreement or any Ancillary Document to a Person’s (i) directors shall include any member of such Person’s governing body, (ii) officers shall include any Person filling a substantially similar position for such Person or (iii) shareholders or stockholders shall include any applicable owners of the equity interests of such Person, in whatever form. The Parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision of this Agreement. When reference is made to “the business of” an entity, such reference shall be deemed to include the business of all direct and indirect Subsidiaries of such entity. Reference to the Subsidiaries of an entity shall be deemed to include all direct and indirect Subsidiaries of such entity.

 

15.12 Counterparts. This Agreement and each other document executed in connection with the transactions contemplated hereby may be executed and delivered (including by facsimile or other electronic transmission) in one or more counterparts, and by the different Parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery by email or facsimile to counsel for the other Party of a counterpart executed by a Party shall be deemed to meet the aforementioned requirements.

 

76

 

 

15.13 Purchaser Representative

 

(a) Each of Purchaser and, solely with respect to subsections (i), (ii), (iii) (vi) and (vii) of this Section 15.13, Pubco, on behalf of itself and its Subsidiaries, successors and assigns, by execution and delivery of this Agreement, hereby irrevocably appoints Alussa Energy Sponsor LLC in the capacity as the Purchaser Representative, as each such Person’s agent, attorney-in-fact and representative, with full power of substitution to act in the name, place and stead of such Person and to act on behalf of such Person from and after the Second Closing in connection with: (i) making on behalf of such Person and taking all actions on their behalf relating to any Leakage; (ii) taking any action in respect of indemnification as contemplated under Article X, (iii), acting on behalf of such Person under the Escrow Agreement; (iv) terminating, amending or waiving on behalf of such Person any provision of this Agreement or any Ancillary Documents to which the Purchaser Representative is a party or otherwise has rights in such capacity; (v) signing on behalf of such Person any releases or other documents with respect to any dispute or remedy arising under this Agreement or any Ancillary Documents to which the Purchaser Representative is a party or otherwise has rights in such capacity; (vi) employing and obtaining the advice of legal counsel, accountants and other professional advisors as the Purchaser Representative, in its reasonable discretion, deems necessary or advisable in the performance of its duties as the Purchaser Representative and to rely on their advice and counsel; (vii) incurring and paying reasonable out-of-pocket costs and expenses, including fees of brokers, attorneys and accountants incurred pursuant to the transactions contemplated hereby, and any other reasonable out-of-pocket fees and expenses allocable or in any way relating to such transaction; and (viii) otherwise enforcing the rights and obligations of any such Persons under this Agreement and the Ancillary Documents to which the Purchaser Representative is a party or otherwise has rights in such capacity, including giving and receiving all notices and communications hereunder or thereunder on behalf of such Person; provided, that the Parties acknowledge that the Purchaser Representative is specifically so authorized and directed to act on behalf of, and for the benefit of, the holders of Pubco Securities from and after the Second Closing (other than the Indemnitors and their respective successors and assigns). All decisions and actions by the Purchaser Representative shall be binding upon Pubco and Purchaser and their respective Subsidiaries, successors and assigns, and neither Pubco, Purchaser nor any other Party shall have the right to object, dissent, protest or otherwise contest the same. The provisions of this Section 15.13 are irrevocable and coupled with an interest. The Purchaser Representative hereby accepts its appointment and authorization as the Purchaser Representative under this Agreement.

 

(b) The Purchaser Representative shall not be liable for any act done or omitted under this Agreement or any Ancillary Document as the Purchaser Representative while acting in good faith and without willful misconduct or gross negligence, and any act done or omitted pursuant to the advice of counsel shall be conclusive evidence of such good faith. Pubco and Purchaser shall jointly and severally indemnify, defend and hold harmless the Purchaser Representative from and against any and all losses, Actions, Orders, Liabilities, damages, amounts paid in settlement, costs and expenses (including reasonable expenses of investigation and court costs and reasonable attorney’s fees and expenses) incurred without gross negligence, bad faith or willful misconduct on the part of the Purchaser Representative (in its capacity as such) and arising out of or in connection with the acceptance or administration of the Purchaser Representative’s duties under this Agreement or any Ancillary Document, including the reasonable fees and expenses of any legal counsel retained by the Purchaser Representative. In no event shall the Purchaser Representative in such capacity be liable hereunder or in connection herewith for any indirect, punitive, special or consequential damages. The Purchaser Representative shall be fully protected in relying upon any written notice, demand, certificate or document that it in good faith believes to be genuine, including facsimiles or copies thereof, and no Person shall have any Liability for relying on the Purchaser Representative in the foregoing manner. In connection with the performance of its rights and obligations hereunder, the Purchaser Representative shall have the right at any time and from time to time to select and engage, at the cost and expense of Purchaser, attorneys, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional and expert assistance, maintain such records and incur other out-of-pocket expenses, as the Purchaser Representative may deem necessary or appropriate from time to time. All of the indemnities, immunities, releases and powers granted to the Purchaser Representative under this Section 15.13 shall survive the Closings and continue indefinitely. With respect to any claim or cause of action arising out of, or related to any act or omission by the Purchaser Representative based upon, arising out of, or related to this Agreement, this Agreement may only be enforced against the Purchaser Representative, and not any of the officers, directors, securityholders, employees or Affiliates of the Purchaser Representative (the “Purchaser Representative Related Parties”). No Purchaser Representative Related Party shall have any liability for any obligations or liabilities of the Purchaser Representative, including but not limited to, for any claim based on, in respect of, or by reason of, any failure by the Purchaser Representative of the transactions contemplated by this Agreement to be consummated or any breach or failure of the Purchaser Representative to perform hereunder.

 

77

 

 

(c) The Person serving as the Purchaser Representative may resign upon ten (10) days’ prior written notice to Pubco, Purchaser and the Shareholder Representative, provided, that the Purchaser Representative appoints in writing a replacement Purchaser Representative and such replacement accepts such appointment. Each successor Purchaser Representative shall have all of the power, authority, rights, obligations and privileges conferred by this Agreement upon the original Purchaser Representative, and the term “Purchaser Representative” as used herein shall be deemed to include any such successor Purchaser Representatives.

 

15.14 Shareholder Representative.

 

(a) The Major Shareholders hereby irrevocably constitute and appoint ATS AS in the capacity as the Shareholder Representative under this Agreement and the Ancillary Documents to which the Shareholder Representative is a party or otherwise has rights in such capacity (the “Shareholder Representative Documents), as the true and lawful agent and attorney-in-fact of such Major Shareholder with full powers of substitution to act in the name, place and stead thereof with respect to the performance on behalf of such Major Shareholder under the terms and provisions of the under the terms and provisions of the Shareholder Representative Documents, as the same may be from time to time amended, and to do or refrain from doing all such further acts and things, and to execute all such documents on behalf of such Major Shareholder, if any, as the Shareholder Representative will deem necessary or appropriate in connection with any of the transactions contemplated by the Shareholder Representative Documents.

 

(b) Any other Person, including the Purchaser Representative, Pubco, Merger Subs, Purchaser and the Company may conclusively and absolutely rely, without inquiry, upon any actions of the Shareholder Representative as the acts of the Major Shareholders under the Shareholder Representative Documents. The Purchaser Representative, Pubco, Merger Subs, Purchaser and the Company shall be entitled to rely conclusively on the instructions and decisions of the Shareholder Representative as to (i) any payment instructions provided by the Shareholder Representative or (ii) any other actions required or permitted to be taken by the Shareholder Representative hereunder, and, in accordance with the Major Shareholder Irrevocable Undertakings, no Major Shareholder will have any cause of action against the Purchaser Representative, Pubco, Merger Subs, Purchaser, or the Company for any action taken by any of them in reliance upon the instructions or decisions of the Shareholder Representative. All notices or other communications required to be made or delivered to a Major Shareholder under any Shareholder Representative Document shall be made to the Shareholder Representative for the benefit of such Major Shareholder, and any notices so made shall discharge in full all notice requirements of the other parties hereto or thereto to such Major Shareholder with respect thereto. All notices or other communications required to be made or delivered by a Major Shareholder shall be made by the Shareholder Representative (except for a notice under Section 15.14(c) of the replacement of the Shareholder Representative).

 

(c) If the Shareholder Representative shall die, become disabled, resign or otherwise be unable or unwilling to fulfill his, her or its responsibilities as representative and agent of the Major Shareholders, then in accordance with the Major Shareholder Irrevocable Undertaking, the Major Shareholders shall, within ten (10) days after such death, disability, dissolution, resignation or other event, appoint a successor Shareholder Representative (by vote or written consent of the Major Shareholders holding in the aggregate in excess of fifty percent (50%) of the Exchange Shares held by all Major Shareholders), and promptly thereafter notify the Purchaser Representative, Purchaser and Pubco in writing of the identity of such successor. Any such successor so appointed shall become the “Shareholder Representative” for purposes of this Agreement and the other Shareholder Representative Documents.

 

78

 

 

(d) The Shareholder Representative shall not be liable for any act done or omitted under this Agreement or any Ancillary Document as the Shareholder Representative while acting in good faith and without willful misconduct or gross negligence, and any act done or omitted pursuant to the advice of counsel shall be conclusive evidence of such good faith. Each of the Major Shareholders shall jointly and severally indemnify, defend and hold harmless the Shareholder Representative from and against any and all losses, Actions, Orders, Liabilities, damages, amounts paid in settlement, costs and expenses (including reasonable expenses of investigation and court costs and reasonable attorney’s fees and expenses) incurred without gross negligence, bad faith or willful misconduct on the part of the Shareholder Representative (in its capacity as such) and arising out of or in connection with the acceptance or administration of the Shareholder Representative’s duties under this Agreement or any Ancillary Document, including the reasonable fees and expenses of any legal counsel retained by the Shareholder Representative. In no event shall the Shareholder Representative in such capacity be liable hereunder or in connection herewith for any indirect, punitive, special or consequential damages. The Shareholder Representative shall be fully protected in relying upon any written notice, demand, certificate or document that it in good faith believes to be genuine, including facsimiles or copies thereof, and no Person shall have any Liability for relying on the Shareholder Representative in the foregoing manner. In connection with the performance of its rights and obligations hereunder, the Shareholder Representative shall have the right at any time and from time to time to select and engage, at the cost and expense of the Major Shareholders, attorneys, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional and expert assistance, maintain such records and incur other out-of-pocket expenses, as the Shareholder Representative may deem necessary or appropriate from time to time. All of the indemnities, immunities, releases and powers granted to the Shareholder Representative under this Section 15.14(d) shall survive the Closings and continue indefinitely. With respect to any claim or cause of action arising out of, or related to any act or omission by the Shareholder Representative based upon, arising out of, or related to this Agreement, this Agreement may only be enforced against the Shareholder Representative, and not any of the officers, directors, securityholders, employees or Affiliates of the Shareholder Representative (the “Shareholder Representative Related Parties”). No Shareholder Representative Related Party shall have any liability for any obligations or liabilities of the Shareholder Representative, including but not limited to, for any claim based on, in respect of, or by reason of, any failure by the Shareholder Representative of the transactions contemplated by this Agreement to be consummated or any breach or failure of the Shareholder Representative to perform hereunder.

 

15.15 Legal Representation.

 

(a) The Parties agree that, notwithstanding the fact that each of Skadden, EGS and Appleby may have, prior to the Closings, individually or jointly represented Purchaser and/or the Purchaser Representative (as applicable) in connection with this Agreement, the Ancillary Documents and the Transactions, and has also represented Purchaser, the Purchaser Representative and/or their respective Affiliates in connection with matters other than the transaction that is the subject of this Agreement, Skadden, EGS and Appleby will be permitted in the future, after the Closings, to represent the Purchaser Representative or its respective Affiliates in connection with matters in which such Persons are adverse to the Company, Pubco, Purchaser or any of their respective Affiliates, including any disputes arising out of, or related to, this Agreement. The Company, Pubco, Purchaser and the Merger Subs, who are or have the right to be represented by independent counsel in connection with the transactions contemplated by this Agreement, hereby agree, in advance, to waive (and to cause their Affiliates to waive) any actual or potential conflict of interest that may hereafter arise in connection with Skadden and/or EGS’s and/or Appleby’s future representation of one or more of the Purchaser Representative or its respective Affiliates in which the interests of such Person are adverse to the interests of Pubco, the Merger Subs, Purchaser and/or the Company or any of their respective Affiliates, including any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior representation by EGS or Appleby of the Purchaser Representative, Purchaser or any of their respective Affiliates. The Parties acknowledge and agree that, for the purposes of the attorney-client privilege, the Purchaser Representative shall be deemed the client of Skadden and/or EGS with respect to the negotiation, execution and performance of this Agreement and the Ancillary Documents. All such communications shall remain privileged after the Closings and the privilege and the expectation of client confidence relating thereto shall belong solely to the Purchaser Representative, shall be controlled by the Purchaser Representative and shall not pass to or be claimed by Pubco or Purchaser; provided, further, that nothing contained herein shall be deemed to be a waiver by Pubco, Purchaser or any of their respective Affiliates of any applicable privileges or protections that can or may be asserted to prevent disclosure of any such communications to any Person who is not a Party.

 

79

 

 

(b) The Parties agree that, notwithstanding the fact that each of WSGR and BAHR may have, prior to the Closings, individually or jointly represented the Company and/or the Major Shareholders (as applicable) in connection with this Agreement, the Ancillary Documents and the Transactions, and has also represented Company, the Major Shareholders and/or their respective Affiliates in connection with matters other than the transaction that is the subject of this Agreement, WSGR and BAHR will be permitted in the future, after the Closings, to represent the Shareholder Representative, the Major Shareholders, Pubco or their respective Affiliates in connection with matters in which such Persons are adverse to the Company, Pubco, Purchaser or any of their respective Affiliates, including any disputes arising out of, or related to, this Agreement. The Company, Pubco and the Merger Subs, who are or have the right to be represented by independent counsel in connection with the transactions contemplated by this Agreement, hereby agree, in advance, to waive (and to cause their Affiliates to waive) any actual or potential conflict of interest that may hereafter arise in connection with WSGR’s and/or BAHR’s future representation of one or more of the Shareholder Representative, the Major Shareholders, Pubco or their respective Affiliates in which the interests of such Person are adverse to the interests of Pubco, the Merger Subs, Purchaser and/or the Company or any of their respective Affiliates, including any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior representation by WSGR or BAHR of the Company, the Major Shareholders or their respective Affiliates. The Parties acknowledge and agree that, for the purposes of the attorney-client privilege, the Shareholder Representative shall be deemed the client of WSGR and/or BAHR with respect to the negotiation, execution and performance of this Agreement and the Ancillary Documents. All such communications shall remain privileged after the Closings and the privilege and the expectation of client confidence relating thereto shall belong solely to the Shareholder Representative, shall be controlled by the Shareholder Representative and shall not pass to or be claimed by Pubco or Purchaser; provided, further, that nothing contained herein shall be deemed to be a waiver by Pubco, Purchaser or any of their respective Affiliates of any applicable privileges or protections that can or may be asserted to prevent disclosure of any such communications to any Person who is not a Party.

 

15.16 No Liability. The Parties acknowledge that certain directors and officers of the Company may serve as directors and officers of the Norway Merger Subs between the date hereof and the Second Closing. Neither Purchaser nor any of the Norway Merger Subs shall be liable to any Person for any action taken or inaction by such directors and officers of the Company in their capacity as directors and officers of the Norway Merger Subs, except where instructed to take such action or inaction by the Purchaser.

 

80

 

 

Article XVI
DEFINITIONS

 

16.1 Certain Definitions. For purpose of this Agreement, the following capitalized terms have the following meanings:

 

Accounting Principles means in accordance with GAAP as in effect at the date of the financial statement to which it refers or if there is no such financial statement, then as of the First Closing Date, using and applying the same accounting principles, practices, procedures, policies and methods (with consistent classifications, judgments, elections, inclusions, exclusions and valuation and estimation methodologies) used and applied by the Target Companies in the preparation of the latest audited Company Financials.

 

Actionmeans any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, settlement, complaint, stipulation, assessment or arbitration, or any request (including any request for information), inquiry, hearing, proceeding or investigation, by or before any Governmental Authority.

 

Affiliatemeans, with respect to any Person, any other Person directly or indirectly Controlling, Controlled by, or under common Control with such Person. For the avoidance of doubt, Purchaser Representative shall be deemed to be an Affiliate of Purchaser prior to the Closings.

 

Aggregate Fully Diluted Company Shares means, without duplication, (a) the aggregate number of shares of Company Shares that are (i) issued and outstanding immediately prior to the Norway Effective Time, (ii) issuable upon, or subject to, the settlement of Company Options, Company Warrants and EDGE Warrants then outstanding (whether or not then vested or exercisable and assuming that one Company Share is issued with respect to each one Company Option, Company Warrant and EDGE Warrant), minus (b) any treasury shares of the Company outstanding immediately prior to the Norway Effective Time, minus (c) any Company Shares held by Pubco immediately prior to the Norway Effective Time (including, for the avoidance of doubt, the Company Preferred Shares and the Company Preferred Linked Warrants).

 

Ancillary Documents means each agreement, instrument or document attached hereto as an Exhibit, including the Pubco Equity Plan, the Lock-Up Agreements, the Registration Rights Agreement, the Commitment Agreements, the Purchaser Shareholder Irrevocable Undertakings, the Major Shareholder Irrevocable Undertakings, the Preferred Share Acquisition Agreement and the other agreements, certificates and instruments to be executed or delivered by any of the Parties hereto in connection with or pursuant to this Agreement, including the Escrow Agreement.

 

Anti-Bribery Laws” means the anti-bribery provisions of the Foreign Corrupt Practices Act of 1977, as amended, and all other applicable anti-corruption and bribery Laws (including the U.K. Bribery Act 2010, and any rules or regulations promulgated thereunder or other Laws of other countries implementing the OECD Convention on Combating Bribery of Foreign Officials).

 

Antitrust Laws means Laws that are designed to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade.

 

Appleby” means Appleby (Cayman) Ltd.

 

Base Consideration” means $410,550,000.

 

81

 

 

Benefit Plans of any Person means any and all deferred compensation, compensation, incentive compensation, equity purchase or other equity-based compensation plan, employment or consulting, severance or termination pay, holiday, vacation or other bonus plan or practice, hospitalization or other medical, life or other insurance, supplemental unemployment benefits, profit sharing, pension, or retirement plan, program, agreement, commitment or arrangement, and each other employee benefit plan, program, agreement or arrangement, including each “employee benefit plan” as such term is defined under Section 3(3) of ERISA, maintained or contributed to or required to be contributed to by a Person for the benefit of any employee or terminated employee of such Person, or with respect to which such Person has any Liability, whether direct or indirect, actual or contingent, whether formal or informal, and whether legally binding or not.

 

Business Day means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New York, Luxembourg, Oslo, Norway or the Cayman Islands are authorized to close for business.

 

Cayman Certificate of Merger means the certificate of merger issued by the Cayman Registrar as prima facie evidence of compliance with all requirements of the Cayman Companies Act in respect of the Cayman Merger.

 

Cayman Companies Act means the Companies Act (2021 Revision), as amended of the Cayman Islands.

 

Cayman Dissent Rights” means the right of each Purchaser Shareholder to dissent in respect of the Cayman Merger pursuant to Section 238 of the Cayman Companies Act.

 

Cayman Merger Filing Documents” means the Cayman Plan of Merger together with such other documents as may be required in accordance with the applicable provisions of the Cayman Companies Act or by any other law to make the Cayman Merger effective, including (i) in respect of the Purchaser (a) the approval of the Cayman Merger by a majority of at least two-thirds of the votes of those Purchaser Shareholders entitled to vote and voting (in person or by proxy) at a duly convened and quorate meeting of the Purchaser Shareholders, (b) the approval of the Cayman Merger by the board of directors of the Purchaser, (c) the declaration and undertaking by a director of the Purchaser in connection with the Cayman Merger in accordance with Section 233 of the Companies Act, and (d) a certificate of good standing of the Purchaser dated as at a recent date; and (ii) in respect of Cayman Merger Sub, (a) the approval of the Cayman Merger by Pubco as the sole shareholder of Cayman Merger Sub, (b) the approval of the Cayman Merger by the board of directors of Cayman Merger Sub, (c) the declaration and undertaking by a director of Cayman Merger Sub in connection with the Cayman Merger in accordance with Section 233 of the Companies Act, and (d) a certificate of good standing of Cayman Merger Sub dated as at a recent date.

 

Cayman Merger Sub Shares” means the ordinary shares, par value $1.00 per share, of Cayman Merger Sub.

 

Cayman Registrar” means the Registrar of Companies of the Cayman Islands.

 

Codemeans the Internal Revenue Code of 1986, as amended, and any successor statute thereto, as amended. Reference to a specific section of the Code shall include such section and any valid treasury regulation promulgated thereunder.

 

Commitment Agreements” means the subscription agreements between the Purchaser, Pubco and the investors thereto, pursuant to which such investors will collectively have committed to purchase a number of Pubco Ordinary Shares at the Second Closing so that the Purchaser and Pubco collectively will have available to them at least $600 million in gross proceeds at the Second Closing.

 

82

 

 

Company Business Plan” means the document set out in folder 9.1 of the Data Room.

 

Company Convertible Securities means, collectively, any options, warrants or rights to subscribe for or purchase any capital shares of the Company or securities convertible into or exchangeable for, or that otherwise confer on the holder any right to acquire any capital shares of the Company.

 

Company Equity Plan means the Company Incentive Stock Option Plan.

 

Company Fallback Option means an option to purchase Company Shares granted pursuant to the Company Equity Plan, subject to the Second Closing not occurring.

 

Company Option means an option to purchase Company Shares that was granted pursuant to the Company Equity Plan, other than any Company Fallback Option.

 

Company Permits” means the permits necessary to lawfully conduct in all material respects the Company’s business as presently conducted or as contemplated to be conducted and to own, lease and operate the Company’s assets and properties

 

Company Preferred Shares” means the preferred shares, par value NOK 0.01 per share (prior to the Norway Demerger), of the Company.

 

Company Preferred Shares Linked Warrants” means the warrants linked to the Company Preferred Shares, conferring, in the aggregate, a right to subscribe Company Shares, par value NOK 0.01 per share (prior to the Norway Demerger), for a subscription price of NOK 0.01 (prior to the Norway Demerger) each.

 

Company Securities means, collectively, the Company Shares, the Company Preferred Shares, the Company Options, the Company Warrants and the EDGE Warrants and any other Company Convertible Securities.

 

Company Shareholders’ Agreement” means the Shareholders’ Agreement, dated December 9, 2019, between EDGE Global LLC, Teknovekst Invest AS, Vanir Invest I AS and ATS AS concerning the Company.

 

Company Shares means the 209,196,827 shares which are not Company Preferred Shares, par value NOK0.01 per share (prior to the Norway Demerger), of the Company in issue as at the time of the entering into of this Agreement and any additional shares issued as a result of the exercise prior to the First Closing of any Company Options, Company Warrants or EDGE Warrants.

 

Company Transaction Expenses” means Expenses incurred by the Company or on its behalf in connection with or related to the authorization, preparation, negotiation, execution or performance of this Agreement or any Ancillary Document related hereto and all other matters related to the consummation of this Agreement, but excluding Transaction Legal Costs.

 

Company Warrants means the warrants to purchase Company Shares that were granted pursuant to the agreements set forth in Schedule 2.8(d). For the avoidance of doubt, Company Warrants shall exclude the EDGE Warrants.

 

83

 

 

Consentmeans any consent, approval, notice of no objection, expiration of applicable waiting period, waiver, authorization or Permit of, or notice to or declaration or filing with any Governmental Authority or any other Person.

 

Contractsmeans all contracts, agreements, binding arrangements, bonds, notes, indentures, mortgages, debt instruments, purchase order, licenses, franchises, leases and other agreements of any kind, written or oral (including any amendments and other modifications thereto).

 

Controlof a Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract, or otherwise. “Controlled”, “Controlling” and “under common Control with” have correlative meanings.

 

Copyrightsmeans any works of authorship, mask works and all copyrights therein, including all renewals and extensions, copyright registrations and applications for registration and renewal, and non-registered copyrights.

 

Cross-Border Merger Resolutions” means the resolutions of the sole shareholder of Pubco approving the Cross-Border Merger.

 

Data Protection Laws” means all applicable Laws in any jurisdiction relating to privacy or the processing or protection of personal data, including (without limitation) the GDPR.

 

Data Room” means the online data room as of the date of this Agreement that was established by the Company and its Representatives.

 

Dissenting Purchaser Ordinary Shares” means Purchaser Ordinary Shares that are (i) issued and outstanding immediately prior to the Cayman Effective Time and (ii) held by Purchaser Shareholders who have validly exercised their rights to dissent from the Cayman Merger in accordance with Section 238 of the Cayman Companies Act (and not waived, withdrawn, lost or failed to perfect such rights), in which case such Dissenting Purchaser Ordinary Shares shall be entitled to be paid the fair value of such Dissenting Purchaser Ordinary Shares and such other rights as are granted by the Cayman Companies Act.

 

Dissenting Purchaser Shareholders” means holders of Dissenting Purchaser Ordinary Shares.

 

EDGE Warrants means the warrants to purchase Company Shares that were granted pursuant to the terms of the EDGE Warrants set forth in the Company’s shareholders’ resolutions passed July 8, 2020 and October 6, 2020, respectively.

 

EGS” means Ellenoff Grossman & Schole (LLP).

 

Environmental Law means any Law in any way relating to (a) the protection of human health and safety, (b) the protection, preservation or restoration of the environment and natural resources (including air, water vapor, surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource), or (c) the exposure to, or the use, storage, recycling, treatment, generation, transportation, processing, handling, labeling, production, release or disposal of Hazardous Materials.

 

84

 

 

Environmental Liabilities means, in respect of any Person, all Liabilities, obligations, responsibilities, Remedial Actions, Actions, Orders, losses, damages, costs, and expenses (including all reasonable fees, disbursements, and expenses of counsel, experts, and consultants and costs of investigation and feasibility studies), fines, penalties, sanctions, and interest incurred as a result of any claim or demand by any other Person or in response to any violation of Environmental Law, whether known or unknown, accrued or contingent, whether based in contract, tort, implied or express warranty, strict liability, criminal or civil statute, to the extent based upon, related to, or arising under or pursuant to any Environmental Law, Environmental Permit, Order, or Contract with any Governmental Authority or other Person, that relates to any environmental, health or safety condition, violation of Environmental Law, or a Release or threatened Release of Hazardous Materials.

 

Equity Consideration” means the Base Consideration, plus or minus any Legal Cost Adjustment (as applicable).

 

ERISAmeans the U.S. Employee Retirement Income Security Act of 1974, as amended.

 

Escrow Agent means Continental Stock Transfer & Trust Company, in its capacity as the escrow agent under the Escrow Agreement or any other escrow agent agreed to by Purchaser and the Company prior to the First Closing (or any successor escrow agent).

 

Escrow Property means, at any given time, the securities and other property held by the Escrow Agent in the Escrow Account in accordance with the terms and conditions of this Agreement and the Escrow Agreement, including the Escrow Shares and any earnings, dividends or distributions paid or payable on the Escrow Shares, giving effect to any disbursements or payments from the Escrow Account.

 

Exchange Act means the U.S. Securities Exchange Act of 1934, as amended.

 

Exchange Ratio means the quotient obtained by dividing (a) the amount of the Equity Consideration divided by the lower of (i) the Redemption Price and (ii) the PIPE Price, by (b) the number of Aggregate Fully Diluted Company Shares. For the avoidance of doubt, assuming no Legal Cost Adjustment applies and assuming the PIPE Price is lower than the Redemption Price, the Exchange Ratio is currently expected to be 0.179031.

 

Existing Registration Rights Agreement means the Registration Rights Agreement, dated as of November 25, 2019, by and among Purchaser and Purchaser Representative.

 

Expensesshall have the meaning given to such term in Section 13.3 of this Agreement.

 

Expiration Date” means, (i) with respect to the representations and warranties of the Company and Major Shareholders contained in this Agreement (other than the Fundamental Representations and the representations and warranties of the Company contained in Sections 7.13(a)-(d) and 7.14) the date which is twelve (12) months after the Second Closing Date and (ii) with respect to the representations and warranties of the Company contained in Sections 7.13(a)-(d) and 7.14, the date that is thirty (30) days after the expiration of the applicable statute of limitations.

 

Final Amended Pubco Articles” means the articles of association of Pubco in the form attached hereto as Exhibit I.

 

Foreign Plan means any plan, fund (including any superannuation fund) or other similar program or arrangement established or maintained outside the United States by the Company or any one or more of its Subsidiaries primarily for the benefit of employees of the Company or such Subsidiaries residing outside the United States, which plan, fund or other similar program or arrangement provides, or results in, retirement income, a deferral of income in contemplation of retirement or payments to be made upon termination of employment, and which plan is not subject to ERISA or the Code.

 

85

 

 

Founder Shares means an aggregate of 7,187,500 of Purchaser Class B Ordinary Shares which were originally issued to the Purchaser Representative prior to the IPO.

 

Fraud Claim means any claim based on willful misconduct or fraud (defined to include scienter) against the Person who committed such fraud.

 

Fundamental Representations” means the representations and warranties of (i) the Company contained in Sections 7.1, 7.2, 7.3(a) and 7.4 and (ii) the Major Shareholders contained in Sections 8.1, 8.2 and 8.3.

 

Funding Commitment Letter” means the funding commitment letter, dated October 23, 2020, between, among others, Encompass Capital Master Fund LP, BEMAP Master Fund Ltd and the Company, as amended and supplemented by (i) that certain Side Letter dated November 19, 2020 and (ii) that certain Side Letter dated as of the date hereof.

 

GAAPmeans generally accepted accounting principles as in effect in the United States of America.

 

GDPR” means the General Data Protection Regulation 2016/679, including any predecessor, successor or implementing legislation in respect of the foregoing, and any amendments or re-enactments of the foregoing.

 

Governmental Authority means any federal, state, local, foreign or other governmental, quasi-governmental or administrative body, instrumentality, department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, regulatory body or other similar regulatory or dispute-resolving panel or body.

 

Hazardous Material means any waste, gas, liquid or other substance or material that is defined, listed or designated as a “hazardous substance”, “pollutant”, “contaminant”, “hazardous waste”, “regulated substance”, “hazardous chemical”, or “toxic chemical” (or by any similar term) under any Environmental Law, or any other material regulated, or that could result in the imposition of Liability or responsibility, under any Environmental Law, including petroleum and its by-products, asbestos, polychlorinated biphenyls, radon, mold, and urea formaldehyde insulation.

 

ICCmeans the International Chamber of Commerce or any successor organization conducting arbitrations.

 

Indebtednessof any Person means, without duplication, (a) all indebtedness of such Person for borrowed money (including the outstanding principal and accrued but unpaid interest), (b) all obligations for the deferred purchase price of property or services (other than trade payables incurred in the ordinary course of business), (c) any other indebtedness of such Person that is evidenced by a note, bond, debenture, credit agreement or similar instrument, (d) all obligations of such Person under leases that should be classified as capital leases in accordance with GAAP (a applicable to such Person), (e) all obligations of such Person for the reimbursement of any obligor on any line or letter of credit, banker’s acceptance, guarantee or similar credit transaction, in each case, that has been drawn or claimed against, (f) all obligations of such Person in respect of banker’s acceptances issued or created, (g) net obligations under interest rate and currency swaps, caps, collars and similar agreements or hedging devices under which payments are obligated to be made by such Person, whether periodically or upon the happening of a contingency, (h) any premiums, prepayment fees or other penalties, fees, costs or expenses associated with payment of any Indebtedness of such Person and (i) all obligations secured by a Lien on any property of such Person; (j) all obligation described in clauses (a) through (j) above of any other Person which is directly or indirectly guaranteed by such Person or which such Person has agreed (contingently or otherwise) to purchase or otherwise acquire or in respect of which it has otherwise assured a creditor against loss.

 

86

 

 

Insider Letter” means the letter agreement dated November 25, 2019, between among others, the Purchaser Representative and the Purchaser.

 

Intellectual Property means all of the following as they exist in any jurisdiction throughout the world: Patents, Trademarks, Copyrights, Trade Secrets, Internet Assets, Software and other intellectual property.

 

Internet Assets means any and all domain name registrations, web sites and web addresses and applications for registration therefor.

 

Investment Company Act means the U.S. Investment Company Act of 1940, as amended.

 

IPOmeans the initial public offering of Purchaser Units pursuant to the IPO Prospectus.

 

IPO Prospectus means the final prospectus of Purchaser, dated as of November 25, 2019, and filed with the SEC on November 27, 2019 (File Nos. 333-234440 and 333-235258).

 

IT Systems” means any information technology and information technology equipment, including any system, network, hardware, computer, software (including in source code and object code and including any system software, operational software, application software, interface or firmware), router, hub, server, database and website used by each Target Company.

 

Knowledgemeans, with respect to (i) the Company, the actual knowledge of Tom Jensen, Torstein Sjøtveit, Peter Matrai, Steffen Foreid and Are Brautaset, after reasonable inquiry, or (ii) any other Party, (A) if an entity, the actual knowledge of its directors and executive officers, after reasonable inquiry, or (B) if a natural person, the actual knowledge of such Person after reasonable inquiry.

 

Lawmeans any federal, state, local, municipal, foreign or other law, statute, legislation, principle of common law, ordinance, code, edict, decree, proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, Order or Consent that is or has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the authority of any Governmental Authority.

 

Leakage” means without duplication (save where such recipient or their Affiliates are the Company or a Target Company): (a) any dividend or distribution declared, paid, or made (whether actual or deemed and in cash or in kind) or any payments in lieu of any dividend declared, made or paid by the Company or any Target Company, directly or indirectly, to any Shareholder or any of their Affiliates; (b) any securities being redeemed, purchased or repaid, or any other return of capital (whether by reduction of capital or otherwise and whether in cash or in kind and whether loan or share capital) by the Company or a Target Company, directly or indirectly, to or for the benefit of any Shareholder or any of their Affiliates; (c) any consultant, advisory, management, monitoring, service, shareholder or other fees, charges or compensation of a similar nature paid to a Shareholder or any of their Affiliates; (d) any amount owed to the Company or any Target Company by a Shareholder or any of their Affiliates, which amount is waived or forgiven; (e) any assets or rights transferred to, or liabilities assumed, guaranteed, indemnified, increased or incurred by the Company or any Target Company, directly or indirectly, for the benefit of any Shareholder or any of their Affiliates, excluding ordinary course compensation for employees and consultants of the Target Companies; (f) the purchase by the Company or any Target Company, directly or indirectly, of any assets from any Shareholder or any of their Affiliates that are not on arms’ length terms; (g) any Transaction bonuses other than Permitted Transaction Bonuses; (h) any agreement or arrangement made or entered into by the Company or any Target Company to do or give effect to any matter referred to in paragraphs; (a) through (g) (inclusive) above; or (i) without duplication, any Tax payable on any of the payments, matters, transactions or circumstances referred to in paragraphs (a) through (h) above, but in each case, excluding any Permitted Leakage.

 

87

 

 

Legal Cost Adjustment” means: (i) to the extent Transaction Legal Costs are greater than $4,500,000, a number equal to the Transaction Legal Costs less $4,500,000 (which number shall be deducted from the Base Consideration in arriving at the Equity Consideration) or (ii) to the extent Transaction Legal Costs are lower than $2,500,000, a number equal to the Transaction Legal Costs less $2,500,000 (which dollar amount shall be added to the Base Consideration in arriving at the Equity Consideration).

 

Legal Expenses Collar” means a dollar range from and including $2,500,000 to and including $4,500,000.

 

Letter of Intent” means the non-binding letter of intent, dated October 8, 2020, between the Purchaser and the Company.

 

Liabilitiesmeans any and all liabilities, Indebtedness, Actions or obligations of any nature (whether absolute, accrued, contingent or otherwise, whether known or unknown, whether direct or indirect, whether matured or unmatured, whether due or to become due and whether or not required to be recorded or reflected on a balance sheet under GAAP or other applicable accounting standards), including Tax liabilities due or to become due.

 

Lienmeans any claim, mortgage, pledge, security interest, attachment, right of first refusal, option, proxy, voting trust, encumbrance, lien or charge of any kind (including any conditional sale or other title retention agreement or lease in the nature thereof), restriction (whether on voting, sale, transfer, disposition or otherwise), any subordination arrangement in favor of another Person, or any filing or agreement to file a financing statement as debtor under the Uniform Commercial Code or any similar Law.

 

Locked Box Date” means September 30, 2020.

 

Locked Box Period” means the period starting on (and including) the Locked Box Date and ending on (and including) the Second Closing Date.

 

Luxembourg Companies Act” means the Law of August 10, 1915 on commercial companies, as amended.

 

Major Shareholder Pro Rata Percentage” means, with respect to each Major Shareholder, a percentage equal to the (i) the number of shares held by such Major Shareholder immediately prior to the Second Closing, divided, by (ii) the aggregate number of shares held by all such Major Shareholders prior to the Second Closing.

 

Major Shareholders” means the shareholders of the Company listed on Schedule 8.3.

 

88

 

 

Material Adverse Effect means any fact, event, occurrence, change or effect that has had, or would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon (a) the business, assets, Liabilities, results of operations or financial condition of the Company and the Target Companies, taken as a whole, or (b) the ability of the Company or any of its Subsidiaries to consummate the transactions contemplated by this Agreement or the Ancillary Documents to which it is a party or bound or to perform its obligations hereunder or thereunder; provided, however, that any facts, events, occurrences, changes or effects directly or indirectly attributable to, resulting from, relating to or arising out of the following (by themselves or when aggregated with any other, facts, events, occurrences, changes or effects) shall not be deemed to be, constitute, or be taken into account when determining whether there has or may, would or could have occurred a Material Adverse Effect: (i) general changes in the financial or securities markets or general economic or political conditions globally or in the countries or regions in which such Person or any of its Subsidiaries do business; (ii) changes, conditions or effects that generally affect the industries in which such Person or any of its Subsidiaries principally operate; (iii) any proposal, enactment or change in interpretation of, or other change in, applicable Law, GAAP or other applicable accounting principles or mandatory changes in the regulatory accounting requirements applicable to any industry in which such Person and its Subsidiaries principally operate; (iv) any outbreak or any development, change, worsening or escalation of hostilities (whether or not armed), acts of war (whether or not declared), sabotage or terrorism; (v) any Act of God, hurricane, tornado, flood, volcano, earthquake or other natural or manmade disaster, including any effects of the COVID-19 epidemic; and (vi) changes attributable to the public announcement or pendency of the transactions contemplated hereby (vii) any failure in and of itself to meet any projections, forecasts, guidance, estimates, milestones, budgets or financial or operating predictions of revenue, earnings, cash flow or cash position, provided that this clause (vii) shall not prevent a determination that any change, event, or occurrence underlying such failure has resulted in a Material Adverse Effect or (viii) any action required by the terms of this Agreement or the transaction contemplated hereby or otherwise consented to in writing by Purchaser; provided further, however, that any event, occurrence, fact, condition, or change referred to in clauses (i) – (v) immediately above shall be taken into account in determining whether a Material Adverse Effect has occurred or could reasonably be expected to occur to the extent that such event, occurrence, fact, condition, or change has a disproportionate effect on such Person or any of its Subsidiaries compared to other participants in the industries and geographic locations in which such Person or any of its Subsidiaries primarily conducts its businesses.

 

NOK” means Norwegian kroner, the lawful means of payment in Norway.

 

Norway Merger Sub 1 Approval Matters shall have the meaning ascribed to such term in Section 9.21.

 

Norway Merger Sub 1 Preferred Shares” means the preferred shares, par value NOK 0.01 per share, of the Company.

 

Norway Merger Sub 1 Preferred Shares Linked Warrants” means the 92,500,000 warrants linked to the Company Preferred Shares, conferring, in the aggregate, a right to subscribe to up to 92,500,000 Norway Merger Sub 1 Shares, par value NOK 0.01 per share, for a subscription price of NOK 0.01 each.

 

Norway Merger Sub 1 Shares means the common shares, par value NOK 0.01 per share, of Norway Merger Sub 1.

 

Norway Merger Sub 1 Shareholders” means the holders of Norway Merger Sub 1 Shares.

 

89

 

 

Norway Merger Sub 2 Shares” means the common shares, par value NOK 0.01 per share, of Norway Merger Sub 2.

 

Norway Merger Sub 2 Approval Matters shall have the meaning ascribed to such term in Section 9.21 of the Norway Plan of Merger.

 

Norwegian Companies Act” means the Norwegian Private Limited Companies Act of 1997.

 

NYSEmeans the New York Stock Exchange.

 

Ordermeans any order, decree, ruling, judgment, injunction, writ, determination, binding decision, verdict, judicial award or other action that is or has been made, entered, rendered, or otherwise put into effect by or under the authority of any Governmental Authority.

 

Organizational Documents means, with respect to any Person, its certificate of incorporation and bylaws, memorandum and articles of association or similar organizational documents, in each case, as amended.

 

Patentsmeans any patents, patent applications and the inventions, designs and improvements described and claimed therein, patentable inventions, and other patent rights (including any divisionals, provisionals, continuations, continuations-in-part, substitutions, or reissues thereof, whether or not patents are issued on any such applications and whether or not any such applications are amended, modified, withdrawn, or refiled).

 

PCAOBmeans the U.S. Public Company Accounting Oversight Board (or any successor thereto).

 

Permitsmeans all federal, state, local or foreign or other third-party permits, grants, easements, consents, approvals, authorizations, exemptions, licenses, franchises, concessions, ratifications, permissions, clearances, confirmations, endorsements, waivers, certifications, designations, ratings, registrations, qualifications or orders of any Governmental Authority or any other Person.

 

Permitted Leakage” means, without duplication, (a) any payments expressly provided for under the terms of this Agreement and any Ancillary Document; (b) any Company Transaction Expenses incurred, paid or agreed to be paid or payable; (c) any payment and/or accrual made in the ordinary course in respect of the salary, bonus, pensions, contributions, life insurance payments, medical insurance, expense reimbursements and vacation days accrued and due to any officer, employee, director or consultant of any Target Company and, where such Person has a Contract or similar arrangement of employment, directorship, services or other consultancy with such Target Company, under and in accordance with such Contract or arrangement; (d) Permitted Transaction Bonuses; and (e) any Leakage in relation to, or arising from, any payment made or agreed to be made or liability incurred in respect of any matter undertaken at the specific written request or with the consent of the Purchaser after the date hereof.

 

Permitted Liens means (a) Liens which result from all statutory or other liens for Taxes or assessments and are not yet due and payable or delinquent or the validity of which is being contested in good faith by appropriate proceedings along with the posting of any security or bond required under applicable Law in connection with such contest, (b) Liens imposed by applicable Law, (c) Liens arising in connection with any cashiers’, landlords’, workers’, mechanics’, carriers’, repairers’ or other similar lien imposed by law and arising out of obligations incurred in the ordinary course of business consistent with past practice, (d) Liens that are expressly listed as exceptions in insurance policies, covenants, conditions, restrictions, encroachments, liens, easements, rights of way, licenses, grants, building or use restrictions, exceptions, reservations, limitations or other imperfections of title with respect of such asset which, individually or in the aggregate, does not materially detract from the value of, or materially interfere with the present occupancy or use of, such asset and the continuation of the present occupancy or use of such asset, (e) purchase money liens or liens securing rental payments under capital lease arrangements, or (f) Liens arising under this Agreement or any Ancillary Document.

 

90

 

 

Permitted Transaction Bonuses means Transaction bonuses of up to $5,000,000, which may be granted by the Company in its sole discretion.

 

Personmeans a natural person, corporation, partnership (including a general partnership, limited partnership or limited liability partnership), company, limited liability company, association, trust or other entity or organization, including a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.

 

Personal Property means any machinery, equipment, tools, vehicles, furniture, leasehold improvements, office equipment, plant, parts and other tangible personal property.

 

PIPE Investment” means the purchase and sale of Pubco Ordinary Shares pursuant to the Commitment Agreements.

 

PIPE Price means $10.00 per Pubco Ordinary Share.

 

Pubco Articles means the current articles of association of Pubco, as amended and in effect under the Luxembourg Companies Act.

 

Pubco Ordinary Shares means the ordinary shares, par value $0.01 per share, of Pubco, along with any equity securities paid as dividends or distributions after the Closings with respect to such shares or into which such shares are exchanged or converted after the Closings.

 

Pubco Private Warrant means each one whole warrant entitling the holder thereof to purchase one (1) Pubco Ordinary Share at a purchase price of $11.50 per share.

 

Pubco Public Warrant means each one whole warrant entitling the holder thereof to purchase one (1) Pubco Ordinary Share at a purchase price of $11.50 per share.

 

Pubco Securities means the Pubco Ordinary Shares and the Pubco Warrants, collectively.

 

Pubco Share Price” means an amount equal to the VWAP of the Pubco Ordinary Shares over the ten (10) Trading Days ending at the close of business on the principal securities exchange or securities market on which the Pubco Ordinary Shares are then traded immediately prior to the date of determination, as equitably adjusted for stock splits, stock dividends, combinations, recapitalizations and the like after the date of this Agreement.

 

Pubco Warrants means Pubco Private Warrants and Pubco Public Warrants, collectively.

 

Purchaser Articles means the memorandum and articles of association of Purchaser, as amended and in effect.

 

Purchaser Class A Ordinary Shares” means the Class A ordinary shares par value $0.0001 each, of Purchaser.

 

91

 

 

Purchaser Class B Ordinary Shares” means the Class B ordinary shares par value $0.0001 each, of Purchaser.

 

Purchaser Ordinary Shares means the Purchaser Class A Ordinary Shares and Purchaser Class B Ordinary Shares.

 

Purchaser Preferred Shares means the preference shares of par value $0.0001 each of Purchaser.

 

Purchaser Private Warrants means the warrants issued in a private placement to the Purchaser Representative by Purchaser at the time of the consummation of the IPO, entitling the holder thereof to purchase one (1) Purchaser Class A Ordinary Share per warrant at a purchase price of $11.50 per share. For the avoidance of doubt, Purchaser Public Warrants shall include any additional whole warrants issued after the date of this Agreement.

 

Purchaser Public Shares” means a Purchaser Class A Ordinary Share issued as part of the Units.

 

Purchaser Public Warrant means each whole warrant (other than the Purchaser Private Warrants), entitling the holder thereof to purchase one (1) Purchaser Class A Ordinary Share at a purchase price of $11.50 per share.

 

Purchaser Securities means the Purchaser Units, the Purchaser Ordinary Shares and the Purchaser Warrants, collectively.

 

Purchaser Shareholder” means, from time to time, each holder of Purchaser Ordinary Shares.

 

Purchaser Shareholder Approval Matters” means together: (i) the approval of the Transactions by a simple majority of the votes of those Purchaser Shareholders entitled to vote and voting (in person or by proxy) at a duly convened and quorate meeting of the Purchaser Shareholders, (ii) the approval of the Cayman Merger by a majority of at least two-thirds of the votes of those Purchaser Shareholders entitled to vote and voting (in person or by proxy) at a duly convened and quorate meeting of the Purchaser Shareholders and (iii) the approval of such other matters as the Company, Pubco and Purchaser shall hereafter mutually determine to be necessary or appropriate in order to effect the Transactions.

 

Purchaser Units means the units issued in the IPO (including overallotment units acquired by Purchaser’s underwriter) consisting of one (1) Purchaser Class A Ordinary Share and one-half (1/2) of one (1) Purchaser Public Warrant.

 

Purchaser Warrants means Purchaser Private Warrants and Purchaser Public Warrants, collectively.

 

Redemption Price means an amount equal to the price at which each Purchaser Ordinary Share is redeemed pursuant to the Redemption (as equitably adjusted for share splits, share dividends, combinations, recapitalizations and the like).

 

Releasemeans any release, spill, emission, leaking, pumping, injection, deposit, disposal, discharge, dispersal, or leaching into the indoor or outdoor environment, or into or out of any property.

 

92

 

 

Relevant EU Directive” means directive 2017/1132/EU of the European Parliament and of the Council of 14 June 2017 relating to certain aspects of company law.

 

Relevant NOK/USD Exchange Rate” means 8.44 NOK per USD.

 

Remedial Action means all actions to (i) clean up, remove, treat, or in any other way address any Hazardous Material, (ii) prevent the Release of any Hazardous Material so it does not endanger or threaten to endanger public health or welfare or the indoor or outdoor environment, (iii) perform pre-remedial studies and investigations or post-remedial monitoring and care, or (iv) correct a condition of noncompliance with Environmental Laws.

 

Representativesmeans, as to any Person, such Person’s Affiliates and the respective managers, directors, officers, employees, independent contractors, consultants, advisors (including financial advisors, counsel and accountants), agents and other legal representatives of such Person or its Affiliates.

 

Required Cayman Merger Sub Shareholder Approval” means the Cayman Merger Sub Shareholder Approval Matters shall have been approved by Pubco, as the sole shareholder of Cayman Merger Sub, in accordance with Cayman Merger Sub’s Organizational Documents and applicable Law.

 

Required Pubco Shareholder Approval” means the Pubco Shareholder Approval Matters have been approved by the Purchaser Representative, as shareholder of Pubco, in accordance with Pubco’s Organizational Documents and applicable Law.

 

RESA” means the Luxembourg Recueil Electronique des Sociétés et Associations, the Luxembourg legal gazette.

 

SECmeans the U.S. Securities and Exchange Commission (or any successor Governmental Authority).

 

Securities Act means the U.S. Securities Act of 1933, as amended.

 

Shareholder Pro Rata Percentage” means, with respect to each Shareholder (other than the Transferors), a percentage equal to the (i) the number of Exchange Shares to which such Shareholder is entitled pursuant to this Agreement, divided by (ii) the number of Exchange Shares to which all Shareholders are entitled pursuant to this Agreement (in each case, disregarding the escrow mechanics set forth in Section 3.1).

 

Shareholders” means the holders of Company Shares.

 

Skadden” means Skadden, Arps, Slate, Meagher & Flom LLP.

 

Softwaremeans any computer software programs, including all source code, object code, and documentation related thereto and all software modules, tools and databases.

 

SOXmeans the U.S. Sarbanes-Oxley Act of 2002, as amended.

 

Special Representations” means the Fundamental Representations and the representations and warranties of the Company contained in Sections 7.13(a)-(d) and 7.14.

 

Purchaser Representative” means Alussa Energy Sponsor LLC.

 

93

 

 

Subsidiarymeans, with respect to any Person, any corporation, partnership, association or other business entity of which (i) if a corporation, a majority of the total voting power of capital shares entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (ii) if a partnership, association or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest in a partnership, association or other business entity if such Person or Persons will be allocated a majority of partnership, association or other business entity gains or losses or will be or control the managing director, managing member, general partner or other managing Person of such partnership, association or other business entity. A Subsidiary of a Person will also include any variable interest entity which is consolidated with such Person under applicable accounting rules.

 

Target Company means each of the Company and its direct and indirect Subsidiaries.

 

Tax Return means any return, declaration, report, claim for refund, information return or other documents (including any related or supporting schedules, statements or information) filed or required to be filed in connection with the determination, assessment or collection of any Taxes or the administration of any Laws or administrative requirements relating to any Taxes.

 

Taxesmeans (a) all direct or indirect federal, state, local, foreign and other net income, gross income, gross receipts, sales, use, value-added, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, social security and related contributions due in relation to the payment of compensation to employees, excise, severance, stamp, occupation, premium, property, windfall profits, alternative minimum, estimated, customs, duties or other taxes, fees, assessments or charges in the nature of a tax, together with any interest and any penalties, additions to tax or additional amounts with respect thereto, (b) any Liability for payment of amounts described in clause (a) whether as a result of being a member of an affiliated, consolidated, combined or unitary group for any period or otherwise through operation of law and (c) any Liability for the payment of amounts described in clauses (a) or (b) as a result of any tax sharing, tax group, tax indemnity or tax allocation agreement with, or any other express or implied agreement to indemnify, any other Person.

 

Trade Secrets means any trade secrets, and any confidential business information, concepts, ideas, designs, research or development information, processes, procedures, techniques, technical information, specifications, operating and maintenance manuals, engineering drawings, methods, know-how, data, mask works, discoveries, inventions, modifications, extensions, improvements, and other proprietary rights (whether or not patentable or subject to copyright, trademark, or trade secret protection).

 

Trademarksmeans any trademarks, service marks, trade dress, trade names, brand names, designs, logos, or corporate names (including, in each case, the goodwill associated therewith), whether registered or unregistered, and all registrations and applications for registration and renewal thereof.

 

Trading Day” means any day on which Pubco Ordinary Shares are actually traded on the principal securities exchange or securities market on which the Pubco Ordinary Shares are then traded.

 

Transaction Legal Costs” means legal Expenses (including, but not limited to, the fees of the Company’s legal advisors) incurred up to the Second Closing by the Company or on its behalf in connection with or related to the authorization, preparation, negotiation, execution or performance of this Agreement or any Ancillary Document and all other matters related to the consummation of the Transactions.

 

94

 

 

Trust Account means the trust account established by Purchaser with the proceeds from the IPO pursuant to the Trust Agreement in accordance with the IPO Prospectus.

 

Trust Agreement means that certain Investment Management Trust Agreement, dated as of November 25, 2019, as it may be amended, by and between Purchaser and the Trustee.

 

Trusteemeans Continental Stock Transfer & Trust Company, in its capacity as trustee under the Trust Agreement.

 

VWAP” means, for any security as of any date(s), the dollar volume-weighted average price for such security on the principal securities exchange or securities market on which such security is then traded during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (set to weighted average) or, or, if not reported therein, in another authoritative source mutually selected by Purchaser Representative and Shareholder Representative.

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK;
SIGNATURE PAGE FOLLOWS]

 

95

 

 

IN WITNESS WHEREOF, each Party hereto has caused this Agreement to be signed and delivered by its respective duly authorized officer as of the date first written above.

 

 

[SIG PAGES TO COME]

 

96

Exhibit 10.1

 

EXECUTION VERSION

 

LOCK-UP AGREEMENT

 

THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of January __, 2021 by and between (i) Alussa Energy Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with its successors, the “Purchaser”), (ii) FREYR Battery, a public limited liability company (société anonyme) under the laws of Luxembourg (“Pubco”), (iii) Alussa Energy Sponsor LLC, a limited liability company formed under the laws of Delaware (the “Purchaser Representative”) and (iv) the undersigned (the “Holder”). The Purchaser, Pubco, Purchaser Representative and the Holder are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Business Combination Agreement (as defined below).

 

WHEREAS, as of the date hereof, the Holder is a holder of ordinary shares of, and options and/or warrants which may be exercisable into ordinary shares of, FREYR AS, a company organized under the laws of Norway (“FREYR”).

 

WHEREAS, the Purchaser, Purchaser Representative, Pubco, Holder and FREYR, among others, entered into the business combination agreement, dated on or around the date hereof (the “Business Combination Agreement”), pursuant to which the parties thereto will consummate a series of transactions, including the exchange of ordinary shares, options and warrants of FREYR into ordinary shares of Pubco (the “Ordinary Shares”), options of Pubco (the “Options”) and warrants of Pubco (the “Warrants”).

 

WHEREAS, following completion of the transactions contemplated by the Business Combination Agreement (the “Transactions”), the Holder will hold Ordinary Shares, Options and/or Warrants.

 

WHEREAS, pursuant to the Business Combination Agreement, and in view of the valuable consideration to be received by the Holder thereunder, the Purchaser, Purchaser Representative, Pubco and the Holder desire to enter into this Agreement, pursuant to which the Ordinary Shares, Options and/or Warrants to be received by the Holder pursuant to the Business Combination Agreement and Ordinary Shares issued or issuable upon the exercise of Options and Warrants (including, for the avoidance of doubt, Escrow Shares) (together with any securities paid as dividends or distributions with respect to such securities or into which such securities are exchanged or converted, the “Restricted Securities”) shall become subject to limitations on disposition as set forth herein.

 

NOW, THEREFORE, in consideration of the premises set forth above, which are incorporated in this Agreement as if fully set forth below, and intending to be legally bound hereby, the Parties hereby agree as follows:

 

1. Lock-Up Provisions.

 

(a) The Holder hereby agrees not to Transfer any Ordinary Shares (including Ordinary Shares issued or issuable upon the exercise or conversion of the Options or Warrants), Options and Warrants that are held by the Holder during the period commencing from the Second Closing and ending on the earlier of (a) one (1) year after the Second Closing Date, (b) a date subsequent to the Second Closing Date, if the last sale price of the Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Second Closing Date and (c) a date after the Second Closing Date on which Pubco completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of Pubco’s shareholders having the right to exchange their Ordinary Shares for cash, securities or other property (the “Lock-Up Period”).

 

 

 

 

(b) Notwithstanding the provisions set forth in Section 1(a), Transfers of the Ordinary Shares (including Ordinary Shares issued or issuable upon the exercise or conversion of the Options or Warrants), Options and Warrants that are held by the Holder (that have complied with this Section 1(b)), are permitted (i) to any affiliates of the Holder; (ii) in the case of an individual, transfers by gift to a member of the individual’s immediate family, to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization; (iii) in the case of an individual, transfers by virtue of laws of descent and distribution upon death of the individual; (iv) to the extent Holder or Holder’s advisors reasonably believe are relevant to cover any direct or indirect tax obligations that may accrue to the Holder or the Holder’s direct or indirect owners relating to the Transactions or the Shares (and, for the avoidance of doubt, Holder shall be provided a reasonable amount of discretion in making this assessment and not be required to provide any evidence of such reasonable belief prior to effecting any such Transfer in reliance on this subclause (iv) and, if the other parties hereto challenge Holder’s reliance on this subclause (iv), such other parties will have to challenge the Transfer within two weeks of becoming aware of the Transfer and must demonstrate that the Holder acted in bad faith in determining that such Transfer is permitted by this subclause (iv)); and (v) in the case of an individual, transfers pursuant to a qualified domestic relations order; provided, however, that these permitted transferees (other than transferees in respect of Section 1(b)(iv)) must enter into a written agreement agreeing to be bound by the restrictions herein.

 

(c) The Holder further acknowledges and agrees that it shall not be permitted to conduct any Transfer (including those Transfers permitted under Section 1(b)) with respect to any Escrow Shares until both the Lock-Up Period has expired and such Escrow Shares have been disbursed to such Holder from the Escrow Account in accordance with the terms and conditions of the Business Combination Agreement and the Escrow Agreement.

 

(d) If any Transfer is made or attempted contrary to the provisions of this Agreement, such Transfer shall be null and void ab initio, and Pubco shall refuse to recognize any such transferee of the Restricted Securities as one of its equity holders for any purpose. In order to enforce this Section 1, Pubco may impose stop-transfer instructions with respect to the Restricted Securities of the Holder (and any permitted transferees and assigns thereof) until the end of the Lock-Up Period or the release of the Escrow Shares, as applicable.

 

(e) During the Lock-Up Period (and with respect to any Escrow Shares, if longer, during the period when such Escrow Shares are held in the Escrow Account), each book entry evidencing any Restricted Securities shall include appropriate restrictions to reflect the fact that the Restricted Securities are subject to the restrictions on Transfer set forth in this Agreement.

 

(f) For the avoidance of any doubt, the Holder shall retain all of its rights as a shareholder of Pubco with respect to the Restricted Securities during the Lock-Up Period and until the release of the Escrow Shares, as applicable, including the right to vote any Restricted Securities.

 

(g) For the purposes of this Section 1, “Transfer” shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the U.S. Securities and Exchange Commission promulgated thereunder with respect to, any security, (b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b).

 

2. Miscellaneous.

 

(a) Effective Date. Section 1 of this Agreement shall become effective upon the Second Closing Date, subject to the consummation of the transactions contemplated by the Business Combination Agreement on the Second Closing Date.

 

(b) Termination of the Business Combination Agreement. Notwithstanding anything to the contrary contained herein, in the event that the Business Combination Agreement is terminated in accordance with its terms prior to the Second Closing, this Agreement and all rights and obligations of the Parties hereunder shall automatically terminate and be of no further force or effect.

 

(c) Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the Parties hereto and their respective permitted successors and assigns. Except as otherwise provided in this Agreement, this Agreement and all obligations of the Parties are personal to the Parties and may not be transferred or delegated by the Parties at any time.

 

2

 

 

(d) Third Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person or entity that is not a Party hereto or thereto or a successor or permitted assign of such a Party.

 

(e) Governing Law; Jurisdiction. This Agreement and any dispute or controversy arising out of or relating to this Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of law principles thereof. All actions arising out of or relating to this Agreement shall be heard and determined exclusively in any state or federal court located in New York, New York (or in any appellate courts thereof) (the “Specified Courts”). Each Party hereto hereby (i) submits to the exclusive jurisdiction of any Specified Court for the purpose of any action arising out of or relating to this Agreement brought by any party hereto and (ii) irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the action is brought in an inconvenient forum, that the venue of the action is improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by any Specified Court. Each Party agrees that a final judgment in any action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each Party irrevocably consents to the service of the summons and complaint and any other process in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such Party at the applicable address set forth in Section 2(h). Nothing in this Section 2(e) shall affect the right of any party to serve legal process in any other manner permitted by applicable law.

 

(f) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 2(f).

 

(g) Interpretation. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii) “including” (and with correlative meaning “include”) means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (iii) the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement; and (iv) the term “or” means “and/or”. The Parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.

 

(h) Notices. All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered (i) in person, (ii) by e-mail, (iii) one (1) Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three (3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable Party at the following addresses (or at such other address for a Party as shall be specified by like notice):

 

3

 

 

     

If to Purchaser (prior to the Second Closing), to:

 

Alussa Energy Acquisition Corp.
PO Box 500, 71 Fort Street
Grand Cayman KY1-1106
Attention: Daniel Barcelo
Email: Daniel@alussaenergy.com

 

With copies to (which shall not constitute notice):

 

the Purchaser Representative

 

and

 

Skadden, Arps, Slate, Meagher & Flom (UK) LLP
40 Bank Street
London, United Kingdom E14 5DS

    Attention: Danny Tricot
      Denis Klimentchenko
    Email: danny.tricot@skadden.com
      denis.klimentchenko@skadden.com
       
     

If to Purchaser Representative, to:

 

Alussa Energy Sponsor LLC
PO Box 500, 71 Fort Street
Grand Cayman KY1-1106
Attention: Daniel Barcelo
Email: Daniel@alussaenergy.com

 

With copies to (which shall not constitute notice):

 

 

 

and

 

Skadden, Arps, Slate, Meagher & Flom (UK) LLP
40 Bank Street
London, United Kingdom E14 5DS

    Attention: Danny Tricot
      Denis Klimentchenko
    Email: danny.tricot@skadden.com
      denis.klimentchenko@skadden.com
       
     

If to Pubco, to:

 

FREYR Battery

412 F, route d’Esch L-2086 Luxembourg

Email: contract-notifications@freyrbattery.com

 

 

 

     
     

If to the Holder, to: the address set forth under the Holder’s name on the signature page hereto.

 

  

(i) Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Purchaser, Purchaser Representative, Pubco and the Holder. No failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.

 

(j) Authorization on Behalf of the Purchaser. The Parties acknowledge and agree that notwithstanding anything to the contrary contained in this Agreement, any and all determinations, actions or other authorizations under this Agreement on behalf of the Purchaser after the Second Closing, including enforcing the Purchaser’s rights and remedies under this Agreement, or providing any waivers with respect to the provisions hereof, shall solely be made, taken and authorized by the Purchaser Representative.

 

4

 

 

(k) Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

 

(l) Specific Performance. The Holder acknowledges that its obligations under this Agreement are unique, recognizes and affirms that in the event of a breach of this Agreement by the Holder, money damages will be inadequate and the Purchaser, Purchaser Representative and Pubco will have no adequate remedy at law, and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed by the Holder in accordance with their specific terms or were otherwise breached. Accordingly, the Purchaser, Purchaser Representative and Pubco shall be entitled to an injunction or restraining order to prevent breaches of this Agreement by the Holder and to enforce specifically the terms and provisions hereof, without the requirement to post any bond or other security or to prove that money damages would be inadequate, this being in addition to any other right or remedy to which such Party may be entitled under this Agreement, at law or in equity.

 

(m) Entire Agreement. This Agreement constitutes the full and entire understanding and agreement among the Parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the Parties is expressly canceled; provided, that, for the avoidance of doubt, the foregoing shall not affect the rights and obligations of the Parties under the Business Combination Agreement or any Ancillary Document. Notwithstanding the foregoing, nothing in this Agreement shall limit any of the rights or remedies of the Purchaser, Purchaser Representative and Pubco or any of the obligations of the Holder under any other agreement between the Holder and the Purchaser, Purchaser Representative or Pubco or any certificate or instrument executed by the Holder in favor of the Purchaser, Purchaser Representative or Pubco, and nothing in any other agreement, certificate or instrument shall limit any of the rights or remedies of the Purchaser, Purchaser Representative or Pubco or any of the obligations of the Holder under this Agreement.

 

(n) Further Assurances. From time to time, at another Party’s request and without further consideration (but at the requesting Party’s reasonable cost and expense), each Party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.

 

(o) Counterparts; Facsimile. This Agreement may also be executed and delivered by facsimile signature or by email in portable document format in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

 

[Remainder of Page Intentionally Left Blank; Signature Pages Follow]

 

5

 

 

IN WITNESS WHEREOF, the parties have executed this Lock-Up Agreement as of the date first written above.

 

  Purchaser:
     
  ALUSSA ENERGY ACQUISITION CORP.
     
  By:  
  Name:
  Title:
   
   
  Pubco:
     
  FREYR BATTERY
     
  By:  
  Name:
  Title:
   
   
  Purchaser Representative:
     
  ALUSSA ENERGY SPONSOR LLC
     
  By:  
  Name:
  Title:

 

6

 

 

IN WITNESS WHEREOF, the parties have executed this Lock-Up Agreement as of the date first written above.

 

Holder:

  

Name of Holder:     
       
By:      

 

 

Address for Notice:

 

Address:

     
     
     
Facsimile No.:     
Telephone No.:     
Email:     

 

 

[Signature Page to Lock-Up Agreement]

 

7

Exhibit 10.2

 

AGREED FORM

 

REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2021, is made and entered into by and among (i) FREYR Battery, a company organized under the laws of Luxembourg (the “Company“), (ii) Alussa Energy Sponsor LLC, a Delaware limited liability company (the “Sponsor”), (iii) certain shareholders of FREYR AS (“FREYR”), a company incorporated under the laws of Norway, set forth on Schedule 1 hereto (the “FREYR Holders”) and (iv) the undersigned parties listed on the signature page hereto (each such party, together with the Sponsor, the FREYR Holders and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).

 

RECITALS

 

WHEREAS, Alussa Energy Acquisition Corp. (“Alussa Energy”) and the Sponsor are party to that certain registration rights agreement, dated November 25, 2019 (the “Original RRA”);

 

WHEREAS, the Company has entered into that certain business combination agreement, dated as of [●], 2021 (the “Business Combination Agreement”), by and between, among others, Alussa Energy, the Sponsor and FREYR;

 

WHEREAS, pursuant to the Business Combination Agreement, the parties thereto will consummate a series of transactions, pursuant to which, among others, (i) ordinary shares of FREYR held by shareholders of FREYR, including the FREYR Holders, will be converted into ordinary shares of the Company, par value $0.01 per share (“Ordinary Shares”), (ii) 7,187,500 class B ordinary shares of Alussa Energy held by the Sponsor will be converted into 7,187,500 Ordinary Shares (the “Founder Shares”), (iii) private placement warrants of Alussa Energy held by the Sponsor will be converted into warrants of the Company (the “Private Placement Warrants”). and (iv) [[●] working capital warrants of Alussa Energy held by the Sponsor will be converted into [●] warrants of the Company (the “Working Capital Warrants)]1.

 

WHEREAS, certain investors (the “PIPE Shareholders”) committed, or have an option, to purchase Ordinary Shares (the “PIPE Shares”) in a transaction exempt from registration under the Securities Act pursuant to the respective subscription agreements, each dated on or about [●], 2021, entered into by and between the Company, Alussa and each of the PIPE Shareholders (each, a “Subscription Agreement” and, collectively, the “Subscription Agreements”);

 

WHEREAS, the Company and the Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement.

 

NOW, THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

Article I

DEFINITIONS

 

1.1 Definitions. The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

 

 

 

1 Note: to be included to the extent working capital warrants are issued between signing and closing

 

 

AGREED FORM

 

Adverse Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief Executive Officer or principal financial officer of the Company, after consultation with counsel to the Company, (i) would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed, and (iii) the Company has a bona fide business purpose for not making such information public.

 

Agreement” shall have the meaning given in the Preamble.

 

Alussa Energy” shall have the meaning given in the Recitals.

 

Board” shall mean the Board of Directors of the Company.

 

Business Combination” shall have the meaning given in the Recitals.

 

Business Combination Agreement” shall have the meaning given in the Recitals.

 

Commission” shall mean the Securities and Exchange Commission.

 

Company” shall have the meaning given in the Preamble.

 

Demand Registration” shall have the meaning given in subsection 2.1.1.

 

Demanding Holder” shall have the meaning given in subsection 2.1.1.

 

Effectiveness Deadline” shall have the meaning given in subsection 2.1.6.

 

Encompass Holders” shall have the meaning given in subsection 5.6.

 

Exchange Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.

 

Form S-1” shall have the meaning given in subsection 2.1.1.

 

Form S-3” shall have the meaning given in subsection 2.3.

 

Founder Shares” shall have the meaning given in the Recitals.

 

FREYR” shall have the meaning given in the Preamble.

 

FREYR Holders” shall have the meaning given in the Preamble.

 

FREYR Shareholder Lock-Up Agreements” shall mean the lock-up agreements, dated on or about [●], 2021, between the Company, Alussa Energy, the Sponsor and the applicable FREYR Holder, and each a “FREYR Shareholder Lock-Up Agreement”.

 

Holders” shall have the meaning given in the Preamble.

 

Lock-Up Agreements” shall mean the FREYR Shareholder Lock-Up Agreements and the Sponsor Lock-Up Agreement, and each, a “Lock-Up Agreement”.

 

Maximum Number of Securities” shall have the meaning given in subsection 2.1.4.

 

Misstatement” shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus in the light of the circumstances under which they were made not misleading.

 

2

AGREED FORM

 

Ordinary Shares” shall have the meaning given in the Recitals.

 

Ordinary Shares Lock-up Period” shall mean, with respect to the Founder Shares and the Ordinary Shares held by the FREYR Holders, the lock-up period set forth in the applicable Lock-Up Agreement.

 

Original RRA” shall have the meaning given in the Recitals.

 

Permitted Transferees” shall mean a person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable Securities prior to the expiration of the Ordinary Shares Lock-up Period or Private Placement Lock-up Period, as the case may be, under the applicable Lock-Up Agreement, this Agreement, and any other applicable agreement between such Holder and the Company, and to any transferee thereafter.

 

Piggyback Registration” shall have the meaning given in subsection 2.2.1.

 

PIPE Shareholders” shall have the meaning given in the Recitals.

 

PIPE Shares” shall have the meaning given in the Recitals.

 

Private Placement Lock-up Period” shall mean, with respect to Private Placement Warrants, the lock-up period set forth in the Sponsor Lock-Up Agreement.

 

Private Placement Warrants” shall have the meaning given in the Recitals.

 

Pro Rata” shall have the meaning given in subsection 2.1.4.

 

Prospectus” shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

 

Registrable Security” shall mean (a) any outstanding Ordinary Shares or any other equity security (including warrants to purchase Ordinary Shares and the Ordinary Shares issued or issuable upon the exercise of any other equity security) of the Company held by a Holder immediately following the Second Closing, (b) any Private Placement Warrants (including any Ordinary Shares issued or issuable upon the exercise of any such Private Placement Warrants), (c) any Working Capital Warrants (including the Ordinary Shares issued or issuable upon the exercise of any such Working Capital Warrants), (d) any outstanding Ordinary Shares or any other equity security (including the Ordinary Shares issued or issuable upon the exercise of any other equity security) of the Company held by a Holder as of the date of this Agreement and (e) any other equity security of the Company issued or issuable with respect to any such Ordinary Shares by way of a share dividend or share split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization; provided, however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such securities shall have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution of such securities shall not require registration under the Securities Act; (C) such securities shall have ceased to be outstanding; (D) such securities may be sold without registration pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions or limitations); or (E) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction.

 

Registration” shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

 

3

AGREED FORM

 

Registration Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:

 

(a) all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.) and any securities exchange on which the Ordinary Shares are then listed;

 

(b) fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in connection with blue sky qualifications of Registrable Securities);

 

(c) printing, messenger, telephone and delivery expenses;

 

(d) reasonable fees and disbursements of counsel for the Company;

 

(e) reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such Registration; and

 

(f) reasonable fees and expenses of one (1) legal counsel selected by the majority-in-interest of the Demanding Holders initiating a Demand Registration to be registered for offer and sale in the applicable Registration.

 

Registration Statement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

 

Requesting Holder” shall have the meaning given in subsection 2.1.1.

 

Resale Shelf Registration Statement” shall have the meaning given in subsection 2.1.6.

 

Second Closing” shall have the meaning given in the Business Combination Agreement.

 

Second Closing Date” shall have the meaning given in the Business Combination Agreement.

 

Securities Act” shall mean the Securities Act of 1933, as amended from time to time.

 

Sponsor” shall have the meaning given in the Preamble.

 

Sponsor Lock-Up Agreement” shall mean the lock-up agreement, dated [●], 2021, between the Company and the Sponsor.

 

Subscription Agreement” shall have the meaning given in the Recitals.

 

Underwriter” shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such dealer’s market-making activities.

 

Underwritten Registration” or “Underwritten Offering” shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.

 

Working Capital Warrants” shall have the meaning given in the Recital hereto.

 

4

AGREED FORM

 

Article II

REGISTRATIONS

 

2.1 Demand Registration.

 

2.1.1 Request for Registration. Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, at any time and from time to time on or after the Second Closing Date, any Holder of Registrable Securities (the “Demanding Holder”) may make a written demand for Registration under the Securities Act of all or part of their Registrable Securities, which written demand shall describe the amount and type of securities to be included in such Registration and the intended method(s) of distribution thereof (such written demand a “Demand Registration”). The Company shall, within ten (10) days of the Company’s receipt of the Demand Registration, notify, in writing, all other Holders of Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in a Registration pursuant to a Demand Registration (each such Holder that includes all or a portion of such Holder’s Registrable Securities in such Registration, a “Requesting Holder”) shall so notify the Company, in writing, within five (5) days after the receipt by the Holder of the notice from the Company. Upon receipt by the Company of any such written notification from a Requesting Holder(s) to the Company, such Requesting Holder(s) shall be entitled to have their Registrable Securities included in a Registration pursuant to a Demand Registration and the Company shall effect, as soon thereafter as practicable, but not more than forty five (45) days immediately after the Company’s receipt of the Demand Registration, the Registration of all Registrable Securities requested by the Demanding Holders and Requesting Holders pursuant to such Demand Registration. Under no circumstances shall the Company be obligated to effect more than an aggregate of three (3) Registrations pursuant to a Demand Registration under this subsection 2.1.1 with respect to any or all Registrable Securities; provided, however, that a Registration shall not be counted for such purposes unless a Form S-1 or any similar long-form registration statement that may be available at such time (“Form S-1”) has become effective and all of the Registrable Securities requested by the Requesting Holders to be registered on behalf of the Requesting Holders in such Form S-1 Registration have been sold, in accordance with Section 3.1 of this Agreement.

 

2.1.2 Effective Registration. Notwithstanding the provisions of subsection 2.1.1 above or any other part of this Agreement, a Registration pursuant to a Demand Registration shall not count as a Registration unless and until (i) the Registration Statement filed with the Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission and (ii) the Company has complied with all of its obligations under this Agreement with respect thereto; provided, further, that if, after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant to a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any other governmental agency the Registration Statement with respect to such Registration shall be deemed not to have been declared effective, unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest of the Demanding Holders initiating such Demand Registration thereafter affirmatively elect to continue with such Registration and accordingly notify the Company in writing, but in no event later than five (5) days, of such election; and provided, further, that the Company shall not be obligated or required to file another Registration Statement until the Registration Statement that has been previously filed with respect to a Registration pursuant to a Demand Registration becomes effective or is subsequently terminated.

 

2.1.3 Underwritten Offering. Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, if a majority-in-interest of the Demanding Holders so advise the Company as part of their Demand Registration that the offering of the Registrable Securities pursuant to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Holder or Requesting Holder (if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder’s participation in such Underwritten Offering and the inclusion of such Holder’s Registrable Securities in such Underwritten Offering to the extent provided herein. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection 2.1.3 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the majority-in-interest of the Demanding Holders initiating the Demand Registration.

 

5

AGREED FORM

 

2.1.4 Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a Demand Registration, in good faith, advises the Company, the Demanding Holders and the Requesting Holders (if any) in writing that the dollar amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other Ordinary Shares or other equity securities that the Company desires to sell and the Ordinary Shares, if any, as to which a Registration has been requested pursuant to separate written contractual piggy-back registration rights held by any other shareholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”), then the Company shall include in such Underwritten Offering, as follows: (i) first, the Registrable Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration (such proportion is referred to herein as “Pro Rata”)) that can be sold without exceeding the Maximum Number of Securities; (ii) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the Registrable Securities of Holders (Pro Rata, based on the respective number of Registrable Securities that each Holder has so requested) exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, without exceeding the Maximum Number of Securities; and (iii) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (iv) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i), (ii) and (iii), the Ordinary Shares or other equity securities of other persons or entities that the Company is obligated to register in a Registration pursuant to separate written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of Securities.

 

2.1.5 Demand Registration Withdrawal. A majority-in-interest of the Demanding Holders initiating a Demand Registration or a majority-in-interest of the Requesting Holders (if any), pursuant to a Registration under subsection 2.1.1 shall have the right to withdraw from a Registration pursuant to such Demand Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to the Registration of their Registrable Securities pursuant to such Demand Registration. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Registration pursuant to a Demand Registration prior to its withdrawal under this subsection 2.1.5.

 

2.1.6 Shelf Registration. The Company agrees that, within thirty (30) calendar days following the Second Closing Date, the Company will submit to or file with the Commission a registration statement for a shelf registration on Form S-1 or Form S-3 (if the Company is then eligible to use a Form S-3 shelf registration) (the “Resale Shelf Registration Statement”), in each case, covering the resale of the Registrable Shares and the Company shall use its commercially reasonable efforts to have the Resale Shelf Registration Statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) the 90th calendar day following the filing date thereof if the Commission notifies the Company that it will “review” the Resale Shelf Registration Statement and (ii) the 10th business day after the date the Company is notified (orally or in writing, whichever is earlier) by the Commission that the Resale Shelf Registration Statement will not be “reviewed” or will not be subject to further review (such earlier date, the “Effectiveness Deadline”); provided, however, that the Company obligations to include the Registrable Shares in the Resale Shelf Registration Statement are contingent upon the applicable Holder furnishing in writing to the Company such information regarding the Holder, the Registrable Shares held by such Holder and the intended method of disposition of the Registrable Shares (which shall be limited to non-underwritten public offerings) as shall be reasonably necessary and requested by the Company to effect the registration of the Registrable Shares, and such Holder shall execute such documents in connection with such registration as the Company may reasonably request that are customary of a selling shareholder in similar situations, including providing that the Company shall be entitled to postpone and suspend the effectiveness or use of the Resale Shelf Registration Statement, if applicable, during any customary blackout or similar period or as permitted hereunder; provided that such Holder shall not in connection with the foregoing be required to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer the Registrable Shares (other than the Lock-Up Agreements).

 

6

AGREED FORM

 

2.2 Piggyback Registration.

 

2.2.1 Piggyback Rights. If, at any time on or after the Second Closing Date, the Company proposes to file a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of shareholders of the Company (or by the Company and by the shareholders of the Company including, without limitation, pursuant to Section 2.1 hereof), other than a Registration Statement (i) filed in connection with any employee share option or other benefit plan, (ii) for an exchange offer or offering of securities solely to the Company’s existing shareholders, (iii) for an offering of debt that is convertible into equity securities of the Company or (iv) for a dividend reinvestment plan, then the Company shall give written notice of such proposed filing to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated filing date of such Registration Statement, which notice shall (A) describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and (B) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable Securities as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration a “Piggyback Registration”). The Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and shall use its best efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this subsection 2.2.1 to be included in a Piggyback Registration on the same terms and conditions as any similar securities of the Company included in such Registration and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection 2.2.1 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company.

 

2.2.2 Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar amount or number of the Ordinary Shares that the Company desires to sell, taken together with (i) the Ordinary Shares, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder (ii) the Registrable Securities as to which registration has been requested pursuant to Section 2.2 hereof, and (iii) the Ordinary Shares, if any, as to which Registration has been requested pursuant to separate written contractual piggy-back registration rights of other shareholders of the Company, exceeds the Maximum Number of Securities, then:

 

(a) If the Registration is undertaken for the Company’s account, the Company shall include in any such Registration (A) first, the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Ordinary Shares, if any, as to which Registration has been requested pursuant to written contractual piggy-back registration rights of other shareholders of the Company, which can be sold without exceeding the Maximum Number of Securities;

 

(b) If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the Company shall include in any such Registration (A) first, the Ordinary Shares or other equity securities, if any, of such requesting persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1, pro rata based on the number of Registrable Securities that each Holder has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities that the Holders have requested to be included in such Underwritten Registration, which can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the Ordinary Shares or other equity securities for the account of other persons or entities that the Company is obligated to register pursuant to separate written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of Securities.

 

7

AGREED FORM

 

2.2.3 Piggyback Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Piggyback Registration. The Company (whether on its own good faith determination or as the result of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration prior to its withdrawal under this subsection 2.2.3.

 

2.2.4 Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.1 hereof.

 

2.3 Registrations on Form S-3. The Holders of Registrable Securities may at any time, and from time to time, request in writing that the Company, pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission), register the resale of any or all of their Registrable Securities on Form S-3 or any similar short form registration statement that may be available at such time (“Form S-3”); provided, however, that the Company shall not be obligated to effect such request through an Underwritten Offering. Within five (5) days of the Company’s receipt of a written request from a Holder or Holders of Registrable Securities for a Registration on Form S-3, the Company shall promptly give written notice of the proposed Registration on Form S-3 to all other Holders of Registrable Securities, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in such Registration on Form S-3 shall so notify the Company, in writing, within ten (10) days after the receipt by the Holder of the notice from the Company. As soon as practicable thereafter, but not more than twelve (12) days after the Company’s initial receipt of such written request for a Registration on Form S-3, the Company shall register all or such portion of such Holder’s Registrable Securities as are specified in such written request, together with all or such portion of Registrable Securities of any other Holder or Holders joining in such request as are specified in the written notification given by such Holder or Holders; provided, however, that the Company shall not be obligated to effect any such Registration pursuant to Section 2.3 hereof if (i) a Form S-3 is not available for such offering; or (ii) the Holders of Registrable Securities, together with the Holders of any other equity securities of the Company entitled to inclusion in such Registration, propose to sell the Registrable Securities and such other equity securities (if any) at any aggregate price to the public of less than $10,000,000.

 

2.4 Restrictions on Registration Rights. If (A) during the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company initiated Registration and provided that the Company has delivered written notice to the Holders prior to receipt of a Demand Registration pursuant to subsection 2.1.1 and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable Registration Statement to become effective; (B) the Holders have requested an Underwritten Registration and the Company and the Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; or (C) in the good faith judgment of the Board such Registration would be seriously detrimental to the Company and the Board concludes as a result that it is essential to defer the filing of such Registration Statement at such time, then in each case the Company shall furnish to such Holders a certificate signed by the Chairman of the Board stating that in the good faith judgment of the Board it would be seriously detrimental to the Company for such Registration Statement to be filed in the near future and that it is therefore essential to defer the filing of such Registration Statement. In such event, the Company shall have the right to defer such filing for a period of not more than thirty (30) days.

 

8

AGREED FORM

 

Article III

COMPANY PROCEDURES

 

3.1 General Procedures. If at any time after the Second Closing Date the Company is required to effect the Registration of Registrable Securities, the Company shall use its best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:

 

3.1.1 prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and use its reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration Statement have ceased to be Registrable Securities;

 

3.1.2 prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may be requested by the Holders or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;

 

3.1.3 prior to filing a Registration Statement or prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities owned by such Holders;

 

3.1.4 prior to any public offering of Registrable Securities, use its best efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;

 

3.1.5 cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities issued by the Company are then listed;

 

3.1.6 provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement;

 

3.1.7 advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued;

 

9

AGREED FORM

 

3.1.8 at least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus, furnish a copy thereof to each seller of such Registrable Securities or its counsel;

 

3.1.9 notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;

 

3.1.10 permit a representative of the Holders (such representative to be selected by a majority of the participating Holders), the Underwriters, if any, and any attorney or accountant retained by such Holders, or Underwriter to participate, at each such person’s own expense, in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; provided, however, that such representative, or Underwriters enter into a confidentiality agreement, in form and substance reasonably satisfactory to the Company, prior to the release or disclosure of any such information;

 

3.1.11 obtain a “cold comfort” letter from the Company’s independent registered public accountants in the event of an Underwritten Registration which the participating Holders may rely on, in customary form and covering such matters of the type customarily covered by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;

 

3.1.12 on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders;

 

3.1.13 in the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing Underwriter of such offering;

 

3.1.14 make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated thereafter by the Commission);

 

3.1.15 if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use its reasonable efforts to make available senior executives of the Company to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in any Underwritten Offering; and

 

3.1.16 otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in connection with such Registration.

 

3.2 Registration Expenses. The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders.

 

10

AGREED FORM

 

3.3 Requirements for Participation in Underwritten Offerings. No person may participate in any Underwritten Offering for equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such person (i) agrees to sell such person’s securities on the basis provided in any underwriting arrangements approved by the Company, (ii) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements, other customary documents as may be reasonably required under the terms of such underwriting arrangements and (iii) any other documents as required under applicable securities laws.

 

3.4 Suspension of Sales; Adverse Disclosure. Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until it is advised in writing by the Company that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration at any time would require the Company to make an Adverse Disclosure or would require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Company’s control, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time, but in no event more than thirty (30) days, determined in good faith by the Company to be necessary for such purpose. In the event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale or offer to sell Registrable Securities. The Company shall immediately notify the Holders of the expiration of any period during which it exercised its rights under this Section 3.4.

 

3.5 Reporting Obligations. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings. The Company further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell shares of the Ordinary Shares held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission), including providing any legal opinions. Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.

 

Article IV

INDEMNIFICATION AND CONTRIBUTION

 

4.1 Indemnification.

 

4.1.1 The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors and each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses (including attorneys’ fees) caused by any untrue or alleged untrue statement of material fact contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same are caused by or contained in any information furnished in writing to the Company by such Holder expressly for use therein. The Company shall indemnify the Underwriters, their officers and directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.

 

11

AGREED FORM

 

4.1.2 In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and officers and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including without limitation reasonable attorneys’ fees) resulting from any untrue statement of material fact contained in the Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly for use therein; provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to indemnification of the Company.

 

4.1.3 Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

 

4.1.4 The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer of securities. The Company and each Holder of Registrable Securities participating in an offering also agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event the Company’s or such Holder’s indemnification is unavailable for any reason.

 

4.1.5 If the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under this subsection 4.1.5 shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3 above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in this subsection 4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any person who was not guilty of such fraudulent misrepresentation.

 

12

AGREED FORM

 

Article V

MISCELLANEOUS

 

5.1 Notices. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail, or facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation. Any notice or communication under this Agreement must be addressed, if to the Company, to: 412 F, route d’Esch L-2086 Luxembourg or contract-notifications@freyrbattery.com, and, if to any Holder, at such Holder’s address or contact information as set forth in the Company’s books and records. Any party may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30) days after delivery of such notice as provided in this Section 5.1.

 

5.2 Assignment; No Third Party Beneficiaries.

 

5.2.1 This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.

 

5.2.2 Prior to the expiration of the Ordinary Shares Lock-up Period or the Private Placement Lock-up Period, as the case may be, no Holder may assign or delegate such Holder’s rights, duties or obligations under this Agreement, in whole or in part, except in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee but only if such Permitted Transferee agrees to become bound by the transfer restrictions set forth in this Agreement. After the expiration of the Ordinary Shares Lock-up Period or the Private Placement Lock-up Period, as the case may be, the Holder may assign or delegate such Holder’s rights, duties or obligations under this Agreement, in whole or in part, to any transferee.

 

5.2.3 This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and the permitted assigns of the Holders, which shall include Permitted Transferees.

 

5.2.4 This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth in this Agreement and Section 5.2 hereof.

 

5.2.5 No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have received (i) written notice of such assignment as provided in Section 5.1 hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other than as provided in this Section 5.2 shall be null and void.

 

5.3 Counterparts. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced.

 

5.4 Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT (I) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION AND (II) THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN NEW YORK COUNTY IN THE STATE OF NEW YORK.

 

13

AGREED FORM

 

5.5 Amendments and Modifications. Upon the written consent of the Company and the Holders of at least a majority in interest of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of the shares of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party.

 

5.6 Other Registration Rights. The Company represents and warrants that no person, other than (a) the PIPE Shareholders who have registration rights with respect to their PIPE Shares pursuant to their respective Subscription Agreements, (b) Encompass Capital Master Fund LP and BEMAP Master Fund LP (together, the “Encompass Holders”), who have registration rights pursuant to the preferred share acquisition agreement, dated [●], 2021, between and among, the Encompass Holders, FREYR, Alussa Energy and the Company, pursuant to which agreement they will acquire Ordinary Shares, (c) shareholders of FREYR immediately prior to the transactions contemplated to occur on the Second Closing Date who have registration rights pursuant to the Business Combination Agreement and (d) a Holder of Registrable Securities, has any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration filed by the Company for the sale of securities for its own account or for the account of any other person. Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.

 

5.7 Term. This Agreement shall terminate upon the earlier of (i) the tenth anniversary of the date of this Agreement or (ii) the date as of which (A) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by the Commission)) or (B) the Holders of all Registrable Securities are permitted to sell the Registrable Securities under Rule 144 (or any similar provision) under the Securities Act without limitation on the amount of securities sold or the manner of sale. The provisions of Section 3.5 and Article IV shall survive any termination.

 

5.8 Termination of Original RRA. Alussa Energy and the Sponsor agree that the Original RRA shall terminate on the Second Closing Date.

 

 

[SIGNATURE PAGES FOLLOW]

 

14

AGREED FORM

 

IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

 

  COMPANY:
     
  FREYR BATTERY
     
  By:  
    Name:
    Title:
   
   
  ALUSSA ENERGY SPONSOR LLC
   
  By:  
    Name: Daniel Barcelo
    Title: Managing Member
   
   
  [SIG BLOCKS TO COME FOR ALL FREYR HOLDERS]

 

 

[Signature Page to Registration Rights Agreement]

 

15

AGREED FORM

 

Schedule I

 

[List of FREYR Major Shareholders with registration rights under RRA to come]

 

 

[Signature Page to Registration Rights Agreement]

 

 

Exhibit 10.3

 

Execution Version  

 

Dated [●] January 2021

 

(1) ALUSSA ENERGY ACQUISITION CORP.

 

(2) FREYR AS

 

(3) [●]

 

 

 

 

 

 

 

VOTING AND SUPPORT AGREEMENT

 

 

 

 

 

 

 

Cayman office
71 Fort Street
PO Box 190
Grand Cayman KY1-1104
Cayman Islands
445844.0002

 

 

 

 

CONTENTS

 

Clause Page
1. Definitions and Interpretation 2
2. Voting; Grant and Appointment of Proxy 3
3. Representations and Warranties 5
4. Covenants 7
5. Restrictions on Disposals 8
6. Specific Performance 9
7. Termination 9
8. Entire Agreement 9
9. Amendment and Variation 9
10. No Assignment 9
11. Waiver 10
12. Severance 10
13. Notices 10
14. Waiver of Immunity 11
15. Appointment of Process Agent 11
16. Counterparts 11
17. Governing Law and Jurisdiction 11
SCHEDULE 1          SHARES 12
SCHEDULE 2          WARRANTS 13
SIGNATORIES 14

 

i

 

 

THIS AGREEMENT is dated 2021

 

PARTIES

 

(1) ALUSSA ENERGY ACQUISITION CORP., an exempted company incorporated under the laws of the Cayman Islands (Company);

 

(2) FREYR AS, a limited liability company incorporated under the laws of Norway (FREYR);

 

(3) [●], a limited partnership organised under the laws of [●] (Shareholder).

 

BACKGROUND

 

(A) WHEREAS, the Company desires and intends to effect a business combination transaction in accordance with the terms of that certain Business Combination Agreement to be entered into on or around the date hereof by and among, amongst others, the Company, FREYR, FREYR Battery, a corporation in the form of a public limited liability company under the laws of Luxembourg (Pubco), Norway Sub 1 AS, a private limited liability company under the laws of Norway (Norway Merger Sub 1), Norway Sub 2 AS, a private limited liability company under the laws of Norway (Norway Merger Sub 2) and Adama Charlie Sub, an exempted company incorporated under the laws of the Cayman Islands (Cayman Merger Sub) (as may be amended, supplemented or otherwise modified, the Business Combination Agreement) whereby (a) the Company will merge with and into Cayman Merger Sub, with the Company continuing as the surviving entity (the Cayman Merger), (b) FREYR will merge with and into Norway Merger Sub 2, with Norway Merger Sub 2 continuing as the surviving entity (the Norway Merger) and (c) Norway Merger Sub 1 will merge with and into Pubco, with Pubco continuing as the surviving entity (the Cross-Border Merger and, together with the Cayman Merger and the Norway Merger, the Mergers and, together with the other transactions contemplated by the Business Combination Agreement and ancillary documents referred to therein, the Transaction).

 

(B) WHEREAS, as of the date hereof, the Shareholder is the owner of record and the beneficial owner of the Class A ordinary shares par value $0.0001 each of the Company set forth next to Shareholder’s name on Schedule I hereto (the Shares and, together with any other Shares acquired (whether beneficially or of record) by the Shareholder after the date hereof and prior to the earlier of the Cayman Effective Time (as defined herein) and the termination of all of the Shareholder’s obligations under this agreement, including any Shares acquired by means of purchase, dividend or distribution, or issued upon the exercise of any warrants or the conversion of any convertible securities or otherwise, being collectively referred to herein as the Subject Shares).

 

(C) WHEREAS, as a condition to the completion of the Transaction under the Business Combination Agreement, the shareholders of the Company must approve the Resolutions (as defined herein) at a special meeting of the shareholders of the Company.

 

(D) WHEREAS, in connection with the consummation of the Transaction and as a material inducement to the willingness of the Company and FREYR to enter into the Business Combination Agreement, the Shareholder has agreed to enter into this agreement and to undertake to vote the Subject Shares as set forth herein.

 

1 of 14

 

 

(E) NOW, THEREFORE, in consideration of the foregoing, the mutual covenants and agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 

AGREED TERMS

 

1. Definitions and Interpretation

 

1.1 The following words and expressions shall have the following meanings, unless the context requires otherwise:

 

Alternative Transaction: a transaction (other than the Transaction) concerning a Business Combination involving the Company.

 

Business Combination: a merger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination involving the Company, with one or more businesses or entities.

 

Cayman Effective Time: has the meaning given to it in the Business Combination Agreement.

 

Cayman Plan of Merger: the plan of merger in the form approved by the board of directors of the Company and to be filed with the Registrar of Companies of the Cayman Islands in accordance with the Companies Law.

 

Companies Law: the Companies Act (2021 Revision), as amended, of the Cayman Islands.

 

Derivative Transaction: any swap transaction, option, warrant, forward purchase or sale transaction, futures transaction, cap transaction, floor transaction, collar transaction or any other similar transaction (including any option with respect to any such transaction) or combination of any such transactions, in each case involving any Subject Shares and which (a) has, or would reasonably be expected to have, the effect of reducing or limiting the Shareholder’s economic interest in the Subject Shares and/or (b) grants a third party the right to vote or direct the voting of the Subject Shares.

 

Governmental Authority: any federal, state, local, foreign or other governmental, quasi-governmental or administrative body, instrumentality, department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, regulatory body or other similar regulatory or dispute-resolving panel or body.

 

Resolutions: together: (i) the approval of the Business Combination Agreement and the Transaction, (ii) the approval of the Cayman Merger and the Cayman Plan of Merger; and (iii) the approval of the adoption of a new amended and restated memorandum and articles of association of the Company in the form approved by the board of directors of the Company in connection with the consummation of the Transaction (the New Memorandum and Articles).

 

2 of 14

 

 

SEC: the United States Securities and Exchange Commission.

 

Securities Act: the United States Securities Act of 1933, as amended.

 

Transfer: with respect to any security, to sell (constructively or otherwise), offer, lend, gift, transfer, assign, tender in any tender or exchange offer, pledge, grant, encumber, hypothecate or similarly dispose of by merger, testamentary disposition, operation of law or otherwise, or the taking of any other action which would result in another person obtaining any beneficial ownership, or agree or commit to do any of the foregoing, and Transferred shall have a correlative meaning.

 

1.2 In this agreement, unless the context requires otherwise, a reference to

 

(a) any statute or statutory provision includes a reference to that statute or statutory provision as from time to time amended, extended, re-enacted or consolidated and all statutory instruments or orders made pursuant to it;

 

(b) an authorisation includes an authorisation, consent, approval, resolution, exemption, filing, notarisation, registration and licence;

 

(c) a clause is a reference to a clause to this agreement;

 

(d) a reference to any party shall include that party’s personal representatives, successors and permitted assigns;

 

(e) a person includes any individual, firm, company, corporation, partnership, association, organisation, government, state, agency, trust or other entity (in each case whether or not having separate legal personality) and that person’s personal representatives, successors, permitted transferees and permitted assigns; and

 

(f) words denoting the singular include the plural and vice versa and words importing any gender include every gender.

 

1.3 In this agreement all obligations, covenants, agreements, undertakings, representations and warranties on the part of two or more persons are entered into, given or made by such persons jointly and severally and shall be construed accordingly.

 

1.4 The index to and the headings in this agreement are for convenience only and shall not affect the construction or interpretation of this agreement.

 

2. Voting; Grant and Appointment of Proxy

 

2.1 From and after the date hereof until the earlier of (a) the Cayman Effective Time and (b) the termination of the Business Combination Agreement in accordance with its terms (such earlier time, the Expiration Time), the Shareholder irrevocably and unconditionally hereby agrees that at any meeting (whether annual or special and each adjourned or postponed meeting) of the shareholders of the Company, however called, or in connection with any written resolution of the shareholders of the Company, the Shareholder shall:

 

3 of 14

 

 

(a) attend such meeting (in person or by proxy) or otherwise cause the Subject Shares to be counted as present thereat for purposes of determining whether a quorum is present; and

 

(b) vote or cause to be voted (including by proxy or written resolution, if applicable) all of the Subject Shares:

 

(i) for approval of the Resolutions;

 

(ii) for approval of such other matters as the Company and FREYR shall hereafter mutually determine to be necessary or appropriate in order to effect the Transaction, provided that such matters are consistent with the terms of the Business Combination Agreement;

 

(iii) for approval of any adjournment or postponement of any meeting of the shareholders of the Company as may be requested by the chairman of the meeting;

 

(iv) against any Alternative Transaction, without regard to the terms of such Alternative Transaction, or any other transaction, proposal, agreement or action made in opposition to approval of the Business Combination Agreement and the Transaction or in competition or inconsistent with the Transaction;

 

(v) against any other action, agreement or transaction that is intended, that could reasonably be expected, or the effect of which could reasonably be expected, to materially impede, interfere with, delay, postpone, discourage or adversely affect the Transaction or any of the other transactions or matters contemplated by the Business Combination Agreement or this agreement or the performance by Shareholder of its obligations under this agreement, including, without limitation: (A) any extraordinary corporate transaction, such as a scheme of arrangement, merger, consolidation or other business combination involving the Company (other than the Cayman Merger and the Transaction); (B) a sale, lease or transfer of a material amount of assets of the Company or a reorganisation, recapitalization or liquidation of the Company (other than the Transaction); (C) an election of new members to the board of directors of the Company, other than nominees to the board of directors of the Company who are serving as directors of the Company on the date of this agreement or as otherwise provided in the Business Combination Agreement; or (D) any material change in the present capitalisation or dividend policy of the Company or any amendment or other change to the Company’s memorandum or articles of association (other than the adoption of the New Memorandum and Articles); and

 

(vi) against any action, proposal, transaction or agreement that would reasonably be expected to result in a breach in any respect of any covenant, representation or warranty or any other obligation or agreement of the Company contained in the Business Combination Agreement, or of the Shareholder contained in this agreement.

 

4 of 14

 

 

2.2 The Shareholder hereby irrevocably appoints each director and officer of the Company (acting individually) as its proxy and attorney-in-fact (with full power of substitution), to vote or cause to be voted (including by proxy or written resolution, if applicable) the Subject Shares in accordance with clause 2.1 at any annual or special meeting of the shareholders of the Company, however called, including any adjournment or postponement thereof, at which any of the matters described in clause 2.1 is to be considered. The Shareholder represents that all proxies, powers of attorney, instructions or other requests given by the Shareholder prior to the execution of this agreement in respect of the voting of the Subject Shares, if any, are not irrevocable and the Shareholder hereby revokes (or causes to be revoked) any and all previous proxies, powers of attorney, instructions or other requests with respect to the Subject Shares. The Shareholder shall take such further action or execute such other instruments as may be necessary to effectuate the intent of this proxy.

 

2.3 The Shareholder affirms that the irrevocable proxy and power of attorney set forth in clause 2.2 is given in connection with the execution of the Business Combination Agreement, and that such irrevocable proxy and power of attorney is given to secure the performance of the duties of the Shareholder under this agreement. The Shareholder further affirms that the irrevocable proxy and power of attorney is coupled with an interest and, except as set forth in clause 2.2, is intended to be irrevocable prior to the Expiration Time. If for any reason the proxy and power of attorney granted herein is not irrevocable, then the Shareholder agrees to vote the Subject Shares in accordance with clause 2.1 above.

 

2.4 The Shareholder acknowledges receipt and review of a copy of the Business Combination Agreement.

 

3. Representations and Warranties

 

3.1 The Shareholder represents and warrants to the Company and FREYR as follows:

 

(a) as of the date hereof, the Shareholder has beneficial ownership (as defined in Rule 13d-3 under the US Securities Exchange Act of 1934) over the type and number of the Shares set forth next to the Shareholder’s name on Schedule I hereto, is the lawful owner of such Shares, has the sole power to vote or cause to be voted such Shares, and has good and valid title to such Shares, free and clear of any and all pledges, mortgages, encumbrances, charges, proxies, voting agreements, liens, adverse claims, options, security interests and demands of any nature or kind whatsoever, other than those imposed by this agreement, the Business Combination Agreement or applicable securities laws, as in effect on the date hereof. There are no claims for finder’s fees or brokerage commission or other like payments in connection with this agreement or the transactions contemplated hereby payable by the Shareholder pursuant to arrangements made by the Shareholder. Except for the Shares and other securities of the Company set forth next to the Shareholder’s name on Schedule I and Schedule 2 hereto, as of the date of this agreement, the Shareholder is not a beneficial owner or record holder of any: (i) equity securities of the Company, (ii) securities of the Company having the right to vote on any matters on which the holders of equity securities of the Company may vote or which are convertible into or exchangeable for, at any time, equity securities of the Company or (iii) options, warrants or other rights to acquire from the Company, any equity securities or securities convertible into or exchangeable for equity securities of the Company;

 

5 of 14

 

 

(b) the Shareholder has full legal right, power, capacity and authority to execute and deliver this agreement, to perform the Shareholder’s obligations hereunder and to consummate the transactions contemplated hereby;

 

(c) the Shareholder has made its own independent decision to enter into this agreement based upon its own judgment and upon advice from such independent advisers as the Shareholder has deemed necessary;

 

(d) this agreement has been duly executed and delivered by the Shareholder and the execution, delivery and performance of this agreement by the Shareholder and the consummation of the transactions contemplated hereby have been duly authorised by all necessary action on the part of the Shareholder and no other actions or proceedings on the part of the Shareholder are necessary to authorise this agreement or to consummate the transactions contemplated hereby;

 

(e) this agreement constitutes the valid and binding agreement of the Shareholder, enforceable against the Shareholder in accordance with its terms;

 

(f) the execution and delivery of this agreement by the Shareholder does not, and the consummation of the transactions contemplated hereby and the compliance with the provisions hereof will not, (i) conflict with or violate any law or agreement binding upon the Shareholder or the Subject Shares, (ii) require any authorisation, consent or approval of, or filing with, any Governmental Authority (other than filings that may be required to be made by the Shareholder with the SEC), or (iii) result in any breach of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or result in the creation of a lien on any property or asset of the Shareholder pursuant to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which the Shareholder is a party or by which such Shareholder or any of its Shares are bound;

 

(g) except for such transfer restrictions of general applicability as may be provided under the Securities Act and the “blue sky” laws of the various states of the United States, as applicable, the Shareholder owns, beneficially and of record, or controls all of the Subject Shares, and all of the Subject Shares are free and clear of any proxy, voting restriction, adverse claim or other lien (other than any restrictions created by this agreement), and has sole voting power and power of disposition with respect to the Subject Shares, with no restrictions on the Shareholder’s rights of voting or disposition pertaining thereto, and no person other than the Shareholder has any right to direct or approve the voting or disposition of any of the Subject Shares;

 

6 of 14

 

 

(h) the Shareholder has not Transferred any Subject Shares pursuant to any Derivative Transaction; and

 

(i) as of the date hereof, there is no action, suit, investigation or proceeding pending against, or, to the knowledge of the Shareholder, threatened against the Shareholder or any of the Shareholder’s properties or assets (including, but not limited to, the Shares) that could reasonably be expected to prevent, materially delay or impair the ability of the Shareholder to perform its obligations under this agreement or consummate any of the Transactions.

 

3.2 The Shareholder understands and acknowledges that the Company and FREYR are entering into the Business Combination Agreement in reliance on the representations, warranties, covenants and other agreements of the Shareholder set forth in this agreement and would not enter into the Business Combination Agreement if the Shareholder did not enter into this agreement.

 

4. Covenants

 

4.1 The Shareholder hereby agrees:

 

(a) prior to the Expiration Time, not to take any action that would make any representation or warranty of the Shareholder contained herein untrue or incorrect or have or could have the effect of preventing, impeding or interfering with or adversely affecting the performance by the Shareholder of its obligations under this agreement;

 

(b) prior to the Expiration Time, to not permit to exist any lien of any nature whatsoever on the Subject Shares (other than those imposed by this agreement, the Business Combination Agreement or applicable securities laws);

 

(c) to promptly notify the Company of the number of any new Shares acquired by the Shareholder after the date hereof and prior to the Expiration Time;

 

(d) to permit the Company, FREYR or Pubco to publish and disclose in any proxy statement, shareholder meeting circular, press release or any filing with the SEC, the Shareholder’s identity and ownership of Subject Shares or other equity securities of the Company and the nature of the Shareholder’s commitments, arrangements and understandings under this agreement. Prior to filing any such disclosure naming the Shareholder, the Company, FREYR or Pubco (as applicable) shall use reasonable efforts to provide the Shareholder with an opportunity to review and comment on such disclosure referring to the Shareholder, and shall use reasonable efforts to incorporate such comments. The Shareholder also agrees to promptly provide any information reasonably requested by the Company for any regulatory application or filing made or approval sought in connection with the Transaction (including filings with the SEC); and

 

7 of 14

 

 

(e) that, upon the request of the Company and FREYR, the Shareholder shall, in its capacity as a shareholder of the Company, execute and deliver any additional documents, consents or instruments and take such further actions as may reasonably be deemed by the Company or FREYR to be necessary or desirable to carry out the provisions of this agreement, provided that the request for the execution of such additional documents, consents, instruments or for the taking of such further actions are consistent with the terms of the Business Combination Agreement.

 

4.2 The Shareholder hereby irrevocably waives, and agrees not to exercise, any rights of appraisal or rights of dissent from the Cayman Merger that the Shareholder may have with respect to the Subject Shares (including without limitation any rights under Section 238 of the Companies Law) prior to the Expiration Time.

 

5. Restrictions on Disposals

 

Except as provided for in the Business Combination Agreement or with the prior written approval of the Company and Freyr, the Shareholder hereby agrees that, from the date hereof until the Expiration Time, the Shareholder shall not, directly or indirectly:

 

(a) redeem any Subject Shares;

 

(b) Transfer, either voluntarily or involuntarily, or enter into any contract, option or other arrangement or understanding with respect to the Transfer of any Subject Shares, including, without limitation, pursuant to any Derivative Transaction; provided that the Shareholder may Transfer any Subject Shares to (i) an affiliate of Shareholder, (ii) if Shareholder is a natural person, to a member of Shareholder’s immediate family, or (iii) to any trust, the beneficiaries of which include only the persons named in the preceding clause (ii), to the extent that any such person under clause (i), (ii) or (iii) agrees in writing to be bound by and subject to the terms of this Agreement in connection with such Transfer as a Shareholder hereunder; provided further that Shareholder shall provide the Company and FREYR notice of any such Transfer prior to effecting such Transfer; provided, further that if the price of the Subject Shares (as may be adjusted for any stock split, stock dividend or other changes in the Subject Shares) is equal to or greater than $20 per share following the execution of the Business Combination Agreement, then, for so long as the trading price of such Subject Shares exceeds $20 per share, the Shareholder may Transfer such Subject Shares to a third party; provided further that in the event any such Transfer results in the Shareholder (together with its respective Affiliates) holding less than 5% of the voting equity securities of the Company, Shareholder shall be released from the obligations set forth under clause 2 hereunder (while, for clarity, continuing to be bound by the other rights and obligations set forth in this agreement);

 

(c) deposit any Subject Shares into a voting trust or enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto that is inconsistent with this agreement;

 

(d) convert or exchange, or take any action which would result in the conversion or exchange, of any Subject Shares; or

 

(e) agree (whether or not in writing) to take any of the actions referred to in the foregoing clauses (a) to (d).

 

8 of 14

 

 

6. Specific Performance

 

The Shareholder acknowledges that monetary damages would not be an adequate remedy in the event that any covenant or agreement in this agreement is not performed in accordance with its terms, and it is therefore agreed that, in addition to and without limiting any other remedy or right the Company or FREYR may have, the Company and FREYR will have the right to an injunction, temporary restraining order or other equitable relief in any court of competent jurisdiction enjoining any such breach and enforcing specifically the terms and provisions hereof. The Shareholder agrees not to oppose the granting of such relief in the event a court determines that such a breach has occurred, and to waive any requirement for the securing or posting of any bond in connection with such remedy. All rights, powers, and remedies provided under this agreement or otherwise available in respect hereof at law or in equity shall be cumulative and not alternative, and the exercise or beginning of the exercise of any thereof by the Company or FREYR shall not preclude the simultaneous or later exercise of any other such right, power or remedy by it.

 

7. Termination

 

This agreement shall terminate and be of no further force or effect upon the earlier to occur of (a) the Cayman Effective Time and (b) the date of termination of the Business Combination Agreement in accordance with its terms. Notwithstanding the preceding sentence, this clause 7 and clauses 8 to 17 shall survive any termination of this agreement. Nothing in this clause 7 shall relieve or otherwise limit any party’s liability for any breach of this agreement prior to termination or any wilful breach of this agreement.

 

8. Entire Agreement

 

This agreement and the documents referred to herein constitute the entire agreement between the parties and supersedes and extinguishes all previous agreements, promises, assurances, warranties, representations and understandings between them, whether written or oral, relating to its subject matter.

 

9. Amendment and Variation

 

No variation, release, discharge, supplement, modification, amendment or restatement of this agreement shall be effective unless it is in writing and signed by the parties (or their authorised representatives).

 

10. No Assignment

 

Except as otherwise contemplated by this agreement, no party may assign any rights, or transfer any obligations, whether voluntarily or otherwise, under this agreement, without the prior written agreement of the parties. Any purported assignment or transfer in violation of this clause is void.

 

9 of 14

 

 

11. Waiver

 

11.1 A waiver of any right or remedy under this agreement or by law is only effective if given in writing and shall not be deemed a waiver of any subsequent breach or default.

 

11.2 A failure or delay by a party to exercise any right or remedy provided under this agreement or by law shall not constitute a waiver of that or any other right or remedy, nor shall it prevent or restrict any further exercise of that or any other right or remedy. No single or partial exercise of any right or remedy provided under this agreement or by law shall prevent or restrict the further exercise of that or any other right or remedy.

 

11.3 A party that waives a right or remedy provided under this agreement or by law in relation to one party, or takes or fails to take any action against that party, does not affect its rights in relation to any other party.

 

12. Severance

 

12.1 If at any time any provision or part-provision of this agreement is or becomes invalid, illegal or unenforceable in any respect, it shall be deemed modified to the minimum extent necessary to make it valid, legal and enforceable. If such modification is not possible, the relevant provision or part-provision shall be deemed deleted. Any modification to or deletion of a provision or part-provision under this clause shall not affect the validity and enforceability of the rest of this agreement.

 

12.2 If any provision or part-provision of this agreement is invalid, illegal or unenforceable, the parties shall negotiate in good faith to amend such provision so that, as amended, it is legal, valid and enforceable, and, to the greatest extent possible, achieves the intended commercial result of the original provision.

 

13. Notices

 

13.1 Any communication in connection with this agreement must be in writing (in the English language) and, unless otherwise stated, may be given in person, by post or by email. All communications hereunder shall be delivered to the address or email address set forth on the signature pages hereto under each party’s name, or pursuant to such other instructions as may be designated in writing by the party to receive such notice.

 

13.2 Except as provided below, any communication in connection with this agreement will be deemed to be given as follows:

 

(a) if delivered in person, at the time of delivery;

 

(b) if posted, three days after being deposited in the post, postage prepaid, in a correctly addressed envelope; and

 

(c) if by email, when sent (except where the sender receives a failed delivery message).

 

10 of 14

 

 

13.3 To prove service, it is sufficient to prove that the notice was transmitted by email to the email address of the party or, in the case of post, that the envelope containing the notice was properly addressed and posted.

 

13.4 This clause does not apply to the service of any proceedings or other documents in any legal action or, where applicable, any arbitration or other method of dispute resolution.

 

14. Waiver of Immunity

 

To the extent that any party may, in any jurisdiction, claim for itself or its assets or revenues immunity from suit, execution, attachment (whether in aid of execution, before judgment or otherwise) or other legal process and to the extent that in any such jurisdiction there may be attributed to itself, its assets or revenues such immunity (whether or not claimed), the parties irrevocably agree not to claim, and irrevocably waive, such immunity to the full extent permitted by the laws of such jurisdiction.

 

15. RESERVED

 

16. Counterparts

 

This agreement may be executed in any number of counterparts, each of which when executed and delivered shall constitute a duplicate original, but all counterparts shall together constitute the one agreement.

 

17. Governing Law and Jurisdiction

 

17.1 This agreement shall be governed and construed in all respects by Cayman Islands law.

 

17.2 Any dispute arising under or in connection with this agreement shall be subject to the non-exclusive jurisdiction of the Cayman Islands courts to which the parties to this agreement hereby submit and each party hereby waives any objection to proceedings in such courts on the grounds of venue or on the grounds that the proceedings have been brought in an inconvenient forum.

 

 

IN WITNESS WHEREOF the parties have duly executed this agreement as a deed on the date stated at the beginning of it.

 

 

[Signature pages follow after Schedule]

 

11 of 14

 

 

Schedule 1          SHARES

 

Name of Shareholder Number and Class of Shares
[●] [●] Class A ordinary shares par value $0.0001 each

 

12 of 14

 

 

Schedule 2          WARRANTS

 

Name of Shareholder Number of Warrants
[●] [●] whole warrants, each warrant entitling the holder thereof to purchase one (1) Class A ordinary share of par value $0.0001 each at a purchase price of $11.50 per share

 

13 of 14

 

 

SIGNATORIES

 

EXECUTED AND DELIVERED AS A DEED by ALUSSA ENERGY ACQUISITION CORP.    )    
  )    
  )    
       

Name:

Title:

Address: c/o Appleby Global Services (Cayman) Limited,
71 Fort Street, PO Box 500,
KY1–1106 Grand Cayman,
Cayman Islands

Email: [●]

 

 

EXECUTED AND DELIVERED AS A DEED by FREYR A/S in the presence of:   )    
  )    
  )    
       

Name:

Title:

Address: [●]

Email: [●]

Witness signature

 

Name:

Address:

       

 

 

EXECUTED AND DELIVERED AS A DEED   )    
by [●]   )    
By [●]   )    
       

Name: Larry Kassman

Title: Chief Financial Officer

Address: [●]

Email: [●]

 

14 of 14

Exhibit 10.4

 

EXECUTION VERSION

 

January __, 2021

 

_______________(“Shareholder”)

 

Shareholder Irrevocable Voting Undertaking

 

Ladies and Gentlemen:

 

Reference is made to the Business Combination Agreement (the “BCA”), dated as of the date hereof, by and among, inter alia, (i) Alussa Energy Acquisition Corp (“Purchaser”), (ii) FREYR AS (the “Company”) and (iii) the Major Shareholders (as defined in the BCA). The transactions contemplated by the BCA are referred to as the “Transaction”. Capitalized terms used herein without definition shall have the meaning ascribed thereto in the BCA.

 

As a condition to the consummation of the Transaction, the shareholders of the Company (the “Shareholders”) must approve the Company Shareholder Approval Matters.

 

The Shareholder owns, as of the date hereof ordinary shares in the Company set out on the signature page hereto (the “Existing Shares”). “Existing Shares” shall also include any ordinary shares of the Company over which the Shareholder owns or otherwise has the power to vote or direct the voting of. “Company Shares” shall refer to (i) the Existing Shares and (ii) any additional ordinary shares of the Company which the Shareholder or any of its controlled entities acquires, or acquires the power to vote or direct the voting of, after the date of this undertaking.

 

As a condition to the willingness of the Purchaser to enter into the BCA, the Shareholder hereby irrevocably undertakes to the Purchaser and the Company as follows:

 

1. Shareholder Vote; Grant and Appointment of Proxy.

 

a) At any meeting or written resolutions of the Shareholders held prior to or on the earlier of (x) the Second Closing and (y) termination of the BCA, as the case may be, concerning the Company Shareholder Approval Matters or any matter relating to the Transaction, or where such may arise for consideration, and at every adjournment or postponement thereof, or in any action proposed to be taken by the consent of the Shareholders prior to the Second Closing concerning the Company Shareholder Approval Matters or any matter relating to the Transaction, the Shareholder irrevocably and unconditionally undertakes to appear (in person or by proxy) to cast votes in respect of the Company Shares:

 

i. in favor of the adoption or approval of the Company Shareholder Approval Matters;

 

ii. in favor of the adoption or approval of such matters as the Company and Purchaser shall hereafter mutually determine to be necessary or appropriate to effect the Transaction, provided that such matters are consistent with the terms of the BCA;

 

iii. in favor of any adjournment or postponement of any meeting of the Shareholders as may be requested by the chairman of the meeting;

 

 

 

 

iv. against any other action, agreement or transaction that is intended, that could reasonably be expected, or the effect of which could reasonably be expected, to materially impede, interfere with, delay, postpone, discourage or adversely affect the Transaction or any of the other matters contemplated by the BCA or this undertaking or the performance by Shareholder of its obligations under this undertaking, including, without limitation: (A) any extraordinary corporate transaction, such as a scheme of arrangement, merger, consolidation or other business combination involving the Company (other than the matters contemplated by the BCA); (B) a sale, lease or transfer of a material amount of assets of the Company or a reorganization, recapitalization or liquidation of the Company (other than the matters contemplated by the BCA); (C) an election of new members to the board of directors of the Company, other than nominees to the board of directors of the Company who are serving as directors of the Company on the date of this undertaking or as otherwise provided in the BCA; or (D) the adoption or approval of any amendment, supplement, or restatement of the Company’s Organizational Documents to the extent such amendment, supplement or restatement would prevent, interfere with, impair or delay the consummation of the Transaction; and

 

v. against any action, proposal, transaction or agreement that would reasonably be expected to result in a breach in any respect of any covenant, representation or warranty or any other obligation or agreement of the Company contained in the BCA, or of the Shareholder contained in this undertaking.

 

b) The Shareholder hereby irrevocably appoints each director and officer of the Company (acting individually) as its proxy and attorney-in-fact (with full power of substitution), to vote or cause to be voted (including by proxy or written resolution, if applicable) the Company Shares in accordance with clause 1.1(a) at any annual or special meeting of the Shareholders, however called, including any adjournment or postponement thereof, at which any of the matters described in clause 1.1(a) is to be considered. The Shareholder represents that all proxies, powers of attorney, instructions or other requests given by the Shareholder prior to the execution of this undertaking in respect of the voting of the Company Shares, if any, are not irrevocable and the Shareholder hereby revokes (or will cause to be revoked) any and all previous proxies, powers of attorney, instructions or other requests with respect to the Company Shares. The Shareholder shall take such further action or execute such other instruments as may be necessary to effectuate the intent of this proxy.

 

c) The Shareholder affirms that the irrevocable proxy and power of attorney set forth in clause 1.1(b) is given in connection with the execution of the BCA, and that such irrevocable proxy and power of attorney is given to secure the performance of the duties of the Shareholder under this undertaking. The Shareholder further affirms that the irrevocable proxy and power of attorney is coupled with an interest and is intended to be irrevocable prior to the termination of this undertaking. If for any reason the proxy and power of attorney granted herein is not irrevocable, then the Shareholder agrees to vote the Company Shares in accordance with clause 1.1(a) above.

 

2. Covenants

 

a) The Shareholder shall not directly or indirectly sell, pledge, permit to exist any lien of any nature whatsoever over, lend, grant an option to purchase, grant or enter into any voting agreement or proxy or otherwise dispose of or offer or agree to do any of the foregoing with respect to any of the Company Shares, any voting rights to the Company Shares or any securities convertible into or exercisable or exchangeable for shares of the Company, provided, however, that this shall not prohibit the entering into or completion of an agreement to (i) dispose of any security issued by Norway Merger Sub 1 to any Major Shareholder, Encompass Capital Master Fund LP, BEMAP Master Fund LP or Encompass Capital E L Master Fund L.P. in exchange for the acquisition of any security issued by SVPH or (ii) dispose of any security issued by SVPH in exchange for the acquisition of any security issued by Norway Merger Sub 1.

 

2

 

 

b) The Shareholder shall not take any action that would make any representation or warranty of the Shareholder contained herein untrue or incorrect or have or could have the effect of preventing, impeding or interfering with or adversely affecting the performance by the Shareholder of its obligations under this undertaking.

 

c) The Shareholder shall promptly notify the Company and Purchaser of the number of any ordinary shares of the Company acquired by the Shareholder after the date hereof and prior to the termination of this undertaking.

 

d) The Shareholder agrees to promptly provide any information reasonably requested by the Company, the Purchaser or any of their respective affiliates for any regulatory application or filing made or approval sought in connection with the Transaction (including filings with the United States Securities and Exchange Commission (the “SEC”)), and to permit the Company, FREYR or Pubco to publish and disclose in any proxy statement, shareholder meeting circular, press release or any filing with the SEC, the Shareholder’s identity and ownership of Company Shares or other equity securities of the Company and the nature of the Shareholder’s commitments, arrangements and understandings under this undertaking.

 

e) The Shareholder shall, upon the request of the Company and Purchaser, execute and deliver any additional documents, consents or instruments and take such further actions as may be reasonably deemed by the Company and Purchaser to be necessary or desirable to carry out the provisions of this undertaking.

 

3. Representations and Warranties

 

a) The Shareholder hereby represents to the Company and Purchaser as follows:

 

i. that it has full corporate power and authority to execute and deliver this undertaking and to perform its obligations hereunder and that this undertaking has been duly executed and delivered by it and constitutes its legal, valid and binding obligations, enforceable against it in accordance with its terms;

 

ii. that it has received and reviewed a copy of the BCA, and made its own independent decision to enter into this undertaking based upon its judgment and upon advice from such independent advisors as the Shareholder has deemed necessary;

 

iii. that the execution and delivery of this undertaking by the Shareholder does not, and the consummation of the transactions contemplated hereby and the compliance with the provisions hereof will not, conflict with or violate any law or agreement binding upon the Shareholder or the Existing Shares, nor require any authorization, consent or approval of, or filing with, any governmental authority, nor result in any breach of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or result in the creation of a lien on any property or asset of such Shareholder pursuant to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which such Shareholder is a party or by which such Shareholder or any of the Existing Shares are bound;

 

3

 

 

iv. that it owns, beneficially and of record, or controls all of the Existing Shares, and all of the Existing Shares are free and clear of any proxy, voting restriction, adverse claim, pledge, mortgage, encumbrance, charge, option, security interest, other lien or demand of any nature or any kind (other than any restrictions created by this undertaking, by the BCA and by applicable securities laws), and has sole voting power and power of disposition with respect to the Existing Shares, with no restrictions on the Shareholder’s rights of voting or disposition pertaining thereto, and no person other than the Shareholder has any right to direct or approve the voting or disposition of any of the Existing Shares;

 

v. that there are no claims for finder’s fees or brokerage commission or other like payments in connection with this undertaking, the BCA, the Transaction or the transactions contemplated hereby payable by Shareholder pursuant to arrangements made by Shareholder;

 

vi. that there is no action, suit, investigation or proceeding pending against, or, to the knowledge of Shareholder, threatened against Shareholder or any of Shareholder’s properties or assets (including, but not limited to, the Existing Shares) that could reasonably be expected to prevent, materially delay or impair the ability of Shareholder to perform its obligations under this undertaking or consummate any of the transactions contemplated hereby;

 

vii. that except for the Existing Shares and other securities of the Company set forth next to Shareholder’s name on Schedule I hereto, as of the date of this undertaking, the Shareholder is not a beneficial owner or record holder of any: (i) equity securities of the Company, (ii) securities of the Company having the right to vote on any matters on which the holders of equity securities of the Company may vote or which are convertible into or exchangeable for, at any time, equity securities of the Company or (iii) options, warrants or other rights to acquire from the Company, any equity securities or securities convertible into or exchangeable for equity securities of the Company.

 

b) The Shareholder understands that the Company and Purchaser are entering into the BCA in reliance on the representations, warranties, covenants and other agreements of the Shareholder set forth in this undertaking and would not enter into the BCA if the Shareholder did not enter into this undertaking.

 

4. Miscellaneous

 

a) This undertaking shall terminate and be of no further effect upon the earlier to occur of (a) the Second Closing and (y) termination of the BCA. Notwithstanding the preceding sentence, clause 4 shall survive any termination of this undertaking. Nothing in this clause 4(a) shall relieve or otherwise limit any party’s liability for any breach of this undertaking prior to or termination or any willful breach of this undertaking.

 

b) All claims or causes of action that may be based upon, arise out of or relate to this undertaking, or the negotiation, execution or performance of this undertaking, may be made only against the Shareholder and no person who is not a party hereto shall have any rights to enforce its terms.

 

c) This undertaking shall be governed by and construed in all respects in accordance with the laws of Norway. No rule of Law which would result in the application of any other Law on this undertaking shall apply.

 

d) Any claim arising out of or in connection with this undertaking shall be subject to the exclusive jurisdiction of the courts of Norway. Oslo shall be the exclusive venue for bringing suit. Injunctive relief and enforcement action in respect of any ruling by the courts of Norway may be sought in any competent court.

 

4

 

 

e) The parties hereto agree that irreparable damage would occur if any provision of this undertaking were not performed in accordance with the terms hereof and that the parties shall be entitled to an injunction or injunctions to prevent breaches of this undertaking or to enforce specifically the performance of the terms and provisions hereof. Such remedies will not be the exclusive remedies for any such breach but will be in addition to all other remedies available to the party.

 

f) The Shareholder consents to the disclosure of the existence and terms of this undertaking in any public announcement, filing with the SEC or other disclosure that is made or issued by either the Company, the Purchaser or any of their respective affiliates in connection with the Transaction.

 

g) Neither this undertaking nor any of the rights or obligations hereunder may be assigned by the parties hereto without the prior written consent of the other parties. Any attempted assignment in violation of this clause 4(g) shall be null and void. Subject to the preceding two sentences, this undertaking will be binding upon, inure to the benefit of and be enforceable by, the parties and their respective successors and assigns.

 

h) All notices and other communications to be given to any party hereunder shall be sufficiently given for all purposes hereunder if in writing and delivered by hand, courier or overnight delivery service, or three (3) days after being mailed by certified or registered mail, return receipt requested, with appropriate postage prepaid, or by e-mail transmission, and shall be directed to the address set forth below (or at such other address as such party shall designate by like notice):

 

If to Purchaser:

 

Alussa Energy Acquisition Corp.
PO Box 500, 71 Fort Street
Grand Cayman KY1-1106, Cayman Islands

Attention: Daniel Barcelo
Email: Daniel@alussaenergy.com

 

with a copy (which shall not constitute notice) to:

 

Skadden, Arps, Slate, Meagher & Flom (UK) LLP
40 Bank Street
London, United Kingdom E14 5DS

Attention: Danny Tricot
    Denis Klimentchenko
Email: danny.tricot@skadden.com
    denis.klimentchenko@skadden.com

 

If to the Company:

 

Freyr AS
Nytorget 1
8622 Mo i Rana, Norway

Attention: Chief Legal Officer
Email: contract-notifications@freyrbattery.com

 

5

 

 

with a copy (which shall not constitute notice) to:

 

Wilson, Sonsini, Goodrich & Rosati
28 State Street, 37th Floor

Boston, MA 02109-1700, United States

Attention: Mark Solakian and Mark Baudler
Email: msolakian@wsgr.com and MBaudler@wsgr.com

 

and

 

Advokatfirmaet BAHR AS
Tjuvholmen allé 16
0252 Oslo, Norway

Attention: John Christian Thaulow and Svein Gerhard Simonnaes
Email: jct@bahr.no and sgs@bahr.no

 

If to the Shareholder:

 

Address: [●]

 

Attention: [●]

 

Email: [●]

 

i) Any provision of this undertaking may be amended or waived if, and only if, such amendment or waiver is in writing and signed (a) in the case of an amendment, by the Purchaser, the Company and the Shareholder, and (b) in the case of a waiver, by the party or parties against whom the waiver is to be effective. No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege.

 

j) This undertaking may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This undertaking shall become effective from the date of this undertaking. No provision of this undertaking is intended to confer any rights, benefits, remedies, obligations, or liabilities hereunder upon any Person other than the parties hereto, and their respective successors and assigns.

 

 

[Signature page follows]

 

6

 

 

IN WITNESS WHEREOF, the parties hereto have caused this undertaking to be duly executed by their respective authorized officers as of the day and year first above written.

 

  Name of shareholder:   

 

  Number of Existing Shares:   

 

  By:  
    Name:
    Title:

 

 

  Alussa Energy Acquisition Corp.
   
  By:  
    Name:
    Title:

 

 

  FREYR AS
   
  By:  
    Name:
    Title:

 

 

[Signature page to Major Shareholder Irrevocable Voting Undertaking]

 

7

Exhibit 10.5

 

EXECUTION VERSION

 

PREFERRED SHARE ACQUISITION AGREEMENT

 

This PREFERRED SHARE ACQUISITION AGREEMENT (this “Agreement”) is entered into on January ___, 2021, by and between (i) Alussa Energy Acquisition Corp, a Cayman Islands exempted company (“Alussa”), (ii) FREYR Battery, a corporation in the form of a public limited liability company (société anonyme) incorporated under the laws of Luxembourg, registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés) (the “Company”), (iii) Norway Sub 1 AS, a corporation incorporated under the laws of Norway (“Norway Merger Sub 1”), (iv) Encompass Capital Master Fund LP (“Encompass Capital Master Fund”), a Cayman Islands company, BEMAP Master Fund Ltd., a Cayman Islands company (“BEMAP”), and Encompass Capital E L Master Fund L.P. (“Encompass Capital E L Master Fund”, and together with Encompass Capital Master Fund and BEMAP, the “Encompass Investors”, and each, an “Encompass Investor”).

 

WHEREAS, this Agreement is being entered into in connection with the Business Combination Agreement, dated as of the date hereof (as may be amended, supplemented or otherwise modified from time to time, including any exhibits and schedules thereto, the “Transaction Agreement”), between, among others, Alussa, the Company, FREYR AS, a corporation incorporated under the laws of Norway (“FREYR”), Norway Merger Sub 1, Norway Sub 2 AS, a limited liability company incorporated under the laws of Norway (“Norway Merger Sub 2”), Adama Charlie Sub, an exempted company incorporated under the laws of the Cayman Islands (“Cayman Merger Sub”) and the other parties thereto, pursuant to which, among other things, (i) Alussa will merge with and into Cayman Merger Sub, with Alussa as the surviving company of such merger, (ii) FREYR will transfer its wind farm business to Sjonfjellet Vindpark Holding AS (“SVHAS”), a corporation to be incorporated under the laws of Norway by way of a demerger resulting in such business becoming held by its shareholders through such company, (iii) FREYR will merge with and into Norway Merger Sub 2, with Norway Merger Sub 2 as the surviving company of such merger and (iv) Norway Merger Sub 1 will merge with and into the Company, with the Company as the surviving company of such merger, and after giving effect to all the transactions, the surviving companies of the transactions contemplated by (i), (ii) and (iii) will be wholly-owned subsidiaries of the Company, with the exception of SVHAS, which will be a separate stand-alone entity, on the terms and subject to the conditions therein (the “Transaction”);

 

WHEREAS, in connection with the Transaction, the Company is seeking commitments from interested investors to purchase, prior to the closing of the Transaction, the Company’s ordinary shares, par value $0.01 per share (the “PIPE Shares”), in a private placement for a purchase price of $10.00 per share (the “Per Share Subscription Price”);

 

WHEREAS, in connection with such private placement, each Encompass Investor has entered into a subscription agreement (the “Encompass Subscription Agreement”) with the Company and Alussa pursuant to which it agreed to subscribe for PIPE Shares for an aggregate purchase price of $5,250,000 (the “Subscription Amount”);

 

WHEREAS, substantially concurrently with the execution of this Agreement and the Encompass Subscription Agreement, the Company and Alussa are entering into separate subscription agreements (collectively, the “Other Subscription Agreements”) with certain investors (other than the Encompass Investors) with an aggregate purchase price of $600,000,000 (inclusive of the Subscription Amount) (the “PIPE Investment”).

 

WHEREAS, Encompass Capital Master Fund and BEMAP are the holders of 7,500,000 convertible preferred shares of FREYR (the “First Tranche FREYR Preferred Shares”) and 92,500,000 warrants to subscribe for common shares of FREYR (the “First Tranche FREYR Warrants”); and each Encompass Investor has agreed with FREYR, pursuant to the funding commitment letter, dated October 23, 2020, as amended by that certain Side Letter dated November 19, 2020, that certain Side Letter dated the date hereof and as otherwise amended or supplemented from time to time, between the Encompass Investors and FREYR (the “Funding Commitment Letter”), to subscribe for additional convertible preferred shares of FREYR, aggregating to 7,500,000 convertible preferred shares (assuming such issuance occurs, the “Second Tranche FREYR Preferred Shares”, and, together with the First Tranche FREYR Preferred Shares the “FREYR Preferred Shares”), and subject to an acquisition by the Encompass Investors of the Second Tranche FREYR Preferred Shares, FREYR and the Encompass Investors have agreed to cancel the First Tranche FREYR Warrants and issue 92,500,000 new warrants to the Encompass Investors (assuming such issuance occurs, the “FREYR Warrants”). For purposes of this Agreement, “FREYR Preferred Shares” shall also include any additional convertible preferred shares of FREYR or, if applicable, ordinary shares of FREYR issued by FREYR as a result of the conversion of FREYR Preferred Shares or FREYR Warrants, which any of the Encompass Investors may acquire between the date of this Agreement and Closing (as defined below) pursuant to the Funding Commitment Letter. For purposes of this Agreement, “FREYR Warrants” shall also include, (i) if applicable, any additional or substitute warrants to subscribe for common shares of FREYR which any of the Encompass Investors may acquire between the date of this Agreement and Closing; and (ii) if the Second Tranche FREYR Preferred Shares are never issued and, accordingly, the First Tranche FREYR Warrants never cancelled, then “FREYR Warrants” shall refer to the First Tranche FREYR Warrants and any additional or substitute warrants referred to in limb (i) above.

 

 

 

 

WHEREAS, in connection with the Transaction, each FREYR Preferred Share and each FREYR Warrant issued and outstanding immediately before the Norway Effective Time (as defined in the Transaction Agreement) will be automatically converted into one convertible preferred share of Norway Merger Sub 1 (each, a “Preferred Share”) and one warrant to subscribe for one common share of Norway Merger Sub 1 (each a “Warrant”).

 

WHEREAS, the Encompass Investors and the Company wish to consummate a transaction pursuant to which all of the Preferred Shares and Warrants held by the Encompass Investors or their Affiliates will be contributed in kind to the Company against such number of newly issued ordinary shares of the Company, par value $0.01 per share as provided in Clause 1(a) below (such newly issued ordinary shares, the “Shares”).

 

WHEREAS, in accordance with the Transaction Agreement, upon completion of the Cross-Border Merger (as defined in the Transaction Agreement), the Warrants shall be cancelled.

 

NOW, THEREFORE, in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth herein, and intending to be legally bound hereby, each of the Encompass Investors, the Company, Alussa and Norway Merger Sub 1 acknowledges and agrees as follows:

 

1. Transactions.

 

(a) Each of the Encompass Investors hereby agrees, severally and not jointly, to contribute in kind to the Company, and the Company agrees to acquire from each of the Encompass Investors, all of the Preferred Shares and Warrants held by each such Encompass Investor or any of their Affiliates at Closing, in exchange for a number of Shares in the aggregate equal to the Base Consideration divided by the Per Share Subscription Price, on the terms and subject to the conditions provided for herein. “Base Consideration” shall equal $7,447,500, provided that if any of the Encompass Investors, individually or in the aggregate, acquires the Second Tranche FREYR Preferred Shares, then “Base Consideration” shall equal $14,895,000.

 

(b) The Encompass Investors, Norway Merger Sub 1 and Pubco acknowledge and agree that, upon completion of the Cross-Border Merger, all of the Warrants contributed by the Encompass Investors and their Affiliates to the Company shall be cancelled.

 

2. Closing.

 

(a) The closing of the contribution of the Preferred Shares and Warrants contemplated hereby (the “Closing”) shall occur on the same date as, but immediately following the consummation of the Norway Merger (as defined in the Transaction Agreement) and immediately prior to the Cross-Border Merger (as defined in the Transaction Agreement) (the “Closing Date”).

 

(b) At least seven (7) business days before the anticipated Closing Date, the Company shall deliver written notice to each Encompass Investor (if applicable) (the “Closing Notice”) specifying: (i) the anticipated Closing Date and (ii) that the Company reasonably expects all conditions to closing of the Transaction to be satisfied or waived prior to or on the anticipated Closing Date. Upon satisfaction (or, if applicable, waiver) of the conditions set forth in Section 3, (i) at or prior to Closing, (A) each Encompass Investor shall perform its obligations under Schedule B, Part 1 appended hereto, and (B) the Company shall perform its obligations under Schedule B, Part 2 appended hereto and shall issue the Shares to the Encompass Investors and subsequently cause the Shares to be registered in book entry form, free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities laws or as set forth herein), in the name of each such Encompass Investor (or its nominee in accordance with its delivery instructions), and (ii) as promptly as practicable after the Closing (but in no event more than two (2) business days thereafter), the Company shall deliver, or cause to be delivered, evidence from the Company’s transfer agent (the “Transfer Agent”) of the issuance to each such Encompass Investor of its appropriate number of the Shares on and as of the Closing Date.

 

2

 

 

(c) Prior to or at the Closing, each Encompass Investor shall deliver to the Company a duly completed and executed Internal Revenue Service Form W-9 or appropriate Form W-8.

 

(d) For purposes of this Agreement, “business day” shall mean a day, other than a Saturday, Sunday or other day on which commercial banks in New York, New York, Oslo, Norway, the Cayman Islands or Luxembourg are authorized or required by law to close.

 

3. Closing Conditions.

 

(a) The obligation of the parties hereto to consummate the transactions contemplated pursuant to this Agreement is subject to the following conditions: (i) there shall not be in force any injunction or order enjoining or prohibiting, or any proceeding seeking to enjoin or prohibit, the transactions contemplated pursuant to this Agreement and (ii) all conditions precedent to the consummation of the Transaction set forth in the Transaction Agreement shall have been satisfied or waived (other than those conditions which, by their nature, are to be satisfied at the applicable closing date under the Transaction Agreement, but subject to the satisfaction or waiver of such conditions as of the closing of the Transaction) and the closing of the Transaction shall occur substantially concurrently with the Closing.

 

(b) The obligation of the Company to consummate the transactions with each Encompass Investor contemplated pursuant to this Agreement is also subject to the satisfaction or waiver by the Company and Alussa of the following additional conditions that, on the Closing Date:

 

(i) all representations and warranties of such Encompass Investor contained in this Agreement shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true in all respects) at and as of the Closing Date (except for representations and warranties made as of a specific date, which shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true in all respects) as of such date); and

 

(ii) such Encompass Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by it at or prior to Closing.

 

(c) The obligation of each Encompass Investor to consummate the transactions contemplated pursuant to this Agreement is also subject to the satisfaction or waiver by each such Encompass Investor of the following additional conditions that, on the Closing Date:

 

(i) all representations and warranties of the Company and Alussa contained in this Agreement shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein), which representations and warranties shall be true in all respects) at and as of the Closing Date (except for representations and warranties made as of a specific date, which shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect, which representations and warranties shall be true in all respects) as of such date);

 

3

 

 

(ii) the Company and Alussa shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company and Alussa at or prior to Closing;

 

(iii) (A) the Transaction Agreement (as the same exists on the date of this Agreement) shall not have been modified, waived or amended to materially adversely affect any Encompass Investor (in its capacity as such), and (B) Section 12.2(c) of the Transaction Agreement (as the same exists on the date of this Agreement) shall not have been modified, waived or amended in any material respect, in each case of clauses (A) and (B), without having received the Encompass Investors’ prior written consent;

 

(iv) the Company shall not have entered into any Other Subscription Agreement with a lower Per Share Subscription Price or, other than with respect to (A) the Other Subscription Agreement entered into with Spring Creek Capital, LLC (a subsidiary of Koch Industries, Inc.) or (B) certain settlement arrangements owing to regulatory constraints, other terms (economic or otherwise) substantively more favorable to such other subscriber or investor than as set forth in this Agreement; and

 

(v) the Shares shall have been approved for listing on the NYSE (as defined below) effective upon the closing of the Transaction (“Transaction Closing”).

 

(d) The Company shall use reasonable efforts to ensure the satisfaction of the conditions set out in: (i) Section 3(c) of this Agreement, and (ii) the Transaction Agreement. Each Encompass Investor shall use reasonable efforts to ensure the satisfaction of the conditions set out in Section 3(b) of this Agreement.

 

4. Further Assurances. At the Closing, the parties hereto shall execute and deliver such additional documents and take such additional actions as is reasonably deemed to be necessary in order to consummate the transactions contemplated by this Agreement; provided, that in no event shall any Encompass Investor be required hereunder to execute and deliver any lock-up or similar market standoff agreement or any other agreement restricting the transfer of the Shares issued pursuant to this Agreement.

 

5. Company and Alussa Representations and Warranties. With respect to Sections 5(a), (c), (d), (e), (g), (h), (i), (j), (k), (l), (m) and (o), each of Alussa and the Company jointly and severally represent and warrant to the Encompass Investors as of the date hereof and as of the Closing Date, and with respect to the remainder of this Section 5, the Company represents and warrants to the Encompass Investors, as of the date hereof and as of the Closing Date, that:

 

(a) The Company is a corporation in the form of a public limited liability company (société anonyme) duly incorporated and validly existing under the laws of Luxembourg. The Company has all power (corporate or otherwise) and authority to own, lease and operate its properties and conduct its business as presently and anticipated to be conducted and to enter into, deliver and perform its obligations under this Agreement. Alussa has been incorporated and is validly existing as a corporation under the laws of the Cayman Islands, with corporate power and authority to own, lease and operate its properties and conduct its business as presently and anticipated to be conducted and to enter into, deliver and perform its obligations under this Agreement.

 

4

 

 

(b) As of the Closing, the Shares will be duly authorized and, when issued and delivered to the Encompass Investors in accordance with the terms of this Agreement, the Shares will be validly issued, fully paid, non-assessable and free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities laws or as set forth herein), will rank pari passu in all respects with all other ordinary shares of the Company and will not have been issued in violation of or subject to any preemptive or similar rights created under the Company’s articles of association (as in effect at such time of issuance) or similar constitutive agreements, or under the laws of Luxembourg.

 

(c) Each of this Agreement, the Other Subscription Agreements, and the Transaction Agreement (the “Transaction Documents”) has been duly authorized, executed and delivered by each of Alussa and the Company and, assuming that each such Transaction Document constitutes a valid and binding obligation of the other parties thereto, is enforceable against each of the Company and Alussa in accordance with its respective terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, or (ii) principles of equity, whether considered at law or equity.

 

(d) The execution and delivery by the Company and Alussa of the Transaction Documents and the performance by the Company and Alussa of their respective obligations under the Transaction Documents, including the issuance and sale by the Company of the Shares pursuant to this Agreement and the consummation of the transactions contemplated herein and therein, do not and will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Company or Alussa or any of their respective subsidiaries pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the Company or Alussa or any of their respective subsidiaries is a party or by which the Company or Alussa or any of their respective subsidiaries is bound or to which any of the property or assets of the Company or Alussa is subject that does or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the business, financial condition or results of operations of the Company or Alussa or their respective subsidiaries, taken as a whole (a “Material Adverse Effect”), or impair the validity of the Shares or the legal authority of the Company or Alussa to comply in all material respects with their respective obligations under the Transaction Documents or impair or delay the ability of the Company or Alussa to timely perform their respective obligations under the Transaction Documents; (ii) result in any violation of any provision of the organizational documents of the Company or Alussa; or (iii) result in any violation of any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Company or Alussa or any of their respective properties that would reasonably be expected to have a Material Adverse Effect or impair the validity of the Shares or the legal authority of the Company or Alussa to comply in all material respects with its obligations under the Transaction Documents or impair or delay the ability of the Company or Alussa to timely perform their respective obligations under the Transaction Documents.

 

(e) Assuming the accuracy of the Encompass Investors’ representations and warranties set forth in Section 6 of this Agreement, neither the Company nor Alussa is required to obtain any material consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the issuance of the Shares pursuant to this Agreement, other than (i) filings with the U.S. Securities and Exchange Commission (the “SEC”), (ii) filings required by applicable state or federal securities laws, (iii) the filings required in accordance with Section 12 of this Agreement; (iv) those required by the New York Stock Exchange (“NYSE”), and (v) those required to consummate the Transaction as provided under the Transaction Agreement.

 

(f) Assuming the accuracy of the Encompass Investors’ representations and warranties set forth in Section 6 of this Agreement, no registration under the Securities Act of 1933, as amended (the “Securities Act”), is required for the offer and sale of any of the Shares by the Company to any of the Encompass Investors.

 

(g) Neither the Company nor Alussa nor any person acting on their respective behalf has engaged or will engage in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with any offer or sale of the Shares in violation of the Securities Act.

 

5

 

 

(h) Neither the Company nor Alussa nor any person acting on their respective behalf is under any obligation to pay any broker’s fee or finder’s fee or commission in connection with the sale of the Shares other than to the Placement Agents (as defined below).

 

(i) Neither the Company nor Alussa nor any person acting on their respective behalf has taken any action, directly or indirectly, including making any offer or sale of any Company security or solicited any offers to buy any security in violation of the Securities Act or under circumstances that would cause the offer and sale of the Shares by the Company to any of the Encompass Investors contemplated hereby to fail to be entitled to the exemption from the registration requirements of the Securities Act (other than offers or sales of securities under an employee benefit plan as defined in Rule 405 under the Securities Act).

 

(j) Except for such matters as have not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect, there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority pending, or, to the knowledge of Alussa or the Company, threatened against Alussa, the Company or FREYR, or (ii) judgment, decree, injunction, ruling or order of any governmental entity or arbitrator outstanding against Alussa, the Company or FREYR. Each of the Company, Alussa and FREYR has not received any written communication from a governmental authority that alleges that the Company, Alussa or FREYR is not in compliance with or in default or violation of any applicable law, except where such non-compliance, default or violation would not be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(k) Other than the Other Subscription Agreements and other than with respect to (A) the Other Subscription Agreement entered into with Spring Creek Capital, LLC (a subsidiary of Koch Industries, Inc.) and (B) certain settlement arrangements owing to regulatory constraints, neither Alussa nor the Company has entered into any side letter or similar agreement with any investor or subscriber in connection with such investor or subscriber’s direct or indirect investment in the Company, and such Other Subscription Agreements have not been amended in any material respect following the date of this Agreement and reflect the same Per Share Subscription Price and terms that are no more favorable to such investor or subscriber thereunder than the terms of this Agreement.

 

(l) As of their respective dates, all SEC Documents (as defined below) complied or will comply, in all material respects, with the requirements of the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the SEC promulgated thereunder. A copy of each form, report, statement, schedule, prospectus, proxy, registration statement and other document, if any, filed by Alussa or the Company with the SEC since Alussa’s initial registration of its Class A ordinary shares under the Exchange Act (the “SEC Documents”) is available to the undersigned via the SEC’s EDGAR system. None of the SEC Documents contained, when filed or, if amended, as of the date of such amendment with respect to those disclosures that are amended, any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. Each of Alussa and the Company has timely filed each report, statement, schedule, prospectus, and registration statement that Alussa or the Company (as applicable) was required to file with the SEC since Alussa’s initial registration of the Class A ordinary shares under the Exchange Act. The financial statements of Alussa and the Company included in the SEC Documents comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing and fairly present in all material respects the financial condition of Alussa and the Company (as applicable) as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments. There are no material outstanding or unresolved comments in comment letters from the staff of the Division of Corporation Finance of the SEC with respect to any of the SEC Documents. The description of the business and financial information of FREYR set forth in the investor presentation dated December 4, 2020 (as updated on January 26, 2021) made available to Investor by Alussa and FREYR prior to the execution of this Agreement (the “Investor Presentation”) shall be consistent and complete in all material respects with the description of the business and financial information of FREYR described or included in the proxy statement to be filed in connection with the approval of the Transaction Agreement by the applicable shareholders. The Investor Presentation shall not have not been amended in any material respect following the date of this Agreement.

 

6

 

 

(m) As of the date of this Agreement, and immediately prior to the First Closing Date (as defined in the Transaction Agreement), the authorized capital stock of Alussa consists of 200,000,000 Class A ordinary shares, $0.0001 par value, 20,000,000 Class B ordinary shares, $0.0001 par value, and 2,000,000 shares of undesignated preferred stock, $0.0001 par value. As of the date of this Agreement and for the period up to the exercise in full of any warrants issued by Alussa, the Company will have a sufficient number of authorized shares available to be issued upon exercise of such warrants. As of the date of this Agreement, the authorized capital stock of the Company consists of 40,000 fully paid redeemable shares with no nominal value, and such shares are duly authorized and validly issued, and are not subject to preemptive rights or encumbrances. As of the date of this Agreement, and immediately prior to Closing, except as set forth above and pursuant to (i) the Other Subscription Agreements and (ii) the Transaction Agreement, there are no outstanding (1) shares, equity interests or voting securities of the Company, (2) securities of the Company convertible into or exchangeable for shares or other equity interests or voting securities of the Company, (3) options, warrants or other rights (including preemptive rights) or agreements, arrangements or commitments of any character, whether or not contingent, of the Company to acquire from any individual, entity or other person, and no obligation of the Company to issue, any shares or other equity interests or voting securities of the Company (collectively, the “Equity Interests”) or securities convertible into or exchangeable or exercisable for Equity Interests. As of the date of this Agreement, other than Cayman Merger Sub, the Company has no subsidiaries and does not own, directly or indirectly, interests or investments (whether equity or debt) in any person, whether incorporated or unincorporated. There are no stockholder agreements, voting trusts or other agreements or understandings to which the Company is a party or by which it is bound relating to the voting of any securities of the Company, other than (A) as set forth in the SEC Documents and (B) as contemplated by the Transaction Agreement. Except as disclosed in the SEC Documents and other than expenses incurred in connection with the transactions contemplated by the Transaction Documents, the Company had no outstanding indebtedness and will not have any outstanding long-term indebtedness as of immediately prior to the Closing.

 

(n) Upon consummation of the Transaction, the issued and outstanding ordinary shares of the Company will be registered pursuant to Section 12(b) of the Exchange Act and will be listed for trading on the NYSE.

 

(o) Neither the Company nor Alussa is, and immediately after receipt of payment for the Shares the Company will not be, subject to registration as an “investment company” under the Investment Company Act of 1940, as amended.

 

(p) The issued and outstanding Class A ordinary shares of Alussa are registered pursuant to Section 12(b) of the Exchange Act and are listed on the NYSE under the symbol “ALUS”. There is no suit, action, proceeding, or investigation pending, or to the knowledge of Alussa, threatened against Alussa by the NYSE or the SEC with respect to any intention by such entity to deregister the Class A ordinary shares of Alussa or prohibit or terminate the listing of such shares on the NYSE. Alussa has taken no action that is designed to terminate the registration of Alussa under the Exchange Act. Prior to the First Closing Date, no suspension of the qualification of Alussa’s Class A ordinary shares for offering or sale or trading on the NYSE, or initiation or threatening of any proceedings for any of such purposes, shall have occurred.

 

(q) Each of Alussa and the Company is in compliance with all applicable laws, except where such non-compliance would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. As of the date hereof, neither Alussa nor the Company has received any written communication from a governmental authority that alleges that the Company or Alussa, as applicable, is not in compliance with or is in default or violation of any applicable law, except where such non-compliance, default or violation would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(r) As of the Closing Date, the Company will be a “foreign private issuer” (as defined in Rule 405) under the Securities Act.

 

(s) The Company is classified as a Subchapter C corporation for U.S. federal income tax purposes.

 

7

 

 

6. Encompass Investors Representations, Warranties and Acknowledgements. Each Encompass Investor, (I) with respect to Section 6(a), the first two sentences of Section 6(e) and Sections 6(g), (h), (j), (k), (l), (m), (p) and (q), represents and warrants to the Company and Alussa, and (II) with respect to the remainder of this Section 6, acknowledges, in each case of the foregoing clauses (I) and (II), as of the date hereof and as of the Closing Date, provided that representations and warranties concerning the Second Tranche FREYR Preferred Shares and the FREYR Warrants issued together with the issuance of the Second Tranche FREYR Preferred Shares are given as of the date of issuance and as of the Closing Date), that:

 

(a) Each Encompass Investor (i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an institutional “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3), (7) or (8) under the Securities Act), in each case, satisfying the applicable requirements set forth on Schedule A, (ii), if resident in a member state of the European Economic Area, is a “qualified investor” within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market (the “EU Prospectus Regulation”), (iii) if resident in the United Kingdom, is a “qualified investor” within the meaning of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the “UK Prospectus Regulation”), (iv) is acquiring the Shares only for its own account and not for the account of others, or if an Encompass Investor is acquiring the Shares as a fiduciary or agent for one or more investor accounts, such Encompass Investor has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account, and (v) is not acquiring the Shares with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the requested information set forth on Schedule A). Each Encompass Investor is not an entity formed for the specific purpose of acquiring the Shares and is an “institutional account” as defined by FINRA Rule 4512(c).

 

(b) Each Encompass Investor acknowledges and agrees that the Shares are being offered in a transaction not involving any public offering within the meaning of the Securities Act or any “offer of securities to the public” within the meaning of the EU Prospectus Regulation or the UK Prospectus Regulation, that the Shares have not been registered under the Securities Act and that the Company is not required to register the Shares except as set forth in Section 7 of this Agreement. Each Encompass Investor acknowledges and agrees that the Shares may not be offered, resold, transferred, pledged or otherwise disposed of by the Encompass Investors absent an effective registration statement under the Securities Act except (i) to the Company or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and, in each case, in accordance with any applicable securities laws of the states of the United States and other applicable jurisdictions, and that any certificates representing the Shares shall contain a restrictive legend to such effect. Each Encompass Investor acknowledges and agrees that the Shares will be subject to these securities law transfer restrictions and, as a result of these transfer restrictions, each Encompass Investor may not be able to readily offer, resell, transfer, pledge or otherwise dispose of the Shares and may be required to bear the financial risk of an investment in the Shares for an indefinite period of time. Each Encompass Investor acknowledges and agrees that the Shares will not immediately be eligible for offer, resale, transfer, pledge or disposition pursuant to Rule 144 promulgated under the Securities Act, and that the provisions of Rule 144(i) will apply to the Shares. Each Encompass Investor acknowledges and agrees that it has been advised to consult legal, tax and accounting advisors prior to making any offer, resale, transfer, pledge or disposition of any of the Shares.

 

(c) Each Encompass Investor acknowledges and agrees the Shares are issued to such Encompass Investor by the Company. Each Encompass Investor further acknowledges that there have been no representations, warranties, covenants and agreements made to such Encompass Investor by or on behalf of the Company, Alussa, FREYR, Norway Merger Sub 1, Norway Merger Sub 2, Cayman Merger Sub, or any of Credit Suisse Securities (USA) LLC, BTIG, LLC, Pareto Securities AS, SpareBank 1 Markets AS or Clarksons Platou Securities, Inc. (with their respective affiliates, each a “Placement Agent” and, collectively, the “the Placement Agents, any of their respective affiliates or any control persons, officers, directors, employees, agents or representatives of any of the foregoing or any other person or entity, expressly or by implication, other than those representations, warranties, covenants and agreements of the Company and Alussa expressly set forth in Section 5 of this Agreement and those representations, warranties, covenants and agreements made with or to such Encompass Investor pursuant to the Ancillary Transaction Agreements. Each Encompass Investor acknowledges that certain information provided by the Company, FREYR or Alussa was based on projections, and such projections were prepared based on assumptions and estimates that are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections. For purposes of this Agreement, “Ancillary Transaction Agreements” shall mean the Funding Commitment Letter and the Encompass Subscription Agreement.

 

8

 

 

(d) Each Encompass Investor acknowledges and agrees that it has received such information as it deems necessary in order to make an investment decision with respect to the Shares, including, with respect to the Company, Alussa, the Transaction and the business of FREYR and its subsidiaries. Without limiting the generality of the foregoing, each Encompass Investor acknowledges that it has had the opportunity to review Alussa’s filings with the SEC. Each Encompass Investor acknowledges and agrees that such Encompass Investor and such Encompass Investor’s professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as such Encompass Investor and its professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Shares.

 

(e) Each Encompass Investor became aware of this offering of the Shares solely by means of direct contact between such Encompass Investor and the Company, Alussa or a representative of the Company or Alussa, or by means of contact from the Placement Agents, and the Shares were offered to the Encompass Investors solely by direct contact between such Encompass Investor and the Company, Alussa or a representative of the Company or Alussa. Each Encompass Investor did not become aware of this offering of the Shares, nor were the Shares offered to such Encompass Investor, by any other means. Each Encompass Investor acknowledges that its Shares (i) were not offered to it by any form of general solicitation or general advertising and (ii) are not being offered to it in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws. Each Encompass Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including, without limitation, the Company, Alussa, the Placement Agents, any of their respective affiliates or any control persons, officers, directors, employees, agents or representatives of any of the foregoing), other than the representations and warranties of the Company or Alussa contained in Section 5 of this Agreement and those contained in the Ancillary Transaction Agreements, in making its investment or decision to invest in the Company.

 

(f) Each Encompass Investor acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares, including those set forth in Alussa’s filings with the SEC and the Investor Presentation. Each Encompass Investor has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Shares, and each Encompass Investor has sought such accounting, legal and tax advice as such Encompass Investor has considered necessary to make an informed investment decision. Each Encompass Investor acknowledges that it shall be responsible for any of its tax liabilities that may arise as a result of the transactions contemplated by this Agreement, and that neither the Company nor Alussa has provided any tax advice or any other representation or guarantee regarding the tax consequences of the transactions contemplated by the Agreement.

 

(g) Alone, or together with any professional advisor(s), each Encompass Investor has adequately analyzed and fully considered the risks of an investment in the Shares and determined that the Shares are a suitable investment for such Encompass Investor and that it is able at this time and in the foreseeable future to bear the economic risk of a total loss of such Encompass Investor’s investment in the Company. Each Encompass Investor acknowledges specifically that a possibility of total loss exists.

 

(h) In making its decision to acquire the Shares, each Encompass Investor has relied solely upon independent investigation made by such Encompass Investor, the Investor Presentation and the representations and warranties made by Alussa and the Company in Section 5 and as applicable, the Ancillary Transaction Agreements. Without limiting the generality of the foregoing, each Encompass Investor has not relied on any statements by or on behalf of the Placement Agents or any of their respective affiliates or any control persons, officers, directors, employees, agents or representatives of any of the foregoing concerning the Company, Alussa, FREYR, the Transaction, the Transaction Agreement, this Agreement or the transactions contemplated hereby or thereby, the Shares or the offer and sale of the Shares other than the representations and warranties of the Company contained in Section 5 of this Agreement and those contained in the Ancillary Transaction Agreements.

 

9

 

 

(i) Each Encompass Investor acknowledges and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Shares or made any findings or determination as to the fairness of this investment.

 

(j) Each Encompass Investor has been duly formed or incorporated and is validly existing and is in good standing under the laws of its jurisdiction of formation or incorporation, with power and authority to enter into, deliver and perform its obligations under this Agreement.

 

(k) The execution, delivery and performance by each Encompass Investor of this Agreement are within the powers of such Encompass Investor, have been duly authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation of any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which such Encompass Investor is a party or by which such Encompass Investor is bound that would reasonably be expected to have a material adverse effect on the legal authority of such Encompass Investor to comply in all material respects with the terms of this Agreement, and will not violate any provisions of such Encompass Investor’s organizational documents, including, without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable. The signature of each Encompass Investor on this Agreement is genuine, and the signatory has been duly authorized to execute this Agreement, and, assuming that this Agreement constitutes the valid and binding agreement of the Company, Norway Merger Sub 1 and Alussa, this Agreement constitutes a legal, valid and binding obligation of such Encompass Investor, enforceable against such Encompass Investor in accordance with its terms except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

(l) None of the Encompass Investors nor any of their respective officers, directors, managers, managing members, general partners or any other person acting in a similar capacity or carrying out a similar function, is (i) a person named on the Specially Designated Nationals and Blocked Persons List, the Foreign Sanctions Evaders List, the Sectoral Sanctions Identification List, or any other similar list of sanctioned persons administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”), or any similar list of sanctioned persons administered by the United Kingdom, the European Union or any individual European Union member state (collectively, “Sanctions Lists”); (ii) directly or indirectly owned or controlled by, or acting on behalf of, one or more persons on a Sanctions List; (iii) organized, incorporated, established, located, resident or born in, or a citizen, national, or the government, including any political subdivision, agency, or instrumentality thereof, of, Cuba, Iran, North Korea, Syria, Venezuela, the Crimea region of Ukraine, or any other country or territory embargoed by the United States, the United Kingdom, the European Union or any individual European Union member state; (iv) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515; or (v) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank (collectively, a “Prohibited Investor”). Each Encompass Investor represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.) (the “BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the “BSA/PATRIOT Act”), that it maintains policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. Each Encompass Investor maintains policies and procedures reasonably designed to ensure compliance with sanctions and export control laws in each of the jurisdictions in which it operates. Each Encompass Investor maintains policies and procedures reasonably designed to ensure that the funds held by such Encompass Investor are legally derived.

 

10

 

 

(m) If the applicable Encompass Investor is or is acting on behalf of (i) an employee benefit plan that is subject to Title I of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), (ii) a plan, an individual retirement account or other arrangement that is subject to Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”), (iii) an entity whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement described in clauses (i) and (ii) (each, an “ERISA Plan”), or (iv) an employee benefit plan that is a governmental plan (as defined in Section 3(32) of ERISA), a church plan (as defined in Section 3(33) of ERISA), a non-U.S. plan (as described in Section 4(b)(4) of ERISA) or other plan that is not subject to the foregoing clauses (i), (ii) or (iii) but may be subject to provisions under any other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of ERISA or the Code (collectively, “Similar Laws,” and together with ERISA Plans, “Plans”), such Encompass Investor represents and warrants that (A) neither the Company nor, to each Encompass Investor’s knowledge, any of its affiliates has provided investment advice or has otherwise acted as the Plan’s fiduciary, with respect to its decision to acquire and hold the Shares, and, to each Encompass Investor’s knowledge, none of the parties to the Transaction is or shall at any time be the Plan’s fiduciary with respect to any decision in connection with the Investor’s investment in the Shares; and (B) its purchase of the Shares will not result in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code, or any applicable Similar Law.

 

(n) Other than the Investor Presentation, each Encompass Investor acknowledges that it has been informed that no disclosure or offering document has been prepared by the Company, Alussa or any of their respective affiliates or representatives in connection with the offer and sale of the Shares.

 

(o) Each Encompass Investor acknowledges that it has been informed that none of the Placement Agents, nor any of their respective affiliates, nor any control persons, officers, directors, employees, agents or representatives of any of the foregoing has made or makes any representation or warranty, whether express or implied, of any kind or character and have not provided any advice or recommendation with respect to the Company, Alussa, FREYR or its subsidiaries or any of their respective businesses, or the Shares or the accuracy, completeness or adequacy of any information supplied to such Encompass Investor by the Company.

 

(p) In connection with the issue and acquisition of the Shares, none of the Placement Agents have acted as any Encompass Investor’s financial advisor or fiduciary.

 

(q) Subject to the merger involving Norway Merger Sub 1, each Encompass Investor owns good and valid title to its respective FREYR Preferred Shares and FREYR Warrants (free and clear of any and all liens) or Preferred Shares and Warrants, as applicable, and there are no proxies, voting rights, shareholders’ agreements or other agreements to which an Encompass Investor is a party or by which such Encompass Investor is bound, with respect to the voting or transfer of any of such Encompass Investor’s FREYR Preferred Shares and FREYR Warrants (other than this Agreement and the Transaction Agreement).

 

11

 

 

7. Registration Rights.

 

(a) The Company agrees that, within thirty (30) calendar days following the Closing Date (such deadline, the “Filing Deadline”), the Company will submit to or file with the SEC a registration statement for a shelf registration on Form S-1 or Form S-3 (if the Company is then eligible to use a Form S-3 shelf registration) (the “Registration Statement”), in each case, covering the resale of all of the Shares acquired by the Encompass Investors pursuant to this Agreement (determined as of two (2) business days prior to such submission or filing) (the “Registrable Shares”) and the Company shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) the 90th calendar day following the Closing Date and (ii) the 10th business day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the Registration Statement will not be “reviewed” or will not be subject to further review (such earlier date, the “Effectiveness Deadline”); provided, however, that the Company’s obligations to include the Registrable Shares in the Registration Statement are contingent upon the applicable Encompass Investor furnishing in writing to the Company such information regarding such Encompass Investor, the securities of the Company held by such Encompass Investor and the intended method of disposition of the Registrable Shares (which shall be limited to non-underwritten public offerings) as shall be reasonably necessary and requested by the Company to effect the registration of the Registrable Shares, and each Encompass Investor shall execute such documents in connection with such registration as the Company may reasonably request that are customary of a selling shareholder in similar situations, including providing that the Company shall be entitled to postpone and suspend the effectiveness or use of the Registration Statement, if applicable, during any customary blackout or similar period or as permitted hereunder; provided that each Encompass Investor shall not in connection with the foregoing be required to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer the Registrable Shares. For as long as any Encompass Investor holds Shares, the Company will use commercially reasonable efforts to file all reports for so long as the condition in Rule 144(c)(1) (or Rule 144(i)(2), if applicable) is required to be satisfied, and provide all customary and reasonable cooperation, necessary to enable the undersigned to resell the Shares pursuant to Rule 144 of the Securities Act (in each case, when Rule 144 of the Securities Act becomes available to the Encompass Investors). Any failure by the Company to file the Registration Statement by the Filing Deadline or to effect such Registration Statement by the Effectiveness Deadline shall not otherwise relieve the Company of its obligations to file or effect the Registration Statement as set forth above in this Section 7. In no event shall the Encompass Investors or any affiliate of the Encompass Investors be identified as a statutory underwriter in the Registration Statement; except that, if the Encompass Investors or any affiliate of the Encompass Investors is required by the SEC to be identified as a statutory underwriter in the Registration Statement, the Company will provide reasonable advance notice to the Encompass Investors of such requirement and the Encompass Investors may, in its sole discretion, elect not to include all or a portion of its Shares in the Registration Statement (and such election shall not be considered a breach of this Agreement by the Company). Notwithstanding the foregoing, if the SEC prevents the Company from including any or all of the shares proposed to be registered under the Registration Statement due to limitations on the use of Rule 415 of the Securities Act for the resale of the Shares by the applicable shareholders or otherwise, the Company shall give each of the Encompass Investors prompt written notice thereof and such Registration Statement shall register (by amendment or otherwise) for resale such number of Shares which is equal to the maximum number of Shares as is permitted by the SEC. In such event, the number of Shares to be registered for each selling shareholders named in the Registration Statement shall be reduced pro rata among all such selling shareholders. In the event the Company amends the Registration Statement in accordance with the foregoing, the Company will use its commercially reasonable efforts to file with the SEC, as promptly as allowed by the SEC, one or more registration statements to register the resale of those Registrable Shares that were not registered on the initial Registration Statement, as so amended. All fees and expenses (i) incident to the performance of, or compliance with, this Section 7, or (ii) related to any threatened or actual litigation against any of the Encompass Investors in connection with any alleged breach of the Subscription Agreement or U.S. securities laws, in each case by the Company, shall be borne by the Company.

 

12

 

 

(b) At its expense the Company shall:

 

(i) except for such times as the Company is permitted hereunder to suspend the use of the prospectus forming part of a Registration Statement, use its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state securities laws which the Company determines to obtain, continuously effective with respect to each Encompass Investor, and to keep the applicable Registration Statement or any subsequent shelf registration statement free of any material misstatements or omissions, until the earlier of the following: (A) the Encompass Investors cease to hold any Registrable Shares, (B) the date all Registrable Shares held by the Encompass Investors may be sold without restriction under Rule 144, including without limitation, any volume and manner of sale restrictions which may be applicable to affiliates under Rule 144 and without the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable), and (C) three years from the date of effectiveness of the Registration Statement;

 

(ii) advise each of the Encompass Investors, as expeditiously as possible:

 

(1) when a Registration Statement or any amendment thereto has been filed with the SEC or has become effective;

  

(2) after the issuance by the SEC of any stop order suspending the effectiveness of any Registration Statement or the initiation of any proceedings for such purpose;

 

(3) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable Shares included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and

 

(4) subject to the provisions in this Agreement, of the occurrence of any event that requires the making of any changes in any Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made) not misleading.

 

Notwithstanding anything to the contrary set forth herein, the Company shall not, when so advising the Encompass Investors of such events, provide each of the Encompass Investors with any material, nonpublic information regarding the Company other than to the extent that providing notice to the Encompass Investors of the occurrence of the events listed in (1) through (4) above might constitute material, nonpublic information regarding the Company;

 

(iii) use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement as soon as reasonably practicable;

 

(iv) upon the occurrence of any event contemplated in Section 7(b)(ii)(4) above, except for such times as the Company is permitted hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, the Company shall use its commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the Registrable Shares included therein, such prospectus will not include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;

 

(v) use its commercially reasonable efforts to cause all Registrable Shares to be listed on the NYSE;

 

(vi) allow each Encompass Investor to review and consent to disclosure specifically regarding such Encompass Investor in the Registration Statement on reasonable advance notice (which consent shall not be unreasonably withheld);

 

13

 

 

(vii) if the SEC shall at any time object to the inclusion of Registrable Shares in the Registration Statement, give prompt notice to the Investor and its counsel and give them fair and reasonable time (but, in any event, at least three (3) business days) to respond and discuss with the Company, prior to answering the SEC or agreeing to the exclusion of such Registrable Shares from the Registration Statement; and

 

(viii) otherwise, cooperate reasonably with, and take such customary actions as may reasonably be requested by such Encompass Investor, consistent with the terms of this Agreement, in connection with the registration of the Registrable Shares.

  

(c) Notwithstanding anything to the contrary in this Agreement, the Company shall be entitled to delay the filing or effectiveness of, or suspend the use of, the Registration Statement if it reasonably determines that (i) in order for the Registration Statement not to contain a material misstatement or omission, an amendment thereto would be needed; (ii) the negotiation or consummation of a transaction by the Company or its subsidiaries is pending or an event has occurred, which negotiation, consummation or event the Company’s board of directors reasonably believes would require additional disclosure by the Company in the Registration Statement of material information that the Company has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Registration Statement would be expected, in the reasonable determination of the Company’s board of directors to cause the Registration Statement to fail to comply with applicable disclosure requirements, or (iii) in the reasonable judgment of the majority of the Company’s board of directors, such filing or effectiveness or use of such Registration Statement, would be seriously detrimental to the Company and the majority of the Company board of directors concludes as a result that it is essential to defer such filing (each such circumstance, a “Suspension Event”); provided, however, that the Company may not delay or suspend the Registration Statement on more than two (2) occasions or for more than sixty (60) consecutive calendar days, or more than ninety (90) total calendar days in each case during any twelve-month period. The Company shall not, when so advising any of the Encompass Investors of such Suspension Event, provide the Encompass Investors with any material, nonpublic information regarding the Company other than to the extent that providing notice to any of the Encompass Investors of the occurrence of the Suspension Event might constitute material, nonpublic information regarding the Company. Upon receipt of any written notice from the Company of the happening of any Suspension Event during the period that the Registration Statement is effective or if as a result of a Suspension Event the Registration Statement or related prospectus contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein (in light of the circumstances under which they were made, in the case of the prospectus) not misleading, each Encompass Investor agrees that it will immediately discontinue offers and sales of the Registrable Shares under the Registration Statement (excluding, for the avoidance of doubt, sales conducted pursuant to Rule 144) until such Encompass Investor receives copies of a supplemental or amended prospectus (which the Company agrees to promptly prepare) that corrects the misstatement(s) or omission(s) referred to above and receives notice that any post-effective amendment has become effective or unless otherwise notified by the Company that it may resume such offers and sales. If so directed by the Company, each Encompass Investor will deliver to the Company or, in each Encompass Investor’s sole discretion destroy, all copies of the prospectus covering the Registrable Shares in such Encompass Investor’s possession; provided, however, that this obligation to deliver or destroy all copies of the prospectus covering the Registrable Shares shall not apply (A) to the extent such Encompass Investor is required to retain a copy of such prospectus (1) in order to comply with applicable legal, regulatory, self-regulatory or professional requirements or (2) in accordance with a bona fide pre-existing document retention policy or (B) to copies stored electronically on archival servers as a result of automatic data back-up.

 

(d) Indemnification.

 

(i) The Company shall, notwithstanding any termination of this Agreement, indemnify, defend and hold harmless, to the extent permitted by law, each Encompass Investor, its directors, officers, members, stockholders, partners, agents, brokers, investment advisors and employees, and each person who controls such Encompass Investor (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the directors, officers, members, stockholders, partners, agents, brokers, investment advisors and employees of each such controlling person, to the fullest extent permitted by law, from and against all losses, claims, damages, liabilities, costs and expenses (including, without limitation, reasonable and documented outside attorneys’ fees) (collectively, “Losses”) that arise out of, are based upon, or caused by any untrue or alleged untrue statement of material fact contained in any Registration Statement, prospectus included in any Registration Statement (“Prospectus”) or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, in the light of the circumstances under which they were made) not misleading, except insofar as the same are based upon, or caused by, or contained in any information or affidavit so furnished in writing to the Company by or on behalf of such Encompass Investor expressly for use therein.

 

14

 

 

(ii) In connection with any Registration Statement in which an Encompass Investor is participating, such Encompass Investor shall furnish (or cause to be furnished) to the Company in writing such necessary information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and officers and each person or entity who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including, without limitation, reasonable and documented outside attorneys’ fees) resulting from any untrue statement of material fact contained or incorporated by reference in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, in the light of the circumstances under which they were made) not misleading, but only to the extent that such untrue statement or omission is contained (or not contained in, in the case of an omission) in any information or affidavit so furnished in writing by on behalf of such Encompass Investor expressly for use therein; provided, however, that the liability of each such Encompass Investor shall be several and not joint with any other investor and shall be limited to the net proceeds received by such Encompass Investor from the sale of Registrable Shares giving rise to such indemnification obligation.

 

(iii) Any person or entity entitled to indemnification herein shall (A) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s or entity’s right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (B) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement includes a statement or admission of fault and culpability on the part of such indemnified party or which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

 

(iv) The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director, member, stockholder, agent, employee or controlling person of such indemnified party and shall survive the transfer of securities.

 

15

 

 

(v) If the indemnification provided under this Section 7(d) from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any Losses, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such Losses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations; provided, however, the liability of an Encompass Investor shall be limited to the net proceeds received by such Encompass Investor from the sale of Registrable Shares giving rise to such indemnification obligation. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by (or not made by, in the case of an omission), or relates to information supplied by (or not supplied by, in the case of an omission), such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the Losses referred to above shall be deemed to include, subject to the limitations set forth in Sections 7(d)(i), (ii) and (iii) above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 7(d)(v) from any person or entity who was not guilty of such fraudulent misrepresentation.

 

8. Termination. This Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (i) such date and time as the Transaction Agreement is terminated in accordance with its terms, (ii) upon the mutual written agreement of each of the parties hereto to terminate this Agreement, (iii) if the conditions to Closing set forth in Section 3 of this Agreement are not satisfied, or are not capable of being satisfied, or waived on or prior to the Closing Date and, as a result thereof, the transactions contemplated by this Agreement will not be or are not consummated at the Closing Date and (iv) July 31, 2021; provided that nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from any such willful breach. The Company shall notify the Encompass Investors of the termination of the Transaction Agreement promptly after the termination of such agreement.

 

9. Trust Account Waiver. Each Encompass Investor acknowledges that Alussa is a blank check company with the powers and privileges to effect a merger, asset acquisition, reorganization or similar business combination involving Alussa and one or more businesses or assets. Each Encompass Investor further acknowledges that, as described in Alussa’s prospectus relating to its initial public offering dated November 25, 2019 (the “Prospectus”) available at www.sec.gov, substantially all of Alussa’s assets consist of the cash proceeds of Alussa’s initial public offering and private placement of its securities, and substantially all of those proceeds have been deposited in a trust account (the “Trust Account”) for the benefit of Alussa, its public shareholders and the underwriters of Alussa’s initial public offering. Except with respect to interest earned on the funds held in the Trust Account that may be released to Alussa to pay its tax obligations, if any, the cash in the Trust Account may be disbursed only for the purposes set forth in the Prospectus. For and in consideration of Alussa entering into this Agreement, the receipt and sufficiency of which are hereby acknowledged, each Encompass Investor hereby irrevocably waives any and all right, title and interest, or any claim of any kind it has or may have in the future, in or to any monies held in the Trust Account, and agrees not to seek recourse against the Trust Account, as a result of, or arising out of, this Agreement; provided however, that nothing in this Section 9 shall be deemed to limit any Encompass Investor’s right to distributions from the Trust Account in accordance with Alussa’s amended and restated certificate of incorporation in respect of Class A ordinary shares of Alussa acquired by any means other than pursuant to this Agreement.

 

10. Miscellaneous.

 

(a) Neither this Agreement nor any rights that may accrue to any of the Encompass Investors hereunder (other than the Shares acquired hereunder, if any, and the rights under Section 7, which shall inure to the benefit of any transferee of Registrable Shares) may be transferred or assigned without the Company’s and Alussa’s written consent, other than an assignment to any affiliate of any Encompass Investor or any fund or account managed by the same investment manager as any Encompass Investor or an affiliate thereof, subject to, if such transfer or assignment is prior to the Closing, such transferee or assignee, as applicable, executing a joinder to this Agreement or a separate subscription agreement in substantially the same form as this Agreement, including with respect to the terms and conditions; provided that, in the case of any such transfer or assignment, the initial party to this Agreement shall remain bound by its obligations under this Agreement in the event that the transferee or assignee, as applicable, does not comply with its obligations to consummate the transactions contemplated by this Agreement. Neither this Agreement nor any rights that may accrue to the Company or Alussa hereunder or any of the Company or Alussa’s obligations may be transferred or assigned.

 

16

 

 

(b) The Company and Alussa may request from each of the Encompass Investors such additional information as is necessary for the Company to comply with public disclosure requirements of applicable securities laws or any filing requirements pursuant to the rules of any stock exchange or the Financial Industry Regulatory Authority, and the appropriate Encompass Investor shall provide such information as may reasonably be requested. Each Encompass Investor acknowledges that the Company may file a copy of the form of this Agreement with the SEC as an exhibit to a current or periodic report or a registration statement of the Company.

 

(c) The Company shall use commercially reasonable efforts, if requested by the Investor, to (i) cause the removal of any restrictive legend set forth on the Shares and (ii) issue Shares without any such legend in certificated or book-entry form or by electronic delivery through The Depository Trust Company, at the Investor’s option, provided that in each case (a) such Shares are registered for resale under the Securities Act and the Investor has sold or proposes to sell such Shares pursuant to such registration, (b) the Investor has sold or transferred, or proposes to sell or transfer, Shares pursuant to Rule 144 and (c) the Company, its counsel or the Transfer Agent have received customary representations and other documentation from the Investor that is reasonably necessary to establish that restrictive legends are no longer required as reasonably requested by the Company, its counsel or the Transfer Agent.

 

(d) Each Encompass Investor acknowledges that the Company, Alussa, the Placement Agents (as third-party beneficiaries with rights of enforcement) and others will rely on the acknowledgments, understandings, agreements, representations and warranties of the Encompass Investors contained in this Agreement. Each of the Company and Alussa acknowledges that the Encompass Investor will rely on the acknowledgments, understandings, agreements, representations and warranties of the Company and Alussa contained in this Agreement. Prior to the Closing, each Encompass Investor agrees to promptly notify the Company, Alussa and the Placement Agents if any of the acknowledgments, understandings, agreements, representations and warranties of such Encompass Investor set forth herein are no longer accurate. Prior to the Closing, each of the Company and Alussa agrees to promptly notify the Encompass Investors if any of the acknowledgments, understandings, agreements, representations and warranties of the Company or Alussa set forth herein are no longer accurate.

 

(e) The Company, Alussa, the Placement Agents and the Encompass Investors are each entitled to rely upon this Agreement and each is irrevocably authorized to produce this Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.

 

(f) All of the representations and warranties contained in this Agreement shall survive the Closing. All of the covenants and agreements made by each party hereto in this Agreement shall survive the Closing.

 

(g) The obligations of each Encompass Investor under this Agreement are several and not joint with the obligations of any other Encompass Investor under this Agreement or the Encompass Subscription Agreement, or of any Other Investor under the Other Subscription Agreements. No Encompass Investor shall be responsible in any way for the performance of any other Encompass Investor or any Other Investor.

 

(h) This Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section 8 above) except by an instrument in writing, signed by each of the parties hereto. No failure or delay of any party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the parties and third-party beneficiaries hereunder are cumulative and are not exclusive of any rights or remedies that they would otherwise have hereunder.

 

17

 

 

(i) This Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof. Except as set forth in Sections 7(d), 10(c) and 10(d) with respect to the persons referenced therein, this Agreement shall not confer any rights or remedies upon any person other than the parties hereto, and their respective successor and assigns.

 

(j) Except as otherwise provided herein, this Agreement shall be binding upon, and inure to the benefit of the parties hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns.

 

(k) If any provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect.

 

(l) This Agreement may be executed in one or more counterparts (including by electronic mail or in .pdf) and by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so executed and delivered shall be construed together and shall constitute one and the same agreement.

 

(m) The parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement, without posting a bond or undertaking and without proof of damages, to enforce specifically the terms and provisions of this Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise.

 

(n) This Agreement shall be governed by, construed and enforced in accordance with the laws of the State of New York without regard to the conflict of laws principles thereof.

 

(o) THE PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK AND THE SUPREME COURT OF THE STATE OF NEW YORK SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS AGREEMENT AND THE DOCUMENTS REFERRED TO IN THIS AGREEMENT (UNLESS OTHERWISE PROVIDED THEREIN) AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF OR ANY SUCH DOCUMENT THAT IS NOT SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH A NEW YORK STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT OR PROCEEDING IN THE MANNER PROVIDED IN THIS SECTION 10(o) OF THIS AGREEMENT OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW SHALL BE VALID AND SUFFICIENT SERVICE THEREOF.

 

18

 

 

(p) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 10(p).

 

11. Non-Reliance and Exculpation. Each Encompass Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by the Placement Agents and any of their affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing), other than the statements, representations and warranties of the Company expressly contained in Section 5 of this Agreement and those contained in the Ancillary Transaction Agreements, in making its investment or decision to invest in the Company. Each Encompass Investor acknowledges and agrees that none of the Placement Agents, their respective affiliates or any control persons, officers, directors employees, partners, agents or representatives of any of the foregoing shall be liable to the Encompass Investors pursuant to this Agreement or any other agreement related to the private placement of the Shares, the negotiation hereof or thereof or the subject matter hereof or thereof, or the transactions contemplated hereby or thereby, for any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the purchase of the Shares.

 

12. Press Releases. Alussa shall, by 9:00 a.m., New York City time on the first (1st) business day immediately following the date of this Agreement, issue one or more press releases or furnish or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure Document”) disclosing, to the extent not previously publicly disclosed, the PIPE Investment, all material terms of the Transaction and any other material, non-public information that the Company and Alussa have provided to the Encompass Investors at any time prior to the filing of the Disclosure Document. From and after the disclosure of the Disclosure Document, to the knowledge of the Company and Alussa, the Encompass Investors shall not be in possession of any material, non-public information received from the Company, Alussa or any of their respective officers, directors or employees. All press releases or other public communications relating to the transactions contemplated hereby between the Company, Alussa and the Encompass Investors, and the method of the release for publication thereof, shall be subject to the prior approval of (i) Alussa, (ii) the Company and (iii) to the extent such press release or public communication references any of the Encompass Investors or any of their affiliates or investment advisers by name, the Encompass Investors. The restrictions in this Section 12 shall not apply to the extent a public announcement is required by applicable securities law, any governmental authority or stock exchange rule; provided, that in such an event, the applicable party shall, to the extent practicable, (A) consult with the other parties in advance as to any applicable announcement’s form, content and timing (B) provide the Encompass Investors advance notice and opportunity to review and comment on such disclosure and such commercially reasonable comments shall be incorporated therein and (C) limit the extent of such disclosure.

 

13. Confidentiality. Except as expressly authorized for use hereunder or as required to be disclosed by public disclosure requirements of applicable securities laws or any filing requirements pursuant to the rules of any stock exchange or the Financial Industry Regulatory Authority, without the prior written consent of Investor, each of the Company, Alussa, the Placement Agents and their respective directors, officers, agents, employees or representatives shall maintain and keep confidential all information provided by each Encompass Investor (whether oral or written) in connection with this Agreement.

 

14. Notices. All notices and other communications among the parties shall be in writing and shall be deemed to have been duly given (i) when delivered in person, (ii) when delivered by FedEx or other nationally or internationally recognized overnight delivery service, or (iii) when delivered by email (in each case in this clause (iii), solely if receipt is confirmed, but excluding any automated reply, such as an out-of-office notification), addressed as follows:

 

19

 

 

If to the Encompass Investors, to the address provided on the Encompass Investors’ signature pages hereto.

 

If to Norway Merger Sub 1, Alussa or the Company, to:

 

Alussa Energy Acquisition Corp.
PO Box 500, 71 Fort Street
Grand Cayman KY1-1106

Cayman Islands

Attention: Daniel Barcelo
Email: daniel@alussaenergy.com

  

with copies to (which shall not constitute notice), to:

 

Skadden, Arps, Slate, Meagher & Flom (UK) LLP
40 Bank Street
London, United Kingdom E14 5DS

Attention: Danny Tricot
    Denis Klimentchenko
  Email: danny.tricot@skadden.com
    denis.klimentchenko@skadden.com

 

or to such other address or addresses as the parties may from time to time designate in writing. Copies delivered solely to outside counsel shall not constitute notice.

 

 

[SIGNATURE PAGES FOLLOW]

 

20

 

 

IN WITNESS WHEREOF, the Encompass Investors have executed or caused this Agreement to be executed by its duly authorized representative as of the date set forth below.

 

Encompass Capital Master Fund LP:   State/Country of Formation or Domicile:
     
By:      
Name:      
Title:      
     
     
Name in which Shares are to be registered (if different):   Date: ________, 2021
     
Investor’s EIN:    
     
Business Address-Street:   Mailing Address-Street (if different):
     
City, State, Zip:   City, State, Zip:
     
Attn:     Attn:  
     
Telephone No.:   Telephone No.:
     
Facsimile No.:   Facsimile No.:

 

 

[Signature Page to Preferred Share Purchase Agreement]

 

21

 

 

BEMAP Master Fund Ltd.,: State/Country of Formation or Domicile:
     
     
     
     
       
     
Name in which Shares are to be registered (if different): Date: ________, 2021
     
Investor’s EIN:    
     
Business Address-Street: Mailing Address-Street (if different):
     
City, State, Zip: City, State, Zip:
     
    Attn:  
       
Telephone No.: Telephone No.:
     
Facsimile No.: Facsimile No.:

 

 

[Signature Page to Preferred Share Purchase Agreement]

 

22

 

 

Encompass Capital E L Master Fund L.P.:   State/Country of Formation or Domicile:
     
By:      
Name:      
Title:      
     
     
Name in which Shares are to be registered (if different):   Date: ________, 2021
     
Investor’s EIN:    
     
Business Address-Street:   Mailing Address-Street (if different):
     
City, State, Zip:   City, State, Zip:
     
Attn:     Attn:  
     
Telephone No.:   Telephone No.:
     
Facsimile No.:   Facsimile No.:

 

 

[Signature Page to Preferred Share Purchase Agreement]

 

23

 

 

IN WITNESS WHEREOF, FREYR Battery, Alussa Energy Acquisition Corp. and Norway Sub 1 AS have accepted this Agreement as of the date set forth below.

 

FREYR Battery
     
  By:  
    Name:  
    Title:  
     
     
  ALUSSA ENERGY ACQUISITION CORP.
     
  By:  
    Name:  
    Title:  
     
     
  Norway Sub 1 AS
     
  By:  
    Name:  
    Title:  

 

Date: January __, 2021

 

 

[Signature Page to Preferred Share Purchase Agreement]

 

24

 

 

SCHEDULE A-1

 

ELIGIBILITY REPRESENTATIONS OF Encompass Capital Master Fund LP

 

A. QUALIFIED INSTITUTIONAL BUYER STATUS
(Please check the applicable subparagraphs):

 

We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act).

 

B. INSTITUTIONAL ACCREDITED INVESTOR STATUS
(Please check the applicable subparagraphs):

 

We are an “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act) or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.”

 

Rule 501(a), in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. Encompass Capital Master Fund LP has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to Encompass Capital Master Fund LP and under which Encompass Capital Master Fund LP accordingly qualifies as an “accredited investor.”

 

Any bank, registered broker or dealer, insurance company, investment adviser registered pursuant to Section 203 of the Investment Advisers Act of 1940 or state laws, investment adviser relying on exemption from registration under Section 203(l) or (m) of the Investment Advisers Act of 1940, registered investment company, business development company, small business investment company, or rural business investment company;

 

Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, partnership, or limited liability company, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person; or

 

Any entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

This page should be completed by Encompass Capital Master Fund LP
and constitutes a part of the Agreement.

 

 

[Schedule to Preferred Share Purchase Agreement]

 

Sch. A-1

 

 

SCHEDULE A-2

 

ELIGIBILITY REPRESENTATIONS OF BEMAP Master Fund Ltd.

 

A. QUALIFIED INSTITUTIONAL BUYER STATUS
(Please check the applicable subparagraphs):

 

We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act).

 

B. INSTITUTIONAL ACCREDITED INVESTOR STATUS
(Please check the applicable subparagraphs):

 

We are an “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act) or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.”

 

Rule 501(a), in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. BEMAP Master Fund Ltd. has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to BEMAP Master Fund Ltd. and under which BEMAP Master Fund Ltd. accordingly qualifies as an “accredited investor.”

 

Any bank, registered broker or dealer, insurance company, investment adviser registered pursuant to Section 203 of the Investment Advisers Act of 1940 or state laws, investment adviser relying on exemption from registration under Section 203(l) or (m) of the Investment Advisers Act of 1940, registered investment company, business development company, small business investment company, or rural business investment company;

 

Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, partnership, or limited liability company, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person; or

 

Any entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

This page should be completed by BEMAP Master Fund Ltd.
and constitutes a part of the Agreement.

 

 

[Schedule to Preferred Share Purchase Agreement]

 

Sch. A-2

 

 

SCHEDULE A-3

 

ELIGIBILITY REPRESENTATIONS OF Encompass Capital E L Master Fund L.P.

 

A. QUALIFIED INSTITUTIONAL BUYER STATUS
(Please check the applicable subparagraphs):

 

We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act).

 

B. INSTITUTIONAL ACCREDITED INVESTOR STATUS
(Please check the applicable subparagraphs):

 

We are an “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act) or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.”

 

Rule 501(a), in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. Encompass Capital E L Master Fund L.P. has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to Encompass Capital E L Master Fund L.P. and under which Encompass Capital E L Master Fund L.P. accordingly qualifies as an “accredited investor.”

 

Any bank, registered broker or dealer, insurance company, investment adviser registered pursuant to Section 203 of the Investment Advisers Act of 1940 or state laws, investment adviser relying on exemption from registration under Section 203(l) or (m) of the Investment Advisers Act of 1940, registered investment company, business development company, small business investment company, or rural business investment company;

 

Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, partnership, or limited liability company, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person; or

 

Any entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

This page should be completed by Encompass Capital E L Master Fund L.P.

and constitutes a part of the Agreement.

 

 

[Schedule to Preferred Share Purchase Agreement]

 

Sch. A-3

 

 

SCHEDULE B

 

Closing Obligations

 

PART 1

 

OBLIGATIONS OF ENCOMPASS INVESTORS

 

1. The Encompass Investors and any of their Affiliates holding Preferred Shares and Warrants, shall each have delivered a duly signed and dated Contribution Agreement substantially in the form attached to Schedule C.

 

2. The Encompass Investors shall contribute the Preferred Shares and Warrants to the Company in accordance with the terms of Schedule C.

 

3. Following execution of the Agreement and no later than upon receipt of the Closing Notice, each Encompass Investor and each of their Affiliates (if applicable) contributing Preferred Shares and Warrants to the Company shall, in order to ensure compliance with the requirements of know-your-customer and anti-money laundering and countering terrorist financing obligations under the applicable laws and regulations, provide the Company with copies of such documents (if any) as are required by law.

 

 

PART 2

 

OBLIGATIONS OF THE COMPANY

 

1. The Company shall countersign each Contribution Agreement delivered by Encompass Investors or any each of their Affiliates holding Preferred Shares and Warrants.

 

2. The Company shall have obtained the report of a statutory auditor (réviseur d’entreprises) required by law.

 

3. The Company shall upon satisfaction of the obligations set out in Part 1 (and Part 2) issue the Shares by entering such Shares in the register of shares of the Company in the name of Custodian for DTC/VPS/Transfer Agent (as applicable) and instruct Custodian for DTC/UPC/Trust (as applicable) to credit the Shares to the Encompass Investors or their Affiliates.

 

 

[Schedule to Preferred Share Purchase Agreement]

 

Sch. B-1

 

 

Schedule C

 

This CONTRIBUTION AND SUBSCRIPTION AGREEMENT (the “Agreement”) is made on ______________ 2021

 

BY AND Between:

 

(1) [ENCOMPASS INVESTOR/AFFILIATE] (the “Contributor”);

 

AND

 

(2) FREYR Battery, a corporation in the form of a public limited liability company (société anonyme) incorporated under the laws of Luxembourg, with registered office at [●], registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés) under number B[●] (the “Company”);

 

together, the “Parties”.

 

RECITALS:

 

(A). Reference is made to the preferred share acquisition agreement, dated [●], 2021, between, among others, the Company and the Contributor (the “Preferred Share Acquisition Agreement”).

 

(B). The Contributor wishes to contribute to the Company [ ] preferred shares (the “Preferred Shares”) and [●] preferred share-linked warrants (“Preferred Share-Linked Warrants”) held by it in Norway Sub 1 AS, a corporation incorporated under the laws of Norway against the issuance by the Company of [ ] new ordinary shares in the Company (the “New Shares”) [with a [nominal] value of USD [0.01] each] for an aggregate subscription price equal to [●] Preferred Shares and [●] Preferred Share-Linked Warrants (the “Contribution Amount”).

 

(C). The Company is willing to accept and receive the Contribution (as defined below) by the Contributor and to issue the New Shares.

 

(D). The Parties wish to enter into this Agreement to provide for the Contribution to the Company in accordance with the terms and conditions of the present Agreement.

 

NOW IT IS HEREBY AGREED AS FOLLOWS:

 

Section 1. Contribution and transfer to the Company

 

1.1 The Contributor hereby agrees to contribute and transfer the Preferred Shares and Preferred Share Linked Warrants to the Company (the “Contribution”) with effect as at the Closing Date (as defined below).

 

1.2 The Company acknowledges and accepts the Contribution.

 

 

[Schedule to Preferred Share Purchase Agreement]

 

Sch. C-1

 

 

Section 2. Consideration

 

2.1 The Preferred Shares and Preferred Share Linked Warrants have been valued by the Company and such valuation is the subject of a valuation report dated [on the date hereof/[ ] 2021], prepared by [EY], a statutory auditor, at a value of USD [ ] per Preferred Share and USD [●] per Preferred Share Linked Warrants.

 

2.2 The Parties agree that as consideration for the Contribution, the Company shall issue the New Shares to the Contributor.

 

Section 3. Completion

 

Completion of the Contribution and the New Shares issue shall take place on the Closing Date (as defined in the Preferred Share Acquisition Agreement).

 

IN WITNESS THEREOF the Parties hereto have executed this Agreement in one or multiple original counterparts, all of which together evidence the same agreement, on the day and year first written above.

 

For and on behalf of [Encompass Investor/Affiliate], as Contributor

 

For and on behalf of
FREYR Battery, as Company

 

     
Name:     Name:  
Title:     Title:  

 

 

[Schedule to Preferred Share Purchase Agreement]

 

Sch. C-2

Exhibit 10.6

 

CONFIDENTIAL

 

SUBSCRIPTION AGREEMENT

 

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is entered into on January ___, 2021, by and between Alussa Energy Acquisition Corp, a Cayman Islands exempted company (“Alussa”), FREYR Battery, a corporation in the form of a public limited liability company (société anonyme) incorporated under the laws of Luxembourg, with registered office at 412F, route d’Esch, L-2086 Luxembourg, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés) (the “Company”) and the undersigned subscriber (the “Investor”).

 

WHEREAS, this Subscription Agreement is being entered into in connection with the Business Combination Agreement, dated as of the date hereof (as may be amended, supplemented or otherwise modified from time to time, including any exhibits and schedules thereto, the “Transaction Agreement”), between, among others, Alussa, the Company, FREYR AS, a limited liability company incorporated under the laws of Norway (“FREYR”), Norway Sub 1 AS, a limited liability company incorporated under the laws of Norway (“Norway Merger Sub 1”), Norway Sub 2 AS, a limited liability company incorporated under the laws of Norway (“Norway Merger Sub 2”), Adama Charlie, an exempted company incorporated under the laws of the Cayman Islands (“Cayman Merger Sub”) and the other parties thereto, pursuant to which, among other things, (i) Alussa will merge with and into Cayman Merger Sub, with Alussa as the surviving company of such merger, (ii) FREYR will transfer its wind farm business to Sjonfjellet Vindpark Holding AS, a corporation to be incorporated under the laws of Norway by way of a demerger resulting in such business becoming held by its shareholders through such company, (iii) FREYR will merge with and into Norway Merger Sub 2, with Norway Merger Sub 2 as the surviving company of such merger and (iv) Norway Merger Sub 1 will merge with and into the Company, with the Company as the surviving company of such merger, and after giving effect to all the transactions, the surviving companies of the transactions contemplated by (i), (ii) and (iii) will be wholly-owned subsidiaries of the Company, with the exception of Sjonfjellet Vindpark Holding AS, which will be a separate stand-alone entity, on the terms and subject to the conditions therein (the “Transaction”);

 

WHEREAS, in connection with the Transaction, the Company is seeking commitments from interested investors to purchase, prior to the closing of the Transaction, the Company’s ordinary shares, par value $0.01 per share (the “Shares”), in a private placement for a purchase price of $10.00 per share (the “Per Share Subscription Price”);

 

WHEREAS, the aggregate purchase price to be paid by the Investor for the subscribed Shares (as set forth on the signature page hereto) is referred to herein as the “Subscription Amount;” and

 

WHEREAS, substantially concurrently with the execution of this Subscription Agreement, the Company and Alussa are entering into separate subscription agreements (collectively, the “Other Subscription Agreements”) with certain investors (other than the Investor) with an aggregate purchase price of $600,000,000 (inclusive of the Subscription Amount) (the “PIPE Investment”).

 

NOW, THEREFORE, in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth herein, and intending to be legally bound hereby, each of the Investor, the Company and Alussa acknowledges and agrees as follows:

 

1. Subscription. The Investor hereby irrevocably subscribes for and agrees to purchase from the Company, and the Company hereby agrees, upon the substantially concurrent consummation of the Transaction, to irrevocably issue and sell to the Investor, the number of Shares set forth on the signature page of this Subscription Agreement at the Per Share Subscription Price and on the terms and subject to the conditions provided for herein.

 

2. Closing.

 

(a) The closing of the subscription of the Shares contemplated hereby (the “Closing”) shall occur on the same date as, but immediately prior to the consummation of those transactions contemplated to occur on the Second Closing Date (as defined in the Transaction Agreement) pursuant to the Transaction Agreement (the “Closing Date”).

 

 

CONFIDENTIAL

 

(b) At least seven (7) business days before the anticipated Closing Date, the Company shall deliver written notice to the Investor (the “Closing Notice”) specifying: (i) the anticipated Closing Date, (ii) that the Company reasonably expects all conditions to closing of the Transaction to be satisfied or waived prior to or on the anticipated Closing Date and (iii) the wire instructions for delivery of the Subscription Amount to the Company. No later than three (3) business days prior to the Closing Date set forth in the Closing Notice, the Investor shall deliver the Subscription Amount by wire transfer of United States dollars in immediately available funds to the account(s) specified by the Company in the Closing Notice, such Subscription Amount to be held by the Company in trust for the benefit of the Investor until Closing (with the Investor being treated as the beneficial owner of the Subscription Amount until Closing). Upon satisfaction (or, if applicable, waiver) of the conditions set forth in Section 3 of this Subscription Agreement, (i) at Closing, the Company shall issue the Shares to the Investor and subsequently cause the Shares to be registered in book entry form, free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities laws or as set forth herein), in the name of Investor (or its nominee in accordance with its delivery instructions), and (ii) as promptly as practicable after the Closing (but in no event more than two (2) business days thereafter), the Company shall deliver, or cause to be delivered, evidence from the Company’s transfer agent (the “Transfer Agent”) of the issuance to Investor of the Shares on and as of the Closing Date. Upon delivery of the Shares to the Investor (or its nominee, if applicable), in accordance with this Section 2(b), the Subscription Amount shall cease to be held by the Company in trust for the benefit of the Investor and shall be owned absolutely by the Company.

 

(c) In the event the Closing Date does not occur within three (3) business days after the anticipated Closing Date specified in the Closing Notice, the Company shall promptly (but not later than two (2) business days thereafter) return the Subscription Amount to the Investor by wire transfer of U.S. dollars in immediately available funds to the account specified by the Investor, and any book entries for the Shares shall be deemed cancelled; provided that, unless this Subscription Agreement has been terminated pursuant to Section 8 hereof, such return of funds shall not terminate this Subscription Agreement or relieve the Investor of its obligation to purchase the Shares at the Closing in accordance with this Subscription Agreement.

 

(d) Prior to or at the Closing, Investor shall deliver to the Company a duly completed and executed Internal Revenue Service Form W-9 or appropriate Form W-8.

 

(e) For purposes of this Subscription Agreement, “business day” shall mean a day, other than a Saturday, Sunday or other day on which commercial banks in New York, New York, Oslo, Norway, the Cayman Islands or Luxembourg are authorized or required by law to close.

 

3. Closing Conditions.

 

(a) The obligation of the parties hereto to consummate the purchase and sale of the Shares pursuant to this Subscription Agreement is subject to the following conditions: (i) there shall not be in force any injunction or order enjoining or prohibiting, or any proceeding seeking to enjoin or prohibit, the issuance and sale of the Shares under this Subscription Agreement and (ii) all conditions precedent to the consummation of the Transaction set forth in the Transaction Agreement shall have been satisfied or waived (other than those conditions which, by their nature, are to be satisfied at the applicable closing date under the Transaction Agreement, but subject to the satisfaction or waiver of such conditions as of the closing of the Transaction) and the closing of the Transaction shall occur substantially concurrently with the Closing.

 

(b) The obligation of the Company to consummate the sale of the Shares pursuant to this Subscription Agreement is also subject to the satisfaction or waiver by the Company and Alussa of the following additional conditions that, on the Closing Date:

 

(i) all representations and warranties of the Investor contained in this Subscription Agreement shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true in all respects) at and as of the Closing Date (except for representations and warranties made as of a specific date, which shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true in all respects) as of such date); and

 

2

CONFIDENTIAL

 

(ii) the Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to Closing.

 

(c) The obligation of the Investor to consummate the purchase of the Shares pursuant to this Subscription Agreement is also subject to the satisfaction or waiver by the Investor of the following additional conditions that, on the Closing Date:

 

(i) all representations and warranties of the Company and Alussa contained in this Subscription Agreement shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein), which representations and warranties shall be true in all respects) at and as of the Closing Date (except for representations and warranties made as of a specific date, which shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect, which representations and warranties shall be true in all respects) as of such date);

 

(ii) the Company and Alussa shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Subscription Agreement to be performed, satisfied or complied with by the Company and Alussa at or prior to Closing;

 

(iii) (A) the Transaction Agreement (as the same exists on the date of this Subscription Agreement) shall not have been modified, waived or amended to materially adversely affect the Investor (in its capacity as such), and (B) Section 12.2(c) of the Transaction Agreement (as the same exists on the date of this Subscription Agreement) shall not have been modified, waived or amended in any material respect, in each case of clauses (A) and (B), without having received Investor’s prior written consent;

 

(iv) the Company shall not have entered into any Other Subscription Agreement with a lower Per Share Subscription Price or, other than with respect to (A) the Other Subscription Agreement entered into with Spring Creek Capital, LLC (a subsidiary of Koch Industries, Inc.) or (B) certain settlement arrangements owing to regulatory constraints, other terms (economic or otherwise) substantively more favorable to such other subscriber or investor than as set forth in this Subscription Agreement; and

 

(v) the Shares shall have been approved for listing on the NYSE (as defined below) effective upon the closing of the Transaction (“Transaction Closing”).

 

(d) The Company shall use reasonable efforts to ensure the satisfaction of the conditions set out in: (i) Section 3(c) of this Subscription Agreement, and (ii) the Transaction Agreement. The Investor shall use reasonable efforts to ensure the satisfaction of the conditions set out in Section 3(b) of this Subscription Agreement.

 

4. Further Assurances. At the Closing, the parties hereto shall execute and deliver such additional documents and take such additional actions as is reasonably deemed to be necessary in order to consummate the subscription as contemplated by this Subscription Agreement; provided, that in no event shall the Investor be required hereunder to execute and deliver any lock-up or similar market standoff agreement or any other agreement restricting the transfer of the Shares issued pursuant to this Subscription Agreement.

 

5. Company and Alussa Representations and Warranties. With respect to Sections 5(a), (c), (d), (e), (g), (h), (i), (j), (k), (l), (m) and (o), each of Alussa and the Company jointly and severally represent and warrant to the Investor as of the date hereof and as of the Closing Date, and with respect to the remainder of this Section 5, the Company represents and warrants to the Investor, as of the date hereof and as of the Closing Date, that:

 

3

CONFIDENTIAL

 

(a) The Company is a corporation in the form of a public limited liability company (société anonyme) duly incorporated and validly existing under the laws of Luxembourg. The Company has all power (corporate or otherwise) and authority to own, lease and operate its properties and conduct its business as presently and anticipated to be conducted and to enter into, deliver and perform its obligations under this Subscription Agreement. Alussa has been incorporated and is validly existing as a corporation under the laws of the Cayman Islands, with corporate power and authority to own, lease and operate its properties and conduct its business as presently and anticipated to be conducted and to enter into, deliver and perform its obligations under this Subscription Agreement.

 

(b) As of the Closing, the Shares will be duly authorized and, when issued and delivered to the Investor against full payment therefor in accordance with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid, non-assessable and free and clear of any liens or other restrictions whatsoever (other than those arising under state or federal securities laws or as set forth herein), will rank pari passu in all respects with all other ordinary shares of the Company and will not have been issued in violation of or subject to any preemptive or similar rights created under the Company’s articles of association (as in effect at such time of issuance) or similar constitutive agreements, or under the laws of Luxembourg.

 

(c) Each of this Subscription Agreement, the Other Subscription Agreements, and the Transaction Agreement (the “Transaction Documents”) has been duly authorized, executed and delivered by each of Alussa and the Company and, assuming that each such Transaction Document constitutes a valid and binding obligation of the other parties thereto, is enforceable against each of the Company and Alussa in accordance with its respective terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, or (ii) principles of equity, whether considered at law or equity.

 

(d) The execution and delivery by the Company and Alussa of the Transaction Documents and the performance by the Company and Alussa of their respective obligations under the Transaction Documents, including the issuance and sale by the Company of the Shares pursuant to this Subscription Agreement and the consummation of the transactions contemplated herein and therein, do not and will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Company or Alussa or any of their respective subsidiaries pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the Company or Alussa or any of their respective subsidiaries is a party or by which the Company or Alussa or any of their respective subsidiaries is bound or to which any of the property or assets of the Company or Alussa is subject that does or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the business, financial condition or results of operations of the Company or Alussa or their respective subsidiaries, taken as a whole (a “Material Adverse Effect”), or impair the validity of the Shares or the legal authority of the Company or Alussa to comply in all material respects with their respective obligations under the Transaction Documents or impair or delay the ability of the Company or Alussa to timely perform their respective obligations under the Transaction Documents; (ii) result in any violation of any provision of the organizational documents of the Company or Alussa; or (iii) result in any violation of any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Company or Alussa or any of their respective properties that would reasonably be expected to have a Material Adverse Effect or impair the validity of the Shares or the legal authority of the Company or Alussa to comply in all material respects with its obligations under the Transaction Documents or impair or delay the ability of the Company or Alussa to timely perform their respective obligations under the Transaction Documents.

 

(e) Assuming the accuracy of the Investor’s representations and warranties set forth in Section 6 of this Subscription Agreement, neither the Company nor Alussa is required to obtain any material consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the issuance of the Shares pursuant to this Subscription Agreement, other than (i) filings with the U.S. Securities and Exchange Commission (the “SEC”), (ii) filings required by applicable state or federal securities laws, (iii) the filings required in accordance with Section 12 of this Subscription Agreement; (iv) those required by the New York Stock Exchange (“NYSE”), and (v) those required to consummate the Transaction as provided under the Transaction Agreement.

 

(f) Assuming the accuracy of the Investor’s representations and warranties set forth in Section 6 of this Subscription Agreement, no registration under the Securities Act of 1933, as amended (the “Securities Act”), is required for the offer and sale of the Shares by the Company to the Investor.

 

4

CONFIDENTIAL

 

(g) Neither the Company nor Alussa nor any person acting on their respective behalf has engaged or will engage in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with any offer or sale of the Shares in violation of the Securities Act.

 

(h) Neither the Company nor Alussa nor any person acting on their respective behalf is under any obligation to pay any broker’s fee or finder’s fee or commission in connection with the sale of the Shares other than to the Placement Agents (as defined below).

 

(i) Neither the Company nor Alussa nor any person acting on their respective behalf has taken any action, directly or indirectly, including making any offer or sale of any Company security or solicited any offers to buy any security in violation of the Securities Act or under circumstances that would cause the offer and sale of the Shares by the Company to the Investor contemplated hereby to fail to be entitled to the exemption from the registration requirements of the Securities Act (other than offers or sales of securities under an employee benefit plan as defined in Rule 405 under the Securities Act).

 

(j) Except for such matters as have not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect, there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority pending, or, to the knowledge of Alussa or the Company, threatened against Alussa, the Company or FREYR, or (ii) judgment, decree, injunction, ruling or order of any governmental entity or arbitrator outstanding against Alussa, the Company or FREYR. Each of the Company, Alussa and FREYR has not received any written communication from a governmental authority that alleges that the Company, Alussa or FREYR is not in compliance with or is in default or violation of any applicable law, except where such non-compliance, default or violation would not be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(k) Other than the Other Subscription Agreements and the Preferred Share Acquisition Agreement (as defined in the Transaction Agreement), and other than with respect to (A) the Other Subscription Agreement entered into with Spring Creek Capital, LLC (a subsidiary of Koch Industries, Inc.) and (B) certain settlement arrangements owing to regulatory constraints, neither Alussa nor the Company has entered into any side letter or similar agreement with any investor or subscriber in connection with such investor or subscriber’s direct or indirect investment in the Company, and such Other Subscription Agreements and Preferred Share Acquisition Agreement have not been amended in any material respect following the date of this Subscription Agreement and reflect the same Per Share Subscription Price and terms that are no more favorable to such investor or subscriber thereunder than the terms of this Subscription Agreement.

 

(l) As of their respective dates, all SEC Documents (as defined below) complied or will comply, in all material respects, with the requirements of the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the SEC promulgated thereunder. A copy of each form, report, statement, schedule, prospectus, proxy, registration statement and other document, if any, filed by Alussa or the Company with the SEC since Alussa’s initial registration of its Class A ordinary shares under the Exchange Act (the “SEC Documents”) is available to the undersigned via the SEC’s EDGAR system. None of the SEC Documents contained, when filed or, if amended, as of the date of such amendment with respect to those disclosures that are amended, any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. Each of Alussa and the Company has timely filed each report, statement, schedule, prospectus, and registration statement that Alussa or the Company (as applicable) was required to file with the SEC since Alussa’s initial registration of the Class A ordinary shares under the Exchange Act. The financial statements of Alussa and the Company included in the SEC Documents comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing and fairly present in all material respects the financial condition of Alussa and the Company (as applicable) as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments. There are no material outstanding or unresolved comments in comment letters from the staff of the Division of Corporation Finance of the SEC with respect to any of the SEC Documents. The description of the business and financial information of FREYR set forth in the investor presentation dated December 4, 2020 (as updated on January 26, 2021) made available to Investor by Alussa and FREYR prior to the execution of this Subscription Agreement (the “Investor Presentation”) shall be consistent and complete in all material respects with the description of the business and financial information of FREYR described or included in the proxy statement to be filed in connection with the approval of the Transaction Agreement by the applicable shareholders. The Investor Presentation shall not have not been amended in any material respect following the date of this Subscription Agreement.

 

5

CONFIDENTIAL

 

(m) As of the date of this Subscription Agreement, and immediately prior to the First Closing Date (as defined in the Transaction Agreement), the authorized capital stock of Alussa consists of 200,000,000 Class A ordinary shares, $0.0001 par value, 20,000,000 Class B ordinary shares, $0.0001 par value, and 2,000,000 shares of undesignated preferred stock, $0.0001 par value. As of the date of this Subscription Agreement and for the period up to the exercise in full of any warrants issued by Alussa, the Company will have a sufficient number of authorized shares available to be issued upon exercise of such warrants. As of the date of this Subscription Agreement, the authorized capital stock of the Company consists of 40,000 fully paid redeemable shares with no nominal value, and such shares are duly authorized and validly issued, and are not subject to preemptive rights or encumbrances. As of the date of this Subscription Agreement, and immediately prior to Closing, except as set forth above and pursuant to (i) the Other Subscription Agreements, (ii) the Transaction Agreement and (iii) the Preferred Share Acquisition Agreement, there are no outstanding (1) shares, equity interests or voting securities of the Company, (2) securities of the Company convertible into or exchangeable for shares or other equity interests or voting securities of the Company, (3) options, warrants or other rights (including preemptive rights) or agreements, arrangements or commitments of any character, whether or not contingent, of the Company to acquire from any individual, entity or other person, and no obligation of the Company to issue, any shares or other equity interests or voting securities of the Company (collectively, the “Equity Interests”) or securities convertible into or exchangeable or exercisable for Equity Interests. As of the date of this Subscription Agreement, other than Cayman Merger Sub, the Company has no subsidiaries and does not own, directly or indirectly, interests or investments (whether equity or debt) in any person, whether incorporated or unincorporated. There are no stockholder agreements, voting trusts or other agreements or understandings to which the Company is a party or by which it is bound relating to the voting of any securities of the Company, other than (A) as set forth in the SEC Documents and (B) as contemplated by the Transaction Agreement. Except as disclosed in the SEC Documents and other than expenses incurred in connection with the transactions contemplated by the Transaction Documents, the Company had no outstanding indebtedness and will not have any outstanding long-term indebtedness as of immediately prior to the Closing.

 

(n) Upon consummation of the Transaction, the issued and outstanding ordinary shares of the Company will be registered pursuant to Section 12(b) of the Exchange Act and will be listed for trading on the NYSE.

 

(o) Neither the Company nor Alussa is, and immediately after receipt of payment for the Shares the Company will not be, subject to registration as an “investment company” under the Investment Company Act of 1940, as amended.

 

(p) The issued and outstanding Class A ordinary shares of Alussa are registered pursuant to Section 12(b) of the Exchange Act and are listed on the NYSE under the symbol “ALUS”. There is no suit, action, proceeding, or investigation pending, or to the knowledge of Alussa, threatened against Alussa by the NYSE or the SEC with respect to any intention by such entity to deregister the Class A ordinary shares of Alussa or prohibit or terminate the listing of such shares on the NYSE. Alussa has taken no action that is designed to terminate the registration of Alussa under the Exchange Act. Prior to the First Closing Date, no suspension of the qualification of Alussa’s Class A ordinary shares for offering or sale or trading on the NYSE, or initiation or threatening of any proceedings for any of such purposes, shall have occurred.

 

(q) Each of Alussa and the Company is in compliance with all applicable laws, except where such non-compliance would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. As of the date hereof, neither Alussa nor the Company has received any written communication from a governmental authority that alleges that the Company or Alussa, as applicable, is not in compliance with or is in default or violation of any applicable law, except where such non-compliance, default or violation would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(r) As of the Closing Date, the Company will be a “foreign private issuer” (as defined in Rule 405) under the Securities Act.

 

(s) The Company is classified as a Subchapter C corporation for U.S. federal income tax purposes.

 

6

CONFIDENTIAL

 

6. Investor Representations, Warranties and Acknowledgements. The Investor, (I) with respect to Section 6(a), the first two sentences of Section 6(e) and Sections 6(g), (h), (j), (k), (l), (m), (p) and (q), represents and warrants to the Company and Alussa, and (II) with respect to the remainder of this Section 6, acknowledges, in each case of the foregoing clauses (I) and (II), as of the date hereof and as of the Closing Date, that:

 

(a) The Investor (i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an institutional “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3), (7) or (8) under the Securities Act), in each case, satisfying the applicable requirements set forth in Schedule A, (ii) if resident in a member state of the European Economic Area, is a “qualified investor” within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market (the “EU Prospectus Regulation”), (iii) if resident in the United Kingdom, is a “qualified investor” within the meaning of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the “UK Prospectus Regulation”), (iv) is acquiring the Shares only for its own account and not for the account of others, or if the Investor is subscribing for the Shares as a fiduciary or agent for one or more investor accounts, the Investor has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account, and (iii) is not acquiring the Shares with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the requested information set forth on Schedule A). The Investor is not an entity formed for the specific purpose of acquiring the Shares and is an “institutional account” as defined by FINRA Rule 4512(c).

 

(b) The Investor acknowledges and agrees that the Shares are being offered in a transaction not involving any public offering within the meaning of the Securities Act or any “offer of securities to the public” within the meaning of the EU Prospectus Regulation or the UK Prospectus Regulation, that the Shares have not been registered under the Securities Act and that the Company is not required to register the Shares except as set forth in Section 7 of this Subscription Agreement. The Investor acknowledges and agrees that the Shares may not be offered, resold, transferred, pledged or otherwise disposed of by the Investor absent an effective registration statement under the Securities Act except (i) to the Company or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and, in each case, in accordance with any applicable securities laws of the states of the United States and other applicable jurisdictions, and that any certificates representing the Shares shall contain a restrictive legend to such effect. The Investor acknowledges and agrees that the Shares will be subject to these securities law transfer restrictions and, as a result of these transfer restrictions, the Investor may not be able to readily offer, resell, transfer, pledge or otherwise dispose of the Shares and may be required to bear the financial risk of an investment in the Shares for an indefinite period of time. The Investor acknowledges and agrees that the Shares will not immediately be eligible for offer, resale, transfer, pledge or disposition pursuant to Rule 144 promulgated under the Securities Act, and that the provisions of Rule 144(i) will apply to the Shares. The Investor acknowledges and agrees that it has been advised to consult legal, tax and accounting advisors prior to making any offer, resale, transfer, pledge or disposition of any of the Shares.

 

(c) The Investor acknowledges and agrees the Shares are issued to the Investor by the Company. The Investor further acknowledges that there have been no representations, warranties, covenants and agreements made to the Investor by or on behalf of the Company, Alussa, FREYR, Norway Merger Sub 1, Norway Merger Sub 2, Cayman Merger Sub, or any of Credit Suisse Securities (USA) LLC, BTIG, LLC, Pareto Securities AS, SpareBank 1 Markets AS or Clarksons Platou Securities, Inc. (with their respective affiliates, each a “Placement Agent” and, collectively, the “Placement Agents”), any of their respective affiliates or any control persons, officers, directors, employees, agents or representatives of any of the foregoing or any other person or entity, expressly or by implication, other than those representations, warranties, covenants and agreements of the Company and Alussa expressly set forth in Section 5 of this Subscription Agreement. The Investor acknowledges that certain information provided by the Company, FREYR or Alussa was based on projections, and such projections were prepared based on assumptions and estimates that are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections.

 

7

CONFIDENTIAL

 

(d) The Investor acknowledges and agrees that the Investor has received such information as the Investor deems necessary in order to make an investment decision with respect to the Shares, including, with respect to the Company, Alussa, the Transaction and the business of FREYR and its subsidiaries. Without limiting the generality of the foregoing, the Investor acknowledges that it has had the opportunity to review Alussa’s filings with the SEC. The Investor acknowledges and agrees that the Investor and the Investor’s professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as the Investor and such Investor’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Shares.

 

(e) The Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and the Company, Alussa or a representative of the Company or Alussa, or by means of contact from the Placement Agents, and the Shares were offered to the Investor solely by direct contact between the Investor and the Company, Alussa or a representative of the Company or Alussa (other than the Placement Agents). The Investor did not become aware of this offering of the Shares, nor were the Shares offered to the Investor, by any other means. The Investor acknowledges that its Shares (i) were not offered to it by any form of general solicitation or general advertising and (ii) are not being offered to it in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws. The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including, without limitation, the Company, Alussa, the Placement Agents, any of their respective affiliates or any control persons, officers, directors, employees, agents or representatives of any of the foregoing), other than the representations and warranties of the Company or Alussa contained in Section 5 of this Subscription Agreement in making its investment or decision to invest in the Company.

 

(f) The Investor acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares, including those set forth in Alussa’s filings with the SEC and the Investor Presentation. The Investor has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Shares, and the Investor has sought such accounting, legal and tax advice as the Investor has considered necessary to make an informed investment decision. The Investor acknowledges that Investor shall be responsible for any of the Investor’s tax liabilities that may arise as a result of the transactions contemplated by this Subscription Agreement, and that neither the Company nor Alussa has provided any tax advice or any other representation or guarantee regarding the tax consequences of the transactions contemplated by the Subscription Agreement.

 

(g) Alone, or together with any professional advisor(s), the Investor has adequately analyzed and fully considered the risks of an investment in the Shares and determined that the Shares are a suitable investment for the Investor and that the Investor is able at this time and in the foreseeable future to bear the economic risk of a total loss of the Investor’s investment in the Company. The Investor acknowledges specifically that a possibility of total loss exists.

 

(h) In making its decision to purchase the Shares, the Investor has relied solely upon independent investigation made by the Investor, the Investor Presentation and the representations and warranties made by Alussa and the Company in Section 5. Without limiting the generality of the foregoing, the Investor has not relied on any statements of the Placement Agents or any of their respective affiliates or any control persons, officers, directors, employees, agents or representatives of any of the foregoing concerning the Company, Alussa, FREYR, the Transaction, the Transaction Agreement, this Subscription Agreement or the transactions contemplated hereby or thereby, the Shares or the offer and sale of the Shares.

 

(i) The Investor acknowledges and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Shares or made any findings or determination as to the fairness of this investment.

 

(j) The Investor, if not a natural person, has been duly formed or incorporated and is validly existing and is in good standing under the laws of its jurisdiction of formation or incorporation, with power and authority to enter into, deliver and perform its obligations under this Subscription Agreement.

 

8

CONFIDENTIAL

 

(k) The execution, delivery and performance by the Investor of this Subscription Agreement are within the powers of the Investor, have been duly authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation of any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the Investor is a party or by which the Investor is bound that would reasonably be expected to have a material adverse effect on the legal authority of Investor to comply in all material respects with the terms of this Subscription Agreement, and will not violate any provisions of the Investor’s organizational documents, including, without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable. The signature of the Investor on this Subscription Agreement is genuine, and the signatory has been duly authorized to execute this Subscription Agreement, and, assuming that this Subscription Agreement constitutes the valid and binding agreement of the Company and Alussa, this Subscription Agreement constitutes a legal, valid and binding obligation of the Investor, enforceable against the Investor in accordance with its terms except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

(l) Neither the Investor nor any of its officers, directors, managers, managing members, general partners or any other person acting in a similar capacity or carrying out a similar function, is (i) a person named on the Specially Designated Nationals and Blocked Persons List, the Foreign Sanctions Evaders List, the Sectoral Sanctions Identification List, or any other similar list of sanctioned persons administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”), or any similar list of sanctioned persons administered by the United Kingdom, the European Union or any individual European Union member state (collectively, “Sanctions Lists”); (ii) directly or indirectly owned or controlled by, or acting on behalf of, one or more persons on a Sanctions List; (iii) organized, incorporated, established, located, resident or born in, or a citizen, national, or the government, including any political subdivision, agency, or instrumentality thereof, of, Cuba, Iran, North Korea, Syria, Venezuela, the Crimea region of Ukraine, or any other country or territory embargoed by the United States, the United Kingdom, the European Union or any individual European Union member state; (iv) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515; or (v) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank (collectively, a “Prohibited Investor”). The Investor represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.) (the “BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the “BSA/PATRIOT Act”), that the Investor maintains policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. Investor maintains policies and procedures reasonably designed to ensure compliance with sanctions and export control laws in each of the jurisdictions in which the Investor operates. Investor maintains policies and procedures reasonably designed to ensure that the funds held by the Investor and used to purchase the Shares were legally derived, and further represents that the funds held by the Investor and used to purchase the shares were legally derived.

 

(m) If the Investor is or is acting on behalf of (i) an employee benefit plan that is subject to Title I of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), (ii) a plan, an individual retirement account or other arrangement that is subject to Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”), (iii) an entity whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement described in clauses (i) and (ii) (each, an “ERISA Plan”), or (iv) an employee benefit plan that is a governmental plan (as defined in Section 3(32) of ERISA), a church plan (as defined in Section 3(33) of ERISA), a non-U.S. plan (as described in Section 4(b)(4) of ERISA) or other plan that is not subject to the foregoing clauses (i), (ii) or (iii) but may be subject to provisions under any other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of ERISA or the Code (collectively, “Similar Laws,” and together with ERISA Plans, “Plans”), the Investor represents and warrants that (A) neither the Company nor, to the Investor’s knowledge, any of its affiliates has provided investment advice or has otherwise acted as the Plan’s fiduciary, with respect to its decision to acquire and hold the Shares, and, to the Investor’s knowledge, none of the parties to the Transaction is or shall at any time be the Plan’s fiduciary with respect to any decision in connection with the Investor’s investment in the Shares; and (B) its purchase of the Shares will not result in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code, or any applicable Similar Law.

 

(n) Other than the Investor Presentation, the Investor acknowledges that it has been informed that no disclosure or offering document has been prepared by the Company, Alussa or any of their respective affiliates or representatives in connection with the offer and sale of the Shares.

 

9

CONFIDENTIAL

 

(o) The Investor acknowledges that it has been informed that none of the Placement Agents, nor any of their respective affiliates, nor any control persons, officers, directors, employees, agents or representatives of any of the foregoing has made or makes any representation or warranty, whether express or implied, of any kind or character and have not provided any advice or recommendation with respect to the Company, Alussa, FREYR or its subsidiaries or any of their respective businesses, or the Shares or the accuracy, completeness or adequacy of any information supplied to the Investor by the Company.

 

(p) In connection with the issue and purchase of the Shares, none of the Placement Agents has acted as the Investor’s financial advisor or fiduciary.

 

(q) The Investor has or has commitments to have and, when required to deliver payment to the Company pursuant to Section 2 above, will have, sufficient funds to pay the Subscription Amount and consummate the purchase and sale of the Shares pursuant to this Subscription Agreement.

 

7. Registration Rights.

 

(a) The Company agrees that, within thirty (30) calendar days following the Closing Date (such deadline, the “Filing Deadline”), the Company will submit to or file with the SEC a registration statement for a shelf registration on Form S-1 or Form S-3 (if the Company is then eligible to use a Form S-3 shelf registration) (the “Registration Statement”), in each case, covering the resale of all of the Shares acquired by the Investor pursuant to this Subscription Agreement (determined as of two (2) business days prior to such submission or filing) (the “Registrable Shares”) and the Company shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) the 90th calendar day following the Closing Date and (ii) the 10th business day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the Registration Statement will not be “reviewed” or will not be subject to further review (such earlier date, the “Effectiveness Deadline”); provided, however, that the Company’s obligations to include the Registrable Shares in the Registration Statement are contingent upon Investor furnishing in writing to the Company such information regarding Investor, the securities of the Company held by Investor and the intended method of disposition of the Registrable Shares (which shall be limited to non-underwritten public offerings) as shall be reasonably necessary and requested by the Company to effect the registration of the Registrable Shares, and Investor shall execute such documents in connection with such registration as the Company may reasonably request that are customary of a selling shareholder in similar situations, including providing that the Company shall be entitled to postpone and suspend the effectiveness or use of the Registration Statement, if applicable, during any customary blackout or similar period or as permitted hereunder; provided that Investor shall not in connection with the foregoing be required to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer the Registrable Shares. For as long as the Investor holds Shares, the Company will use commercially reasonable efforts to file all reports for so long as the condition in Rule 144(c)(1) (or Rule 144(i)(2), if applicable) is required to be satisfied, and provide all customary and reasonable cooperation, necessary to enable the undersigned to resell the Shares pursuant to Rule 144 of the Securities Act (in each case, when Rule 144 of the Securities Act becomes available to the Investor). Any failure by the Company to file the Registration Statement by the Filing Deadline or to effect such Registration Statement by the Effectiveness Deadline shall not otherwise relieve the Company of its obligations to file or effect the Registration Statement as set forth above in this Section 7. In no event shall the Investor or any affiliate of the Investor be identified as a statutory underwriter in the Registration Statement; except that, if the Investor or any affiliate of the Investor is required by the SEC to be identified as a statutory underwriter in the Registration Statement, the Company will provide reasonable advance notice to the Investor of such requirement and the Investor may, in its sole discretion, elect not to include all or a portion of its Shares in the Registration Statement (and such election shall not be considered a breach of this Agreement by the Company). Notwithstanding the foregoing, if the SEC prevents the Company from including any or all of the shares proposed to be registered under the Registration Statement due to limitations on the use of Rule 415 of the Securities Act for the resale of the Shares by the applicable shareholders or otherwise, the Company shall give the Investor prompt written notice thereof and such Registration Statement shall register (by amendment or otherwise) for resale such number of Shares which is equal to the maximum number of Shares as is permitted by the SEC. In such event, the number of Shares to be registered for each selling shareholders named in the Registration Statement shall be reduced pro rata among all such selling shareholders. In the event the Company amends the Registration Statement in accordance with the foregoing, the Company will use its commercially reasonable efforts to file with the SEC, as promptly as allowed by the SEC, one or more registration statements to register the resale of those Registrable Shares that were not registered on the initial Registration Statement, as so amended. All fees and expenses (i) incident to the performance of, or compliance with, this Section 7, or (ii) related to any threatened or actual litigation against the Investor in connection with any alleged breach of the Subscription Agreement or U.S. securities laws, in each case by the Company, shall be borne by the Company.

 

10

CONFIDENTIAL

 

(b) At its expense the Company shall:

 

(i) except for such times as the Company is permitted hereunder to suspend the use of the prospectus forming part of a Registration Statement, use its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state securities laws which the Company determines to obtain, continuously effective with respect to Investor, and to keep the applicable Registration Statement or any subsequent shelf registration statement free of any material misstatements or omissions, until the earlier of the following: (A) Investor ceases to hold any Registrable Shares, (B) the date all Registrable Shares held by Investor may be sold without restriction under Rule 144, including without limitation, any volume and manner of sale restrictions which may be applicable to affiliates under Rule 144 and without the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable), and (C) three years from the date of effectiveness of the Registration Statement;

 

(ii) advise Investor, as expeditiously as possible:

 

(1) when a Registration Statement or any amendment thereto has been filed with the SEC or has become effective;

 

(2) after the issuance by the SEC of any stop order suspending the effectiveness of any Registration Statement or the initiation of any proceedings for such purpose;

 

(3) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable Shares included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and

 

(4) subject to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in any Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made) not misleading.

 

Notwithstanding anything to the contrary set forth herein, the Company shall not, when so advising Investor of such events, provide Investor with any material, nonpublic information regarding the Company other than to the extent that providing notice to Investor of the occurrence of the events listed in (1) through (4) above might constitute material, nonpublic information regarding the Company;

 

(iii) use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement as soon as reasonably practicable;

 

(iv) upon the occurrence of any event contemplated in Section 7(b)(ii)(4) above, except for such times as the Company is permitted hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, the Company shall use its commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the Registrable Shares included therein, such prospectus will not include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;

 

11

CONFIDENTIAL

 

(v) use its commercially reasonable efforts to cause all Registrable Shares to be listed on the NYSE;

 

(vi) allow the Investor to review and consent to disclosure specifically regarding the Investor in the Registration Statement on reasonable advance notice (which consent shall not be unreasonably withheld);

 

(vii) if the SEC shall at any time object to the inclusion of Registrable Shares in the Registration Statement, give prompt notice to the Investor and its counsel and give them fair and reasonable time (but, in any event, at least three (3) business days) to respond and discuss with the Company, prior to answering the SEC or agreeing to the exclusion of such Registrable Shares from the Registration Statement; and

 

(viii) otherwise, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Investor, consistent with the terms of this Agreement, in connection with the registration of the Registrable Shares.

 

(c) Notwithstanding anything to the contrary in this Subscription Agreement, the Company shall be entitled to delay the filing or effectiveness of, or suspend the use of, the Registration Statement if it reasonably determines that (i) in order for the Registration Statement not to contain a material misstatement or omission, an amendment thereto would be needed; (ii) the negotiation or consummation of a transaction by the Company or its subsidiaries is pending or an event has occurred, which negotiation, consummation or event the Company’s board of directors reasonably believes would require additional disclosure by the Company in the Registration Statement of material information that the Company has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Registration Statement would be expected, in the reasonable determination of the Company’s board of directors to cause the Registration Statement to fail to comply with applicable disclosure requirements, or (iii) in the reasonable judgment of the majority of the Company’s board of directors, such filing or effectiveness or use of such Registration Statement, would be seriously detrimental to the Company and the majority of the Company board of directors concludes as a result that it is essential to defer such filing (each such circumstance, a “Suspension Event”); provided, however, that the Company may not delay or suspend the Registration Statement on more than two (2) occasions or for more than sixty (60) consecutive calendar days, or more than ninety (90) total calendar days, in each case during any twelve-month period. The Company shall not, when so advising Investor of such Suspension Event, provide Investor with any material, nonpublic information regarding the Company other than to the extent that providing notice to Investor of the occurrence of the Suspension Event might constitute material, nonpublic information regarding the Company. Upon receipt of any written notice from the Company of the happening of any Suspension Event during the period that the Registration Statement is effective or if as a result of a Suspension Event the Registration Statement or related prospectus contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein (in light of the circumstances under which they were made, in the case of the prospectus) not misleading, Investor agrees that it will immediately discontinue offers and sales of the Registrable Shares under the Registration Statement (excluding, for the avoidance of doubt, sales conducted pursuant to Rule 144) until Investor receives copies of a supplemental or amended prospectus (which the Company agrees to promptly prepare) that corrects the misstatement(s) or omission(s) referred to above and receives notice that any post-effective amendment has become effective or unless otherwise notified by the Company that it may resume such offers and sales. If so directed by the Company, Investor will deliver to the Company or, in Investor’s sole discretion destroy, all copies of the prospectus covering the Registrable Shares in Investor’s possession; provided, however, that this obligation to deliver or destroy all copies of the prospectus covering the Registrable Shares shall not apply (A) to the extent Investor is required to retain a copy of such prospectus (1) in order to comply with applicable legal, regulatory, self-regulatory or professional requirements or (2) in accordance with a bona fide pre-existing document retention policy or (B) to copies stored electronically on archival servers as a result of automatic data back-up.

 

12

CONFIDENTIAL

 

(d) Indemnification.

 

(i) The Company shall, notwithstanding any termination of this Subscription Agreement, indemnify, defend and hold harmless, to the extent permitted by law Investor, its directors, officers, members, stockholders, partners, agents, brokers, investment advisors and employees, and each person who controls Investor (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the directors, officers, members, stockholders, partners, agents, brokers, investment advisors and employees of each such controlling person, to the fullest extent permitted by law, from and against all losses, claims, damages, liabilities, costs and expenses (including, without limitation, reasonable and documented outside attorneys’ fees) (collectively, “Losses”) that arise out of, are based upon, or caused by any untrue or alleged untrue statement of material fact contained in any Registration Statement, prospectus included in any Registration Statement (“Prospectus”) or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, in the light of the circumstances under which they were made) not misleading, except insofar as the same are based upon, or caused by, or contained in any information or affidavit so furnished in writing to the Company by or on behalf of such Investor expressly for use therein.

 

(ii) In connection with any Registration Statement in which an Investor is participating, such Investor shall furnish (or cause to be furnished) to the Company in writing such necessary information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and officers and each person or entity who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including, without limitation, reasonable and documented outside attorneys’ fees) resulting from any untrue statement of material fact contained or incorporated by reference in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, in the light of the circumstances under which they were made) not misleading, but only to the extent that such untrue statement or omission is contained (or not contained in, in the case of an omission) in any information or affidavit so furnished in writing by on behalf of such Investor expressly for use therein; provided, however, that the liability of each such Investor shall be several and not joint with any other investor and shall be limited to the net proceeds received by such Investor from the sale of Registrable Shares giving rise to such indemnification obligation.

 

(iii) Any person or entity entitled to indemnification herein shall (A) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s or entity’s right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (B) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement includes a statement or admission of fault and culpability on the part of such indemnified party or which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

 

(iv) The indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director, member, stockholder, agent, employee or controlling person of such indemnified party and shall survive the transfer of securities.

 

13

CONFIDENTIAL

 

(v) If the indemnification provided under this Section 7(d) from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any Losses, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such Losses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations; provided, however, the liability of the Investor shall be limited to the net proceeds received by such Investor from the sale of Registrable Shares giving rise to such indemnification obligation. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by (or not made by, in the case of an omission), or relates to information supplied by (or not supplied by, in the case of an omission), such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the Losses referred to above shall be deemed to include, subject to the limitations set forth in Sections 7(c)(i), (ii) and (iii) above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 7(d)(v) from any person or entity who was not guilty of such fraudulent misrepresentation.

 

8. Termination. This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (i) such date and time as the Transaction Agreement is terminated in accordance with its terms, (ii) upon the mutual written agreement of each of the parties hereto to terminate this Subscription Agreement, (iii) if the conditions to Closing set forth in Section 3 of this Subscription Agreement are not satisfied, or are not capable of being satisfied, or waived on or prior to the Closing Date and, as a result thereof, the transactions contemplated by this Subscription Agreement will not be or are not consummated at the Closing Date and (iv) July 31, 2021; provided that nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from any such willful breach. The Company shall notify the Investor of the termination of the Transaction Agreement promptly after the termination of such agreement. Upon the termination of this Subscription Agreement in accordance with this Section 8, any monies paid by the Investor to the Company in connection herewith shall be promptly (and in any event within one business day after such termination) returned to the Investor.

 

9. Trust Account Waiver. The Investor acknowledges that Alussa is a blank check company with the powers and privileges to effect a merger, asset acquisition, reorganization or similar business combination involving Alussa and one or more businesses or assets. The Investor further acknowledges that, as described in Alussa’s prospectus relating to its initial public offering dated November 25, 2019 (the “IPO Prospectus”) available at www.sec.gov, substantially all of Alussa’s assets consist of the cash proceeds of Alussa’s initial public offering and private placement of its securities, and substantially all of those proceeds have been deposited in a trust account (the “Trust Account”) for the benefit of Alussa, its public shareholders and the underwriters of Alussa’s initial public offering. Except with respect to interest earned on the funds held in the Trust Account that may be released to Alussa to pay its tax obligations, if any, the cash in the Trust Account may be disbursed only for the purposes set forth in the IPO Prospectus. For and in consideration of Alussa entering into this Subscription Agreement, the receipt and sufficiency of which are hereby acknowledged, the Investor hereby irrevocably waives any and all right, title and interest, or any claim of any kind it has or may have in the future, in or to any monies held in the Trust Account, and agrees not to seek recourse against the Trust Account, as a result of, or arising out of, this Subscription Agreement; provided however, that nothing in this Section 9 shall be deemed to limit Investor’s right to distributions from the Trust Account in accordance with Alussa’s amended and restated certificate of incorporation in respect of Class A ordinary shares of Alussa acquired by any means other than pursuant to this Subscription Agreement.

 

14

CONFIDENTIAL

 

10. Miscellaneous.

 

(a) Neither this Subscription Agreement nor any rights that may accrue to the Investor hereunder (other than the Shares acquired hereunder, if any, and the rights under Section 7, which shall inure to the benefit of any transferee of Registrable Shares) may be transferred or assigned without the Company’s and Alussa’s written consent, other than an assignment to any affiliate of the Investor or any fund or account managed by the same investment manager as the Investor or an affiliate thereof, subject to, if such transfer or assignment is prior to the Closing, such transferee or assignee, as applicable, executing a joinder to this Subscription Agreement or a separate subscription agreement in substantially the same form as this Subscription Agreement, including with respect to the Subscription Amount and other terms and conditions; provided, that, in the case of any such transfer or assignment, the initial party to this Subscription Agreement shall remain bound by its obligations under this Subscription Agreement in the event that the transferee or assignee, as applicable, does not comply with its obligations to consummate the purchase of Shares contemplated hereby. Neither this Subscription Agreement nor any rights that may accrue to the Company or Alussa hereunder or any of the Company or Alussa’s obligations may be transferred or assigned.

 

(b) The Company and Alussa may request from the Investor such additional information as is necessary for the Company to comply with public disclosure requirements of applicable securities laws or any filing requirements pursuant to the rules of any stock exchange or the Financial Industry Regulatory Authority, and the Investor shall provide such information as may reasonably be requested. The Investor acknowledges that the Company may file a copy of the form of this Subscription Agreement with the SEC as an exhibit to a current or periodic report or a registration statement of the Company.

 

(c) The Company shall use commercially reasonable efforts, if requested by the Investor, to (i) cause the removal of any restrictive legend set forth on the Shares and (ii) issue Shares without any such legend in certificated or book-entry form or by electronic delivery through The Depository Trust Company, at the Investor’s option, provided that in each case (a) such Shares are registered for resale under the Securities Act and the Investor has sold or proposes to sell such Shares pursuant to such registration, (b) the Investor has sold or transferred, or proposes to sell or transfer, Shares pursuant to Rule 144 and (c) the Company, its counsel or the Transfer Agent have received customary representations and other documentation from the Investor that is reasonably necessary to establish that restrictive legends are no longer required as reasonably requested by the Company, its counsel or the Transfer Agent.

 

(d) The Investor acknowledges that the Company, Alussa, the Placement Agents (as third party beneficiaries with rights of enforcement) and others will rely on the acknowledgments, understandings, agreements, representations and warranties of the Investor contained in this Subscription Agreement. Each of the Company and Alussa acknowledges that the Investor will rely on the acknowledgments, understandings, agreements, representations and warranties of the Company and Alussa contained in this Subscription Agreement. Prior to the Closing, the Investor agrees to promptly notify the Company, Alussa and the Placement Agents if any of the acknowledgments, understandings, agreements, representations and warranties of the Investor set forth herein are no longer accurate. Prior to the Closing, each of the Company and Alussa agrees to promptly notify the Investor if any of the acknowledgments, understandings, agreements, representations and warranties of the Company or Alussa set forth herein are no longer accurate.

 

(e) The Company, Alussa, the Placement Agents and the Investor are each entitled to rely upon this Subscription Agreement and each is irrevocably authorized to produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.

 

(f) All of the representations and warranties contained in this Subscription Agreement shall survive the Closing. All of the covenants and agreements made by each party hereto in this Subscription Agreement shall survive the Closing.

 

(g) The obligations of the Investor under this Subscription Agreement are several and not joint with the obligations of any Other Investor under the Other Subscription Agreements, and the Investor shall not be responsible in any way for the performance of any Other Investor.

 

15

CONFIDENTIAL

 

(h) This Subscription Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section 8 above) except by an instrument in writing, signed by each of the parties hereto. No failure or delay of any party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the parties and third party beneficiaries hereunder are cumulative and are not exclusive of any rights or remedies that they would otherwise have hereunder.

 

(i) This Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof. Except as set forth in Sections 7(d), 10(c) and 10(d) with respect to the persons referenced therein, this Subscription Agreement shall not confer any rights or remedies upon any person other than the parties hereto, and their respective successor and assigns.

 

(j) Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns.

 

(k) If any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect.

 

(l) This Subscription Agreement may be executed in one or more counterparts (including by electronic mail or in .pdf) and by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so executed and delivered shall be construed together and shall constitute one and the same agreement.

 

(m) The parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties hereto shall be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement, without posting a bond or undertaking and without proof of damages, to enforce specifically the terms and provisions of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise.

 

(n) This Subscription Agreement shall be governed by, construed and enforced in accordance with the laws of the State of New York without regard to the conflict of laws principles thereof.

 

(o) THE PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK AND THE SUPREME COURT OF THE STATE OF NEW YORK SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS SUBSCRIPTION AGREEMENT AND THE DOCUMENTS REFERRED TO IN THIS SUBSCRIPTION AGREEMENT (UNLESS OTHERWISE PROVIDED THEREIN) AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF OR ANY SUCH DOCUMENT THAT IS NOT SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS SUBSCRIPTION AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH A NEW YORK STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT OR PROCEEDING IN THE MANNER PROVIDED IN THIS SECTION 10(o) OF THIS SUBSCRIPTION AGREEMENT OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW SHALL BE VALID AND SUFFICIENT SERVICE THEREOF.

 

16

CONFIDENTIAL

 

(p) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 10(p).

 

11. Non-Reliance and Exculpation. The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by the Placement Agents and any of their affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing in making its investment or decision to invest in the Company. The Investor acknowledges and agrees that none of the Placement Agents, their respective affiliates or any control persons, officers, directors employees, partners, agents or representatives of any of the foregoing shall be liable to the Investor, or to any other investor, pursuant to this Subscription Agreement or any other subscription agreement related to the private placement of the Shares, the negotiation hereof or thereof or the subject matter hereof or thereof, or the transactions contemplated hereby or thereby, for any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the purchase of the Shares.

 

12. Press Releases. Alussa shall, by 9:00 a.m., New York City time, on the first (1st) business day immediately following the date of this Subscription Agreement, issue one or more press releases or furnish or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure Document”) disclosing, to the extent not previously publicly disclosed, the PIPE Investment, all material terms of the Transaction and any other material, non-public information that the Company and Alussa have provided to the Investor at any time prior to the filing of the Disclosure Document. From and after the disclosure of the Disclosure Document, to the knowledge of the Company and Alussa, the Investors shall not be in possession of any material, non-public information received from the Company, Alussa or any of their respective officers, directors or employees. All press releases or other public communications relating to the transactions contemplated hereby between the Company, Alussa and the Investor, and the method of the release for publication thereof, shall be subject to the prior approval of (i) Alussa, (ii) the Company and (iii) to the extent such press release or public communication references the Investor or its affiliates or investment advisers by name, the Investor. The restrictions in this Section 12 shall not apply to the extent a public announcement is required by applicable securities law, any governmental authority or stock exchange rule; provided, that in such an event, the applicable party shall, to the extent practicable, (A) consult with the other parties in advance as to any applicable announcement’s form, content and timing, (B) provide Investor advance notice and opportunity to review and comment on such disclosure and such commercially reasonable comments shall be incorporated therein and (C) limit the extent of such disclosure.

 

13. Confidentiality. Except as expressly authorized for use hereunder or as required to be disclosed by public disclosure requirements of applicable securities laws or any filing requirements pursuant to the rules of any stock exchange or the Financial Industry Regulatory Authority, without the prior written consent of Investor, each of the Company, Alussa, the Placement Agents and their respective directors, officers, agents, employees or representatives shall maintain and keep confidential all information provided by the Investor (whether oral or written) in connection with this Subscription Agreement.

 

17

CONFIDENTIAL

 

14. Notices. All notices and other communications among the parties shall be in writing and shall be deemed to have been duly given (i) when delivered in person, (ii) when delivered by FedEx or other nationally or internationally recognized overnight delivery service, or (iii) when delivered by email (in each case in this clause (iii), solely if receipt is confirmed, but excluding any automated reply, such as an out-of-office notification), addressed as follows:

 

If to the Investor, to the address provided on the Investor’s signature page hereto.

 

If to Alussa or the Company, to:

 

Alussa Energy Acquisition Corp.
PO Box 500, 71 Fort Street

Grand Cayman KY1-1106

Cayman Islands

Attention: Daniel Barcelo

Email: daniel@alussaenergy.com

 

 

with copies to (which shall not constitute notice), to:

 

Skadden, Arps, Slate, Meagher & Flom (UK) LLP
40 Bank Street
London, United Kingdom E14 5DS

Attention: Danny Tricot
    Denis Klimentchenko
Email: danny.tricot@skadden.com
    denis.klimentchenko@skadden.com

 

 

or to such other address or addresses as the parties may from time to time designate in writing. Copies delivered solely to outside counsel shall not constitute notice.

 

 

[SIGNATURE PAGES FOLLOW]

 

18

CONFIDENTIAL

 

IN WITNESS WHEREOF, the Investor has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the date set forth below.

 

Name of Investor:   State/Country of Formation or Domicile:
     
By:      
Name:      
Title:      
     
Name in which Shares are to be registered (if different):   Date: ________, 2021
     
Investor’s EIN:    
     
Business Address-Street:   Mailing Address-Street (if different):
     
City, State, Zip:   City, State, Zip:
     
Attn:     Attn:  
         
Telephone No.:   Telephone No.:
     
Facsimile No.:   Facsimile No.:
     
Number of Shares subscribed for:    
     
Aggregate Subscription Amount: $   Price Per Share: $10.00

 

You must pay the Subscription Amount by wire transfer of United States dollars in immediately available funds to the account specified by the Company in the Closing Notice.

 

 

[Signature Page to Subscription Agreement]

 

19

CONFIDENTIAL

 

IN WITNESS WHEREOF, FREYR Battery and Alussa Energy Acquisition Corp. have accepted this Subscription Agreement as of the date set forth below.

 

  FREYR BATTERY
   
  By:  
    Name:
    Title:

 

 

  ALUSSA ENERGY ACQUISITION CORP.
   
  By:  
    Name:
    Title:

 

Date: January ______ , 2021

 

 

[Signature Page to Subscription Agreement]

 

20

CONFIDENTIAL

 

SCHEDULE A

 

ELIGIBILITY REPRESENTATIONS OF THE INVESTOR

 

A. QUALIFIED INSTITUTIONAL BUYER STATUS
(Please check the applicable subparagraphs):

 

We are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act).

 

B. INSTITUTIONAL ACCREDITED INVESTOR STATUS
(Please check the applicable subparagraphs):

 

We are an “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act) or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.”

 

Rule 501(a), in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to the Investor and under which the Investor accordingly qualifies as an “accredited investor.”

 

Any bank, registered broker or dealer, insurance company, investment adviser registered pursuant to Section 203 of the Investment Advisers Act of 1940 or state laws, investment adviser relying on exemption from registration under Section 203(l) or (m) of the Investment Advisers Act of 1940, registered investment company, business development company, small business investment company, or rural business investment company;

 

Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, partnership, or limited liability company, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person; or

 

Any entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

  

This page should be completed by the Investor
and constitutes a part of the Subscription Agreement.

 

 

[Schedule A to Subscription Agreement]

 

Sch. A-1

Exhibit 99.1

 

 

Joint Press Release

 

FREYR, a Developer of Clean, Next-Generation Battery Cells, to List on NYSE Through a Business Combination with Alussa Energy Acquisition Corp.

 

FREYR has entered into a definitive business combination agreement with Alussa Energy Acquisition Corp. (NYSE: ALUS); upon closing, the combined company will be renamed “FREYR Battery” and be listed on the New York Stock Exchange under the new ticker symbol “FREY”

 

FREYR’s mission is to accelerate the decarbonization of transportation and energy systems by delivering the world’s cleanest and most cost-effective batteries

 

FREYR is expected to receive approximately $850 million in equity proceeds as a part of the business combination, enabling the company to accelerate the development of up to 43 GWh of clean battery cell manufacturing capacity in Norway by 2025

 

Transaction includes a $600 million fully committed Private Investment in Public Equity (“PIPE”) anchored by strategic and institutional investors, including Koch Strategic Platforms, Glencore, Fidelity Management & Research Company LLC, Franklin Templeton, Sylebra Capital and Van Eck Associates Corporation

 

100% of FREYR’s existing shares will roll over into in the combined company

 

Pro forma equity value of the combined company would be approximately $1.4 billion

 

NEW YORK, NY and OSLO, Norway, January 29, 2021 -- FREYR AS, (the “Company” or “FREYR”), a Norway-based developer of clean, next-generation battery cell production capacity, today announced that it will become a publicly listed company through a business combination with Alussa Energy Acquisition Corp. (“Alussa Energy”) (NYSE: ALUS), a Cayman Islands exempted, publicly listed special purpose acquisition company (“SPAC”). The transaction represents a pro forma equity value of $1.4 billion for the combined company upon closing which will be named “FREYR Battery” (“Pubco”). Pubco’s common stock is expected to start trading on the New York Stock Exchange under the ticker symbol FREY upon closing, expected in the second quarter of 2021.

 

FREYR is targeting development of up to 43 GWh of battery cell production capacity in Norway by 2025 to position the Company as one of Europe’s largest battery cell suppliers. FREYR expects to deliver safer, higher energy density and lower cost clean battery cells made with renewable energy from an ethically and sustainably sourced supply chain. The Company’s ambition is to become the battery cell producer with the lowest lifecycle carbon footprint in the world. FREYR plans to utilize Norway’s inherent advantages, including access to renewable energy, some of Europe’s lowest electricity prices and shorter delivery distances to main markets in Europe and the US as compared to competitors in Asia.

 

The Company is partnering strategically on next-generation semi-solid battery cell technology that is expected to materially reduce manufacturing costs and provide a highly competitive market position for FREYR. The Company’s solutions will address the rapidly growing global markets for electric vehicles, energy storage, and marine applications, representing an estimated addressable market of about 5,000 GWh per year by 2030.

 

 

 

 

 

Daniel Barcelo, Chief Executive Officer and Founder of Alussa Energy, commented, “We are excited and privileged to partner with FREYR, as this transaction represents a compelling investment opportunity to address the rapidly growing market for electrification of global transportation and energy systems. Furthermore, Norway with its entrepreneurial cities like Mo i Rana provide a great foundation for FREYR’s Gigafactories. We evaluated over 75 investment opportunities across the global energy and energy transition sectors since our IPO in late 2019, and FREYR clearly stood out as a frontline player in adopting leading-edge battery technology to address a significant and growing market with a unique commitment to full-cycle sustainability. We have full confidence that FREYR’s experienced execution team, combined with the capital resources from this transaction, including strategic investors Koch Strategic Platforms and Glencore, makes the Company well-positioned to play a transformational role in decarbonizing global energy and transportation markets.”

 

Tom Jensen, Chief Executive Officer of FREYR, said, “We believe the combination of foundational capital from committed investors with commercially available, advanced battery solutions is the fastest way to accelerate the energy transition. FREYR is dedicated to delivering one of the most sustainable and cost-effective clean battery cells based on 100% renewable energy and ethically sourced raw materials. We are truly excited to share our ambition with Alussa Energy and some of the leading international investors as we embark on our plan for the production of one of the most environmentally friendly battery cells in the world. We believe our partnership-based business model positions FREYR to accelerate long-term value creation by targeting sustainable, superior returns to our shareholders and stakeholders.”

 

Torstein Dale Sjøtveit, Founder and Executive Chairman of FREYR, continued, “FREYR has attracted a diversified and experienced team, partners and initial customers in a short period of time. The capital raise and NYSE listing add further momentum to our progress and positions us as a catalyst for European battery cell production and the Nordic battery ecosystem. We see this transaction as a strong confirmation of FREYR’s growth potential enabled by cutting-edge technology and access to clean renewable energy. Moving ahead, FREYR will focus on executing our project plans, attracting more talent, cultivating partnerships and providing our customers with sustainable and cost-effective clean battery cells.”

 

Todd Kantor, Portfolio Manager of Encompass Capital Advisors LLC, a Member of Alussa Energy’s Sponsor, added, “As a hedge fund primarily focused on investing across the energy eco-chain, we view FREYR as one of the most exciting investment opportunities in the energy transition movement, particularly given the Company’s potential to deliver innovative electrification solutions through a sustainable and clean platform.”

 

Transaction Overview

 

The business combination values the combined company at an implied $1.4 billion pro forma equity value. The transaction will provide an estimated $850 million of net proceeds to the Company, assuming no redemptions by Alussa Energy shareholders, including a $600 million fully committed PIPE at $10.00 per share of the Company anchored by strategic and institutional investors, including Koch Strategic Platforms, Glencore, Fidelity Management & Research Company LLC, Franklin Templeton, Sylebra Capital and Van Eck Associates Corporation. 100% of FREYR’s existing shares will roll over into the combined company.

 

The transaction implies an equity value of FREYR of approximately $410 million. Current FREYR shareholders (fully diluted) are expected to own approximately 30% of the combined company after transaction close, representing an exchange ratio of approximately 0.179031 of shares of the combined company for each share of FREYR based on the currently available information and assuming a $600 million PIPE.

 

The boards of directors of both Alussa Energy and FREYR have approved the proposed business combination, which is expected to be completed in the second quarter of 2021, subject to, among other things, the approval by Alussa Energy’s and FREYR’s shareholders and satisfaction or waiver of other customary conditions set forth in the definitive documentation.

 

2

 

 

 

Additional information about the proposed transactions contemplated by the business combination agreement (the “Transaction”), including a copy of the business combination agreement and investor presentation, will be provided in a Current Report on Form 8-K to be filed by Alussa Energy with the Securities and Exchange Commission (“SEC”) and available at www.sec.gov.

 

Advisors

 

Credit Suisse Securities (USA) LLC acted as the equity capital markets advisor to Alussa Energy. Credit Suisse Securities (USA) LLC, BTIG, LLC and BTIG Norway AS acted as the financial advisors to Alussa Energy. Skadden Arps, Slate, Meagher & Flom LLP served as M&A legal counsel to Alussa Energy, Ellenoff Grossman & Schole LLP served as securities counsel to Alussa Energy, Wiersholm AS served as Norwegian counsel to Alussa Energy, and Appleby (Cayman) Ltd served as Cayman Islands legal counsel to Alussa Energy. Rystad Energy and Sustainable Governance Partners acted as business and environmental, social and governance advisors, respectively, to Alussa Energy. Kite Hill PR LLC acted as the public relations advisor to Alussa Energy.

 

Wilson Sonsini Goodrich & Rosati P.C. served as U.S. legal counsel to FREYR, and Advokatfirmaet BAHR AS, served as Norwegian legal counsel to FREYR. Crux Advisers AS acted as investor relations and communications adviser to FREYR.

 

Credit Suisse Securities (USA) LLC, BTIG, LLC and Pareto Securities AS served as placement agents for the PIPE financing. Davis Polk & Wardwell LLP served as legal counsel to the placement agents.

 

Investor Webcast / Conference Call Information

 

FREYR and Alussa Energy will host a joint investor conference call to discuss the proposed business combination today, Friday, January 29, 2021 at 8:00 EST/14:00 CET.

 

To follow the conference call via webcast, please use this link:

https://streams.eventcdn.net/freyer/investor-conference-call/

 

To listen to the prepared remarks via telephone, please dial
US: +1-833-350-1443
NO: +47 23 96 63 25
Conference ID: 4357642

 

About FREYR A/S

 

FREYR plans to develop up to 43 GWh of battery cell production capacity by 2025 to position the company as one of Europe’s largest battery cell suppliers. The facilities will be located in the Mo i Rana industrial complex in Northern Norway, leveraging Norway’s highly skilled workforce and abundant, low-cost renewable energy sources from hydro and wind in a crisp, clear and energized environment. FREYR will supply safe, high energy density and cost competitive clean battery cells to the rapidly growing global markets for electric vehicles, energy storage, and marine applications. FREYR is committed to supporting cluster-based R&D initiatives and the development of an international ecosystem of scientific, commercial, and financial stakeholders to support the expansion of the battery value chain in our region. For more information, please visit www.freyrbattery.com.

 

3

 

 

 

About Alussa Energy Acquisition Corp.

 

Alussa Energy is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While Alussa Energy may pursue an acquisition opportunity in any industry or sector, Alussa Energy intends to focus on businesses across the entire global energy supply chain. For more information, please visit www.alussaenergy.com.

 

Forward-Looking Statements

 

This press release contains, and certain oral statements made by representatives of Alussa Energy and FREYR and their respective affiliates, from time to time may contain, “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Alussa Energy’s, Pubco’s and FREYR’s actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “might” and “continues,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, Alussa Energy’s, Pubco’s and FREYR’s expectations with respect to future performance of the combined company, anticipated financial impacts of the Transaction, the anticipated addressable market for the combined company, the satisfaction of the closing conditions to the Transaction, the exchange ratio (which is subject to certain inputs that may change prior to completion of the Transaction) and the timing of the completion of the Transaction. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expected results. Most of these factors are outside the control of Alussa Energy, Pubco or FREYR and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement; (2) the inability to consummate the Transaction, including due to failure to obtain approval of the shareholders of Alussa Energy or other conditions to the Closing in the Business Combination Agreement; (3) the failure of investors in the PIPE to fund their commitments upon the Closing; (4) delays in obtaining or the inability to obtain any necessary regulatory approvals required to complete the Transaction; (5) the inability to obtain the listing of Pubco’s ordinary shares on the New York Stock Exchange following the Transaction; (6) the risk that the Transaction disrupts current plans and operations as a result of the announcement and consummation of the Transaction; (7) the ability to recognize the anticipated benefits of the Transaction, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth economically and hire and retain key employees; (8) costs related to the Transaction; (9) changes in applicable laws or regulations; (10) the effect of the COVID-19 pandemic on Alussa Energy, Pubco and FREYR and their ability to consummate the Transaction; (11) the possibility that Alussa Energy, Pubco or FREYR may be adversely affected by other economic, business, and/or competitive factors; and (12) other risks and uncertainties to be identified in the registration/proxy statement (when available) relating to the Transaction, including those under “Risk Factors” therein, and in other filings with the SEC made by Alussa Energy, Pubco and FREYR. Alussa Energy, Pubco and FREYR caution that the foregoing list of factors is not exclusive, and caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. None of Alussa Energy, Pubco or FREYR undertakes or accepts any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, subject to applicable law.

 

No Offer or Solicitation

 

This press release is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities pursuant to the Transaction or otherwise, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

 

4

 

 

 

No Assurances

 

There can be no assurance that the Transaction will be completed, nor can there be any assurance, if the Transaction is completed, that the potential benefits of combining the companies will be realized.

 

Information Sources; No Representations

 

This press release has been prepared for use by Alussa Energy, Pubco and FREYR in connection with the Transaction. The information herein does not purport to be all-inclusive. The information herein is derived from various internal and external sources, with all information relating to the business, past performance, results of operations and financial condition of Alussa Energy was derived entirely from Alussa Energy and all information relating to the business, past performance, results of operations and financial condition of FREYR and Pubco was derived entirely from FREYR. No representation is made as to the reasonableness of the assumptions made with respect to the information herein, or to the accuracy or completeness of any projections or modeling or any other information contained herein. Any data on past performance or modeling contained herein is not an indication as to future performance.

 

No representations or warranties, express or implied, are given in respect of this press release. To the fullest extent permitted by law in no circumstances will Alussa Energy, Pubco or FREYR, or any of their respective subsidiaries, affiliates, shareholders, representatives, partners, directors, officers, employees, advisors or agents, be responsible or liable for any direct, indirect or consequential loss or loss of profit arising from the use of this press release, its contents (including without limitation any projections or models), any omissions, reliance on information contained within it, or on opinions communicated in relation thereto or otherwise arising in connection therewith, which information relating in any way to the operations of FREYR or Pubco has been derived, directly or indirectly, exclusively from FREYR and has not been independently verified by Alussa Energy. Neither the independent auditors of Alussa Energy nor the independent auditors of FREYR or Pubco audited, reviewed, compiled or performed any procedures with respect to any projections or models for the purpose of their inclusion in this press release and, accordingly, neither of them expressed any opinion or provided any other form of assurances with respect thereto for the purposes of this press release.

 

Important Information about the Transaction and Where to Find It

 

In connection with the Transaction, Alussa Energy and Pubco will file relevant materials with the SEC, including a Form S-4 registration statement to be filed by Pubco (the “S-4”), which will include a prospectus with respect to Pubco’s securities to be issued in connection with the proposed business combination and a proxy statement (the “Proxy Statement”) with respect to Alussa Energy’s shareholder meeting at which Alussa Energy’s shareholders will be asked to vote on the proposed Business Combination and related matters. ALUSSA ENERGY SHAREHOLDERS AND OTHER INTERESTED PERSONS ARE ADVISED TO READ, WHEN AVAILABLE, THE S-4 AND THE AMENDMENTS THERETO AND OTHER INFORMATION FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION, AS THESE MATERIALS WILL CONTAIN IMPORTANT INFORMATION ABOUT ALUSSA ENERGY, PUBCO, FREYR AND THE TRANSACTION. When available, the Proxy Statement contained in the S-4 and other relevant materials for the Transaction will be mailed to shareholders of Alussa Energy as of a record date to be established for voting on the proposed business combination and related matters. The preliminary S-4 and Proxy Statement, the final S-4 and definitive Proxy Statement and other relevant materials in connection with the Transaction (when they become available), and any other documents filed by Alussa Energy with the SEC, may be obtained free of charge at the SEC’s website (www.sec.gov) or by writing to Alussa Energy Acquisition Corp. at c/o PO Box 500, 71 Fort Street, Grand Cayman KY1-1106, Cayman Islands.

 

5

 

 

 

Participants in Solicitation

 

Alussa Energy, Pubco and FREYR and their respective directors, executive officers and employees and other persons may be deemed to be participants in the solicitation of proxies from the holders of Alussa Energy ordinary shares in respect of the proposed business combination. Alussa Energy shareholders and other interested persons may obtain more detailed information regarding the names and interests in the Transaction of Alussa Energy’s directors and officers in Alussa Energy’s and Pubco’s filings with the SEC, including when filed, the S-4 and the Proxy Statement. These documents can be obtained free of charge from the sources indicated above.

 

For investor inquiries, please contact:

 

For FREYR:

Steffen Føried

Chief Financial Officer

(+47) 975 57 406

steffen.foreid@freyrbattery.com

 

For Alussa Energy:

Chi Chow
Investor Relations

cchow@alussaenergy.com

Tel: 929-303-6514

 

For media inquiries, please contact:

 

For Alussa Energy:

Emma Wolfe
alussa@kitehillpr.com

 

 

6

 

 

Exhibit 99.2

 

January 2021 Clean Battery Solutions for a Better Planet

 

 

Legal Disclaimer 2 This presentation has been prepared for use by Alussa Energy Acquisition Corp. (“Alussa”) and FREYR AS (“FREYR”) in connection with their proposed business combination. This presentation is for information purposes only and is being provided to you solely in your capacity as a potential investor in considering an investment in Alussa and may not be reproduced or redistributed, in whole or in part, without the prior written consent of Alussa and FREYR. Neither Alussa nor FREYR makes any representation or warranty as to the accuracy or completeness of the information contained in this presentation. This presentation is not intended to be all - inclusive or to contain all the information that a person may desire in considering an investment in Alussa and is not intended to form the basis of any investment decision in Alussa. You should consult your own legal, regulatory, tax, business, financial and accounting advisors to the extent you deem necessary, and must make your own investment decision and perform your own independent investigation and analysis of an investment in Alussa and the transactions contemplated in this presentation. This presentation shall neither constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. The information contained in this presentation is only addressed to and directed at persons in member states of the European Economic Area and the United Kingdom (each a “Relevant State”) who are “qualified investors” within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129) (“Qualified Investors”). In addition, in the United Kingdom, the presentation is being distributed only to, and is directed only at, Qualified Investors who are persons (i) having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) (ii) falling within Article 49(2)(a) to (d) of the Order, or (iii) to whom it may otherwise lawfully be communicated (all such persons together being referred to as “Relevant Persons”). The information must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any Relevant State, by persons who are not Qualified Investors. Any investment or investment activity to which the information relates is available only to or will be engaged in only with, (i) Relevant Persons in the United Kingdom, and (ii) Qualified Investors in any Relevant State. NEITHER THE SECURITIES AND EXCHANGE COMMISSION (“SEC”) NOR ANY STATE OR TERRITORIAL SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE SECURITIES OR DETERMINED IF THIS PRESENTATION IS TRUTHFUL OR COMPLETE. Industry and Market Data . The data contained herein is derived from various internal and external sources. No representation is made as to the reasonableness of the assumptions made within or the accuracy or completeness of any projections or modeling or any other information contained herein. Any data on past performance or modeling contained herein is not an indication as to future performance. Alussa and FREYR assume no obligation to update the information in this presentation. Further, these financials were prepared by FREYR in accordance with private Company AICPA standards. FREYR is currently in the process of uplifting its financials to comply with public company and SEC requirements. Use of Projections . The financial projections, estimates and targets in this presentation are forward - looking statements that are based on assumptions that are inherently subject to significant uncertainties and contingencies, many of which are beyond Alussa’s and FREYR’s control. While all financial projections, estimates and targets are necessarily speculative, Alussa and FREYR believe that the preparation of prospective financial information involves increasingly higher levels of uncertainty the further out the projection, estimate or target extends from the date of preparation. The assumptions and estimates underlying the projected, expected or target results are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the financial projections, estimates and targets. The inclusion of financial projections, estimates and targets in this presentation should not be regarded as an indication that Alussa and FREYR, or their representatives, considered or consider the financial projections, estimates and targets to be a reliable prediction of future events. Use of Non - GAAP Financial Measures . This presentation includes certain financial measures, including EBITDA and EBITDA Margin, and measures calculated based on these measures, that are not prepared in accordance with accounting principles generally accepted in the United States ("GAAP") and that may be different from non - GAAP financial measures used by other companies. These non - GAAP measures, and other measures that are calculated using these non - GAAP measures, are an addition, and not a substitute for or superior to measures of financial performance prepared in accordance with GAAP and should not be considered as an alternative to operating income, net income or any other performance measures derived in accordance with GAAP. FREYR believes that these non - GAAP measures of financial results (including on a forward - looking basis) provide useful supplemental information to investors about FREYR. FREYR’s management uses forward looking non - GAAP measures to evaluate FREYR’s projected financial and operating performance. However, there are a number of limitations related to the use of these non - GAAP measures and their nearest GAAP equivalents. For example other companies may calculate non - GAAP measures differently, or may use other measures to calculate their financial performance, and therefore FREYR’s non - GAAP measures may not be directly comparable to similarly titled measures of other companies. Additionally, to the extent that forward - looking non - GAAP financial measures are provided, they are presented on a non - GAAP basis without reconciliations of such forward - looking non - GAAP measures due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliations. Additional Information; Participants in the Solicitation . If the contemplated business combination is pursued, Alussa will be required to file a preliminary and definitive proxy statement, which may include a registration statement, and other relevant documents with the SEC. Stockholders and other interested persons are urged to read the proxy statement and any other relevant documents filed with the SEC when they become available because they will contain important information about Alussa, FREYR and the contemplated business combination. Shareholders will be able to obtain a free copy of the proxy statement (when filed), as well as other filings containing information about Alussa, FREYR and the contemplated business combination, without charge, at the SEC’s website located at www.sec.gov. Alussa and its directors and executive officers may be deemed to be participants in the solicitation of proxies from Alussa’s shareholders in connection with the proposed transaction. A list of the names of such directors and executive officers and information regarding their interests in the business combination will be contained in the proxy statement/prospectus when available. You may obtain free copies of these documents as described in the preceding paragraph. This Presentation does not contain all the information that should be considered in the contemplated business combination. It is not intended to form any basis of any investment decision or any decision in respect to the contemplated business combination. The definitive proxy statement will be mailed to shareholder as of a record date to be established for voting on the contemplated business combination when it becomes available. Forward Looking Statements . Certain statements in this presentation may constitute “forward - looking statements” within the meaning of the federal securities laws. Forward - looking statements include, but are not limited to, statements with respect to (i) FREYR’s Gigafactory development, including the expected cost, capacity and start date of such facilities, (ii) trends in the battery market, (iii) FREYR’s targeted customers and suppliers and the expected arrangement with them, (iv) FREYR’s projected operational performance, including relative to its competitors and (v) other statements regarding Alussa’s or FREYR’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward - looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “exp ect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward - looking statements, but the absence of these words does not mean that a statement is not forward - looking. Forward - looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of Alussa’s registration statement on Form S - 1, the proxy statement/prospectus on Form S - 4 relating to the business combination, which is expected to be filed by Alussa with the SEC and other documents filed by Alussa from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward - looking statements. Forward - looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward - looking statements, and Alussa and FREYR assume no obligation and do not intend to update or revise these forward - looking statements, whether as a result of new information, future events, or otherwise. Neither Alussa nor FREYR gives any assurance that either Alussa or FREYR will achieve its expectations.

 

 

Transaction Overview O verview ▪ FREYR is a developer of clean, next - generation battery cells targeting ~43 GWh of capacity by 2025 ▪ Alussa Energy Acquisition Corp. is a Special Purpose Acquisition Company focused on global energy markets with $290 million in cash held in trust ▪ Alussa Energy and FREYR are combining with a goal to accelerate the development of FREYR’s clean, fully sustainable battery cell production in Norway ▪ FREYR will trade under the ticker symbol ‘FREY’ on the NYSE F REYR Team Proposed Transaction Summary C apital Structure ▪ Anticipated PIPE of $600 million ▪ Transaction proceeds are being retained to grow FREYR’s business ▪ 100% of FREYR’s existing shares will roll over into the combined company, comprising ~30% of the pro forma equity at closing 1) ▪ Pro forma for the transaction (assuming no redemptions): – FREYR will hold $849 million of cash to fund growth based on cash held in trust and PIPE proceeds – Equity capital for the execution of planned development of up to ~43 GWh of battery cell production capacity ▪ Potential OSEBX listing within 12 - 24 months Valuation ▪ Transaction implies a post - transaction enterprise value of $529 million and equity value of $1.4 billion – 0.8x 2025e EBITDA of $703 million ▪ Highly attractive entry valuation relative to battery peer group metrics 1) See Slide 34 for key assumptions and additional details Torstein Dale Sjøtveit Executive Chairman & Founder Alussa Energy Acquisition Corp. Alussa Energy views FREYR as a strong early - stage opportunity to invest in one of the world’s cleanest, most advanced battery cell producers Tom Einar Jensen Chief Executive Officer & Co - Founder Steffen Føreid Chief Financial Officer Peter Matrai Board Member & Co - Founder James Musselman, Chairman of the Board Daniel Barcelo, Chief Executive Officer & President Todd Kantor, Encompass Capital, A Member of our Sponsor 3

 

 

O ur Mission: Accelerating the decarbonization of all transportation and energy systems by delivering the world’s cleanest and most cost - effective batteries “As a society, we must substantially accelerate our efforts to reduce CO 2 emissions at scale over the next ten years. Electrification and batteries are instrumental parts of the solution, representing one of the most exciting and sustainable growth vectors in the market.” Torstein Dale Sjøtveit Executive Chairman & Founder 4

 

 

FREYR: A Low Carbon, Cost Advantaged Battery Supplier Shift to renewable power grids and electric vehicles driving demand for energy storage Shift to renewable power grids and electric vehicles driving demand for energy storage A highly attractive market entry opportunity… …captured by a well - positioned emerging player Positioned as an industry cost leader in 2025 Targeted partnerships provide flexible, technology - agnostic development Equity funded model for up to ~43 GWh of production capacity Aiming to be the lowest carbon battery cell producer in the world Highly attractive entry valuation relative to battery peer group metrics 25 – 30% expected long - term EBITDA margins 2 0 3 0 e ~ 5 , 3 0 0 GWh of D e m a n d GWh Supply Shortfall ~ 3 , 7 0 0 32 % Estimated 2020 – 2030 demand CAGR …utilizing Norway’s unique advantages… Cost advantage from among the lowest electricity prices in Europe Carbon advantage from renewable, sustainable input sources Logistics advantage from clean Nordic battery supply to European markets 5

 

 

Delivering clean, low - cost battery cells from an ethically and sustainably - sourced supply chain Cell production is the segment with the highest revenue share within the battery value chain Strategic partnering of next - generation semi - solid battery cell technology is expected to materially reduce costs Leveraging Norway’s skilled workforce and abundant, low - cost renewable energy sources to target net zero carbon Planning for ~43 GWh of capacity by 2025 to position as one of Europe’s largest cell suppliers, displacing dependency on Asian imports Projected 2025e Revenue and EBITDA of $2.9 billion and $703 million, respectively 1) FREYR at a Glance: Addressing the Life Cycle Carbon Footprint of Battery Cells $78 $62 Targeting Lower Battery Cell Costs 2) ($/kWh) 20% Lower ~ 80 ~ 1 5 Targeting Lower Carbon Footprint 2) (kg CO 2e /kWh) 81% Lower Global average Global average Source: Study commissioned from global management consultancy 6 1) See Slide 33 for key assumptions and additional details 2) Global average based on stated sources, FREYR data based on company projections

 

 

2022 Norway (NO4) G e r m a n y N e t he r l a n d s U K Norway’s Advantage: Among the Lowest Carbon Intensity & Electricity Prices in Europe Carbon Intensity of Electricity Produced Electricity Price Estimates, 2022 - 40 1) Source: electricityMap.org, Dec 2020 FREYR has signed a MoU for the delivery of electricity in Mo i Rana 3) 1) Source: The Norwegian Water Resources and Energy Directorate (NVE), Oct 2019 2) Point estimates for 2022 and 2040 for these countries. Estimates for 2025 and 2030 are interpolations between the prices of 2022 and 2040; Eastern Europe is an average of prices in Poland, Estonia, Latvia and Lithuania 3) MOU Based on spot price + margin for up to 200GWh. Source: Company data 2025 Sweden 2) France 2030 Finland 2) 2040 Eastern Europe 2) E U R / M W h 50 45 40 35 30 25 20 7

 

 

Our Targeted Value Chain Partners are Innovative, Global Leaders ▪ Global technology leader in renewable and fuel - efficient conventional energies ▪ MOU on offtake for marine and energy storage systems (ESS) applications ▪ Revolutionizing the lithium - ion cell manufacturing process and platform ▪ Strategic technology partner with FREYR for semi - solid technology Technology Supply Chain Product Offtake ▪ Leading Norway - based manufacturer of environmentally responsible metals and materials ▪ Active anode material supply targeting higher silicon content ▪ One of the world’s largest chemical producers in 2019 ▪ Active cathode material supply targeting higher voltage materials ▪ Major Japanese trading company & leader in domestic ESS ▪ MOU on offtake for domestic ESS for European & US markets ▪ Itochu is an investor in 24M Source: Company reports ▪ Leading integrated independent renewable power producer ▪ Pursuing combined solar and battery deployments globally ▪ MOU on offtake for high energy density, low cost ESS systems ▪ Leading global producer of sustainably - sourced battery raw materials ▪ Nickel, copper and cobalt with transparency and traceability based on blockchain technology ▪ A Leading Japanese trading company for non - ferrous metals ▪ Part of the broader Sumitomo group with broad activities in battery materials ▪ Leading international logistics company and one of the largest container shipping lines ▪ MOU to develop sustainable battery solutions for end - to - end logistics ▪ Supporting Maersk’s goal of decarbonizing its fleet 8

 

 

Investment Highlights 1 Clean and Low - Cost Battery Cells 2 High Growth Energy Storage and Electric Vehicle Markets 3 Innovative and Disruptive Semi - Solid Technology 4 Advantaged Margins from a Partnership - Based Business Model 5 Experienced Execution Team 9

 

 

Mo i Rana, Norway Clean and Low - Cost Battery Cells

 

 

FREYR Focuses on the Core of the Battery Value Chain 1) Percentage of total value added per value chain step, based on expected 2030 demand from transportation, energy storage and consumer electronics applications + battery pack prices 2 8 % 1 1 % 2 5 % 4 % Value add: 1) = 100% Cathode materials Anode materials Separator materials Electrolyte materials Battery cell Mining and Refining Active m a t e r i a l s Cell 32% Pack/ M o d u l e s R e c y c l i n g Initial Focus Partnership - based value chain integration strategy 11 Source: Study commissioned from global management consultancy

 

 

FREYR Advantage: Targeting 81% Lower CO 2 e Emissions ~ 8 0 1 FREYR ‘net zero’ cell production ( ~ 25 ) Active material production in Norway/Nordics 2) ( ~ 15 ) Building a Nordic ecosystem of additional supply 2) ( ~ 15 ) Packaging and recycling 2) ( ~ 10 ) = ~15 Global Battery Industry CO 2 e Baseline 1) : Emissions kg CO 2 /kWh 2 3 4 FREYR Target CO 2 e Emissions Level 3) : 1) Global battery industry average for 2020 2) Estimated medium - term benefits from localized Supply Chain 3) Company estimate 1 2 3 4 Global A ve r a g e F R E Y R Target 81% CO 2 e Reduction - 31% - 19% - 13% - 19% Targeted FREYR CO 2 e Footprint Reduction 12 1 9 % Source: Study commissioned from global management consultancy

 

 

Aiming to be the Lowest Carbon Battery Cell Producer in the World 0 2 0 1 0 3 0 90 0 80 0 70 0 40 0 60 0 4 0 1 , 0 0 0 10 0 50 0 0 6 0 8 0 30 0 7 0 5 0 20 0 1,100 1,200 Plant size, GWh Other Asia Other F R E Y R China North America Europe Life cycle emissions kg CO 2 e/kWh Source: Study commissioned from global management consultancy , Company estimate, press search ▪ FREYR expects to have the lowest emissions in the industry ▪ European & North American producers projected to lead on emissions globally ▪ Majority of production will remain located in Asia, primarily in China Projected Battery Cell Life Cycle Emissions 13

 

 

Emerging European Battery Supply Chain Facilitates Full - Cycle Sustainability Sources: Battery Norway, FRAME, Company data Development across all aspects of the emerging European battery supply chain, from raw materials to recycling Map of Energy Critical Elements: Cobalt, Lithium, Graphite Europe Preliminary Result, May 2019 Mo i Rana, Norway Project development Oslo, Norway Headquarters R aw - Material Providers ▪ Glencore ▪ Elkem ▪ MRC ▪ Tiotech ▪ Hydro ESS Providers S olar & Marine ▪ Siemens ▪ Corvus ▪ ZEM ▪ Kongsberg ▪ Scatec Solar R esearch Organizations ▪ NTNU ▪ SINTEF ▪ IFE ▪ UiO Supportive Norway Battery Ecosystem FREYR’s Aspirational Goal: Full - Cycle Sustainability Responsible sourcing of raw materials Improved labor conditions Low water stress & enhanced biodiversity Reduced toxic emissions & waste 14

 

 

FREYR Positioned as a Low - Cost Producer Projected 2025 Global Battery Cell Cost 1) FREYR vs Bottom 5 FREYR C h i n a USA Europe South Korea Japan Other Cell Cost $/kWh 1) Total cost including profit to ensure ROI for various battery cell manufacturing factories based on outside - in estimates 2) FREYR P&L result divided by capacity produced in 2025 for all materials except for cathode, based on data from 24M FREYR projected cost leadership in 2025 is intended to be achieved by: ▪ Utilizing state - of - the - art production technology to significantly simplify manufacturing process & reduce raw material costs ▪ Leveraging a deep partnership model to unlock value chain innovation & lower costs ▪ Catalyzing a Nordic ecosystem that leverages low - cost renewable energy Source: Study commissioned from global management consultancy 12 0 0 80 0 60 0 40 0 900 1,000 1,100 Plant Size, GWh 6 0 10 0 0 50 0 30 0 20 0 4 0 14 0 8 0 10 0 2 0 70 0 - 5 3 % 2 ) 15

 

 

High Growth Energy Storage and Electric Vehicle Markets Sortland, Norway

 

 

2 , 6 2 2 82 9 806 19 6 19 3 202 5 202 6 202 7 202 8 202 9 22 8 365 388 670 3,869 203 0 19 1 24 1 40 6 1 , 4 1 0 59 0 1 , 0 6 8 1 , 9 2 6 Other Commercial Vehicles Energy System Storage 1) Passenger Vehicles 21 4 Lower Cost Solutions Accelerate Battery Demand Across Markets Global Battery Demand Expected to Reach ~5,300 GWh by 2030 GWh installed/year 5 , 2 9 2 4,264 3,402 2018 2019 2020 2021 2022 2023 2024 Note: The indicated outlook should not be construed as estimates or guidance for future developments of the Company CAGR, 2020 - 30 Passenger Vehicles 3 7 % Energy System Storage 44% Commercial Vehicles 4 1 % Other 1 3 % Total 3 2 % 1) Includes an increased adoption of ESS systems with a lower cost offering similar to the Company 17 Source: Study commissioned from global management consultancy

 

 

1 , 0 0 0 2 , 0 0 0 3 , 0 0 0 4 , 0 0 0 5 , 0 0 0 6 , 0 0 0 2 0 2 6 202 8 2 0 3 0 China Supply North America Supply Europe Supply Asia ex. China Supply Global Battery Demand Significant Global Battery Supply Shortfall by 2030 ▪ ~5,300 GWh projected global demand in 2030 ▪ ~1,600 GWh announced production capacity by 2030 based upon announced battery production projects ▪ Equivalent shortfall in 2030: 115 Gigafactories (@ 32 GWh per facility) ▪ Excluding China, the world is expected to be short of battery cell production capacity by 2023/2024 GWh installed/year Global Battery Supply/Demand Outlook, 2010 - 30 Source: Rystad Energy, Study commissioned from global management consultancy All Gigafactory solutions needed to meet expected surge in global demand 203 0 e Potential ~3,700 GWh supply shortfall = 115 Required Gigafactories 0 2010 2012 2014 2016 2018 2020 2022 2024 Note: The indicated outlook should not be construed as estimates or guidance for future developments of the Company 18

 

 

~3,870 ~590 ~ 3,090 ~ 2,060 FREYR Target Total Addressable Market: 97% of Global Battery Market by 2030 ~690 S e g m en t s Initial Targeted Strategic Partnerships 1) 2) 1 ) Other Mobility Energy Storage System (ESS) Electric Vehicles T otal ~5,150 GWh xx % Addressable Share of Total Segment Market (2020 / 2025 / 2030), FREYR’s Addressable Market (high - level assessment) FREYR Total Addressable Market GWh installed / year 1) Including assumption for an accelerated lead - acid to Li - ion migration 2020 - 30 and increased adoption of ESS system with a lower cost offering similar to FREYR 2) FREYR technology roadmap begins addressing parts of EV segment from 2023, fully addressable by 2030 % of End Market T otal 727 GWh 1) 2) Total 46 GWh 2 0 2 0 20 2 5 2 0 3 0 2 0 3 0 EU/USA China and ROW Other Mobility Energy Storage System Electric Vehicles ~ 33 % / 100%/ 100% 100%/ 100%/ 100% ~ 10 % / ~ 50 % / 100% Source: Study commissioned from global management consultancy Targeting OEM Partners 19

 

 

Innovative and Disruptive Semi - Solid Technology Norsk Teknisk Museum, Oslo, Norway

 

 

FREYR’s Technology Leadership ▪ ▪ Co - Founder Peter Matrai: accomplished executive in executing disruptive, IP - centric technology strategies ▪ Over 20 years experience in technology commercialization & operations ▪ Developed, implemented and successfully executed technology licensing strategies and business models ▪ Extensive experience in sustainability ventures Butamax and BP Biofuels North America CTO Ryuta Kawaguchi: extensive battery technology expertise ▪ Over 25 years direct battery and fuel cell engineering experience ▪ Responsible at Nissan for battery technology development for the LEAF and other EV models ▪ Solution Owner at Dyson EV Battery ▪ ▪ In depth technology selection process ▪ Started selection process in June 2019 ▪ Engaged with over 20 companies in Europe, China, Korea, Japan and the US ▪ 24M Technologies selected for strategic licensing partnership Focus on 24M Technologies licensing partnership ▪ 24M is revolutionizing the lithium - ion cell manufacturing process and platform 1) ▪ Advantages include production readiness, technology flexibility, large cell forms and ease of recycling 1) Ryuta Kawaguchi Chief Technology Officer 21 Highly accomplished and experienced FREYR technical team in battery technology, production and applications Peter Matrai Board Member & Co - Founder 1) Source: 24M Technologies

 

 

24M Technologies: Disruptive, Innovative Design and Process Technology 24M Technology Advantages 1. Revolutionizing the lithium - ion cell manufacturing process and platform, allowing cell production for different battery applications within one facility 2. Semi - solid technology that provides a simpler, more reliable and safer manufacturing process that accelerates production while lowering costs of existing and next - generation cell technology 3. Chemistry - agnostic platform that supports current and next - generation cell technologies, such as Silicone Electrode, Dual Electrolyte System and Pre - Lithiation implementation ▪ MIT spin - off founded in 2010 by Yet - Ming Chiang – MIT Professor, Materials Science – Pioneer in new material development 1) – Founded A123 Systems & American Superconductor ▪ Developed new cell architecture, cost - optimized for large batteries ▪ 78+ issued patents, 108+ pending ▪ Market validation 2) : Cambridge, MA Headquarters Recognitions Source: 24M Technologies 1) 24M was recognized by Bloomberg New Energy Finance as a 2016 New Energy Pioneer, Source: Business Wire 2) Kyocera press release, January 6, 2020 22

 

 

Streamlined FREYR Production Process vs. Conventional Solutions Electrolyte Cathode Anode S e p a r a t o r N M C LCO S N C A NM L M O LFP LTO Natural Gr TiO2 Artificial Gr Si Sn Li metal Prismatic cell Pouch cell Cylindric cell C o n d u c t o r Electrode Separator Electrode C o n d u c t o r Repeating structure Electrode Creation Cell Assembly Stack Weld Insert Electrolyte A nod e M i x S l i t C a l e n d a r Die Punch C l e a n Vacuum Dry C a t h o d e M i x S l i t C a l e n d a r Die Punch C l e a n Vacuum Dry Solvent Recovery C o a t D r y I n s p e c t C o a t D r y I n s p e c t Solvent Recovery Conductor Separator Electrode Few and thick layers Conductor Electrode 5 production steps Stack Weld Insert Cell Assembly Electrode Creation Anode Cathode Mix Coat Mix Coat Prismatic cell Pouch cell FREYR Cell Production Using existing raw materials With a simpler production process Resulting in next - generation battery cells Conventional Cell Production 15 production steps (including solvent recovery) Multiple thin layers vs. Source: 24M Technologies 23

 

 

Advantaged Margins from a Partnership - Based Business Model Mo Industrial Park, Mo i Rana, Norway

 

 

FREYR Long - Term Margin Advantage ▪ Technology Strategy – Partnership with 24M Technologies – Lowers footprint and costs ▪ Partnership Strategy – Limits need for internal R&D – Partnering for low - cost materials ▪ Nordic Ecosystem – Low cost, 100% renewable power – Lower logistics costs to Europe $4 8 $43 $1 6 $8 $1 4 Global Average in 2025 T e c h n o l o g y Strategy P a r t n e r s h i p Strategy Nordic E c o s y s t e m 2025 Battery Cell Cost 1) Breakdown Materials Costs 25 Manufacturing Costs Corporate & Profit $78 $62 ( $ 10 ) Cell Cost $/kWh ( $ 3 ) ( $ 3 ) FREYR strategic advantages target 20% lower battery cell costs ($16/kWh) vs. the projected global average in 2025 3) Includes R&D and license fees 1) Total cost including profit 2) Company estimate based on 24M data FREYR Production Cost 2) in 2025 $11 3) FREYR Aims to Deliver Market Leading Costs and Margins Source: Study commissioned from global management consultancy

 

 

Phased Development from Balanced Partnership - Based Strategies ▪ Next Generation Technology Solution : Partnership with 24M Technologies to industrialize improved process technology ▪ Traditional Technology Solution : Joint venture partnership of proven OEM technology Source: 24M Technologies, Company data Target Market Verticals ▪ Energy Storage Systems ▪ Other Mobility (Marine, Commercial) ▪ All Electric Vehicles (EV, PHEV, xEV) ▪ All Electric Vehicles (EV, PHEV, xEV) ▪ Energy System Storage ▪ All other applications Target Offtake Customers ▪ Utilities ▪ Automotive OEMs ▪ Solar/Wind Developers ▪ Home Energy Storage Systems ▪ Automotive OEMs ▪ Utilities Expected Strategic Advantages ▪ Chemistry - agnostic cell production process and platform ▪ Semi - solid electrode structurally reduces materials costs ▪ Higher energy density cells with improved safety and reliability ▪ Simpler production process lowers capex and opex requirements ▪ Lower footprint and increase capital efficiency unlocks modularity ▪ Less scrap, fully recyclable & increased in - plant reuse of active materials ▪ Flexible platform covers current next generation chemistry & cell design ▪ Significant, untapped market to leverage FREYR’s competitive production platform ▪ Collaborate with OEMs for industrially scaled supply of traditional technology ▪ Considerable logistics advantages relative to Asian cell manufacturers ▪ Flexibility to host multiple - OEM partnerships with separate Gigafactories Relevant Targeted Partnerships Targeting OEM JV partners Next Generation Technology Development Focus Traditional Technology Development Focus 26

 

 

Mo Industrial Park 1) ▪ Gigafactory 1 (5.3 GWh) ▪ Gigafactory 2 (8.0 GWh) Mo Industrial Park – Quay 1) ▪ Customer Qualification Plant (375 MWh) ▪ Gigafactory 3 (10.6 GWh) ▪ Gigafactory 4 (10.6 GWh) Planned Construction of FREYR Production Facilities Mo i Rana, Norway Mo i Rana, Norway Project development Oslo, Norway Headquarters Source: Company data 27 1) Flexibility in final configuration and size of Modularized Gigafactories over time across ~180,000 m2 of secured regulated acreage. Capacity refers to 80% of nameplate capacity. Operations for Gigafactories projected for 2023 or later. Customer Qualification Plant

 

 

0 1 0 2 0 3 0 5 0 6 0 20 2 2 20 2 3 2 0 2 4 2 0 2 5 20 2 6 20 2 7 20 2 8 2 0 2 9 2025 Target Installed Capacity: 43 GWh 40 FREYR’s Phased Gigafactory Development: 80+ GWh Installed by 2028 Capex Capacity 1) Operational Asset ($ millions) (GWh) Start Customer Qualification Plant $35 0.2 2022 Gigafactory 1 $275 5 2023 Gigafactory 2 $310 8 2024 Joint Venture Gigafactory 1 $565 8 2024 Gigafactory 3 $380 11 2025 Gigafactory 4 $380 11 2025 Gigafactory 5 $775 16 2026 Joint Venture Gigafactory 2 $565 8 2027 Gigafactory 6 $775 16 2028 TOTAL $4,060 83 Note: Company projection based on 24M data; the indicated outlook should not be construed as estimates or guidance for future developments of the Company Source: Company data Gigafactory 1 Gigafactory 2 Gigafactory 3 Gigafactory 4 Gigafactory 5 FREYR Battery Manufacturing Facility Development Installed Capacity GWh 90 2028 Target Installed Capacity : 83 GWh 80 Gigafactory 6 70 Joint Venture Gigafactory 1 Joint Venture Gigafactory 2 1) Capacity refers to 80% of nameplate capacity for Gigafactories and 100% of nameplate capacity for Joint Venture Gigafactories 28

 

 

Experienced Execution Team Skagsanden Beach, Flakstad, Norway

 

 

▪ FREYR’s Experienced Execution Team ▪ ▪ Torstein Dale Sjøtveit Executive Chair & Founder ▪ 35+ years of experience in utility, shipbuilding & upstream energy businesses ▪ Former CEO, Sarawak Energy, Malaysia ▪ President & CEO, Aker Yards ▪ EVP Upstream Aluminum, Norsk Hydro Tom Einar Jensen Chief Executive Officer & Co - Founder ▪ 25 years of experience in energy, industry, agriculture and start - ups ▪ 13 of which in investment and project development in the sustainability space ▪ Partner & Co - Founder, EDGE Global LLC, Senior Advisor, SYSTEMIQ ▪ EVP Corporate Development, Joule Unlimited, US ▪ CEO Agrinos and various commercial roles in Norsk Hydro Peter Matrai Board Member & Co - Founder ▪ 20 years of experience in finance, technology commercialization and operations within bioenergy and sustainability ventures ▪ Partner & Co - Founder, EDGE Global LLC ▪ CFO, Joule Unlimited, US ▪ COO & CFO, Butamax (BP - DuPont JV) Einar Kilde Chief Operating Officer ▪ 30+ years of experience in leading large - scale development projects within the energy, renewables and transport sectors ▪ EVP Project Execution, BaneNOR ▪ EVP Project Execution, Sarawak Energy, Malaysia ▪ EVP Projects, REC Ryuta Kawaguchi Chief Technology Officer ▪ 25 years of experience in battery engineering and technology development ▪ Solution Owner, Dyson EV Battery ▪ Senior Manager Battery & ePT Strategy Planning, Nissan ▪ Senior Manager Battery System Engineering & Technical Sales, AESC Steffen Føreid Chief Financial Officer ▪ 20 years finance experience within LNG, engineering, fabrication and energy industries ▪ CEO/CFO, Höegh LNG Partners LP ▪ CFO, Höegh LNG Holdings Ltd ▪ CFO, Grenland Group ASA ▪ EVP, TH Global PLC Tove Nilsen Ljunqquist Executive Vice President, Operations ▪ 30 years of experience in global manufacturing and oil & gas businesses ▪ EVP Operationalization Moreld ▪ CEO Agility Subsea Fabrication / Agility Group ▪ Head of Performance Management Hydro Downstream ▪ Managing Director Hydro Aluminium Clervaux Are Brautaset Chief Legal Officer ▪ 20 years practice as in - house counsel in the energy sector ▪ Head of Legal and Compliance in Statoil Tanzania ▪ Vice President Legal in Equinor ▪ Chief Legal Officer in Aker Energy 30

 

 

International Energy and Capital Markets Expertise, FREYR Director Nominees Daniel Barcelo Chief Executive Officer, President & Director ▪ Portfolio Manager, Moore Capital ▪ Managing Director, Renaissance Capital ▪ CFO, Ruspetro plc, Russia ▪ Co - Founder, Director, CFO, Invicti Terra Argentina Ltd Germán Curá Director ▪ Board of Directors & Vice Chairman of the Board, Tenaris ▪ President & CEO, Maverick Tubulars ▪ President & CEO, Hydril Encompass Capital, A Member of Our Sponsor Todd Kantor Founder, Managing Member & Portfolio Manager ▪ 20 years of experience in global energy markets ▪ Portfolio Manager, PioneerPath (Citadel LLC) ▪ Analyst; Touradji Capital, Solstice Equity Management, JP Morgan Global Oil & Gas Investment Banking Alussa Energy Acquisition Corp. Overview ▪ Alussa Energy Acquisition Corp. is a NYSE listed SPAC which completed its $287 million IPO in November 2019 ▪ Over 100 years of combined experience of starting and operating public companies globally ▪ Board members/management have operated companies in the US, Africa, Russia and the Middle East ▪ Encompass Capital Advisors LLC, a Member of our Sponsor, is a SEC registered investment advisor with a primary focus on investing across the energy eco - chain, including exploration and production, services, energy - related industrials, cyclicals, materials, alternative energy and renewables in the private and public markets Alussa Energy Due Diligence and Assessment Conducted on FREYR ▪ General corporate, legal, intellectual property, contract review, employment matters and benefits and capital structure due diligence conducted by Skadden Arps and Ellenoff Grossman & Schole ▪ Accounting and tax due diligence performed by Ernst & Young ▪ Environmental, governance and social communication strategy assessment performed by Sustainable Governance Partners ▪ Business due diligence and assessment performed by Alussa Energy and Rystad Energy 31 Alussa Energy Acquisition Corp. Overview

 

 

FREYR Financial Overview Barcode Business District, Oslo, Norway

 

 

Pro Forma Financial Projections 1) Non - GAAP financial metric – EBITDA defined as earnings before interest expense, interest income and other income, taxes, depreciation, amortization and stock - based compensation Projected annual free cash flow of ~$1.6 billion upon completion of FREYR’s Gigafactory build - out plan ($ millions) 202 1 2022 2023 2024 2025 2026 2027 2028 Income Statement Items Customer Qualification Plant $ 0 $1 1 $1 6 $ 1 6 $1 6 $16 $ 1 6 $ 1 6 Gigafactories 0 0 30 5 8 7 7 2 , 15 4 2,869 3 , 4 5 1 4 , 0 7 3 Joint Venture Gigafactories 0 0 0 4 9 9 70 5 687 1 , 1 3 2 1 , 3 0 7 Total Revenue $ 0 $ 1 1 $ 3 2 1 $ 1 , 3 9 2 $ 2 , 8 7 5 $3,573 $ 4 , 6 0 0 $5 , 39 6 % Growth n m nm n m 3 3 3 % 1 07 % 2 4% 29 % 17 % COGS $ 0 $ 9 $ 25 7 $ 9 5 1 $1 , 98 0 $2,358 $3 , 1 3 1 $ 3 , 6 9 3 Gross Profit $ 0 $ 1 $ 6 5 $ 4 4 1 $ 8 9 5 $1,215 $ 1 , 4 6 8 $1 , 70 3 Gross Profit Margin % n m 13.0% 2 0 . 1% 3 1 . 7 % 3 1 . 1 % 3 4 . 0% 3 1 . 9 % 3 1 . 6 % Technology Licensing Fees $ 0 $ 1 $1 3 $ 3 6 $8 7 $116 $ 1 3 9 $ 1 6 4 Other Expenses and SG&A 3 5 4 5 4 5 6 6 10 5 113 1 2 5 1 2 7 EBITDA 1) ( $ 3 5 ) ( $ 4 4 ) $ 7 $ 3 3 9 $ 7 0 3 $986 $ 1 , 2 0 5 $1 , 41 2 EBITDA Margin % n m nm n m 2 4 . 4 % 2 4 . 4 % 2 7 . 6% 2 6 . 2 % 2 6 . 2 % Balance Sheet and Cash Flow Items Debt $ 0 $120 $ 8 9 6 $ 1 , 4 9 3 $ 2 , 0 1 1 $2,497 $ 2 , 7 4 3 $3 , 20 3 Net Debt/EBITDA n m nm n m 3 . 0 x 1 . 9 x 1 . 6x 1 . 6 x 1 . 5 x Capital Expenditures $144 $517 $ 8 3 2 $ 6 0 9 $ 6 1 2 $880 $ 9 9 6 $1 , 11 0 % of Revenues n m nm n m 4 4 % 21 % 2 5% 22 % 21 % 33

 

 

Cash to FREYR Balance Sheet 8 4 9 65 % Estimated Transaction Fees & Expenses 4 6 4 % Total Uses $ 1 , 31 3 100 % Sources and Uses Pro Forma Valuation 3) 4) 5) ($ millions) ( $ ) ( % ) ($ millions, except for per share data) Estimated Alussa Energy Cash in Trust 1) $29 0 22 % Share Price $10 . 0 0 PIPE Proceeds 2) 60 0 4 6 % Pro Forma Shares Outstanding 137 . 7 Consideration to Existing FREYR Shareholders 3) 41 8 3 2 % Equity Value $1 , 37 7 Proceeds from FREYR options exercise 5 0 % Plus: Debt $ 0 Total Sources $ 1 , 31 3 100 % Less: Cash to Balance Sheet $ 8 4 9 Consideration to Existing FREYR Shareholders 3) $41 8 32 % Enterprise Value $ 5 2 9 Transaction Overview 1) Assumes no redemptions from Alussa Energy’s existing public shareholders 2) Excludes cash from 0.75 million shares (equivalent to $7.5 million investment) that could be funded before close in connection with an existing FREYR shareholder’s preferred equity investment in FREYR rolled for $10.00 per share 3) Includes $7.5 million in respect of preferred equity investment in FREYR rolled for $10.00 per share; assumes full dilution at the transaction price from in - the - money FREYR options; proceeds from FREYR option exercise shown separately in the Total Sources section 4) Assumes new shares issued at $10.00 per share 5) Excludes the impact of Alussa Energy warrants (23.0 million at $11.50 per share strike price) Pro Forma Ownership 1) 2) 3) 4) 5) ▪ 100% of FREYR’s existing shares will roll over into the combined company ▪ Equity capital for the execution of planned development of up to ~43 GWh of battery cell production capacity – Development of the company’s planned Gigafactory system – Working capital requirements to support growth – Research & development efforts for advanced battery solutions ▪ Transaction completion expected during the second quarter of 2021 (% / million of shares) ALUS Shareholders 21% / 28.8 34 ALUS Sponsor Shares 5% / 7.2 PIPE Investors 44% / 60.0 Existing FREYR Shareholders 30% / 41.8

 

 

Attractive Transaction Pricing ▪ F uture enterprise value: Apply 10.0x 2 - year forward multiple to FREYR 2025e EBITDA of $703 million – 9.0x - 11.0x multiple at a discount to public comparables ▪ ▪ ▪ F uture equity value: Adjusting for FREYR year - end 2024e net debt of $1,020 million D iscounted equity value: Discounting future equity value back 3.75 years (assuming March 2021 close) at 20% discount rate T ransaction Equity Value: Implies a 77% discount to the midpoint of implied future equity value and 55% discount to the midpoint of implied discounted equity value Methodology Assumptions ▪ Forward EV/EBITDA multiples: 9.0x - 11.0x ▪ 2025e EBITDA: $703 million ▪ 2024e Net debt: $1,020 million ▪ Equity discount rate: 20% ($ millions) E nterprise Value Indication $7,728 $7,025 $6,323 $6,708 $6,006 $5,303 Equity Value Indications $3,386 $3,031 $2,677 77% Discount 55% Discou $1,377 ($10.00/sh) Implied future enterprise value Implied future equity value Implied discounted equity value Transaction equity value n t 35

 

 

2 5 . 0 x 6 . 3 x ' 27 e ' 25 e 5 2 . 2 x 2 5 . 6 x 1 8 . 6 x 8 . 2 x 5 . 2 x 3 . 8 x 1 . 6 x n m 0 . 8 x 0 . 5 x 0 . 4 x ' 25 e ' 26 e ' 27 e 7 8 . 4 x 7 7 . 1 x 3 3 . 9 x 6 1 . 0 x 3 6 . 6 x 2 0 . 1 x 1 5 . 7 x 1 2 . 9 x 4 . 1 x 2 . 9 x ' 27 e ' 25 e Asian Battery Comps (‘21 EV/EBITDA) 3) US Battery Comps At Deal 2) Fuel Cell Comps (‘25 EV/EBITDA) 3) US Electric Vehicle Comps (‘24 EV/EBITDA) 2) US Battery Comps Current 2) FREYR 1) Avg. 29.3x F R E Y R V a l u a t i o n B e n c h m a r k i n g : E V / E B I T D A Avg. 16.5x 36 ( 3 ) ( 3 ) 1) Presented multiples are based upon current year enterprise value; adjusted enterprise value for future net debt balances would imply ’25e multiple of 3.4x, ’26e multiple of 2.8x, and ’27e multiple of 2.5x 2) Valuation is based upon current year enterprise value and public management EBITDA forecasts at time of SPAC merger announcement and securities prices as of January 25, 2021, unless otherwise noted 3) Valuation is based upon current year enterprise value and consensus EBITDA estimates as of January 25, 2021 Source: Bloomberg, Company reports

 

 

2 1 . 5% 1 7 . 2% 1 5 . 7% 1 1 . 3% 5 . 2% 28.8% 2 2 . 4% 1 8 . 9% 1 3 . 1% 1 2 . 1% 1 0 . 4% 1 . 3% 2 5 . 2% 2 0 . 5% ' 27 e ' 25 e 2 4 . 4% 2 7 . 6% 2 6 . 2% ' 25 e ' 26 e ' 27 e Asian Battery Comps (‘21 EBITDA Margin) 2) US Battery Comps 1) US Electric Vehicle Comps (‘24 EBITDA Margin) 1) FREYR FREYR Valuation Benchmarking: EBITDA Margin Avg. 15.7% 1 9 . 2% 1 5 . 0% 1 2 . 6% Avg. 14.2% 1) Based upon public management financial forecasts at time of SPAC merger announcement, unless otherwise noted 2) Based upon consensus EBITDA estimates as of January 25, 2021 Fuel Cell Comps (‘25 EBITDA Margin) 2) ( 2 ) ( 2 ) 18.9% Source: Bloomberg, Company reports 37

 

 

“As a society, we must substantially accelerate our efforts to reduce CO 2 emissions at scale over the next ten years. Electrification and batteries are instrumental parts of the solution, representing one of the most exciting and sustainable growth vectors in the market.” Torstein Dale Sjøtveit Executive Chairman & Founder

 

 

Appendix Lillehammer Wilderness, Norway

 

 

FREYR’s Holistic Approach to ESG Leadership Environment ▪ FREYR is committed to producing one of the most environmentally - friendly, cost - effective and ethically - manufactured battery cells in the world ▪ We plan to leverage sustainable practices across the entire supply chain and product lifecycle, including its recyclability Social ▪ FREYR is committed to safe, healthy and reliable operations and the well - being of our employees ▪ We value a diverse and inclusive culture ▪ Our communities are critical participants in our ecosystem thus we will invest in the strength of our ‘social license’ to ensure alignment as we grow Governance ▪ FREYR is committed to the best practices of corporate governance, as foundational tenets of the long - term success of our business ▪ We commit to transparent business practices and accountability to our shareholders and stakeholders Meeting the world’s rapidly growing need for carbon - free energy for storage, transportation and other end uses Reduced scrap rate, higher material utilization, and higher rates of battery recyclability Future Norwegian operations powered exclusively by zero - carbon energy supplies including both wind and hydro power Our vision of accelerating decarbonization globally aligns our corporate strategy directly with key UN Sustainable Development Goals ▪ B o a r d : i n depen d en t , d i v e r s e , c a p a b l e , o b j e c t i v e a n d e n g a g e d ▪ ▪ P o l i c i e s : l e a d i n g s t a nd a r d s f o r e t h i c s , s up p l y c h a i n , i n t e r n a l c o n t r o l s a n d o v e r s i g h t ▪ Disclosure : committed to SASB - aligned disclosure as soon as practicable KPIs : management and workforce alignment to ESG performance FREYR ESG Leadership will be underscored by our commitments to sustainability, governance and transparency 40

 

 

Norway’s Battery Ecosystem Supports Our Growth Aluminium Battery Recycling @ Multi locations Battery System for Marine: SPBES @Trondheim Corvus @Bergen TiO Anode @ Bergen Natural Graphite Mine Anode material @Skaland Sci. & Tech. Univ. @Trondheim Energy Institute @Oslo (Kjeller) Si anode research, Cell prototyping/testing Defence Research @Oslo (Kjeller) Battery safety testing Univ. Oslo @Oslo Fundamental material research Univ. Southeast @Porsgrunn SINTEF Helgeland @Mo I Rana Energy/Process optimization SINTEF Energy @Trondheim Large battery cell/pack testing SINTEF Industry @Trondheim Battery materials, Cell prototyping/testing Zero Emission Marine @Oslo (Høvik) Raw Materials: ▪ AL (Hydro, Alcoa) ▪ Si (Elkem, Dynatec) ▪ Ni, Co, Cu (Glencore) ▪ Ti (Joma) ▪ Li (under development) ▪ Graphite (MRC, Elkem, Saint - Gobain) Siemens @Trondheim Lithium - ion Battery @Mo I Rana Kongsberg Maritime @Kongsberg LiB Recycling @Fredrikstad ESS for PV @Oslo Lithium - ion Capacitor @ S t a v a n g e r Artificial Graphite & Si Anodes @Herøya Lithium - ion Battery @TBD ▪ FREYR to secure battery cell manufacturing within Norway’s burgeoning battery industry ▪ Emerging companies across all aspects of the battery supply chain, from raw materials to recycling ▪ Unique development of specific battery solutions for the maritime industry ▪ Strong technological development from local research organizations and universities 41 Industry Players Research Organizations

 

 

Strategies to Build a Nordic Supply Chain ▪ Striving to develop a long - term Nordic battery supply chain ▪ Initial supply chain to leverage 24M relationships for active materials ▪ Long - term evolution of supply chain focused on European/North American suppliers and eventually 100% Norway ▪ Supplier qualification focused on sample analysis process of 1 - 2 years C o m p o n en t # 1 N M C 2 L F P 3 Carbon black 4 Graphite 5 A l u m i n u m 6 Copper 7 S ep a r a t o r 8 P o u c h 9 Electrolyte Step 1: 24M Supply Chain Step 2: Utilizing Existing EU and US Supply Chain Opportunities Step 3: Long - term Aspiration A s i a A s i a A s i a A s i a A s i a A s i a A s i a A s i a USA / Asia Qualification of existing s u p p lie r 1. Sample analysis (12 - 24 months) Joint venture to establish production capacity 1. Feasibility analysis (3 - 6 months) 2. Sample analysis (12 - 24 months) Source: 24M, Company data Potential Nordic Supply Chain Development FREYR plans to source materials from existing battery material suppliers in Europe and USA Following FREYR’s partnership model to localize as many battery supply chain materials as possible in Norway 42

 

 

Europe Battery Production Capacity, 2030e Europe battery cell manufacturing targeted 2030 capacity 1) G W h Plant size (GWh): 3 0 2 0 1 1 0 10 0 N o r t h v o l t AESC Sunderland A MT E/ B ritis h v o lt LG Chem Leclanche SAFT/PSA Opel France SAFT pilot Northvolt/Volkswagen Norway G e r m a n y France Hungary Poland Slovakia Sweden United Kingdom M ic ro v a st Tesla BM Z F R E Y R Morrow Batteries SK innovation 1 inoBat GS Yuasa Samsung SK innovation 2 CATL Va r ta SAFT/PSA Opel Germany Liacon F a r a sis ▪ 21 companies expected to hold battery production capacity in eight European countries ▪ Largest capacities in Norway, Germany and Poland ▪ Nordic region emerging as the most advanced battery production corridor in Europe ▪ FREYR’s ambition to lead Norway into a market capacity leading position 1) Figures represent current targeted capacity expected to be achieved by 2030 New players reshaping the Nordic region as the market leading battery corridor in Europe, producing technologically advanced battery solutions using 100% renewable energy starting in 2021 Source: Rystad Energy, Company analysis 43

 

 

4 4 Source: Kyocera press release, website, Company internals 1) Over 10 years operation @ 80% DoD 2) @ 30 ƒ C, 100% DoD; nominal charge time 3 hrs (Automotive standard) 3) (Ready for) Start of (Commercial) Production 4) Cycle life estimates are based on the assumptions that a) cell development objectives are achieved, b) cycles are performed at 80% depth of discharge and c) end of life condition is 80% capacity retention. Cycle life estimates may be materially lower if development objectives are not achieved. 24M: A Next Generation Technology Commercially in the Market Today Target specifications Specific Energy (Wh/Kg): Energy Density (W/l): Charge Time (time): Cycle Life (# of cycles) 4 : 2013 2017 2017 - 2019 Jun 2019 Jan 2020 Late 2020 Joint research Kyocera Industrializing Pilot Commercial Mass a c t ivi t y w i t h li c e n s e i n t h e s o l u t i o n p r o d u c t i o n s a le s s t a r t f o r p r o d u c t i o n 24M 24M begins residential ESS initiated May 2019 Feb 2020 2021 40 sample EPC contract 100 MWh cells to for first GPSC production GPSC plant signed capacity pl a nn e d 2017 GPSC license in 24M Safety Features across: Operating Temperature: ESS F360 ESS F500 EV F500 (SOP 3 : 2022) (SOP 3 : 2023) (SOP 3 : 2023/24) 284 300 319 >568 >625 >720 3 hrs 3 hrs 15 - 25 mins >3,500 1 >3,500 1 1,000 2 0 to 50 ƒ C - 20 to 50 ƒ C - 20 to 60 ƒ C Integrated fuse link Unit cell a r c h it e c t u r e Exceptional abuse tolerance 2014 GPSC invests in 24M

 

Exhibit 99.3

 

 

 

FREYR Business Combination with Alussa Energy Acquisition Corp.

 

Investor Conference Call

 

January 29, 2021

 

Operator

 

 

Greetings and welcome to the FREYR and Alussa Energy Acquisition Corp. Transaction pre-recorded Conference Call. I would now like to turn the conference over to Chi Chow, Head of Investor Relations for Alussa Energy.

 

Chi Chow – Strategy & Investor Relations, Alussa Energy Acquisition Corp.

 

 

Good morning, good afternoon and good evening to everyone joining us today on the call. My name is Chi Chow, head of Investor Relations for Alussa Energy. We are joined today by Daniel Barcelo, Alussa Energy’s CEO, Torstein Dale Sjøtveit, Executive Chair and founder of FREYR, Tom Jensen, FREYR’s CEO and Steffen Føreid, FREYR’s CFO.

 

On behalf of both Alussa Energy and FREYR, we welcome you to the call to discuss this exciting business combination between our two companies.

 

Before we proceed, I would like to first remind everyone that this call may contain forward-looking statements including, but not limited to, FREYR and Alussa Energy’s expectations or predictions of financial and business performance and conditions, expectations or assumptions as to completion of the proposed transaction between the parties, product development and performance, including but not limited to the timing of development milestones, competitive and industry outlook and the timing and completion of the transaction. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions and they are not guaranteed of performance. I encourage you to read the joint press release issued today and Alussa Energy’s filings with the Securities and Exchange Commission for a discussion of the risks that can affect the business combination, FREYR’s business and the business of the combined company after completion of the proposed business combination.

 

Alussa Energy and FREYR are under no obligation and expressly disclaim any obligation to update, alter or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

For everyone on the line, Alussa Energy and FREYR will not be fielding any questions on today’s call. I will now turn the call over to Alussa Energy’s CEO, Mr. Daniel Barcelo. Dan?

 

Daniel Barcelo – Chief Executive Officer and Founder, Alussa Energy Acquisition Corp.

 

 

Thanks, Chi and hello to everyone on the call. My name is Daniel Barcelo and I am the Chief Executive Officer and Founder of Alussa Energy. We are thrilled and privileged to announce today’s transaction between FREYR and Alussa Energy. FREYR is a Norway-based developer of clean battery cells using renewable hydro power and leading-edge technology to address the growing market for transportation and energy storage electrification. We believe this transaction represents an intriguing investment opportunity for a new, European-based competitor in the Giga-scale landscape of battery production and we are excited to discuss the merits of the deal with you today.

 

Briefly on Alussa Energy, we are a New York Stock Exchange-listed SPAC and completed our $288 million IPO in late 2019 and began focusing on merger opportunities across the entire energy supply chain. Our team consolidates over a century of combined engineering, operational and investment experience, with many members of our board and management team having started and operated public energy companies across the globe.

 

 

 

 

 

In terms of our selection process, we looked at over 75 opportunities across traditional energy and energy transition before focusing specifically on the battery supply chain which we see as highly compelling in terms of strong demand already today and the expected accelerating growth in the coming years between both transportation and energy storage applications. Once we were introduced to FREYR and began evaluating the company’s leading-edge technology, scalable development strategy and strong execution team, we knew our search had ended.

 

We spent upwards of five months working with the company, including spending two months in Norway myself, to help delineate and develop its business model. The end result of our process is the company we present to you today. We believe FREYR is one of the most uniquely positioned battery cell investment opportunities in the world, with three primary differentiating factors, including:

 

First, adopting a technology partnership strategy to bring a next-generation, semi-solid battery platform to scale.

 

Second, FREYR’s advantaged production location in Norway where we expect the company to build battery cells with one of the lowest possible carbon footprints in the world.

 

And third, FREYR’s strong execution team with its extensive operational experience in successfully executing large, complex capital projects on time and on budget.

 

As a result, we are highly confident that FREYR is well-positioned to play a transformational role in decarbonizing global energy and transportation markets.

 

The transaction announced today is expected to provide FREYR with net proceeds of approximately $850 million, including a $600 million fully committed PIPE including Koch Strategic Platforms and Glencore. The proceeds will be used to fully fund the company’s equity capital needs with an aim to scale production capacity to 43 gigawatt hours by 2025. From FREYR’s side, speed to market was an important factor and the need for a quantum of capital that Alussa Energy brings along with a NYSE listing will properly position the company as a competitive counterparty to leading OEMs and suppliers.

 

Importantly, we feel the transaction valuation is both fair to all stakeholders and highly compelling for public investors as implied future multiples, at under 1.0x EV/EBITDA based on FREYR’s expected 2025-27 earnings levels, are priced at significant discounts relative to publicly traded battery comps and certain other recent battery de-SPAC deals.

 

Lastly, I would like to thank a member of our Sponsor Encompass Capital, a leading New York-based hedge fund focused on investing throughout the energy eco-chain, for its strong support in embracing our discovery of energy transition opportunities.

 

With that, I would like to turn the call over to Torstein, Executive Chair and founder of FREYR to tell you more about the company. Torstein?

 

Torstein Dale Sjøtveit – Executive Chair and Founder, FREYR

 

 

Thanks Daniel, and hi everyone! It’s a true pleasure to be here today.

 

Accelerating the decarbonization of the transportation sector and our energy systems require very large volumes of batteries, and we believe that these will benefit from being decarbonized from the outset. We started FREYR three years ago after a feasibility study by the Norwegian University of Science and Technology and FREYR co-founder Tore Ivar Slettemoen. Based on that, we understood that we were positioned to play a fundamental role in enabling that ambition by delivering sustainable and cost-effective batteries. Today, together with Alussa Energy and backed by a set of very strong and dedicated new investors, we announce a significant step towards our shared ambition of creating a more sustainable energy future.

 

We believe FREYR represents a highly attractive market opportunity and one of few opportunities for exposure to this industry for investors. We believe the ongoing shift to renewable power grids and electric vehicles is accelerating demand for lithium-ion battery solutions. We believe a large market is emerging and creating a strong basis for FREYR’s growth.

 

2

 

 

 

We also believe Norway has critically important advantages to offer in this regard with ultra-low-cost electricity prices relative to other locations in Europe combined with the clean nature of that energy. Norway is also located closer to large and rapidly growing market segments in Europe relative to where most current supply comes from, which is from Asia in general, and China in particular.

 

Another important feature is Norway’s century-long experience in energy, energy-intensive and process intensive industries, with a highly skilled, engineering-based competence - critically important to ensure that battery cell production and battery value chains are operated flawlessly with high uptime, high regularity and low scrap rates.

 

Turning back to FREYR, the company has attracted a diversified and experienced team, partners and initial customers in a short period of time. The capital raise and NYSE listing announced today add further momentum to our progress and positions us as a catalyst for European battery cell production and the Nordic battery ecosystem. We see this transaction as a strong confirmation of FREYR’s growth potential enabled by cutting-edge technology and access to clean renewable energy. Moving ahead, FREYR will focus on executing our project plans, attracting more talent, cultivating partnerships and providing our customers with sustainable and cost-effective clean battery cells.

 

Long story short, FREYR offers a clean Nordic solution to the rapidly growing global demand for high-density and cost competitive battery cells. We believe our plan for production of our environmentally friendly battery cells through our partnership-based business model, which positions FREYR to accelerate long-term value creation and target sustainable, superior returns to our stakeholders and shareholders.

 

With that, I will turn the call over to FREYR’s CEO Tom Jensen. Tom?

 

Tom Einar Jensen – Chief Executive Officer and Co-Founder, FREYR

 

 

Thanks Torstein, and hi everyone! As CEO of FREYR, I'm here today to talk about FREYR and our clean battery solutions. I’ll take you through our ambitions, and why we believe this is a fundamentally exciting opportunity and industry.

 

FREYR is targeting being one of the best positioned players in this industry, and we aspire to be an industry cost leader and deliver high EBITDA margins. We plan to start this journey by building more than 40 gigawatt hours of production capacity by 2025. We believe we offer unique exposure to an industry with exponential growth potential. We believe we can achieve our ambitions by targeting to be the lowest carbon battery cell producer in the world and having a flexible business model, through an in-licensing and partnership-based approach, commercializing and scaling best available commercially introduced technology.

 

FREYR's initial focus is on the battery cell production itself. This makes up roughly one third of the value creation across that value chain and is the most energy intensive and process intensive part; and where FREYR’s and Norway’s comparative advantages can be utilized the best.

 

Since our incorporation in early 2018, a broad variety of stakeholders, all across the value chain from raw material providers - to active material producers - to module and pack suppliers and recycling players alike, have recognized the benefits of co-locating activities in Norway. The opportunity for us to get exposure to a broader part of the value chain is strong, and we believe for Norway as a nation, the battery industry outcompetes other opportunities in the renewable spectrum in the next decade.

 

We have analyzed with a leading global consultancy the growth perspectives of the battery market. We have filtered it through the lens of continued technology development coupled with increased, regulatory pressure from governments around the world for further decarbonization. The European union increased their ambition from 40% to 55% decarbonization by 2030 and many other countries are implementing more ambitious CO2 reduction targets. The Chinese government recently announced a 25% EV penetration ambition by 2025 requiring an increased amount of the Chinese produced batteries to stay in China. Our belief is that these markets will, driven by technology development and increased regulatory pressure, grow faster than most analysts think. Batteries are going to play a fundamental role in decarbonizing large sectors of the economy and low carbon batteries should have an increasingly important role to play. This is where FREYR and Norway can play a substantial role from an advantaged position.

 

3

 

 

 

We have since our inception entered into multiple agreements with many different companies along the value chain and are currently in number of customer processes. We have also licensed in our first cutting edge technology through 24M Technologies, which is in our opinion, the best commercially introduced, available technology. We believe 24M offers a step change in cost and performance in Lithium-Ion battery cell production and represents a fundamental innovation in how batteries are designed and produced.

 

We have entered into initial agreements with some of leading global players in the supply chain that can provide high quality materials into our production, which is a raw material-based business. Having the best possible suppliers through long-term agreements and value chain partnerships are going to be important. Initial customer discussions and agreements also give us comfort that we will be able to increase our sales of decarbonized batteries over time.

 

Our starting point is to decarbonize the battery value chain through four distinct steps. First, we are going to locate battery cell production in Norway at scale with the right technology. Second, we will seek to source our active materials from Norwegian/Nordic providers or providers which have low carbon footprint in their production. Third, we will enter into partnerships and long-term agreements with additional stakeholders to source other input factors into battery production into the cell production itself, such as lithium hydroxide, electrolyte and copper foil production or any other energy intensive product that forms part of the value chain. Finally, packaging and recycling will also reduce footprint further in a Norwegian context. These actions provide us with the basis to have an ambition to reduce the life cycle CO2 footprint in battery production by more than 80% in the medium term with potential for even further reduction.

 

This reduction will place us on the left-hand side of the so-called carbon curve documented through a bottom-up analysis done by a leading consultancy firm ranking all battery producers in 2025 by carbon intensity in battery cell production. This ambition is a catalyst for partners lining up and customers signing up, and the opportunity to build capacity in Norway is very strong across a broad variety of locations. FREYR is thus comfortable that we are offering a fundamentally important, strategic advantage.

 

Another important aspect is that Norway has been and still is leading the charge in terms of electrification. Norway started large scale rollout of electric vehicles a number of years ago. This has already triggered a lot of development in the Norwegian battery scene. Fundamental research and education are ongoing at SINTEF, NTNU, IFE to the university of Oslo and others. Infrastructure development is picking up pace to support the electric vehicle adoption. Norway is electrifying a broad set of the marine segments in the country, and a number of commercial stakeholders are producing battery modules, packs and solutions for rapidly growing market segments. Most of these stakeholders are today sourcing their battery cells from Asia as there is no industrial scale battery cell production in Norway today. This is a void that Norwegian producers can fill, and FREYR plans to be the first producer of battery cells at industrial scale in Norway. On top of this there is a large presence of the elements critical to battery production in the Nordic region. Over time we believe the Nordic region could be home to substantial industrial-scale battery production and a very broad industry along the entire value chain also triggering a large upstream industry, where Norway’s exploration and competence industry can be leveraged.

 

We are now actively seeking additional employees, suppliers, customers and investors and we have seen very strong interest in joining FREYR on this journey. This is also supported by Norway and Norwegian companies having strong ESG credentials.

 

FREYR’s technology strategy is to seek partners with, what we believe are the best available, commercially introduced technologies, as opposed to in house R&D for two main strategic reasons. First, we believe speed to market and actual production is essential to succeed in this business to be relevant in off-taker discussions immediately and start deploying production systems at giga-scale today. Second, we retain flexibility in terms of partnering for the latest technology which could ensure ongoing cost competitiveness as a strong strategic advantage, as opposed to developing a proprietary platform in house which could be much more time consuming and costly.

 

4

 

 

 

We launched our technology selection process in the first half of 2019 for battery cell technologies. Our key selection criteria included the following three aspects: One, it needs to deliver step change benefits in terms of cost and performance relative to the currently market dominant traditional LIB technology. Two, it needs to be ready for mass production today and three it needs to meet current customers’ requirements and fit into the existing supply chains.

 

We have built a strong team to execute this strategy with our CTO having spent his 25+ year career covering most aspects of the battery space. He led Nissan’s battery technology development for the Nissan Leaf as well as recently leading the battery cell technology development for Dyson’s EV project. FREYR’s co-founder and Board member who leads our in-licensing efforts also has 15 years of experience in commercializing disruptive technologies in the sustainability space. This combination of deep technology and disruptive technology commercialization experience, supported by a broad network of specific field experts resulted in a robust selection process, which ultimately led to us choosing a SemiSolid technology platform developed by 24M Technologies as our first cutting edge technology adoption.

 

24M Technologies is a spin-off from MIT and is based in Boston, USA. 24M has spent 10 years in Research and Development mode focusing on two things in parallel. One, they have significantly advanced the conventional LIB cell by developing a Semi-Solid cell architecture. Two, they have developed a fundamentally simpler manufacturing process to produce this new cell. 24M Technologies’ Semisolid solution is as such a complete technology and production platform which can deliver several step changes relative to conventional lithium-ion battery solutions. The platform is already established in commercial production in Asia; however, FREYR has limited exclusivity within certain market segments.

 

The key innovation is the Semi-Solid battery cell structure itself. Key features include that the electrodes are substantially thicker requiring less inactive materials than in conventional cells. As a result, the SemiSolid cells have a structural bill of materials cost advantage. The production process for these Semisolid electrodes is also novel. The electrolyte and active materials are mixed at the beginning of the process so there is no need for binders, additives nor solvents which allows for elimination of several key process steps relative to the conventional production process. The electrode production platform is reduced from 15 steps in the conventional process to 5 process steps with the 24M Technologies platform. The technology also enables the production of larger cells, which could provide many additional commercial and cost related advantages.

 

This technology also stays within the existing battery supply chain paradigm and does as such neither require the creation of new materials nor a new supply chain. The solution is as such compatible with mainstream cathode and anode chemistries and it is furthermore chemistry agnostic allowing us to swap between chemistries flexibly without changing the underlying production process.

 

In summary this cell design and production platform can provide benefits like a modular, scalable, chemistry agnostic platform with a smaller production footprint at low cost. We also believe there are opportunities for further automation that could provide higher reliability, increased safety performance and increased recycling opportunities.

 

The combination of our choice of technology, the advantaged Norwegian location, and our scale ambition could place FREYR on the left-hand side of the cost curve. FREYR believes demand will outstrip supply by 2025 and aspires to be a cost-leader in this industry by then. We aim to grow beyond that with an ambition to be one of the largest producers of battery cells in the European domain by 2030.

 

We believe that FREYR has the potential to achieve its industry cost leadership aspiration from combination the following beliefs. First, the fundamental advantages of the 24M Technologies platform offers a structural bill of materials and manufacturing cost advantage. Second, we avoid large inhouse R&D costs through licensing in or partnering for best available technologies. Third, we locate the production of battery cells in a low cost and low carbon electricity environment and reduce logistical costs by sourcing materials from local partners.

 

In addition to selecting, in our opinion, best available next generation, commercially introduced technologies, such as 24M Technologies, FREYR also targets joint venture partnerships with tier 1 battery cell producers from Asia. Many Asian battery cell producers have a target to establish production presence in the European region, and we are in partnership discussions. We believe additional partnerships for FREYR in Norway to set up large battery cell production facilities with potential for up- and downstream activities adds flexibility and momentum to our cutting edge technology approach. FREYR will keep growing its partnership-based approach, to provide an as broad product range out of the Norwegian battery industry as possible.

 

5

 

 

 

FREYR will start its production-based rollout in Mo i Rana, where we have been active for more than three years. We are very happy with the support that we have seen from the local authorities and the local industrial players in the region. This is one of Norway’s largest ports with excellent logistics by sea, road, rail and air. Mo Industrial Park is a leading industrial development zone. FREYR has secured 180,000 m2 of land in this park, in addition to a 13,000 m2 building where we plan to install Norway’s first large-scale lithium-ion battery production facility with targeted completion in 1H-2022. In parallel with this we aim in a modular way, to scale out capacity adjusted to increasing demand. Our ambitions inside Mo Industrial Park, based on the benefits of the 24M Technologies platform, is to build up to 35 GWh in the short term, and our joint venture ambitions with conventional technology providers scale to 43 GWh by 2025.

 

[The active participation from local government and industrial stakeholders combined with the support from the National Government through Innovation Norway and ENOVA provide us with very strong comfort that Norway can play a material role in the battery industry moving forward.]

 

To deliver on these ambitions FREYR has focused on building an organization with deep expertise in technology selection and partnerships, significant experience in project and operational execution combined with broad battery expertise from fundamental research to operations of battery cell facilities. FREYR’s organization is growing rapidly with accelerating interest to join the team from several countries covering relevant initial disciplines. FREYR also plans to continue to support educational and R&D programs with Norwegian institutions and promote retraining programs for existing industry professionals in Norway.

 

Today FREYR has announced that we are combining our business with Alussa Energy and plans to list on the NYSE. The capital raised in connection with this business combination and Alussa Energy’s cash in trust will provide FREYR with the liquidity and equity capital to go ahead with our investments and our business plan which targets to build up to 43 GWh of production capacity in Norway by 2025. This ambition could deliver revenues of 2.9 BUSD and an EBITDA of 700 million in 2025. FREYR’s shareholders will roll 100% of their shares into the combined entity and sit on 32% of the shares in the new fully capitalized company.

 

Now, I would like to turn the call over to our CFO, Steffen Føreid.

 

Steffen Føreid – Chief Financial Officer, FREYR

 

 

Thank you, Tom and hello to everyone on the call, it is a pleasure to be here,

 

The proceeds from this transaction will provide FREYR with approximately $850 million in cash on the balance sheet, which will be used to fully fund the company’s equity capital needs in building up to 43 gigawatt hours of production capacity by 2025. Reaching this production capacity would position the company as one of Europe’s largest battery cells suppliers, addressing an estimated global market demand of around five terrawatt hours per year by 2030.

 

We plan to order long lead items for the first two plants this year and grow module based as additional offtake is secured. Normally we would like to see offtake for approximately 50% of the production capacity for at least three years before making an investment decision for a new plant.

 

We expect to generate revenue from 2022, when the customer qualification plant is scheduled to start operations. After ramping up production, revenue is expected to reach several hundred million in 2023 and several billion in 2025. We plan to invest in growth beyond 2025 and expect revenue to increase by approximately 20% per annum in the subsequent three years.

 

6

 

 

 

We expect to go EBITDA break-even during 2023 and deliver EBITDA-margins in the mid-20 percentage range by 2025. In subsequent years, the EBITDA margin is expected to increase, as scale in production is expected to offset ramp-up effects.

 

The company is licensing in a next-generation battery cell technology that is expected to materially reduce costs and provide a highly competitive market position for FREYR, underpinning the long-term sustainability of the profit margins. Combining this with access to low-cost renewable energy, the company’s ambition is to become not only the lowest cost producer, but also the lowest carbon footprint producer of high energy-density battery cells in the world.

 

For additional information, we encourage you to review our investor presentation that was released along with other transaction-related materials filed with the SEC.

 

With that, I’ll turn the word back to Tom for his closing remarks

 

Tom Einar Jensen – Chief Executive Officer and Co-Founder, FREYR

 

 

Thank you, Steffen.

 

In summary, FREYR believes the decarbonization of society is accelerating and existing battery supply has played a key role. Low-carbon batteries will further accelerate the required decarbonization and enable this industry to grow substantially for decades to come. FREYR is proud to be a foundational part of the strong and growing ecosystem of commercial and scientific stakeholders in Norway and we wish everyone in the battery industry all the best of luck in their endeavors. FREYR is open for business, ready to take additional orders and to collaborate deeply with our suppliers, partners and customers to speed up the required energy transition for a substantial near-term contribution to mitigating climate change.

 

We look forward to closing our transaction with Daniel and his team at Alussa Energy and emerging as a leading Nordic producer of clean and sustainable battery cells. Thank you for joining us and have a wonderful day.

 

 

7